data_2rra_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rra _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 120.763 0.316 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.28 144.31 45.91 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.239 1.816 . . . . 0.0 110.526 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.38 145.82 17.73 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.804 1.669 . . . . 0.0 110.603 167.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.45 128.75 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.81 2.044 . . . . 0.0 107.71 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -133.84 145.14 49.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.546 1.138 . . . . 0.0 111.329 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.72 9.13 44.16 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.532 1.063 . . . . 0.0 115.706 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.03 150.36 48.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.445 1.498 . . . . 0.0 114.273 -169.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.4 t -75.48 146.1 40.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.061 0.944 . . . . 0.0 110.935 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.5 -15.0 60.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.403 1.081 . . . . 0.0 113.836 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.77 -0.15 51.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.353 1.461 . . . . 0.0 113.749 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.0 m -71.65 139.41 49.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.914 1.286 . . . . 0.0 109.77 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.8 p -110.89 163.42 13.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.314 1.046 . . . . 0.0 111.451 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -59.77 -28.21 67.21 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.96 0.904 . . . . 0.0 111.137 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.13 -39.0 75.68 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.844 1.258 . . . . 0.0 112.041 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.12 -47.38 74.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.148 0.431 . . . . 0.0 110.285 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.5 mt -57.34 -46.54 83.18 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.846 -0.534 . . . . 0.0 110.882 173.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -63.44 -39.02 93.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.376 0.989 . . . . 0.0 112.707 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.4 -29.89 68.68 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.739 1.609 . . . . 0.0 112.572 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.34 -30.24 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.404 1.082 . . . . 0.0 112.253 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -100.37 -26.25 13.95 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -71.06 -14.01 62.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.344 1.429 . . . . 0.0 113.996 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -67.32 -13.49 62.04 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.016 -1.052 . . . . 0.0 113.547 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -96.98 -9.12 28.89 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.268 1.427 . . . . 0.0 113.686 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.26 -175.78 27.39 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.968 1.271 . . . . 0.0 114.882 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.41 136.01 19.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.504 3.47 . . . . 0.0 112.228 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.6 mt -128.79 122.73 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.658 1.583 . . . . 0.0 109.845 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.61 -31.32 28.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.121 0.969 . . . . 0.0 112.873 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -164.26 162.23 22.39 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.594 1.158 . . . . 0.0 112.276 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -148.0 137.06 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.112 2.165 . . . . 0.0 108.012 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.8 t -144.09 120.03 10.65 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 111.407 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -85.87 146.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.184 0.994 . . . . 0.0 108.648 172.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.6 t . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 108.778 -177.534 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.223 0 CA-C-O 119.073 -0.848 . . . . 0.0 114.181 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -144.59 160.94 40.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.628 1.214 . . . . 0.0 113.586 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.86 172.27 17.94 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.535 1.934 . . . . 0.0 111.053 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.28 149.02 40.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.768 1.227 . . . . 0.0 111.04 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.63 120.8 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.608 1.963 . . . . 0.0 108.182 -170.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -106.68 98.34 8.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.328 1.051 . . . . 0.0 111.003 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -74.66 160.97 30.13 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.479 -0.763 . . . . 0.0 111.742 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.26 6.68 41.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.171 0.988 . . . . 0.0 113.006 171.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -158.56 135.22 9.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.341 1.456 . . . . 0.0 111.748 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -68.38 -29.63 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.072 0.949 . . . . 0.0 112.746 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.63 -26.05 45.16 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.36 0.982 . . . . 0.0 113.178 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -78.71 -29.36 45.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.774 0.83 . . . . 0.0 111.677 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.65 77.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.275 0.63 . . . . 0.0 111.343 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.06 -34.02 74.23 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.99 -1.069 . . . . 0.0 112.55 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.03 -63.12 1.15 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.758 0.823 . . . . 0.0 109.758 172.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.21 70.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -61.11 -34.37 74.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.081 0.952 . . . . 0.0 112.593 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -87.81 -24.25 23.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.533 0.733 . . . . 0.0 112.31 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.43 -46.48 22.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.509 1.124 . . . . 0.0 113.074 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.91 -11.12 27.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -170.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -66.68 111.06 3.48 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 120.658 -1.276 . . . . 0.0 111.248 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.04 7.06 68.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.078 1.799 . . . . 0.0 114.627 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -74.72 168.96 18.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.713 1.757 . . . . 0.0 111.326 170.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -111.12 137.09 49.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.237 1.015 . . . . 0.0 110.974 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.06 116.8 9.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.776 1.63 . . . . 0.0 109.377 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 58.14 25.11 12.07 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.011 1.725 . . . . 0.0 113.901 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.99 2.76 68.67 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.93 1.252 . . . . 0.0 114.965 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -110.19 139.27 45.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.702 1.601 . . . . 0.0 110.516 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 138.76 47.4 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 167.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.1 pt -111.82 149.3 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.721 0.808 . . . . 0.0 110.285 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 34.5 mtm-85 -117.61 153.07 33.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 109.007 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.0 t -143.67 136.05 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.45 1.1 . . . . 0.0 110.879 -168.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -150.38 162.04 41.31 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.288 1.835 . . . . 0.0 111.484 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -69.77 142.5 53.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.849 0.86 . . . . 0.0 112.081 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 CA--C 1.544 0.728 0 O-C-N 121.33 -0.856 . . . . 0.0 112.602 177.867 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 14.8 p . . . . . 0 CA--C 1.537 0.476 0 CA-C-O 121.557 0.694 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.19 146.83 50.6 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.964 1.706 . . . . 0.0 110.889 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.47 147.48 18.55 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.838 1.685 . . . . 0.0 109.731 166.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.054 1.742 . . . . 0.0 107.832 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.69 154.23 51.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.845 0.858 . . . . 0.0 111.773 -168.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.81 34.55 30.66 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.685 0.659 . . . . 0.0 113.285 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.57 164.93 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.357 1.463 . . . . 0.0 113.203 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.6 t -83.09 153.05 25.06 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.239 0.615 . . . . 0.0 111.13 168.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.56 -15.91 62.82 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.495 -0.753 . . . . 0.0 112.386 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -95.45 -4.27 45.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.617 1.567 . . . . 0.0 114.031 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 85.2 m -67.8 133.54 49.4 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.503 1.121 . . . . 0.0 109.263 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 p -106.79 163.65 12.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -61.14 -27.58 68.49 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.093 0.557 . . . . 0.0 111.181 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.56 1.144 . . . . 0.0 112.301 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.81 -47.45 75.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.682 0.674 . . . . 0.0 110.399 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.48 -44.59 85.03 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.673 -0.642 . . . . 0.0 110.679 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -63.63 -39.71 95.05 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.013 0.824 . . . . 0.0 112.772 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.86 -28.33 65.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.36 1.436 . . . . 0.0 112.852 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.66 -33.92 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.929 0.891 . . . . 0.0 111.831 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -99.96 -24.67 14.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.2 p -71.38 -18.39 62.36 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.518 1.508 . . . . 0.0 114.112 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -69.38 -7.12 34.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.017 -1.052 . . . . 0.0 113.83 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.5 -5.1 27.48 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.107 1.363 . . . . 0.0 113.642 171.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.23 -174.92 23.06 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.602 1.573 . . . . 0.0 115.087 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.87 128.69 14.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.231 3.288 . . . . 0.0 112.642 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.0 mt -116.91 126.11 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.909 1.684 . . . . 0.0 109.281 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.54 -40.45 42.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.684 1.194 . . . . 0.0 111.859 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.51 174.41 6.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.777 1.231 . . . . 0.0 113.094 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.84 142.63 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.115 2.166 . . . . 0.0 108.524 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.6 t -137.52 118.48 14.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.467 0.707 . . . . 0.0 111.673 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 94.2 mt -82.69 142.7 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.1 t . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 123.829 0.852 . . . . 0.0 109.76 -174.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.24 0 CA-C-O 118.964 -0.909 . . . . 0.0 114.839 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.05 164.64 31.47 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.585 1.183 . . . . 0.0 113.824 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.83 171.44 20.05 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.785 2.034 . . . . 0.0 110.994 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -142.59 151.25 41.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.814 1.246 . . . . 0.0 110.906 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.3 t -131.47 126.86 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.298 1.839 . . . . 0.0 108.513 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -105.61 112.3 25.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.149 0.98 . . . . 0.0 110.441 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.65 157.96 16.67 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.322 -0.862 . . . . 0.0 111.245 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.34 -9.05 59.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -151.64 146.58 25.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.774 1.63 . . . . 0.0 111.573 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.6 -33.21 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.11 -24.57 58.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -81.42 -29.31 33.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.901 1.281 . . . . 0.0 111.801 174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.47 70.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 110.628 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -58.99 -40.03 83.6 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.16 -0.962 . . . . 0.0 112.23 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.49 -62.34 1.95 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.929 0.892 . . . . 0.0 110.242 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.83 71.68 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -63.06 -33.25 75.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.004 0.922 . . . . 0.0 112.641 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -84.49 -24.07 29.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.638 0.654 . . . . 0.0 112.703 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -82.84 -45.97 13.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.398 1.079 . . . . 0.0 113.318 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -100.25 -11.49 20.32 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.4 112.97 4.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.684 -1.26 . . . . 0.0 110.933 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.25 9.12 70.55 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.242 1.401 . . . . 0.0 114.633 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ptm -75.65 172.93 11.75 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.703 1.751 . . . . 0.0 111.502 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.24 134.66 54.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.075 0.95 . . . . 0.0 111.136 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -141.68 116.87 10.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.587 1.555 . . . . 0.0 109.239 -174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.84 25.23 10.12 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.571 1.548 . . . . 0.0 113.199 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.85 -3.55 83.01 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.395 1.474 . . . . 0.0 114.613 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.48 130.52 44.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.122 1.369 . . . . 0.0 110.15 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.4 122.25 22.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.033 0.833 . . . . 0.0 110.011 170.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -101.65 151.63 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.677 0.791 . . . . 0.0 111.631 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -106.82 149.87 26.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.317 1.847 . . . . 0.0 109.37 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.0 t -144.37 132.48 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.766 1.226 . . . . 0.0 110.224 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -156.47 154.72 30.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 112.651 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -70.01 136.18 50.13 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.362 -0.836 . . . . 0.0 112.328 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 CA--C 1.545 0.757 0 O-C-N 121.417 -0.802 . . . . 0.0 112.975 -178.071 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 C--O 1.239 0.502 0 CA-C-O 121.686 0.755 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.8 mt -127.98 148.98 50.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.346 1.858 . . . . 0.0 111.389 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.67 146.28 17.49 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 126.297 1.903 . . . . 0.0 109.57 166.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.68 123.91 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.502 1.921 . . . . 0.0 107.372 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -130.64 153.33 49.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.883 1.273 . . . . 0.0 112.735 -167.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.9 12.26 60.68 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.265 1.412 . . . . 0.0 114.502 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.33 160.77 26.54 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.31 1.844 . . . . 0.0 114.275 -169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.4 t -75.06 151.45 38.69 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.478 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -68.68 -16.11 63.73 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.549 -0.72 . . . . 0.0 112.629 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -100.58 -2.52 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.622 1.569 . . . . 0.0 114.313 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.7 m -64.9 139.77 58.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.693 1.197 . . . . 0.0 109.495 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 p -108.76 161.65 14.91 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.177 0.991 . . . . 0.0 111.471 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -59.04 -30.94 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.681 0.792 . . . . 0.0 111.136 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -67.31 -40.0 85.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.817 1.247 . . . . 0.0 112.015 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.48 -49.78 67.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.795 0.438 . . . . 0.0 110.273 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.4 -43.56 79.41 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 110.997 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -62.48 -44.74 95.65 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.352 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.31 -29.29 67.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.645 1.111 . . . . 0.0 112.872 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.88 -28.69 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.363 1.065 . . . . 0.0 112.057 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -100.16 -20.52 15.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.0 p -68.73 -16.16 63.73 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.289 1.404 . . . . 0.0 113.979 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.72 -15.34 63.46 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 171.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.54 -12.36 27.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.977 1.311 . . . . 0.0 113.586 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.28 177.84 25.48 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.008 1.289 . . . . 0.0 114.323 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.4 134.18 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 124.569 3.512 . . . . 0.0 112.332 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.7 127.45 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.93 1.692 . . . . 0.0 109.889 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.08 -25.43 17.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.228 1.411 . . . . 0.0 113.574 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -159.91 156.86 27.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.938 0.895 . . . . 0.0 112.548 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.2 t -153.05 135.85 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.131 2.173 . . . . 0.0 108.282 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -149.07 125.01 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.567 0.747 . . . . 0.0 111.79 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.3 mt -86.16 146.75 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.182 0.993 . . . . 0.0 108.846 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.469 0.478 0 C-N-CA 124.301 1.041 . . . . 0.0 109.38 -175.652 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 CA-C-O 119.145 -0.808 . . . . 0.0 113.287 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -154.54 164.57 38.5 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.841 1.305 . . . . 0.0 114.246 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.09 170.43 22.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.622 1.969 . . . . 0.0 111.449 -168.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -135.56 151.76 50.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.388 1.475 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.48 130.42 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.833 2.053 . . . . 0.0 109.046 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -119.52 113.85 21.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.031 1.333 . . . . 0.0 112.254 -170.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.23 154.79 17.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.985 0.914 . . . . 0.0 111.929 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -81.73 4.64 21.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.215 1.006 . . . . 0.0 112.841 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -155.98 129.22 8.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.081 1.752 . . . . 0.0 110.777 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.87 -27.14 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.83 -24.33 48.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.101 0.864 . . . . 0.0 113.08 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -78.85 -27.41 44.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.611 0.764 . . . . 0.0 111.734 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.24 73.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.976 0.51 . . . . 0.0 110.507 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.74 -34.66 76.22 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.013 -1.054 . . . . 0.0 112.688 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.18 -63.56 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.022 0.929 . . . . 0.0 110.045 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.83 -36.52 67.59 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.83 -38.12 77.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.059 0.943 . . . . 0.0 112.673 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.06 -21.12 27.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.547 0.739 . . . . 0.0 112.444 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -81.44 -46.51 14.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.602 1.161 . . . . 0.0 112.849 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.93 -14.59 25.82 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -64.69 111.03 2.57 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.658 -1.276 . . . . 0.0 110.76 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.82 5.82 64.16 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.47 1.509 . . . . 0.0 114.774 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.9 ptm -76.97 173.31 11.92 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.931 1.866 . . . . 0.0 111.36 169.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -118.45 137.91 52.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.28 1.032 . . . . 0.0 111.361 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.9 tp -145.8 120.46 9.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.454 1.502 . . . . 0.0 109.976 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.3 t70 57.63 23.36 9.27 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.678 1.591 . . . . 0.0 113.466 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.28 83.09 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.499 1.523 . . . . 0.0 114.625 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.72 130.24 45.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.276 1.43 . . . . 0.0 110.668 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.29 138.91 54.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 168.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 pt -115.92 143.95 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.351 0.661 . . . . 0.0 111.266 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -106.95 144.43 33.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.799 1.639 . . . . 0.0 108.297 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 t -140.3 135.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.98 0.912 . . . . 0.0 110.628 -170.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.32 162.59 39.13 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.543 1.537 . . . . 0.0 111.654 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.47 139.23 40.75 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 112.111 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.8 m . . . . . 0 CA--C 1.542 0.647 0 O-C-N 121.206 -0.934 . . . . 0.0 112.911 -177.566 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.7 mt -102.73 145.65 29.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.12 1.368 . . . . 0.0 110.452 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.02 144.95 16.13 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.879 1.704 . . . . 0.0 110.651 168.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.06 124.83 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.864 2.066 . . . . 0.0 107.634 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.03 154.71 47.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.832 1.253 . . . . 0.0 113.141 -166.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.39 18.01 61.3 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.798 1.189 . . . . 0.0 114.263 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.93 163.13 22.75 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.539 1.936 . . . . 0.0 114.237 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -80.28 149.05 30.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.828 168.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.55 -16.36 64.15 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.435 -0.791 . . . . 0.0 112.675 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -96.22 -4.39 42.54 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.449 1.5 . . . . 0.0 114.302 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -68.52 133.43 48.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.529 1.132 . . . . 0.0 109.377 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.8 p -106.3 164.16 12.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.182 0.993 . . . . 0.0 111.598 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -60.51 -29.47 69.12 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.176 0.59 . . . . 0.0 111.123 172.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -69.1 -40.16 78.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.711 1.205 . . . . 0.0 112.232 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.05 -49.47 67.53 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.187 0.449 . . . . 0.0 110.266 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.52 -42.47 78.5 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.907 -0.496 . . . . 0.0 110.978 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.61 -44.82 95.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.26 175.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.26 -32.38 72.52 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.929 1.241 . . . . 0.0 112.4 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.26 -29.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 112.273 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.16 -21.02 15.69 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 74.2 m -66.74 -17.24 64.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 120.105 1.321 . . . . 0.0 113.644 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -67.76 -14.52 63.02 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.999 -1.063 . . . . 0.0 113.829 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -97.5 -13.62 21.59 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.91 1.284 . . . . 0.0 113.857 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.81 -174.12 31.66 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.55 1.071 . . . . 0.0 114.761 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.04 136.27 16.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.437 3.425 . . . . 0.0 111.988 -171.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.5 mt -129.35 125.43 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.683 1.593 . . . . 0.0 109.742 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.16 -33.62 26.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.758 1.223 . . . . 0.0 112.669 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -166.39 170.2 13.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.254 1.021 . . . . 0.0 112.805 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.8 138.18 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.939 2.095 . . . . 0.0 108.5 175.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.0 m -138.33 109.06 6.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.256 1.022 . . . . 0.0 111.306 -171.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.89 149.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 171.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.469 0.519 0 C-N-CA 124.433 1.093 . . . . 0.0 109.61 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 CA-C-O 119.5 -0.611 . . . . 0.0 113.975 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.51 164.49 38.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.822 1.296 . . . . 0.0 113.98 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.57 172.67 17.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.21 1.804 . . . . 0.0 111.273 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.63 154.87 48.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.0 1.32 . . . . 0.0 111.233 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.8 t -134.34 121.13 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.521 1.928 . . . . 0.0 108.116 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -102.51 98.81 8.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.252 1.021 . . . . 0.0 110.552 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -76.57 161.68 28.39 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.189 -0.945 . . . . 0.0 112.174 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.18 7.94 45.12 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.547 1.139 . . . . 0.0 113.026 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -155.42 132.84 11.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.57 1.548 . . . . 0.0 111.13 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.63 -27.07 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 112.783 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.458 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 9.6 t70 -80.16 -29.74 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.189 0.904 . . . . 0.0 113.049 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.28 -30.32 60.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.26 0.624 . . . . 0.0 111.495 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.5 -43.29 77.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.352 0.661 . . . . 0.0 111.679 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 21.1 mtmt -58.03 -36.93 73.42 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.082 -1.011 . . . . 0.0 112.674 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.71 -57.31 4.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.196 0.599 . . . . 0.0 110.878 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.65 67.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.977 -1.077 . . . . 0.0 112.93 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -55.9 -47.23 77.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.819 1.248 . . . . 0.0 112.293 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -27.96 37.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.359 0.663 . . . . 0.0 111.675 -174.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -71.36 -52.41 18.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.937 1.695 . . . . 0.0 113.374 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.74 -14.12 37.96 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -64.22 111.0 2.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.766 -1.209 . . . . 0.0 111.144 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.78 8.13 65.69 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.628 1.585 . . . . 0.0 114.646 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -75.76 173.11 11.54 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.793 1.796 . . . . 0.0 111.457 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.07 136.64 53.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.214 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.4 tp -145.47 118.99 9.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.5 1.52 . . . . 0.0 109.531 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 58.13 22.74 9.39 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.422 1.489 . . . . 0.0 113.428 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.81 -5.77 83.27 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.633 1.587 . . . . 0.0 114.605 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.56 130.36 41.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.336 1.454 . . . . 0.0 110.707 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.52 131.44 43.29 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.3 pt -110.94 152.64 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.946 0.898 . . . . 0.0 110.225 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -122.75 153.13 39.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.485 1.114 . . . . 0.0 109.489 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -142.79 137.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.575 -167.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -150.18 169.84 20.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.643 1.977 . . . . 0.0 111.54 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -78.31 142.29 37.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.347 1.059 . . . . 0.0 112.003 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 178.725 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 83.8 m . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.996 0.427 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.82 145.83 29.53 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.056 1.342 . . . . 0.0 111.225 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.68 144.91 17.57 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.864 1.697 . . . . 0.0 109.563 167.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 t -132.67 121.29 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.364 1.866 . . . . 0.0 107.469 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.54 153.36 46.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.091 1.356 . . . . 0.0 112.013 -167.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.62 28.51 26.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.041 0.829 . . . . 0.0 113.607 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.94 161.65 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.381 1.472 . . . . 0.0 113.595 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.1 t -77.01 153.1 34.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.268 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.55 -16.8 63.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.442 -0.786 . . . . 0.0 112.261 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -96.2 -4.16 43.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.626 1.57 . . . . 0.0 114.528 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.9 m -65.05 138.15 58.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.643 1.177 . . . . 0.0 109.57 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -110.72 162.98 14.22 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.168 0.987 . . . . 0.0 111.464 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -57.67 -31.71 66.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.097 0.959 . . . . 0.0 111.172 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -67.32 -40.35 85.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.91 1.284 . . . . 0.0 112.066 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.49 -48.87 68.46 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.877 0.471 . . . . 0.0 110.284 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.75 -44.75 82.05 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.837 -0.539 . . . . 0.0 110.812 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.67 -44.13 97.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.213 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.05 -29.94 68.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.757 1.162 . . . . 0.0 112.922 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.95 -28.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.366 1.066 . . . . 0.0 111.894 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -100.43 -21.53 15.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.3 p -68.48 -17.7 64.24 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.383 1.447 . . . . 0.0 114.004 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -66.72 -13.49 61.39 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -97.27 -9.1 28.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.122 1.369 . . . . 0.0 113.756 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.2 -175.99 25.37 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.936 1.255 . . . . 0.0 114.837 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.34 134.83 17.72 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.428 3.419 . . . . 0.0 112.241 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 93.8 mt -124.39 125.93 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.695 1.598 . . . . 0.0 109.76 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.68 -34.75 24.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.921 1.288 . . . . 0.0 112.828 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -164.49 166.47 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.302 1.041 . . . . 0.0 112.569 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.7 t -147.55 135.75 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.901 2.08 . . . . 0.0 108.936 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.6 m -138.44 110.26 7.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.648 1.179 . . . . 0.0 111.506 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.61 144.76 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 -174.01 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.872 0 CA-C-O 119.189 -0.784 . . . . 0.0 113.239 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -154.87 165.45 36.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.993 1.377 . . . . 0.0 113.971 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.33 173.03 17.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.786 2.034 . . . . 0.0 110.943 -169.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.64 151.83 49.74 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.245 1.418 . . . . 0.0 110.873 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.26 118.95 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.551 1.941 . . . . 0.0 108.177 -170.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -104.24 100.61 10.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.523 1.129 . . . . 0.0 110.906 -170.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -78.45 158.02 28.78 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.446 -0.783 . . . . 0.0 111.733 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -86.1 6.29 29.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.091 0.956 . . . . 0.0 113.136 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -159.16 139.69 12.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.516 1.527 . . . . 0.0 111.719 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.47 -31.59 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.984 0.914 . . . . 0.0 112.896 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.428 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 23.1 t70 -78.21 -28.82 48.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.321 0.964 . . . . 0.0 112.921 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -73.43 -28.2 61.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.515 0.726 . . . . 0.0 111.64 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.0 65.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.459 0.703 . . . . 0.0 111.371 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 55.7 mtmt -59.58 -36.29 75.95 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 120.797 -1.19 . . . . 0.0 112.492 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -62.87 -64.4 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.122 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.51 68.56 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -60.2 -32.79 71.43 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.292 1.037 . . . . 0.0 112.986 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -91.1 -22.06 20.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.539 0.736 . . . . 0.0 112.441 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -80.23 -47.32 14.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.557 1.143 . . . . 0.0 113.098 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.23 -11.43 30.29 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -171.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -66.03 112.83 4.05 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.704 -1.247 . . . . 0.0 110.925 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.22 3.42 63.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.592 1.568 . . . . 0.0 114.794 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -76.97 170.23 16.89 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.855 1.827 . . . . 0.0 112.439 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.6 137.05 44.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.719 1.208 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 24.6 tp -148.0 116.91 6.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.701 1.6 . . . . 0.0 109.602 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 54.85 33.91 20.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.339 1.456 . . . . 0.0 112.45 -170.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.88 -17.95 8.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.157 1.361 . . . . 0.0 114.313 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.0 mmt-85 -76.66 135.99 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.445 1.123 . . . . 0.0 109.748 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.38 129.48 34.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -111.12 157.78 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 111.302 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.8 152.6 45.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.883 1.673 . . . . 0.0 109.327 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -142.53 137.96 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.148 0.979 . . . . 0.0 110.838 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -156.2 162.2 40.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.413 1.485 . . . . 0.0 111.882 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.17 143.99 36.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.996 0.918 . . . . 0.0 111.685 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.477 0.882 0 O-C-N 120.894 -1.129 . . . . 0.0 112.703 179.281 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.542 0.652 0 CA-C-O 120.947 0.403 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.6 mt -118.3 145.77 44.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.327 1.851 . . . . 0.0 110.412 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.98 148.65 18.88 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.775 1.655 . . . . 0.0 110.542 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.64 130.86 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.342 1.857 . . . . 0.0 108.221 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.74 152.12 48.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.031 0.932 . . . . 0.0 111.41 -168.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.69 32.63 18.13 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 123.765 0.697 . . . . 0.0 113.668 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.5 159.52 21.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.994 1.318 . . . . 0.0 113.252 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.3 t -76.02 156.37 34.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.681 169.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.52 -19.26 63.72 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.505 -0.747 . . . . 0.0 112.127 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -94.05 -4.6 49.17 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.573 1.549 . . . . 0.0 114.282 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -66.97 132.93 48.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.465 1.106 . . . . 0.0 109.256 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.9 p -106.54 162.79 13.42 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.279 1.032 . . . . 0.0 111.153 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -60.7 -27.97 68.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.958 0.503 . . . . 0.0 111.22 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -70.94 -37.67 72.86 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.583 1.153 . . . . 0.0 112.514 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.83 -47.63 71.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.662 0.665 . . . . 0.0 110.438 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.1 -44.38 83.17 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.819 -0.55 . . . . 0.0 110.647 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -61.89 -41.68 98.18 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.419 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.17 -32.84 72.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.313 1.415 . . . . 0.0 112.689 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -77.42 -29.2 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.556 1.143 . . . . 0.0 111.933 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -99.99 -24.58 14.58 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.141 0.882 . . . . 0.0 113.364 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.9 m -69.33 -19.79 63.87 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.235 1.379 . . . . 0.0 113.693 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -70.19 -7.23 40.18 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.964 -1.085 . . . . 0.0 113.909 173.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -102.32 -5.57 24.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.456 1.502 . . . . 0.0 113.753 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.41 -175.65 24.86 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.385 1.469 . . . . 0.0 114.969 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.57 135.75 20.39 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.324 3.349 . . . . 0.0 112.476 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.51 127.71 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.767 1.627 . . . . 0.0 110.121 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.29 -32.03 19.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.933 1.293 . . . . 0.0 112.837 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -163.59 166.16 22.72 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.9 t -146.55 136.14 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 127.062 2.145 . . . . 0.0 108.161 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.8 m -133.0 110.24 10.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.037 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.0 mt -80.03 143.29 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 CA-C-O 119.293 -0.726 . . . . 0.0 113.766 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.05 160.92 41.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.554 1.169 . . . . 0.0 113.148 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.93 15.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.381 1.873 . . . . 0.0 111.517 -168.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.44 152.1 42.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.404 1.482 . . . . 0.0 110.627 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.42 128.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.125 1.77 . . . . 0.0 109.071 -169.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.65 100.41 9.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.865 1.266 . . . . 0.0 111.826 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -76.78 159.06 30.43 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.576 -0.703 . . . . 0.0 111.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.27 3.72 45.58 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.954 0.902 . . . . 0.0 113.134 172.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -160.83 139.97 10.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.555 1.542 . . . . 0.0 111.67 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.79 -31.6 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.52 0.728 . . . . 0.0 112.567 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.62 -23.22 56.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.279 0.945 . . . . 0.0 113.12 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -82.52 -30.32 29.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.858 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.71 76.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.336 0.654 . . . . 0.0 111.458 169.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -61.54 -32.66 72.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.641 1.176 . . . . 0.0 112.489 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.94 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.889 0.876 . . . . 0.0 109.663 171.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.04 69.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.24 -34.27 74.86 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.932 0.893 . . . . 0.0 112.651 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -87.95 -23.62 23.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.557 0.743 . . . . 0.0 112.272 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -77.81 -45.8 23.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.51 1.124 . . . . 0.0 113.037 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.1 -12.34 21.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -65.66 112.83 3.85 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.615 -1.303 . . . . 0.0 110.861 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.17 8.58 71.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.495 1.522 . . . . 0.0 114.595 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.9 ptm -76.35 173.85 10.93 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.811 1.805 . . . . 0.0 111.523 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.61 135.16 54.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.296 1.039 . . . . 0.0 111.27 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -143.12 117.36 9.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.769 1.628 . . . . 0.0 109.224 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 29.0 t70 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.168 1.387 . . . . 0.0 112.45 -169.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.64 -5.18 65.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.648 1.118 . . . . 0.0 114.66 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.6 mmt-85 -92.05 129.62 37.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.891 1.346 . . . . 0.0 109.931 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.91 128.33 35.24 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.135 170.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -107.35 155.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 111.671 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -115.21 148.52 39.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.395 1.878 . . . . 0.0 108.64 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.8 t -144.73 136.44 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.46 1.104 . . . . 0.0 110.499 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.17 158.47 36.33 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.954 1.302 . . . . 0.0 112.438 -170.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -72.8 138.08 46.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.661 0.784 . . . . 0.0 111.822 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 CA--C 1.544 0.731 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.217 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 CA--C 1.541 0.629 0 CA-C-O 120.922 0.391 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -112.06 142.47 44.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.89 1.676 . . . . 0.0 110.151 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.61 145.05 17.57 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.497 1.522 . . . . 0.0 110.255 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.93 119.61 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.049 1.74 . . . . 0.0 107.814 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -126.47 158.85 35.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.406 1.482 . . . . 0.0 111.998 -167.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.56 25.03 55.11 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.127 0.87 . . . . 0.0 113.6 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.24 154.41 37.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.884 1.273 . . . . 0.0 113.342 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.8 t -72.67 143.24 48.18 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.778 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.02 -12.5 51.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -100.92 3.93 42.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.998 1.719 . . . . 0.0 114.032 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -63.46 143.04 58.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 109.806 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.5 p -110.96 159.71 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.681 0.792 . . . . 0.0 111.618 170.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.52 -30.79 67.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.889 0.876 . . . . 0.0 111.041 172.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -69.08 -38.33 78.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.748 1.219 . . . . 0.0 112.359 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -65.11 -48.05 75.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.486 0.585 . . . . 0.0 110.169 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.3 mt -59.01 -42.23 89.61 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.77 -0.581 . . . . 0.0 111.193 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.25 -45.91 92.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.107 0.867 . . . . 0.0 111.382 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -67.68 -31.32 71.21 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.406 1.457 . . . . 0.0 112.744 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.7 -29.22 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.521 1.128 . . . . 0.0 112.547 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -100.57 -27.8 13.22 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.1 p -73.31 -12.58 60.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 120.456 1.48 . . . . 0.0 114.311 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -67.64 -10.32 51.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.952 -1.092 . . . . 0.0 113.434 168.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -102.79 -7.89 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.479 1.511 . . . . 0.0 114.084 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.05 -175.95 31.35 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.597 1.094 . . . . 0.0 115.377 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.31 137.66 19.12 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.313 3.342 . . . . 0.0 112.036 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 73.4 mt -134.24 124.58 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.679 1.592 . . . . 0.0 109.902 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.2 -24.77 18.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.304 1.042 . . . . 0.0 113.557 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.38 159.73 28.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.725 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.9 t -150.83 136.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.354 2.261 . . . . 0.0 108.273 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -146.25 122.76 11.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.528 0.731 . . . . 0.0 112.024 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.62 143.96 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.363 1.065 . . . . 0.0 108.596 172.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 124.26 1.024 . . . . 0.0 110.205 -170.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 CA-C-O 119.274 -0.737 . . . . 0.0 113.755 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -154.53 166.7 32.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.937 1.351 . . . . 0.0 114.204 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.41 171.51 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 111.056 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.47 150.7 48.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.146 1.378 . . . . 0.0 111.065 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.0 t -135.63 120.25 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.482 1.913 . . . . 0.0 108.303 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -107.17 100.69 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.57 1.148 . . . . 0.0 111.053 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.69 161.94 29.18 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.787 0.835 . . . . 0.0 111.983 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -94.13 7.61 44.6 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.289 1.036 . . . . 0.0 112.851 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.13 130.49 7.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.515 1.526 . . . . 0.0 111.571 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.26 -28.96 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.897 0.879 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.87 -24.5 48.51 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.407 1.003 . . . . 0.0 113.27 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -81.61 -29.46 33.28 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.802 0.841 . . . . 0.0 111.76 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.92 83.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.191 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -59.85 -34.38 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.283 1.033 . . . . 0.0 112.631 172.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.53 -62.85 1.22 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.773 0.829 . . . . 0.0 109.845 173.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.87 -35.2 70.64 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.27 -33.66 71.31 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.306 1.042 . . . . 0.0 112.852 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -89.05 -24.11 22.4 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.682 0.793 . . . . 0.0 112.307 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -78.79 -45.06 21.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.425 1.09 . . . . 0.0 113.152 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.1 -11.82 27.57 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.56 113.07 3.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.594 -1.316 . . . . 0.0 110.904 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.54 7.29 72.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.26 1.409 . . . . 0.0 114.733 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptm -76.22 173.16 11.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.693 1.746 . . . . 0.0 111.278 170.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -115.55 135.47 54.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.162 0.985 . . . . 0.0 111.028 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.9 tp -141.46 121.25 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 109.797 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.65 25.87 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.761 1.625 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.86 19.41 57.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.562 1.077 . . . . 0.0 114.445 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -131.7 132.12 43.66 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.544 1.538 . . . . 0.0 110.19 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.91 133.02 46.09 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.724 -0.61 . . . . 0.0 110.518 174.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.9 pt -111.0 159.0 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.887 0.875 . . . . 0.0 111.797 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -126.31 145.28 50.49 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.855 2.062 . . . . 0.0 108.857 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.36 134.46 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 118.968 0.803 . . . . 0.0 111.396 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -152.76 162.97 40.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 111.236 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -70.22 142.76 52.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.696 0.799 . . . . 0.0 111.655 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 CA--C 1.545 0.777 0 O-C-N 121.276 -0.89 . . . . 0.0 112.634 177.6 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.7 m . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.867 0.365 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.3 mt -115.44 146.76 41.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.281 1.433 . . . . 0.0 110.702 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.79 149.45 17.26 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.147 1.832 . . . . 0.0 110.614 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.6 t -136.67 129.23 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.028 2.131 . . . . 0.0 107.853 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -133.83 154.72 50.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.38 1.072 . . . . 0.0 112.684 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.45 30.21 50.26 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.056 0.836 . . . . 0.0 114.074 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.46 160.93 23.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.48 1.512 . . . . 0.0 113.521 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.1 t -72.34 155.09 40.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.013 0.925 . . . . 0.0 111.861 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.59 -17.61 62.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.457 0.703 . . . . 0.0 112.628 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -96.17 -5.55 40.31 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.083 1.353 . . . . 0.0 114.402 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.7 m -69.29 136.29 51.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.6 p -106.88 164.83 11.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.639 1.175 . . . . 0.0 111.484 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -59.26 -30.22 68.13 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.629 0.772 . . . . 0.0 111.147 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -70.61 -38.64 73.99 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.597 1.159 . . . . 0.0 112.166 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -66.36 -48.41 70.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.267 0.485 . . . . 0.0 110.341 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.0 mt -56.69 -44.79 81.83 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.815 -0.553 . . . . 0.0 110.941 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -60.97 -45.67 93.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.131 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -67.14 -29.05 68.66 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.227 1.376 . . . . 0.0 112.878 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.33 -27.68 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.44 1.096 . . . . 0.0 112.046 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -100.48 -23.73 14.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.4 p -70.39 -17.73 63.03 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.242 1.383 . . . . 0.0 113.911 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.57 -11.24 52.22 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 170.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.72 -7.14 24.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.376 1.47 . . . . 0.0 113.717 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.21 -178.47 24.82 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.221 1.391 . . . . 0.0 115.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.99 135.6 21.38 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.561 3.507 . . . . 0.0 112.668 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.47 124.26 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.062 1.745 . . . . 0.0 109.654 -174.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.12 -23.26 20.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.349 1.06 . . . . 0.0 113.493 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -161.48 162.44 30.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.0 t -151.28 135.49 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.236 2.214 . . . . 0.0 107.956 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.4 m -137.97 116.73 12.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.752 1.221 . . . . 0.0 111.393 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.84 147.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 N--CA 1.466 0.367 0 C-N-CA 124.111 0.964 . . . . 0.0 108.827 179.135 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.09 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.241 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -144.96 161.35 39.57 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.747 1.273 . . . . 0.0 113.424 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.1 13.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.051 1.74 . . . . 0.0 111.815 -168.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -145.69 156.27 43.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.999 1.72 . . . . 0.0 110.853 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.95 134.33 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.369 1.867 . . . . 0.0 109.171 -169.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.16 99.18 6.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.238 1.415 . . . . 0.0 111.078 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -79.58 158.91 27.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.02 0.928 . . . . 0.0 112.202 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.81 3.52 50.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.741 1.217 . . . . 0.0 113.063 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -157.99 137.35 11.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.563 1.545 . . . . 0.0 111.246 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.22 -32.83 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.318 0.647 . . . . 0.0 112.673 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.4 -24.42 54.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.901 0.773 . . . . 0.0 113.014 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.97 -29.15 35.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.307 1.043 . . . . 0.0 111.914 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.6 73.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.211 0.604 . . . . 0.0 110.97 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -59.78 -35.24 74.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.409 1.084 . . . . 0.0 112.502 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.22 -64.39 0.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.032 0.933 . . . . 0.0 110.015 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.11 -35.56 69.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.61 -34.5 72.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.172 0.989 . . . . 0.0 112.83 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -88.48 -24.71 22.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.611 0.764 . . . . 0.0 112.197 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -78.22 -45.57 22.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.429 1.092 . . . . 0.0 113.164 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.67 -11.43 29.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -66.02 112.98 4.12 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.611 -1.305 . . . . 0.0 111.106 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.68 8.68 73.08 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.35 1.452 . . . . 0.0 114.609 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 ptm -75.91 173.65 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.739 1.77 . . . . 0.0 111.435 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.38 134.54 54.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.204 1.002 . . . . 0.0 111.057 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.6 tp -143.7 118.87 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.51 1.524 . . . . 0.0 109.389 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 54.77 31.78 16.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.404 1.481 . . . . 0.0 112.44 -169.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.42 -4.87 66.01 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.694 1.14 . . . . 0.0 114.504 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.7 mmt-85 -92.98 130.06 38.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.933 1.367 . . . . 0.0 109.897 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.48 130.17 40.03 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.094 0.861 . . . . 0.0 109.817 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -109.08 160.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.027 0.931 . . . . 0.0 111.08 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.6 mtm-85 -127.81 156.31 42.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.481 1.112 . . . . 0.0 109.775 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.9 t -143.96 140.26 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.781 1.232 . . . . 0.0 110.962 -168.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.8 161.46 40.64 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.374 1.47 . . . . 0.0 112.151 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -72.66 137.79 46.27 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.03 0.932 . . . . 0.0 111.561 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.544 0.72 0 O-C-N 121.25 -0.906 . . . . 0.0 112.56 -174.202 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.9 m . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.3 mt -102.17 146.94 27.25 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.627 1.171 . . . . 0.0 111.295 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.02 148.86 16.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.322 1.915 . . . . 0.0 110.47 168.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.54 124.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.192 1.797 . . . . 0.0 108.011 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -132.12 155.19 48.58 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.892 1.277 . . . . 0.0 111.91 -167.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.14 29.96 43.93 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.886 0.755 . . . . 0.0 113.398 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.79 163.84 25.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 113.168 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.8 t -76.06 154.51 35.59 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.005 168.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.0 -18.57 64.76 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.225 -0.922 . . . . 0.0 112.244 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -96.93 -1.43 45.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.846 1.658 . . . . 0.0 114.589 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 93.4 m -63.1 137.7 58.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.383 1.073 . . . . 0.0 109.611 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 p -110.34 161.64 15.43 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.861 0.864 . . . . 0.0 111.556 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.65 -27.22 68.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.336 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -69.61 -39.84 76.99 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.633 1.173 . . . . 0.0 112.251 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -65.88 -47.96 73.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.227 0.467 . . . . 0.0 110.315 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.0 mt -56.8 -44.36 81.87 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.764 -0.585 . . . . 0.0 110.921 174.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -63.17 -41.1 99.18 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.49 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.45 -31.12 69.24 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.174 1.352 . . . . 0.0 112.62 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.79 -28.91 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.374 1.07 . . . . 0.0 112.393 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -100.58 -27.47 13.39 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.1 p -71.83 -15.42 62.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.307 1.412 . . . . 0.0 114.109 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.9 -11.13 55.12 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.95 -1.094 . . . . 0.0 113.751 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -102.85 -5.18 23.86 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.302 1.441 . . . . 0.0 114.061 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.2 28.4 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.785 1.183 . . . . 0.0 115.307 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.5 135.42 18.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.313 3.342 . . . . 0.0 112.227 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.51 127.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.658 1.583 . . . . 0.0 110.187 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.91 -28.19 19.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.121 1.369 . . . . 0.0 113.325 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -162.61 167.08 23.8 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -149.38 137.16 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.448 2.299 . . . . 0.0 108.338 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.1 m -135.4 113.54 11.3 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.467 1.107 . . . . 0.0 111.635 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.34 144.97 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.294 -0.879 . . . . 0.0 108.835 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.338 1.055 . . . . 0.0 109.935 -173.922 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.006 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.53 165.15 36.02 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.948 1.356 . . . . 0.0 114.448 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.18 172.2 18.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.416 1.886 . . . . 0.0 111.509 -169.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.87 156.33 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.603 1.561 . . . . 0.0 110.908 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.84 131.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.801 2.04 . . . . 0.0 108.726 -168.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -114.79 97.5 6.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.688 1.195 . . . . 0.0 111.517 -170.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -76.57 156.89 32.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.105 0.562 . . . . 0.0 111.592 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -86.78 3.82 43.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.775 0.83 . . . . 0.0 113.189 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -160.64 143.38 13.02 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.537 1.535 . . . . 0.0 111.781 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.13 -31.72 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -74.48 -28.58 61.08 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.583 1.083 . . . . 0.0 112.859 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -75.42 -30.71 60.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.921 0.888 . . . . 0.0 111.673 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.97 -43.62 67.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.695 0.798 . . . . 0.0 111.444 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -59.33 -35.16 73.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.248 1.019 . . . . 0.0 112.419 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.17 -64.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.161 0.984 . . . . 0.0 110.163 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.3 69.54 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.41 -33.82 71.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.503 1.121 . . . . 0.0 112.845 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -89.34 -21.63 23.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.674 0.789 . . . . 0.0 112.391 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -81.17 -44.73 17.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.546 1.138 . . . . 0.0 113.071 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.7 -12.07 26.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -172.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -64.68 114.79 4.66 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.682 -1.261 . . . . 0.0 111.024 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.04 4.85 77.8 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.472 1.51 . . . . 0.0 114.695 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.4 ptm -73.25 169.18 17.63 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.839 1.82 . . . . 0.0 111.373 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -106.24 134.96 48.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.706 0.803 . . . . 0.0 110.975 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 46.7 tp -144.86 123.22 12.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.81 1.644 . . . . 0.0 109.327 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 55.25 33.57 20.93 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.099 1.36 . . . . 0.0 112.649 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.21 4.61 89.84 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.781 1.181 . . . . 0.0 114.601 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.8 mmt-85 -113.28 131.67 55.84 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.243 1.417 . . . . 0.0 110.431 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.43 131.08 44.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.91 0.777 . . . . 0.0 109.196 168.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.4 pt -110.68 160.19 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.733 0.813 . . . . 0.0 112.064 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -119.82 148.14 43.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.13 1.772 . . . . 0.0 108.919 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -141.95 135.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.316 1.047 . . . . 0.0 110.395 -172.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -156.57 165.52 36.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.222 1.409 . . . . 0.0 111.884 -170.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -80.87 141.95 34.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.371 1.068 . . . . 0.0 111.634 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.475 0.797 0 O-C-N 121.004 -1.06 . . . . 0.0 112.68 -177.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.492 ' HG ' ' CB ' ' A' ' 194' ' ' SER . 27.3 p . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 121.912 0.863 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.0 mt -126.48 151.58 47.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.893 2.077 . . . . 0.0 110.539 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.84 149.71 18.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.131 1.824 . . . . 0.0 110.496 167.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.8 129.49 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.396 1.878 . . . . 0.0 107.889 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -136.73 150.6 48.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 111.641 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.19 32.6 19.84 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.923 0.773 . . . . 0.0 113.26 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.9 mt -77.34 162.83 26.98 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.36 1.464 . . . . 0.0 113.642 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -78.91 152.52 31.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.792 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -16.75 63.31 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.427 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.57 -5.06 52.44 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.465 1.506 . . . . 0.0 114.288 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -67.71 135.42 52.71 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.476 1.111 . . . . 0.0 109.615 172.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.5 p -118.02 163.85 15.98 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.747 1.219 . . . . 0.0 110.761 172.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.77 -24.54 65.85 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.444 0.697 . . . . 0.0 111.725 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -58.02 -45.78 86.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.965 1.706 . . . . 0.0 111.774 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.92 -48.32 46.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.914 0.885 . . . . 0.0 110.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.57 -38.62 81.63 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.323 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -62.05 -45.97 91.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.239 0.927 . . . . 0.0 112.054 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.92 -31.01 69.6 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.097 1.317 . . . . 0.0 112.771 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.4 t -80.12 -30.58 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.603 1.161 . . . . 0.0 112.484 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -100.6 -25.59 14.11 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.7 p -71.29 -14.21 62.14 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.388 1.449 . . . . 0.0 113.91 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -67.2 -14.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.948 -1.095 . . . . 0.0 113.586 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.71 -8.54 34.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.009 1.324 . . . . 0.0 113.718 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -177.82 25.93 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.102 1.334 . . . . 0.0 114.65 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.98 135.48 25.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.327 3.351 . . . . 0.0 112.272 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.54 132.76 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.891 1.676 . . . . 0.0 110.504 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.81 -28.8 15.07 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.105 1.362 . . . . 0.0 113.111 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -164.3 164.45 22.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.008 0.923 . . . . 0.0 113.007 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.9 t -147.9 132.01 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.074 2.15 . . . . 0.0 107.732 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 56.6 m -132.63 104.83 6.85 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.5 mt -81.21 138.82 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 168.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -175.743 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.047 0 CA-C-O 119.464 -0.631 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -150.99 162.86 40.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.793 1.282 . . . . 0.0 113.484 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.82 172.72 17.73 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.237 1.815 . . . . 0.0 111.686 -169.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.78 155.1 46.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.823 1.649 . . . . 0.0 110.396 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.9 132.61 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.758 1.623 . . . . 0.0 109.298 -168.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.92 107.62 14.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.779 1.232 . . . . 0.0 111.996 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -85.52 157.55 20.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.411 1.085 . . . . 0.0 111.39 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -83.84 7.73 17.07 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.955 0.902 . . . . 0.0 113.18 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -160.89 143.44 12.67 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.774 1.629 . . . . 0.0 111.281 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.88 -33.8 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.525 0.73 . . . . 0.0 112.492 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.44 -25.53 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -78.91 -28.29 43.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.115 0.966 . . . . 0.0 111.968 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.6 64.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.547 0.739 . . . . 0.0 111.017 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -59.31 -36.97 76.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 0.0 112.285 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.05 -65.19 0.73 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.524 0.729 . . . . 0.0 109.944 170.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.0 65.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -61.57 -25.04 67.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.624 1.17 . . . . 0.0 113.329 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.28 4.59 36.72 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.612 1.565 . . . . 0.0 113.007 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -107.91 -52.23 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.21 1.404 . . . . 0.0 113.02 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.01 46.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -65.83 112.4 3.73 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.851 -1.156 . . . . 0.0 111.171 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.27 7.73 69.44 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.087 1.803 . . . . 0.0 114.746 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.3 ptm -75.58 162.22 28.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.75 1.775 . . . . 0.0 112.816 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.36 133.02 34.15 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.215 . . . . 0.0 110.733 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.3 tp -145.53 111.4 5.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 109.085 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.4 t70 54.36 36.23 24.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.235 1.414 . . . . 0.0 112.064 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.83 -22.01 6.14 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.287 1.422 . . . . 0.0 114.224 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -73.18 141.34 47.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.29 1.045 . . . . 0.0 110.322 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -85.3 126.05 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.2 pt -106.07 139.32 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.238 0.615 . . . . 0.0 111.294 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.11 146.78 23.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.655 1.182 . . . . 0.0 109.006 170.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -141.67 134.71 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.77 1.228 . . . . 0.0 110.097 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -156.67 159.96 38.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.909 1.284 . . . . 0.0 112.224 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -69.04 142.27 54.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.772 0.829 . . . . 0.0 112.041 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' SER . . . . . 0.492 ' CB ' ' HG ' ' A' ' 119' ' ' CYS . 74.8 m . . . . . 0 CA--C 1.545 0.77 0 O-C-N 121.441 -0.787 . . . . 0.0 112.291 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 121.639 0.733 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.49 144.22 44.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.741 1.616 . . . . 0.0 110.337 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.62 143.14 16.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.0 124.99 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.877 1.671 . . . . 0.0 107.697 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -129.01 163.99 24.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.249 1.42 . . . . 0.0 111.311 -168.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 29.93 59.56 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.471 -0.768 . . . . 0.0 113.574 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.3 mt -76.54 166.82 22.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.659 1.184 . . . . 0.0 112.924 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -85.71 151.92 23.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.039 0.936 . . . . 0.0 110.12 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.54 -18.69 65.5 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.065 -1.022 . . . . 0.0 112.327 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.39 -3.6 55.06 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.678 1.591 . . . . 0.0 114.559 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.0 m -66.8 135.27 53.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.195 0.998 . . . . 0.0 109.427 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 p -109.64 162.82 14.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.098 0.959 . . . . 0.0 111.64 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -61.08 -27.63 68.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.313 0.645 . . . . 0.0 111.297 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.01 -40.08 75.45 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.776 1.23 . . . . 0.0 112.085 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -65.97 -48.84 69.95 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.185 0.448 . . . . 0.0 110.219 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.26 -43.13 82.77 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.943 -0.473 . . . . 0.0 111.119 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.57 -49.1 79.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.733 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -66.9 -29.38 69.25 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.815 1.189 . . . . 0.0 112.944 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.53 -29.15 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.549 1.139 . . . . 0.0 112.122 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -100.64 -23.44 14.66 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.7 p -69.22 -15.84 63.47 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.287 1.403 . . . . 0.0 113.939 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.55 -15.33 63.6 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -95.07 -15.26 23.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 0.0 113.631 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.8 -175.6 32.82 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.823 1.202 . . . . 0.0 114.738 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.71 138.61 21.58 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.594 3.529 . . . . 0.0 111.955 -173.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.3 mt -130.0 123.33 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.162 1.385 . . . . 0.0 109.678 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.87 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.136 0.974 . . . . 0.0 111.771 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.86 175.07 5.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.417 1.087 . . . . 0.0 113.054 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.77 142.16 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.965 2.106 . . . . 0.0 108.785 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.5 t -139.98 118.87 12.52 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 111.67 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.72 147.4 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.731 0.812 . . . . 0.0 109.31 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.469 0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 109.472 -176.353 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 CA-C-O 118.979 -0.901 . . . . 0.0 113.833 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -148.11 165.93 29.36 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.753 1.263 . . . . 0.0 114.185 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.86 169.13 25.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.813 2.045 . . . . 0.0 111.169 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -133.32 147.05 51.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.013 1.325 . . . . 0.0 110.838 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.6 t -129.32 124.82 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.708 2.003 . . . . 0.0 107.856 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.1 100.38 9.72 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.576 0.75 . . . . 0.0 110.634 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.03 156.26 31.95 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.873 -1.142 . . . . 0.0 111.489 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.93 8.11 21.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.957 0.903 . . . . 0.0 112.769 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -157.07 135.82 11.6 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.107 1.763 . . . . 0.0 110.861 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.12 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.296 0.639 . . . . 0.0 112.441 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.53 -24.66 49.91 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -172.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.44 -26.94 34.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.05 0.94 . . . . 0.0 112.0 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.64 -41.16 65.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.579 0.752 . . . . 0.0 111.355 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -59.33 -31.91 69.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 0.0 112.584 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.64 -63.58 1.04 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.257 1.023 . . . . 0.0 110.039 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -36.43 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.47 -30.1 68.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.748 1.219 . . . . 0.0 113.313 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -93.48 -22.58 18.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.942 0.897 . . . . 0.0 112.42 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -79.77 -45.54 18.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.553 1.141 . . . . 0.0 113.145 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.43 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -66.83 113.49 4.94 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.649 -1.282 . . . . 0.0 111.197 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.18 75.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.537 1.541 . . . . 0.0 114.521 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -73.94 162.71 28.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.744 1.772 . . . . 0.0 111.467 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -104.28 134.31 47.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.429 1.091 . . . . 0.0 110.943 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.8 tp -144.46 114.96 7.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.06 1.744 . . . . 0.0 109.079 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 23.71 10.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.338 1.455 . . . . 0.0 113.272 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.39 -10.89 72.98 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.72 1.629 . . . . 0.0 114.536 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -90.05 134.41 34.26 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.415 1.486 . . . . 0.0 109.756 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.77 135.95 38.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.23 0.923 . . . . 0.0 108.888 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.3 pt -106.39 152.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.042 0.937 . . . . 0.0 110.652 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -110.86 155.92 21.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.075 0.95 . . . . 0.0 109.606 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -143.76 136.45 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.424 1.09 . . . . 0.0 110.416 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -155.64 161.06 40.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.171 1.389 . . . . 0.0 111.249 -175.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -69.98 137.15 51.19 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.47 -0.769 . . . . 0.0 110.392 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 CA--C 1.544 0.745 0 O-C-N 121.191 -0.943 . . . . 0.0 112.127 178.476 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.6 m . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.1 mt -117.6 144.13 45.45 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.838 1.655 . . . . 0.0 110.615 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.16 147.71 18.66 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.784 1.659 . . . . 0.0 110.06 167.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.13 131.34 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.509 1.924 . . . . 0.0 107.851 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -138.13 139.87 39.63 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.942 0.897 . . . . 0.0 111.342 -168.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.32 26.43 6.93 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.024 0.821 . . . . 0.0 114.18 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.9 mt -74.47 162.72 28.55 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.631 1.173 . . . . 0.0 113.388 -174.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -84.67 155.88 21.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.3 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.93 -17.65 63.34 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.308 -0.87 . . . . 0.0 112.416 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -92.8 -5.05 51.95 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.846 1.658 . . . . 0.0 114.271 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.7 m -68.87 136.02 51.99 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.562 1.145 . . . . 0.0 109.548 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.1 p -118.66 162.29 18.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.598 1.159 . . . . 0.0 111.004 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.32 -27.74 66.16 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.7 0.8 . . . . 0.0 111.654 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -56.0 -46.84 78.6 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.349 1.86 . . . . 0.0 111.905 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -69.89 -46.87 64.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.93 0.892 . . . . 0.0 110.046 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.4 -41.39 84.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.182 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.19 -47.77 84.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.317 0.962 . . . . 0.0 111.11 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.5 -30.85 69.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.245 1.384 . . . . 0.0 113.014 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.7 -30.93 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.629 1.171 . . . . 0.0 112.356 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -100.44 -26.45 13.86 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -73.16 -8.99 58.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.534 1.515 . . . . 0.0 114.234 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.07 -15.54 63.79 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.857 -1.152 . . . . 0.0 113.033 168.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -94.73 -11.67 28.65 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.437 . . . . 0.0 113.621 176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.26 -178.29 29.56 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.006 1.289 . . . . 0.0 114.52 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.58 138.1 28.88 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.223 3.282 . . . . 0.0 112.114 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 55.6 mt -130.94 126.66 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.819 1.648 . . . . 0.0 110.179 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.25 -19.26 17.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -158.46 162.07 37.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.074 0.852 . . . . 0.0 113.183 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.9 t -146.5 136.21 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.013 2.125 . . . . 0.0 107.472 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -133.48 109.16 9.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 110.936 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.22 134.99 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.499 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.175 0 CA-C-O 119.254 -0.748 . . . . 0.0 114.125 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -147.45 163.6 35.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.469 1.135 . . . . 0.0 113.186 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.07 174.23 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.159 1.784 . . . . 0.0 112.054 -168.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.41 150.04 43.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.292 1.837 . . . . 0.0 109.99 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.5 t -136.79 135.11 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.288 1.835 . . . . 0.0 108.716 -169.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -120.43 97.79 5.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.496 1.118 . . . . 0.0 112.245 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -77.73 161.9 27.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.346 0.659 . . . . 0.0 112.012 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.27 10.28 38.42 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.209 1.003 . . . . 0.0 112.799 171.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -156.72 131.35 8.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.59 1.556 . . . . 0.0 111.383 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.09 -29.17 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.939 0.896 . . . . 0.0 112.585 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.77 -28.18 44.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.239 0.927 . . . . 0.0 112.916 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.08 -30.02 55.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.514 0.726 . . . . 0.0 111.635 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.08 80.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.179 0.592 . . . . 0.0 111.419 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -60.07 -40.29 88.98 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.4 -58.08 8.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.707 0.803 . . . . 0.0 110.408 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.31 -38.63 77.48 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.13 -40.16 88.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.949 0.9 . . . . 0.0 112.222 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -81.65 -26.32 34.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.127 0.571 . . . . 0.0 112.506 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -74.83 -48.26 26.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.638 1.175 . . . . 0.0 113.286 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.31 -12.27 30.46 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -169.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -66.65 111.88 3.89 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.614 -1.304 . . . . 0.0 111.141 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.83 7.2 68.84 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.367 1.937 . . . . 0.0 114.572 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -73.76 168.65 18.96 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.68 1.74 . . . . 0.0 111.721 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.71 135.82 49.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.6 tp -145.07 117.97 8.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.145 1.778 . . . . 0.0 109.353 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 55.39 28.46 11.52 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.751 1.621 . . . . 0.0 113.42 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.38 6.96 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.721 1.153 . . . . 0.0 114.527 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -109.08 140.61 42.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.706 1.602 . . . . 0.0 110.503 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 136.63 39.09 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 168.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.9 pt -117.22 154.66 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -116.8 156.27 27.53 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.512 1.525 . . . . 0.0 109.498 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.82 137.43 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.853 1.261 . . . . 0.0 110.024 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -156.92 166.1 34.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.815 1.246 . . . . 0.0 111.853 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.79 140.29 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.234 -0.916 . . . . 0.0 112.211 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.304 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.0 t . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 121.005 0.431 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.04 149.48 24.52 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.836 1.654 . . . . 0.0 110.952 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.51 142.36 15.47 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.078 1.799 . . . . 0.0 110.227 167.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.98 127.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.623 1.969 . . . . 0.0 107.638 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -136.85 157.06 47.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.972 0.909 . . . . 0.0 111.386 -168.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.96 36.22 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.211 0.91 . . . . 0.0 113.675 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.24 160.29 31.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.426 1.491 . . . . 0.0 113.38 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -77.65 152.52 33.79 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 167.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.62 -18.2 65.24 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.307 -0.871 . . . . 0.0 112.726 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -100.74 -1.7 34.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.812 1.645 . . . . 0.0 114.243 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -65.85 136.41 56.13 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.615 1.166 . . . . 0.0 109.366 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.8 p -115.16 165.56 12.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.151 0.981 . . . . 0.0 111.644 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.94 -25.34 67.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.458 0.703 . . . . 0.0 111.748 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -68.61 -42.18 78.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.261 1.024 . . . . 0.0 111.461 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -66.87 -49.23 66.31 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.167 0.587 . . . . 0.0 110.386 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -58.93 -40.1 83.56 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.709 -0.619 . . . . 0.0 111.402 174.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.3 ttp-105 -59.53 -49.46 77.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.043 0.838 . . . . 0.0 111.625 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.01 -30.24 69.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.7 1.137 . . . . 0.0 113.057 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.56 -28.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.53 1.132 . . . . 0.0 112.042 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -100.67 -23.44 14.64 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.4 p -70.65 -18.3 62.85 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.363 1.438 . . . . 0.0 113.942 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -67.46 -10.51 52.18 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -101.79 -5.83 24.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.314 1.446 . . . . 0.0 113.912 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -178.16 25.7 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.951 1.262 . . . . 0.0 115.049 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.79 137.82 25.26 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.433 3.422 . . . . 0.0 112.28 -170.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.66 131.05 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.948 1.699 . . . . 0.0 110.032 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.46 -26.59 15.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.996 1.318 . . . . 0.0 113.222 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -163.41 165.23 24.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 113.077 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -146.89 133.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.837 2.055 . . . . 0.0 107.762 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.0 m -131.38 102.96 6.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.555 1.142 . . . . 0.0 110.749 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.6 mt -77.59 140.5 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.192 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.742 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -148.46 162.57 39.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.962 1.363 . . . . 0.0 114.256 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.31 172.25 17.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.761 2.024 . . . . 0.0 111.272 -169.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -138.94 155.6 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.363 1.465 . . . . 0.0 110.217 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -138.78 126.27 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.642 1.577 . . . . 0.0 109.151 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -108.51 101.19 10.37 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 111.737 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -76.75 159.76 29.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.294 1.038 . . . . 0.0 111.573 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.87 4.79 43.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.881 0.872 . . . . 0.0 113.005 171.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -159.82 136.14 8.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.368 1.467 . . . . 0.0 111.754 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.12 -30.71 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.001 0.921 . . . . 0.0 112.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.11 -23.57 51.81 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.479 1.036 . . . . 0.0 113.224 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -80.98 -29.6 35.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.788 170.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.57 81.97 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.236 0.614 . . . . 0.0 110.99 168.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.45 -31.94 71.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.31 1.044 . . . . 0.0 112.862 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.67 -64.25 0.9 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.76 0.824 . . . . 0.0 109.671 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.73 -34.96 70.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.27 -34.72 72.59 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.064 0.946 . . . . 0.0 112.883 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -88.78 -23.44 22.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.59 -45.38 19.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 113.114 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.82 31.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.33 111.32 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.698 -1.252 . . . . 0.0 111.057 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.56 8.64 70.26 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.278 1.418 . . . . 0.0 114.703 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.7 ptm -75.75 172.33 12.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.758 1.779 . . . . 0.0 111.471 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.28 135.41 54.18 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.974 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 40.0 tp -141.28 118.7 11.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.575 1.55 . . . . 0.0 109.534 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.5 t70 56.78 25.03 9.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.683 1.593 . . . . 0.0 113.417 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.08 8.6 71.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.01 1.291 . . . . 0.0 114.805 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -116.35 133.0 56.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.887 1.675 . . . . 0.0 110.614 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.43 129.69 38.94 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.819 -0.551 . . . . 0.0 110.267 173.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.9 pt -107.24 166.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.094 0.958 . . . . 0.0 111.008 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -142.54 151.15 41.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.096 1.759 . . . . 0.0 109.096 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.7 t -144.18 143.51 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.324 1.05 . . . . 0.0 112.569 -165.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -153.38 166.36 32.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.025 2.13 . . . . 0.0 111.419 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.02 149.0 48.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.522 -0.736 . . . . 0.0 111.543 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 91.6 p . . . . . 0 CA--C 1.548 0.891 0 O-C-N 121.081 -1.012 . . . . 0.0 113.374 -176.446 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.2 t . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.3 mt -121.2 141.45 50.84 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.65 1.58 . . . . 0.0 110.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.23 144.73 17.42 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.482 1.515 . . . . 0.0 110.197 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.03 122.45 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.444 1.898 . . . . 0.0 107.472 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -129.23 147.58 51.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.767 1.227 . . . . 0.0 111.786 -167.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.53 31.7 11.18 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 124.071 0.843 . . . . 0.0 113.547 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.13 162.43 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.438 1.495 . . . . 0.0 113.153 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.3 t -81.83 154.62 25.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.27 0.628 . . . . 0.0 110.998 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.3 -17.38 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 112.601 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.37 -4.22 54.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.535 1.534 . . . . 0.0 114.279 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.5 m -66.81 133.59 50.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.67 1.188 . . . . 0.0 109.649 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.6 p -108.67 163.77 12.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.268 1.027 . . . . 0.0 111.546 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -61.32 -27.32 68.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.279 0.632 . . . . 0.0 111.176 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -73.69 -36.77 65.32 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.824 1.249 . . . . 0.0 112.57 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -66.07 -48.47 70.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.639 0.654 . . . . 0.0 110.28 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.95 -41.22 86.92 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.786 -0.571 . . . . 0.0 111.009 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -58.36 -50.04 75.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.867 0.758 . . . . 0.0 111.667 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.47 -29.39 68.82 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.655 1.116 . . . . 0.0 113.135 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -80.01 -29.42 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.093 0.957 . . . . 0.0 112.011 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -100.6 -22.0 15.1 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -69.19 -20.35 63.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.366 1.439 . . . . 0.0 113.799 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -67.68 -11.3 57.97 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 172.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.1 -9.38 22.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.191 1.396 . . . . 0.0 113.7 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.9 -173.09 27.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.914 1.245 . . . . 0.0 115.185 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.25 132.78 12.8 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.288 3.325 . . . . 0.0 112.758 -169.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.07 128.73 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.813 1.645 . . . . 0.0 109.367 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.04 -40.98 29.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.749 1.22 . . . . 0.0 111.872 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -169.6 173.86 6.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.993 1.717 . . . . 0.0 111.614 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.15 140.08 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.492 1.917 . . . . 0.0 108.428 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 t -142.37 116.25 9.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.253 0.621 . . . . 0.0 111.765 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.46 150.69 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.093 0.957 . . . . 0.0 109.974 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.467 0.398 0 C-N-CA 124.173 0.989 . . . . 0.0 109.265 177.184 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.168 0 CA-C-O 119.168 -0.796 . . . . 0.0 113.94 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -149.27 161.45 42.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.897 1.332 . . . . 0.0 113.633 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -161.5 174.03 14.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.582 1.953 . . . . 0.0 110.54 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -143.56 152.86 41.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.07 120.67 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.321 1.848 . . . . 0.0 108.091 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -98.81 125.59 44.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.61 1.164 . . . . 0.0 109.573 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -105.86 148.94 27.0 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.101 0.96 . . . . 0.0 112.089 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.52 -1.97 54.92 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -155.88 132.91 10.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.672 1.589 . . . . 0.0 111.062 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.47 -30.52 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.29 -17.87 60.18 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -86.78 -28.34 23.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.642 1.177 . . . . 0.0 112.076 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.01 -39.27 79.4 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.729 -0.607 . . . . 0.0 110.408 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -64.16 -23.58 67.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.706 1.202 . . . . 0.0 113.283 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.98 -64.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.776 0.83 . . . . 0.0 109.183 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -36.62 61.71 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -58.83 -31.97 68.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.188 0.995 . . . . 0.0 113.286 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -92.66 -10.53 36.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.103 0.961 . . . . 0.0 112.74 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -96.5 -49.83 4.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.896 1.278 . . . . 0.0 112.559 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.28 -16.19 40.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -63.99 115.66 5.12 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.989 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.84 6.54 76.0 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.226 1.393 . . . . 0.0 114.397 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -77.17 169.22 18.72 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.732 1.766 . . . . 0.0 111.704 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -117.22 123.96 47.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.888 0.875 . . . . 0.0 111.51 -174.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 11.5 tp -127.75 111.86 14.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.158 1.783 . . . . 0.0 109.351 -169.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.5 t70 56.31 27.27 11.62 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.081 1.353 . . . . 0.0 112.991 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.8 -1.18 80.68 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.386 1.469 . . . . 0.0 114.738 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -103.14 127.37 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.381 1.473 . . . . 0.0 110.041 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.01 128.57 36.41 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.34 155.64 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.725 0.81 . . . . 0.0 111.394 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -124.52 151.96 44.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.548 1.539 . . . . 0.0 109.245 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.1 t -141.51 136.2 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.285 1.034 . . . . 0.0 111.287 -168.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -147.25 159.27 43.85 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.357 1.863 . . . . 0.0 111.504 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -69.89 143.63 52.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.416 0.686 . . . . 0.0 111.855 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -172.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 88.3 m . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 120.738 0.304 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.2 mt -114.83 143.91 44.35 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.911 1.685 . . . . 0.0 110.475 172.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.52 148.38 18.3 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.646 1.594 . . . . 0.0 110.552 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.11 131.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.412 1.885 . . . . 0.0 107.823 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -137.36 154.87 49.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.541 1.136 . . . . 0.0 111.608 -168.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.25 30.14 38.49 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.8 0.714 . . . . 0.0 113.603 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.73 162.12 25.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.291 1.436 . . . . 0.0 113.159 -176.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -79.85 156.65 27.26 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.999 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.3 mt -70.44 -18.82 63.01 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.714 -0.616 . . . . 0.0 111.996 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.21 -4.71 51.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.727 1.611 . . . . 0.0 114.452 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.7 m -66.84 136.98 56.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.451 1.1 . . . . 0.0 109.397 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.3 p -110.22 162.56 14.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.371 1.069 . . . . 0.0 111.434 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -60.19 -29.09 68.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.673 0.789 . . . . 0.0 111.028 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.73 -37.5 79.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.458 1.103 . . . . 0.0 112.197 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.16 -48.9 66.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.358 0.527 . . . . 0.0 110.279 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.34 -43.17 88.18 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.764 -0.585 . . . . 0.0 110.897 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -57.99 -49.47 76.72 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.758 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.24 -29.73 69.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.779 1.172 . . . . 0.0 113.018 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -80.15 -29.25 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.454 1.102 . . . . 0.0 112.208 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -100.61 -24.5 14.43 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.4 p -69.34 -17.6 63.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.312 1.415 . . . . 0.0 113.913 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -67.78 -14.38 62.9 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.86 -13.02 24.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.777 1.231 . . . . 0.0 113.635 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -174.54 30.65 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.734 1.159 . . . . 0.0 114.941 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.78 140.74 23.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.563 3.509 . . . . 0.0 112.174 -171.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.26 131.9 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 0.0 110.197 -173.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 -25.55 14.97 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.203 1.401 . . . . 0.0 113.658 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -161.83 157.77 24.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.357 1.063 . . . . 0.0 112.39 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -148.27 130.4 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 127.182 2.193 . . . . 0.0 107.653 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.5 t -143.65 118.03 9.65 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.484 0.714 . . . . 0.0 111.802 -174.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.03 144.55 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 169.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -177.881 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.016 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.236 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -148.99 163.68 36.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.594 1.187 . . . . 0.0 113.277 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.77 170.4 22.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.57 1.948 . . . . 0.0 111.568 -168.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -141.35 150.13 42.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.359 1.464 . . . . 0.0 111.171 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.71 127.29 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 109.347 -170.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -99.18 109.02 21.75 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.334 1.454 . . . . 0.0 111.007 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -83.29 160.99 21.59 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.342 -0.849 . . . . 0.0 111.03 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -94.88 8.72 41.8 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.064 0.946 . . . . 0.0 113.001 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -156.68 133.18 10.03 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.511 1.525 . . . . 0.0 111.241 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.03 -30.13 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.54 0.736 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -75.8 -28.52 58.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.435 1.016 . . . . 0.0 113.115 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.73 -27.46 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.225 0.61 . . . . 0.0 111.78 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.33 -41.24 70.07 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.317 0.647 . . . . 0.0 111.307 169.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -60.73 -35.71 77.03 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.196 0.999 . . . . 0.0 112.21 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.52 -63.68 1.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.021 0.928 . . . . 0.0 110.16 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.82 68.86 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.47 -36.01 79.23 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.959 0.904 . . . . 0.0 112.61 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.87 -24.4 26.7 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.515 0.726 . . . . 0.0 112.234 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -76.67 -47.12 23.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.54 1.136 . . . . 0.0 112.98 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.14 -12.43 26.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -170.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -65.62 113.38 4.19 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.517 -1.364 . . . . 0.0 110.866 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.21 8.53 71.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.235 1.398 . . . . 0.0 114.728 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -76.55 175.67 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.741 1.771 . . . . 0.0 111.485 169.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -119.72 135.37 54.86 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.254 1.021 . . . . 0.0 111.57 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.1 tp -146.07 121.33 10.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.982 1.713 . . . . 0.0 109.321 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 56.44 27.56 12.31 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.272 1.429 . . . . 0.0 112.603 -169.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.09 81.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.751 1.167 . . . . 0.0 114.355 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.48 130.29 43.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.874 1.337 . . . . 0.0 109.636 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.07 128.83 37.28 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.6 pt -108.65 159.45 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.941 0.896 . . . . 0.0 111.581 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -121.02 149.5 42.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.506 1.923 . . . . 0.0 108.938 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -145.98 137.24 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.453 1.101 . . . . 0.0 110.371 -171.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -157.15 162.82 39.37 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 112.329 -172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -73.43 138.36 45.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.454 -0.779 . . . . 0.0 111.286 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 56.1 m . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -118.0 148.96 41.72 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.899 1.68 . . . . 0.0 111.049 175.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.14 147.15 16.2 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.363 1.935 . . . . 0.0 110.832 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.46 128.63 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 108.576 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -133.13 153.56 51.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.153 1.381 . . . . 0.0 111.141 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 30.94 21.11 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 123.861 0.743 . . . . 0.0 113.696 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -78.33 160.62 27.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.952 1.301 . . . . 0.0 113.4 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -81.36 151.56 27.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.488 0.715 . . . . 0.0 110.354 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.34 -16.67 64.02 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.073 -1.017 . . . . 0.0 112.819 175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -95.39 -3.17 47.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.421 1.488 . . . . 0.0 114.233 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.1 m -65.62 135.14 54.66 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.709 1.204 . . . . 0.0 109.69 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -108.04 162.68 13.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.355 1.062 . . . . 0.0 111.463 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.89 -29.35 69.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.304 0.641 . . . . 0.0 111.165 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -68.72 -38.39 80.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.501 1.12 . . . . 0.0 112.395 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -66.6 -49.8 65.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.639 0.654 . . . . 0.0 110.463 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.32 -41.37 84.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.717 -0.615 . . . . 0.0 111.09 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -62.99 -43.2 99.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.081 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.68 -33.45 74.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.185 1.357 . . . . 0.0 112.502 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.51 -28.18 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.45 1.1 . . . . 0.0 112.331 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -100.15 -23.12 14.93 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.6 m -69.15 -14.86 63.23 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.207 1.367 . . . . 0.0 113.691 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -68.17 -14.31 62.89 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.868 -1.145 . . . . 0.0 113.696 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -95.75 -13.8 23.86 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.878 1.271 . . . . 0.0 113.605 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.24 -174.58 31.91 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.099 1.333 . . . . 0.0 114.339 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.91 136.84 21.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.193 3.262 . . . . 0.0 111.934 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.1 mt -131.81 127.1 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.588 1.555 . . . . 0.0 109.789 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.87 -25.08 20.03 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.926 1.29 . . . . 0.0 113.322 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -164.28 167.33 20.02 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.12 135.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.213 2.205 . . . . 0.0 107.76 171.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.0 m -127.05 102.86 7.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.892 1.277 . . . . 0.0 110.511 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.5 mt -78.53 140.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.998 -1.064 . . . . 0.0 108.157 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.4 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.104 0 CA-C-O 119.137 -0.813 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -153.27 161.92 41.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 123.028 1.394 . . . . 0.0 113.811 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.69 175.02 13.67 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.575 1.95 . . . . 0.0 111.371 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.8 156.4 46.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.479 1.511 . . . . 0.0 110.101 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.9 t -139.54 136.76 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.306 1.842 . . . . 0.0 109.193 -168.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -120.5 94.21 4.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.687 1.195 . . . . 0.0 111.678 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -74.62 161.45 29.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.685 0.794 . . . . 0.0 111.96 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.28 8.85 43.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.469 1.107 . . . . 0.0 112.871 171.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -157.45 135.51 10.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.503 1.521 . . . . 0.0 111.714 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.78 -33.15 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.572 0.749 . . . . 0.0 112.633 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -73.64 -27.6 61.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.306 0.957 . . . . 0.0 112.725 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.36 -29.03 41.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.648 0.779 . . . . 0.0 111.881 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.26 -41.85 69.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.447 0.699 . . . . 0.0 111.351 169.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -59.86 -35.69 75.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.587 1.155 . . . . 0.0 112.322 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.43 -62.67 1.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.293 1.037 . . . . 0.0 110.031 171.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.37 68.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -175.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.35 -30.02 68.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.808 1.243 . . . . 0.0 113.202 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -93.14 -28.77 16.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.867 0.867 . . . . 0.0 112.178 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -74.19 -47.09 37.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.21 1.004 . . . . 0.0 113.355 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.93 -12.35 39.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.89 115.26 5.17 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.209 -0.932 . . . . 0.0 110.982 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 86.76 4.18 82.8 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.421 1.486 . . . . 0.0 114.647 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -73.84 158.91 33.65 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.73 1.765 . . . . 0.0 111.748 172.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -103.89 116.77 32.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.077 0.951 . . . . 0.0 110.724 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.6 tp -122.7 111.65 16.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.443 1.897 . . . . 0.0 109.151 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.53 23.56 9.33 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.239 1.416 . . . . 0.0 113.467 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.35 8.82 65.82 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.024 1.297 . . . . 0.0 114.699 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -115.37 134.24 55.29 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.994 1.718 . . . . 0.0 110.107 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -78.93 126.62 30.94 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 109.663 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.85 167.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.924 0.889 . . . . 0.0 111.789 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -137.23 142.41 42.06 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.728 2.011 . . . . 0.0 108.048 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -137.96 140.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.651 0.78 . . . . 0.0 111.581 -168.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -152.57 164.8 36.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.17 1.788 . . . . 0.0 111.224 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.31 141.96 41.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.347 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 CA--C 1.54 0.587 0 O-C-N 121.162 -0.961 . . . . 0.0 112.855 -178.989 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.1 t . . . . . 0 CA--C 1.543 0.703 0 CA-C-O 121.072 0.463 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.1 mt -118.67 146.54 44.62 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.488 1.915 . . . . 0.0 110.379 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.06 149.25 18.7 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.723 1.63 . . . . 0.0 110.955 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.47 128.46 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.505 1.922 . . . . 0.0 107.838 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -136.88 150.81 48.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.156 0.982 . . . . 0.0 112.175 -167.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.15 30.18 23.4 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 123.972 0.796 . . . . 0.0 113.383 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.09 162.87 23.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 113.349 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 t -81.81 157.8 24.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.694 0.798 . . . . 0.0 112.216 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.83 -19.91 62.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.402 0.681 . . . . 0.0 112.083 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.56 -6.38 54.77 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.447 1.499 . . . . 0.0 114.364 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.7 m -69.02 134.56 49.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.727 1.211 . . . . 0.0 109.482 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 p -108.22 162.66 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.289 1.036 . . . . 0.0 111.348 173.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -61.12 -28.65 69.25 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.075 0.55 . . . . 0.0 111.132 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -70.43 -36.73 74.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 112.53 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -67.22 -49.49 64.31 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.605 0.639 . . . . 0.0 110.289 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.54 -43.62 80.08 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.806 -0.559 . . . . 0.0 110.901 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -57.22 -50.33 73.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.657 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.11 -29.9 68.94 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.593 1.088 . . . . 0.0 113.074 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.82 -27.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.479 1.112 . . . . 0.0 112.015 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -100.51 -24.15 14.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.055 0.942 . . . . 0.0 113.488 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.3 p -69.82 -17.19 63.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.362 1.437 . . . . 0.0 113.868 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -66.86 -12.81 60.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -98.68 -8.28 26.44 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.287 1.435 . . . . 0.0 113.751 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.52 -175.55 26.81 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.982 1.277 . . . . 0.0 115.004 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.14 137.21 21.12 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 124.413 3.409 . . . . 0.0 112.248 -170.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.5 mt -128.62 131.35 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.977 1.711 . . . . 0.0 110.016 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.03 -25.18 15.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.065 1.346 . . . . 0.0 113.439 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.11 164.19 25.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.5 t -148.49 134.44 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.175 2.19 . . . . 0.0 108.056 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.9 m -132.83 110.6 10.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.36 1.064 . . . . 0.0 111.351 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.41 139.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.513 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.95 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -153.47 162.55 41.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 122.615 1.198 . . . . 0.0 113.318 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.65 173.59 16.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.251 1.82 . . . . 0.0 111.875 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -141.17 152.4 44.63 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.784 1.633 . . . . 0.0 110.485 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 67.1 t -137.74 132.61 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.176 1.79 . . . . 0.0 108.955 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -115.89 101.67 8.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 111.509 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -78.73 160.08 27.62 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.918 0.887 . . . . 0.0 111.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -91.29 6.68 44.29 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.118 0.967 . . . . 0.0 113.017 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -158.23 134.73 9.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.398 1.479 . . . . 0.0 111.57 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.63 -29.39 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.91 0.884 . . . . 0.0 112.672 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.91 -27.37 49.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.468 1.031 . . . . 0.0 112.989 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.45 -29.2 52.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.675 0.79 . . . . 0.0 111.786 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.41 -39.5 74.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.259 0.624 . . . . 0.0 111.65 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.29 -39.1 85.71 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.112 -0.993 . . . . 0.0 111.962 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.91 -61.94 2.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.794 0.838 . . . . 0.0 110.079 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.21 -39.27 69.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -61.58 -39.18 90.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.856 0.863 . . . . 0.0 112.466 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -82.66 -25.36 33.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.276 0.63 . . . . 0.0 112.417 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -76.12 -51.84 11.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.534 1.134 . . . . 0.0 112.792 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.13 -14.19 39.36 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.1 112.6 3.45 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.521 -1.362 . . . . 0.0 111.068 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.22 8.4 68.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.47 1.509 . . . . 0.0 114.609 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -75.68 174.72 9.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.739 1.769 . . . . 0.0 111.465 169.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -120.12 135.32 55.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.248 1.019 . . . . 0.0 111.494 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -145.46 120.58 10.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.966 1.706 . . . . 0.0 109.276 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 56.53 27.47 12.36 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.424 1.489 . . . . 0.0 112.573 -169.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.58 84.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.727 1.156 . . . . 0.0 114.274 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.82 130.36 44.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.855 1.328 . . . . 0.0 109.622 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.26 130.92 42.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 122.09 -0.381 . . . . 0.0 110.171 171.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.0 pt -110.84 143.99 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.566 0.746 . . . . 0.0 111.389 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -102.35 144.41 30.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.694 1.598 . . . . 0.0 108.634 172.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.8 t -141.62 134.92 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.566 1.147 . . . . 0.0 109.911 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -156.31 158.2 37.04 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.925 1.29 . . . . 0.0 111.731 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.43 140.64 54.13 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.578 -0.701 . . . . 0.0 110.98 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 CA--C 1.54 0.559 0 O-C-N 121.411 -0.806 . . . . 0.0 112.261 -179.503 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 120.994 0.426 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.8 mt -118.39 148.07 42.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.579 1.952 . . . . 0.0 110.593 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.1 149.61 18.0 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.132 1.825 . . . . 0.0 111.461 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.63 128.78 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.786 2.034 . . . . 0.0 108.027 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -136.05 145.42 45.99 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.304 1.042 . . . . 0.0 111.635 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 29.06 9.83 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 124.343 0.973 . . . . 0.0 114.014 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.6 mt -83.65 156.51 22.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.008 1.323 . . . . 0.0 112.874 -173.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 t -79.71 152.69 29.75 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 171.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.84 -18.86 65.59 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.481 -0.762 . . . . 0.0 112.232 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.81 -6.88 57.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.374 1.47 . . . . 0.0 114.358 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 m -74.98 130.98 40.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.3 p -104.5 165.51 11.01 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.377 1.071 . . . . 0.0 111.567 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -60.64 -29.12 69.07 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.2 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.25 -37.87 71.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.471 1.108 . . . . 0.0 112.422 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.87 -48.7 70.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.563 0.619 . . . . 0.0 110.284 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.5 mt -55.64 -43.66 76.4 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.912 -0.493 . . . . 0.0 110.865 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.42 -43.24 99.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.871 0.759 . . . . 0.0 112.366 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.3 -29.96 67.94 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.067 1.303 . . . . 0.0 112.633 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.27 -29.92 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.398 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -100.29 -24.86 14.43 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.3 p -70.97 -11.47 60.98 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.228 1.377 . . . . 0.0 114.097 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -66.61 -15.87 63.77 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.987 -1.071 . . . . 0.0 113.608 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -95.59 -14.84 23.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.85 1.26 . . . . 0.0 113.645 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.77 -177.89 33.48 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 124.878 1.227 . . . . 0.0 114.687 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.67 136.83 21.69 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 124.33 3.353 . . . . 0.0 111.931 -172.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.31 125.87 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.72 1.608 . . . . 0.0 109.755 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.65 -27.01 21.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.919 1.288 . . . . 0.0 113.176 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.08 166.19 23.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.82 137.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.972 2.109 . . . . 0.0 107.883 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -138.29 106.42 5.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.131 0.973 . . . . 0.0 111.053 -172.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.7 146.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.344 -0.847 . . . . 0.0 108.969 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.044 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.057 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -150.2 159.5 44.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.601 1.191 . . . . 0.0 112.9 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.6 175.42 13.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.148 1.779 . . . . 0.0 111.568 -168.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -142.81 154.99 44.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.48 1.512 . . . . 0.0 110.6 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -138.42 131.65 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.213 1.805 . . . . 0.0 109.194 -168.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -114.4 96.73 5.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 0.0 111.463 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.81 158.41 32.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 111.7 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.36 0.67 53.47 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -157.13 157.46 34.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.176 1.39 . . . . 0.0 112.224 173.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.21 -26.16 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.62 -33.15 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.507 1.049 . . . . 0.0 112.874 -170.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -75.76 -23.59 55.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.562 0.745 . . . . 0.0 112.063 169.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.42 62.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.362 0.665 . . . . 0.0 111.233 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -60.03 -37.76 80.72 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.292 1.037 . . . . 0.0 111.975 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.76 -63.34 1.24 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.005 0.922 . . . . 0.0 110.195 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.98 69.75 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -60.49 -38.05 83.05 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.889 0.875 . . . . 0.0 112.464 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -83.54 -26.43 30.12 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.57 0.748 . . . . 0.0 112.128 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -76.09 -46.37 29.34 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.432 1.093 . . . . 0.0 112.973 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -91.9 -15.22 28.4 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -64.46 112.28 3.05 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.745 -1.222 . . . . 0.0 110.717 172.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.23 7.26 70.13 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.34 1.448 . . . . 0.0 114.796 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.3 ptm -74.91 172.13 12.8 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.889 1.845 . . . . 0.0 111.449 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -116.49 134.1 55.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.342 1.057 . . . . 0.0 111.242 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.2 tp -145.79 119.37 9.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.286 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.5 t70 56.94 27.69 13.53 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.529 1.532 . . . . 0.0 112.468 -169.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.43 -2.49 82.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.737 1.16 . . . . 0.0 114.175 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.81 128.16 42.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.814 1.307 . . . . 0.0 109.694 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.76 127.93 34.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.853 170.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.9 pt -108.66 154.24 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.03 0.832 . . . . 0.0 112.327 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -110.78 146.78 35.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.885 1.674 . . . . 0.0 108.697 172.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.91 139.16 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.557 1.143 . . . . 0.0 110.674 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -155.52 164.49 38.61 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.223 1.409 . . . . 0.0 112.387 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -79.74 142.81 35.09 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.199 -0.938 . . . . 0.0 111.517 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.544 0.717 0 O-C-N 121.126 -0.984 . . . . 0.0 113.592 -176.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.543 0.691 0 CA-C-O 121.12 0.486 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.59 145.44 45.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.423 1.889 . . . . 0.0 110.27 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 148.2 18.56 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.804 1.669 . . . . 0.0 110.589 168.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.77 132.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.713 2.005 . . . . 0.0 108.034 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -137.91 152.15 48.72 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.444 1.098 . . . . 0.0 111.958 -167.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.08 29.15 26.36 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.172 0.891 . . . . 0.0 113.759 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.89 159.07 29.14 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.278 1.431 . . . . 0.0 113.596 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.0 t -72.83 155.41 39.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.613 0.721 . . . . 0.0 111.878 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -70.97 -12.46 61.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.793 0.837 . . . . 0.0 112.723 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -103.86 -4.68 23.21 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.478 1.911 . . . . 0.0 114.615 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.4 m -62.61 134.95 57.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.41 1.084 . . . . 0.0 110.058 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -108.25 162.18 14.31 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.26 1.024 . . . . 0.0 111.667 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.57 -26.68 68.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.298 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.37 -36.19 66.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.161 0.984 . . . . 0.0 112.203 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.51 -50.61 68.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.748 0.704 . . . . 0.0 110.289 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.8 mt -60.15 -40.05 88.49 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.537 -0.727 . . . . 0.0 111.15 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.89 -47.44 84.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.141 0.882 . . . . 0.0 111.775 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.31 -32.59 72.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.82 1.191 . . . . 0.0 112.478 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.07 -29.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.438 1.095 . . . . 0.0 112.463 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.47 -22.97 14.84 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -68.03 -17.06 64.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.281 1.401 . . . . 0.0 113.631 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -68.08 -13.86 62.53 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.868 -1.145 . . . . 0.0 113.72 172.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -96.22 -10.82 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.93 1.292 . . . . 0.0 113.747 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.14 -173.95 28.0 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.968 1.271 . . . . 0.0 114.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.64 138.03 21.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.427 3.418 . . . . 0.0 112.147 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.5 mt -130.9 130.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.897 1.679 . . . . 0.0 109.891 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.02 -23.7 16.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.896 1.278 . . . . 0.0 113.468 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.67 162.5 29.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.83 0.852 . . . . 0.0 112.97 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.93 134.16 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.047 2.139 . . . . 0.0 107.399 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.3 t -137.08 111.18 8.34 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.529 0.732 . . . . 0.0 110.804 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.3 mt -84.82 138.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.392 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.583 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -147.38 159.75 43.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.934 1.35 . . . . 0.0 113.971 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.54 174.77 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.446 1.898 . . . . 0.0 111.368 -169.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -143.09 153.09 42.56 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.567 1.547 . . . . 0.0 110.667 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.7 129.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.96 1.704 . . . . 0.0 108.993 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -114.15 97.94 6.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.709 1.204 . . . . 0.0 111.2 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -75.81 160.66 29.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.822 0.849 . . . . 0.0 111.807 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -92.13 7.01 44.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.154 0.982 . . . . 0.0 112.969 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.06 134.32 9.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.362 1.465 . . . . 0.0 111.483 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.91 -29.48 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 112.711 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.27 -27.26 47.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 0.977 . . . . 0.0 113.136 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -77.77 -28.27 50.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.63 0.772 . . . . 0.0 111.726 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.06 -39.5 72.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.209 0.604 . . . . 0.0 111.464 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.59 -37.51 81.57 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.055 -1.028 . . . . 0.0 112.156 172.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.85 -62.51 1.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.895 0.878 . . . . 0.0 109.976 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.98 -38.59 70.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.7 -35.36 77.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.969 0.907 . . . . 0.0 112.487 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -86.29 -25.43 25.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.453 0.701 . . . . 0.0 112.299 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -76.35 -47.94 21.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.597 1.159 . . . . 0.0 112.972 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.63 -12.09 30.19 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -66.67 110.9 3.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.626 -1.296 . . . . 0.0 111.041 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.13 6.84 68.59 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.84 1.686 . . . . 0.0 114.61 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.3 ptm -74.52 168.22 20.17 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.793 1.796 . . . . 0.0 111.453 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -111.8 133.87 53.73 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.054 0.942 . . . . 0.0 111.15 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -141.72 116.58 9.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.001 1.72 . . . . 0.0 109.153 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.17 32.27 15.6 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.22 1.408 . . . . 0.0 112.569 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.68 -1.49 82.84 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.953 -1.092 . . . . 0.0 114.756 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -96.27 133.41 40.64 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.875 1.338 . . . . 0.0 110.114 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -73.35 127.29 32.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.181 0.9 . . . . 0.0 109.146 169.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -103.64 155.9 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.737 0.815 . . . . 0.0 110.586 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -122.64 155.16 36.94 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.939 1.295 . . . . 0.0 109.587 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.5 t -144.0 139.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.763 1.225 . . . . 0.0 110.585 -169.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -155.05 158.12 38.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.253 1.421 . . . . 0.0 111.94 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -72.68 138.32 46.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 CA--C 1.542 0.644 0 O-C-N 121.311 -0.868 . . . . 0.0 113.192 -177.222 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.546 0.789 0 CA-C-O 120.9 0.381 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -119.85 147.18 44.99 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.731 2.013 . . . . 0.0 110.482 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.4 150.84 17.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.993 1.758 . . . . 0.0 111.086 168.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.43 131.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.558 1.943 . . . . 0.0 108.105 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.46 151.8 47.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.404 1.082 . . . . 0.0 111.959 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.87 30.01 33.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.103 0.858 . . . . 0.0 113.422 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.29 159.23 25.91 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.408 1.483 . . . . 0.0 112.68 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 t -77.94 151.35 33.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.011 0.524 . . . . 0.0 111.737 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -16.05 63.68 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -96.98 0.84 49.5 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.974 1.709 . . . . 0.0 114.106 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.1 m -65.14 142.8 58.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.943 1.297 . . . . 0.0 109.829 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.3 p -119.87 161.11 21.39 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.901 0.88 . . . . 0.0 110.865 169.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -59.15 -24.96 63.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.828 0.851 . . . . 0.0 111.621 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -58.61 -44.44 89.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.113 1.765 . . . . 0.0 111.861 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -71.17 -45.96 62.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.021 0.928 . . . . 0.0 110.322 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.4 mt -59.42 -44.33 92.91 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.776 -0.578 . . . . 0.0 110.79 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -58.5 -47.59 83.61 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.864 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.68 -29.38 69.38 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.763 1.165 . . . . 0.0 113.163 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.6 t -79.22 -30.08 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.405 1.082 . . . . 0.0 112.371 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -100.57 -26.63 13.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.4 p -70.09 -20.07 63.22 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.357 1.435 . . . . 0.0 113.885 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.27 -11.97 58.91 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -104.11 -6.44 21.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.089 1.355 . . . . 0.0 114.329 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.13 -175.31 32.41 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.85 138.73 19.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.59 3.526 . . . . 0.0 111.986 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.14 133.33 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.85 1.66 . . . . 0.0 110.503 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.06 -22.69 14.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.254 1.421 . . . . 0.0 113.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -160.87 159.26 29.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.006 0.922 . . . . 0.0 112.696 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.1 t -152.86 132.7 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.621 2.368 . . . . 0.0 107.536 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -148.53 123.32 9.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.315 0.646 . . . . 0.0 112.234 -171.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.27 144.0 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.963 0.905 . . . . 0.0 108.681 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.284 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.114 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.859 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -149.53 161.18 42.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.65 1.214 . . . . 0.0 113.786 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.68 173.79 15.54 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 111.963 -168.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.39 155.21 44.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.686 1.594 . . . . 0.0 111.47 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 88.6 t -140.93 134.15 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.659 1.984 . . . . 0.0 108.838 -169.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.29 101.88 8.3 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.087 1.355 . . . . 0.0 111.39 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.65 162.5 27.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.907 172.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -91.75 6.74 44.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.257 1.023 . . . . 0.0 112.981 171.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -159.24 137.77 10.76 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.638 1.575 . . . . 0.0 111.596 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.07 -35.88 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.637 . . . . 0.0 112.645 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.403 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 35.3 t70 -72.71 -27.49 62.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.215 0.916 . . . . 0.0 112.596 -174.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -77.4 -36.07 53.71 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.976 0.91 . . . . 0.0 111.885 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.87 90.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.258 0.623 . . . . 0.0 111.298 169.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 27.2 ttpp -65.37 -27.15 68.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.956 1.702 . . . . 0.0 112.793 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.99 -61.48 1.83 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.276 1.031 . . . . 0.0 109.431 168.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.15 67.79 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.45 -33.54 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.671 1.188 . . . . 0.0 112.842 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -88.92 -18.74 26.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.927 0.891 . . . . 0.0 112.461 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -84.64 -43.93 13.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.713 1.205 . . . . 0.0 112.948 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.87 -12.4 29.01 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -64.39 116.58 6.22 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.602 -1.311 . . . . 0.0 111.061 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.18 5.52 76.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.599 1.571 . . . . 0.0 114.872 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.2 ptm -76.24 163.1 27.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.656 1.728 . . . . 0.0 112.595 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -83.9 128.52 34.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.57 1.148 . . . . 0.0 110.189 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.9 tp -150.45 123.13 8.59 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.927 1.291 . . . . 0.0 110.175 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 55.02 31.51 16.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.541 1.536 . . . . 0.0 113.04 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.88 4.0 85.16 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.389 1.471 . . . . 0.0 114.69 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -116.96 153.36 32.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.619 1.568 . . . . 0.0 111.271 -175.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -87.9 121.62 30.54 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.6 pt -99.58 155.14 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.014 0.526 . . . . 0.0 112.044 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -112.75 144.7 41.82 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.943 1.697 . . . . 0.0 108.662 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.4 t -141.61 134.67 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.552 1.141 . . . . 0.0 109.796 -172.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -156.69 159.75 38.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.661 1.184 . . . . 0.0 112.225 -169.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.05 138.84 50.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.521 0.728 . . . . 0.0 111.281 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 CA--C 1.541 0.608 0 O-C-N 121.494 -0.754 . . . . 0.0 112.105 -179.843 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.2 m -66.7 140.54 57.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.331 1.052 . . . . 0.0 112.789 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.6 t -164.42 143.77 7.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.014 1.326 . . . . 0.0 110.884 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.28 146.19 10.73 Favored Glycine 0 N--CA 1.469 0.874 0 C-N-CA 123.857 0.741 . . . . 0.0 114.368 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.9 m -58.76 125.47 23.6 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.793 1.237 . . . . 0.0 111.692 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.4 m 68.03 -7.89 0.6 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.549 1.94 . . . . 0.0 114.725 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.46 -34.63 10.2 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.201 1.381 . . . . 0.0 111.747 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -67.07 138.31 57.05 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.044 0.937 . . . . 0.0 110.396 169.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -127.8 17.21 6.84 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -170.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.65 36.41 4.62 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.018 1.727 . . . . 0.0 112.039 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -176.99 60.52 0.17 Allowed Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 128.446 2.698 . . . . 0.0 111.836 -169.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.9 176.33 10.27 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.281 3.321 . . . . 0.0 112.062 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -150.16 151.93 32.67 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.745 1.618 . . . . 0.0 111.237 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -45.87 134.93 14.04 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.263 3.975 . . . . 0.0 116.801 -168.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -158.41 141.56 14.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.496 1.918 . . . . 0.0 109.591 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 61.5 m -55.78 -31.74 62.87 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.659 1.183 . . . . 0.0 112.508 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.8 m -85.04 131.33 34.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.288 1.035 . . . . 0.0 110.7 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.28 144.31 45.91 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.239 1.816 . . . . 0.0 110.526 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.38 145.82 17.73 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.804 1.669 . . . . 0.0 110.603 167.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.45 128.75 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.81 2.044 . . . . 0.0 107.71 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -133.84 145.14 49.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.546 1.138 . . . . 0.0 111.329 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.72 9.13 44.16 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.532 1.063 . . . . 0.0 115.706 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.03 150.36 48.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.445 1.498 . . . . 0.0 114.273 -169.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.4 t -75.48 146.1 40.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.061 0.944 . . . . 0.0 110.935 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.5 -15.0 60.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.403 1.081 . . . . 0.0 113.836 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.77 -0.15 51.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.353 1.461 . . . . 0.0 113.749 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.0 m -71.65 139.41 49.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.914 1.286 . . . . 0.0 109.77 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.8 p -110.89 163.42 13.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.314 1.046 . . . . 0.0 111.451 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -59.77 -28.21 67.21 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.96 0.904 . . . . 0.0 111.137 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.13 -39.0 75.68 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.844 1.258 . . . . 0.0 112.041 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.12 -47.38 74.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.148 0.431 . . . . 0.0 110.285 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.5 mt -57.34 -46.54 83.18 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.846 -0.534 . . . . 0.0 110.882 173.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -63.44 -39.02 93.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.376 0.989 . . . . 0.0 112.707 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.4 -29.89 68.68 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.739 1.609 . . . . 0.0 112.572 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.34 -30.24 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.404 1.082 . . . . 0.0 112.253 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -100.37 -26.25 13.95 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -71.06 -14.01 62.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.344 1.429 . . . . 0.0 113.996 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -67.32 -13.49 62.04 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.016 -1.052 . . . . 0.0 113.547 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -96.98 -9.12 28.89 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.268 1.427 . . . . 0.0 113.686 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.26 -175.78 27.39 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.968 1.271 . . . . 0.0 114.882 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.41 136.01 19.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.504 3.47 . . . . 0.0 112.228 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.6 mt -128.79 122.73 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.658 1.583 . . . . 0.0 109.845 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.61 -31.32 28.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.121 0.969 . . . . 0.0 112.873 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -164.26 162.23 22.39 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.594 1.158 . . . . 0.0 112.276 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -148.0 137.06 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.112 2.165 . . . . 0.0 108.012 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.8 t -144.09 120.03 10.65 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 111.407 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -85.87 146.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.184 0.994 . . . . 0.0 108.648 172.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.6 t -97.47 129.06 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 108.778 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.14 154.73 37.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.889 1.276 . . . . 0.0 113.662 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -71.9 140.24 49.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.277 1.431 . . . . 0.0 112.107 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -77.23 -22.16 52.69 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -104.19 -27.75 11.86 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.092 0.86 . . . . 0.0 112.898 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 100.0 p -120.93 -12.59 8.75 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 61.82 15.54 7.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.036 1.734 . . . . 0.0 114.386 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -74.64 153.06 39.11 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.46 1.504 . . . . 0.0 110.292 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.8 t -61.34 142.89 56.58 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.708 -0.62 . . . . 0.0 111.103 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -84.64 -1.39 55.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.181 0.993 . . . . 0.0 112.772 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.92 7.72 62.43 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.15 1.357 . . . . 0.0 114.181 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -144.59 160.94 40.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.628 1.214 . . . . 0.0 113.586 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.86 172.27 17.94 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.535 1.934 . . . . 0.0 111.053 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.28 149.02 40.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.768 1.227 . . . . 0.0 111.04 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.63 120.8 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.608 1.963 . . . . 0.0 108.182 -170.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -106.68 98.34 8.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.328 1.051 . . . . 0.0 111.003 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -74.66 160.97 30.13 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.479 -0.763 . . . . 0.0 111.742 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.26 6.68 41.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.171 0.988 . . . . 0.0 113.006 171.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -158.56 135.22 9.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.341 1.456 . . . . 0.0 111.748 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -68.38 -29.63 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.072 0.949 . . . . 0.0 112.746 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.63 -26.05 45.16 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.36 0.982 . . . . 0.0 113.178 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -78.71 -29.36 45.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.774 0.83 . . . . 0.0 111.677 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.65 77.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.275 0.63 . . . . 0.0 111.343 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.06 -34.02 74.23 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.99 -1.069 . . . . 0.0 112.55 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.03 -63.12 1.15 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.758 0.823 . . . . 0.0 109.758 172.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.21 70.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -61.11 -34.37 74.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.081 0.952 . . . . 0.0 112.593 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -87.81 -24.25 23.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.533 0.733 . . . . 0.0 112.31 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.43 -46.48 22.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.509 1.124 . . . . 0.0 113.074 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.91 -11.12 27.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -170.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -66.68 111.06 3.48 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 120.658 -1.276 . . . . 0.0 111.248 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.04 7.06 68.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.078 1.799 . . . . 0.0 114.627 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -74.72 168.96 18.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.713 1.757 . . . . 0.0 111.326 170.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -111.12 137.09 49.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.237 1.015 . . . . 0.0 110.974 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.06 116.8 9.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.776 1.63 . . . . 0.0 109.377 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 58.14 25.11 12.07 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.011 1.725 . . . . 0.0 113.901 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.99 2.76 68.67 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.93 1.252 . . . . 0.0 114.965 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -110.19 139.27 45.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.702 1.601 . . . . 0.0 110.516 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 138.76 47.4 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 167.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.1 pt -111.82 149.3 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.721 0.808 . . . . 0.0 110.285 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 34.5 mtm-85 -117.61 153.07 33.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 109.007 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.0 t -143.67 136.05 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.45 1.1 . . . . 0.0 110.879 -168.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -150.38 162.04 41.31 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.288 1.835 . . . . 0.0 111.484 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -69.77 142.5 53.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.849 0.86 . . . . 0.0 112.081 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.0 m -66.54 125.93 27.27 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.33 -0.856 . . . . 0.0 112.602 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.8 pt -83.19 -19.87 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.246 1.019 . . . . 0.0 112.477 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.8 p -156.48 155.97 32.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 130.724 3.61 . . . . 0.0 107.323 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.49 158.91 34.97 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -70.65 -40.46 10.82 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -58.59 150.17 71.18 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.332 3.355 . . . . 0.0 113.349 170.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -160.99 146.76 14.51 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.381 1.473 . . . . 0.0 112.098 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.05 1.74 . . . . 0.0 110.859 -174.39 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.257 1 O4'-C1'-N19 112.597 4.397 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 C3'-C2'-C1' 103.46 2.177 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 O4'-C4'-C3' 108.411 2.08 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 O5'-C5'-C4' 114.717 3.226 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.55 0 C4'-C3'-C2' 99.662 -3.038 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.014 0 O4'-C1'-N19 111.76 3.56 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.8 m -138.03 12.45 2.86 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -170.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.5 m -163.53 155.24 17.15 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.402 1.881 . . . . 0.0 110.992 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.09 -71.6 2.6 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.769 1.176 . . . . 0.0 111.993 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.0 p -167.89 147.43 4.85 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.026 1.731 . . . . 0.0 111.675 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 m -171.29 146.92 2.4 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.68 1.992 . . . . 0.0 110.709 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -95.81 144.49 17.28 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.659 1.123 . . . . 0.0 111.82 173.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -158.8 148.95 19.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.295 1.438 . . . . 0.0 112.213 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 ttm105 -75.56 31.77 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.689 1.996 . . . . 0.0 115.384 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.79 172.7 7.21 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.85 1.26 . . . . 0.0 111.627 172.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -51.04 119.16 11.57 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 124.045 0.938 . . . . 0.0 112.448 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -85.32 -175.16 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.902 3.068 . . . . 0.0 111.754 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -149.02 160.54 34.84 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 126.53 1.932 . . . . 0.0 110.615 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.3 138.49 46.01 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.27 3.313 . . . . 0.0 115.319 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -154.94 156.98 37.04 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.686 1.594 . . . . 0.0 110.384 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.83 10.6 0.49 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.599 1.559 . . . . 0.0 114.42 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 14.8 p -152.87 150.64 29.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.092 1.357 . . . . 0.0 111.442 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.19 146.83 50.6 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.964 1.706 . . . . 0.0 110.889 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.47 147.48 18.55 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.838 1.685 . . . . 0.0 109.731 166.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.054 1.742 . . . . 0.0 107.832 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.69 154.23 51.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.845 0.858 . . . . 0.0 111.773 -168.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.81 34.55 30.66 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.685 0.659 . . . . 0.0 113.285 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.57 164.93 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.357 1.463 . . . . 0.0 113.203 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.6 t -83.09 153.05 25.06 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.239 0.615 . . . . 0.0 111.13 168.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.56 -15.91 62.82 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.495 -0.753 . . . . 0.0 112.386 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -95.45 -4.27 45.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.617 1.567 . . . . 0.0 114.031 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 85.2 m -67.8 133.54 49.4 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.503 1.121 . . . . 0.0 109.263 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 p -106.79 163.65 12.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -61.14 -27.58 68.49 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.093 0.557 . . . . 0.0 111.181 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.56 1.144 . . . . 0.0 112.301 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.81 -47.45 75.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.682 0.674 . . . . 0.0 110.399 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.48 -44.59 85.03 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.673 -0.642 . . . . 0.0 110.679 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -63.63 -39.71 95.05 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.013 0.824 . . . . 0.0 112.772 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.86 -28.33 65.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.36 1.436 . . . . 0.0 112.852 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.66 -33.92 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.929 0.891 . . . . 0.0 111.831 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -99.96 -24.67 14.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.2 p -71.38 -18.39 62.36 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.518 1.508 . . . . 0.0 114.112 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -69.38 -7.12 34.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.017 -1.052 . . . . 0.0 113.83 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.5 -5.1 27.48 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.107 1.363 . . . . 0.0 113.642 171.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.23 -174.92 23.06 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.602 1.573 . . . . 0.0 115.087 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.87 128.69 14.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.231 3.288 . . . . 0.0 112.642 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.0 mt -116.91 126.11 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.909 1.684 . . . . 0.0 109.281 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.54 -40.45 42.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.684 1.194 . . . . 0.0 111.859 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.51 174.41 6.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.777 1.231 . . . . 0.0 113.094 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.84 142.63 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.115 2.166 . . . . 0.0 108.524 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.6 t -137.52 118.48 14.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.467 0.707 . . . . 0.0 111.673 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 94.2 mt -82.69 142.7 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.1 t -92.82 128.76 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.829 0.852 . . . . 0.0 109.76 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -125.44 153.62 43.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.327 1.451 . . . . 0.0 112.927 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.63 150.83 48.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.408 1.083 . . . . 0.0 111.565 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -81.18 -20.95 40.11 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -127.36 -39.67 1.86 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.972 0.909 . . . . 0.0 112.708 -170.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 67.9 m -82.36 -20.44 37.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.457 0.703 . . . . 0.0 112.132 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 58.56 21.79 9.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.487 1.915 . . . . 0.0 114.044 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -76.88 147.68 36.91 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 128.365 2.666 . . . . 0.0 110.804 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.1 t -69.07 134.76 49.81 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -87.29 -2.08 58.37 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 96.09 6.6 58.96 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 125.102 1.334 . . . . 0.0 114.839 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.05 164.64 31.47 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.585 1.183 . . . . 0.0 113.824 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.83 171.44 20.05 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.785 2.034 . . . . 0.0 110.994 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -142.59 151.25 41.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.814 1.246 . . . . 0.0 110.906 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.3 t -131.47 126.86 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.298 1.839 . . . . 0.0 108.513 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -105.61 112.3 25.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.149 0.98 . . . . 0.0 110.441 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.65 157.96 16.67 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.322 -0.862 . . . . 0.0 111.245 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.34 -9.05 59.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -151.64 146.58 25.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.774 1.63 . . . . 0.0 111.573 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.6 -33.21 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.11 -24.57 58.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -81.42 -29.31 33.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.901 1.281 . . . . 0.0 111.801 174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.47 70.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 110.628 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -58.99 -40.03 83.6 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.16 -0.962 . . . . 0.0 112.23 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.49 -62.34 1.95 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.929 0.892 . . . . 0.0 110.242 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.83 71.68 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -63.06 -33.25 75.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.004 0.922 . . . . 0.0 112.641 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -84.49 -24.07 29.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.638 0.654 . . . . 0.0 112.703 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -82.84 -45.97 13.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.398 1.079 . . . . 0.0 113.318 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -100.25 -11.49 20.32 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.4 112.97 4.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.684 -1.26 . . . . 0.0 110.933 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.25 9.12 70.55 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.242 1.401 . . . . 0.0 114.633 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ptm -75.65 172.93 11.75 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.703 1.751 . . . . 0.0 111.502 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.24 134.66 54.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.075 0.95 . . . . 0.0 111.136 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -141.68 116.87 10.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.587 1.555 . . . . 0.0 109.239 -174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.84 25.23 10.12 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.571 1.548 . . . . 0.0 113.199 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.85 -3.55 83.01 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.395 1.474 . . . . 0.0 114.613 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.48 130.52 44.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.122 1.369 . . . . 0.0 110.15 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.4 122.25 22.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.033 0.833 . . . . 0.0 110.011 170.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -101.65 151.63 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.677 0.791 . . . . 0.0 111.631 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -106.82 149.87 26.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.317 1.847 . . . . 0.0 109.37 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.0 t -144.37 132.48 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.766 1.226 . . . . 0.0 110.224 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -156.47 154.72 30.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 112.651 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -70.01 136.18 50.13 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.362 -0.836 . . . . 0.0 112.328 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.3 m -68.84 126.94 31.33 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.417 -0.802 . . . . 0.0 112.975 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.5 pt -83.2 -19.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.084 0.954 . . . . 0.0 113.138 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.9 p -155.48 158.13 38.03 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 129.998 3.319 . . . . 0.0 107.508 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.77 159.05 41.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 -176.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 6.4 tpp85 -63.47 -50.54 72.88 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.921 1.689 . . . . 0.0 114.776 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.09 149.84 47.1 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.226 2.617 . . . . 0.0 111.397 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -151.97 2.6 0.37 Allowed 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -174.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.461 1.905 . . . . 0.0 111.812 -173.265 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.128 0 O4'-C1'-N19 111.795 3.595 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.245 1 O4'-C1'-N19 115.624 7.424 . 0.191 2z . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.117 1 O4'-C1'-N19 112.318 4.118 . 0.028 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.351 0 O4'-C1'-N19 111.21 3.01 . 0.133 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.592 0 O4'-C1'-N19 111.633 3.433 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.43 -1.942 0 O4'-C1'-N19 112.151 3.951 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.5 t -163.26 150.78 13.03 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.289 1.436 . . . . 0.0 111.171 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.7 p -81.65 -11.57 59.04 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.406 1.082 . . . . 0.0 113.363 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.52 31.01 2.45 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.703 1.62 . . . . 0.0 114.61 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.3 p -82.62 -20.22 36.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.7 p -169.22 158.62 8.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.97 1.708 . . . . 0.0 111.595 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.53 104.45 1.68 Allowed Glycine 0 N--CA 1.47 0.926 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -152.58 20.36 0.62 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -169.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 58.88 32.56 22.35 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.916 1.686 . . . . 0.0 114.346 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.64 33.61 2.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.611 1.565 . . . . 0.0 112.035 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -174.73 39.34 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 128.297 2.639 . . . . 0.0 114.799 -169.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.43 162.44 40.65 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.472 2.781 . . . . 0.0 112.14 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -157.81 143.44 12.46 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.608 1.563 . . . . 0.0 110.314 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.86 136.07 58.98 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.143 3.228 . . . . 0.0 114.003 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -149.22 28.48 0.82 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.176 0.99 . . . . 0.0 112.883 -168.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 58.2 m 68.11 1.36 2.77 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.429 2.292 . . . . 0.0 114.73 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.7 p -156.79 154.44 29.94 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.044 1.338 . . . . 0.0 112.088 -172.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.8 mt -127.98 148.98 50.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.346 1.858 . . . . 0.0 111.389 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.67 146.28 17.49 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 126.297 1.903 . . . . 0.0 109.57 166.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.68 123.91 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.502 1.921 . . . . 0.0 107.372 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -130.64 153.33 49.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.883 1.273 . . . . 0.0 112.735 -167.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.9 12.26 60.68 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.265 1.412 . . . . 0.0 114.502 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.33 160.77 26.54 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.31 1.844 . . . . 0.0 114.275 -169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.4 t -75.06 151.45 38.69 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.478 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -68.68 -16.11 63.73 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.549 -0.72 . . . . 0.0 112.629 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -100.58 -2.52 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.622 1.569 . . . . 0.0 114.313 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.7 m -64.9 139.77 58.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.693 1.197 . . . . 0.0 109.495 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 p -108.76 161.65 14.91 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.177 0.991 . . . . 0.0 111.471 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -59.04 -30.94 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.681 0.792 . . . . 0.0 111.136 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -67.31 -40.0 85.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.817 1.247 . . . . 0.0 112.015 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.48 -49.78 67.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.795 0.438 . . . . 0.0 110.273 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.4 -43.56 79.41 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 110.997 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -62.48 -44.74 95.65 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.352 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.31 -29.29 67.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.645 1.111 . . . . 0.0 112.872 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.88 -28.69 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.363 1.065 . . . . 0.0 112.057 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -100.16 -20.52 15.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.0 p -68.73 -16.16 63.73 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.289 1.404 . . . . 0.0 113.979 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.72 -15.34 63.46 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 171.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.54 -12.36 27.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.977 1.311 . . . . 0.0 113.586 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.28 177.84 25.48 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.008 1.289 . . . . 0.0 114.323 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.4 134.18 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 124.569 3.512 . . . . 0.0 112.332 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.7 127.45 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.93 1.692 . . . . 0.0 109.889 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.08 -25.43 17.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.228 1.411 . . . . 0.0 113.574 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -159.91 156.86 27.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.938 0.895 . . . . 0.0 112.548 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.2 t -153.05 135.85 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.131 2.173 . . . . 0.0 108.282 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -149.07 125.01 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.567 0.747 . . . . 0.0 111.79 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.3 mt -86.16 146.75 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.182 0.993 . . . . 0.0 108.846 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.74 132.55 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.301 1.041 . . . . 0.0 109.38 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -124.69 153.51 42.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.992 1.317 . . . . 0.0 113.112 -170.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.85 141.32 53.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.257 1.423 . . . . 0.0 111.366 172.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -75.54 -20.31 58.75 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -113.45 -38.28 4.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.385 1.074 . . . . 0.0 112.853 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 60.0 p -94.51 -17.85 22.02 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 62.89 12.46 5.8 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.406 1.882 . . . . 0.0 114.081 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.76 154.47 31.94 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.326 1.45 . . . . 0.0 110.308 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.1 t -61.68 141.33 57.9 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.558 -0.714 . . . . 0.0 110.82 172.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -75.92 0.22 19.12 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.879 0.872 . . . . 0.0 112.754 170.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.04 18.86 55.15 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.955 1.264 . . . . 0.0 113.287 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -154.54 164.57 38.5 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.841 1.305 . . . . 0.0 114.246 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.09 170.43 22.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.622 1.969 . . . . 0.0 111.449 -168.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -135.56 151.76 50.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.388 1.475 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.48 130.42 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.833 2.053 . . . . 0.0 109.046 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -119.52 113.85 21.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.031 1.333 . . . . 0.0 112.254 -170.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.23 154.79 17.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.985 0.914 . . . . 0.0 111.929 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -81.73 4.64 21.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.215 1.006 . . . . 0.0 112.841 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -155.98 129.22 8.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.081 1.752 . . . . 0.0 110.777 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.87 -27.14 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.83 -24.33 48.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.101 0.864 . . . . 0.0 113.08 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -78.85 -27.41 44.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.611 0.764 . . . . 0.0 111.734 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.24 73.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.976 0.51 . . . . 0.0 110.507 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.74 -34.66 76.22 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.013 -1.054 . . . . 0.0 112.688 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.18 -63.56 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.022 0.929 . . . . 0.0 110.045 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.83 -36.52 67.59 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.83 -38.12 77.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.059 0.943 . . . . 0.0 112.673 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.06 -21.12 27.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.547 0.739 . . . . 0.0 112.444 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -81.44 -46.51 14.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.602 1.161 . . . . 0.0 112.849 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.93 -14.59 25.82 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -64.69 111.03 2.57 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.658 -1.276 . . . . 0.0 110.76 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.82 5.82 64.16 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.47 1.509 . . . . 0.0 114.774 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.9 ptm -76.97 173.31 11.92 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.931 1.866 . . . . 0.0 111.36 169.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -118.45 137.91 52.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.28 1.032 . . . . 0.0 111.361 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.9 tp -145.8 120.46 9.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.454 1.502 . . . . 0.0 109.976 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.3 t70 57.63 23.36 9.27 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.678 1.591 . . . . 0.0 113.466 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.28 83.09 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.499 1.523 . . . . 0.0 114.625 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.72 130.24 45.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.276 1.43 . . . . 0.0 110.668 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.29 138.91 54.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 168.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 pt -115.92 143.95 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.351 0.661 . . . . 0.0 111.266 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -106.95 144.43 33.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.799 1.639 . . . . 0.0 108.297 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 t -140.3 135.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.98 0.912 . . . . 0.0 110.628 -170.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.32 162.59 39.13 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.543 1.537 . . . . 0.0 111.654 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.47 139.23 40.75 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 112.111 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.8 m -70.06 126.86 30.92 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.206 -0.934 . . . . 0.0 112.911 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 6.4 pt -86.12 -0.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.5 p -155.19 -163.64 1.59 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 129.24 3.016 . . . . 0.0 109.322 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -150.88 169.3 22.05 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.921 1.288 . . . . 0.0 113.861 169.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.9 159.37 55.25 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.119 0.968 . . . . 0.0 112.572 171.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -70.77 149.18 60.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.377 2.718 . . . . 0.0 113.28 -171.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 68.2 -16.82 0.18 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 127.799 2.44 . . . . 0.0 117.0 169.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.58 1.552 . . . . 0.0 113.358 -178.422 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.429 1 O4'-C1'-N19 112.555 4.355 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.197 0 C4'-C3'-C2' 100.009 -2.691 . 0.134 5n . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.266 0 O4'-C1'-N19 110.444 2.244 . 0.612 1z . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.222 0 O4'-C1'-N19 111.094 2.894 . 0.169 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 C5'-C4'-C3' 110.813 -3.125 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 0 C5'-C4'-C3' 110.795 -3.137 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.541 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.6 p -164.13 170.83 15.88 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.205 1.402 . . . . 0.0 111.802 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.1 m -74.35 3.12 7.88 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.0 -11.17 84.96 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.902 1.239 . . . . 0.0 115.206 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.8 t -162.32 133.8 5.24 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.941 1.296 . . . . 0.0 111.361 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.3 p -167.43 144.55 4.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.456 1.502 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -99.84 -11.1 44.54 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 124.647 1.117 . . . . 0.0 114.677 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -66.82 142.61 57.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.848 1.259 . . . . 0.0 111.248 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 78.14 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.415 1.086 . . . . 0.0 111.849 170.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.98 37.92 0.18 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.073 2.149 . . . . 0.0 111.708 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -168.52 34.38 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 126.707 2.003 . . . . 0.0 115.855 -168.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.04 149.69 88.94 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.134 2.556 . . . . 0.0 112.335 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -151.94 153.09 31.05 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 126.204 1.802 . . . . 0.0 110.639 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -38.1 125.17 0.77 Allowed 'Trans proline' 0 C--N 1.355 0.909 1 C-N-CA 125.97 4.447 . . . . 0.0 116.896 -168.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -156.97 137.38 12.98 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.409 1.884 . . . . 0.0 109.43 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.9 m -59.48 -28.26 66.85 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.096 0.958 . . . . 0.0 112.697 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 81.7 m -85.33 117.17 24.1 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.123 0.969 . . . . 0.0 110.058 171.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.7 mt -102.73 145.65 29.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.12 1.368 . . . . 0.0 110.452 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.02 144.95 16.13 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.879 1.704 . . . . 0.0 110.651 168.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.06 124.83 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.864 2.066 . . . . 0.0 107.634 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.03 154.71 47.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.832 1.253 . . . . 0.0 113.141 -166.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.39 18.01 61.3 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.798 1.189 . . . . 0.0 114.263 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.93 163.13 22.75 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.539 1.936 . . . . 0.0 114.237 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -80.28 149.05 30.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.828 168.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.55 -16.36 64.15 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.435 -0.791 . . . . 0.0 112.675 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -96.22 -4.39 42.54 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.449 1.5 . . . . 0.0 114.302 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -68.52 133.43 48.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.529 1.132 . . . . 0.0 109.377 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.8 p -106.3 164.16 12.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.182 0.993 . . . . 0.0 111.598 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -60.51 -29.47 69.12 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.176 0.59 . . . . 0.0 111.123 172.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -69.1 -40.16 78.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.711 1.205 . . . . 0.0 112.232 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.05 -49.47 67.53 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.187 0.449 . . . . 0.0 110.266 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.52 -42.47 78.5 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.907 -0.496 . . . . 0.0 110.978 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.61 -44.82 95.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.26 175.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.26 -32.38 72.52 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.929 1.241 . . . . 0.0 112.4 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.26 -29.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 112.273 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.16 -21.02 15.69 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 74.2 m -66.74 -17.24 64.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 120.105 1.321 . . . . 0.0 113.644 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -67.76 -14.52 63.02 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.999 -1.063 . . . . 0.0 113.829 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -97.5 -13.62 21.59 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.91 1.284 . . . . 0.0 113.857 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.81 -174.12 31.66 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.55 1.071 . . . . 0.0 114.761 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.04 136.27 16.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.437 3.425 . . . . 0.0 111.988 -171.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.5 mt -129.35 125.43 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.683 1.593 . . . . 0.0 109.742 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.16 -33.62 26.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.758 1.223 . . . . 0.0 112.669 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -166.39 170.2 13.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.254 1.021 . . . . 0.0 112.805 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.8 138.18 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.939 2.095 . . . . 0.0 108.5 175.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.0 m -138.33 109.06 6.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.256 1.022 . . . . 0.0 111.306 -171.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.89 149.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 171.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t -103.84 133.08 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.433 1.093 . . . . 0.0 109.61 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -128.24 153.73 46.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.191 1.396 . . . . 0.0 113.456 -169.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.41 138.83 49.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.787 1.235 . . . . 0.0 111.155 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -74.42 -21.31 59.68 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -118.0 -38.16 3.28 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.337 1.055 . . . . 0.0 112.463 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.9 m -83.84 -14.15 51.97 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.785 0.834 . . . . 0.0 113.177 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 54.08 38.71 29.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.273 1.829 . . . . 0.0 113.476 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -131.32 153.52 49.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.606 2.362 . . . . 0.0 109.53 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.3 t -60.09 138.19 57.94 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.05 -0.406 . . . . 0.0 111.474 -177.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -76.89 0.62 20.23 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.807 0.843 . . . . 0.0 112.939 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.47 13.58 53.38 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.28 1.419 . . . . 0.0 113.975 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.51 164.49 38.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.822 1.296 . . . . 0.0 113.98 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.57 172.67 17.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.21 1.804 . . . . 0.0 111.273 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.63 154.87 48.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.0 1.32 . . . . 0.0 111.233 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.8 t -134.34 121.13 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.521 1.928 . . . . 0.0 108.116 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -102.51 98.81 8.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.252 1.021 . . . . 0.0 110.552 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -76.57 161.68 28.39 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.189 -0.945 . . . . 0.0 112.174 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.18 7.94 45.12 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.547 1.139 . . . . 0.0 113.026 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -155.42 132.84 11.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.57 1.548 . . . . 0.0 111.13 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.63 -27.07 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 112.783 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.458 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 9.6 t70 -80.16 -29.74 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.189 0.904 . . . . 0.0 113.049 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.28 -30.32 60.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.26 0.624 . . . . 0.0 111.495 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.5 -43.29 77.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.352 0.661 . . . . 0.0 111.679 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 21.1 mtmt -58.03 -36.93 73.42 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.082 -1.011 . . . . 0.0 112.674 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.71 -57.31 4.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.196 0.599 . . . . 0.0 110.878 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.65 67.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.977 -1.077 . . . . 0.0 112.93 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -55.9 -47.23 77.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.819 1.248 . . . . 0.0 112.293 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -27.96 37.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.359 0.663 . . . . 0.0 111.675 -174.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -71.36 -52.41 18.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.937 1.695 . . . . 0.0 113.374 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.74 -14.12 37.96 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -64.22 111.0 2.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.766 -1.209 . . . . 0.0 111.144 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.78 8.13 65.69 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.628 1.585 . . . . 0.0 114.646 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -75.76 173.11 11.54 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.793 1.796 . . . . 0.0 111.457 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.07 136.64 53.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.214 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.4 tp -145.47 118.99 9.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.5 1.52 . . . . 0.0 109.531 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 58.13 22.74 9.39 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.422 1.489 . . . . 0.0 113.428 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.81 -5.77 83.27 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.633 1.587 . . . . 0.0 114.605 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.56 130.36 41.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.336 1.454 . . . . 0.0 110.707 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.52 131.44 43.29 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.3 pt -110.94 152.64 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.946 0.898 . . . . 0.0 110.225 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -122.75 153.13 39.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.485 1.114 . . . . 0.0 109.489 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -142.79 137.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.575 -167.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -150.18 169.84 20.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.643 1.977 . . . . 0.0 111.54 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -78.31 142.29 37.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.347 1.059 . . . . 0.0 112.003 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.3 t -64.69 138.78 58.59 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 6.7 pt -96.16 -21.28 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.672 1.189 . . . . 0.0 113.665 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.5 p -161.4 146.01 13.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.472 2.709 . . . . 0.0 108.404 -171.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -152.44 165.78 33.99 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -170.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -69.07 -48.57 27.36 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.26 145.33 24.06 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.142 2.561 . . . . 0.0 111.064 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -72.51 -14.51 61.67 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 129.201 3.0 . . . . 0.0 114.1 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.345 1 O4'-C1'-N19 113.99 5.79 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.209 0 O4'-C1'-N19 111.655 3.455 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 0 O4'-C1'-N19 110.449 2.249 . 0.403 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 O5'-C5'-C4' 114.455 3.039 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.104 0 O4'-C1'-N19 112.05 3.85 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.292 0 C5'-C4'-C3' 112.142 -2.239 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -64.05 -27.15 68.91 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -171.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -72.92 -16.62 61.55 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.011 0.924 . . . . 0.0 113.292 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.4 -42.08 3.28 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.443 1.497 . . . . 0.0 112.299 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.4 m -148.17 115.97 6.37 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.479 1.112 . . . . 0.0 111.782 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.6 p -167.72 172.68 9.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.885 1.674 . . . . 0.0 111.419 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.16 11.5 60.44 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.723 1.154 . . . . 0.0 114.041 172.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -57.76 128.09 35.31 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.675 1.238 . . . . 0.0 110.773 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -97.23 2.39 50.85 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.566 1.546 . . . . 0.0 114.792 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.45 47.87 0.98 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.897 1.679 . . . . 0.0 113.268 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -169.07 32.02 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.546 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -167.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.55 155.95 65.23 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.65 2.234 . . . . 0.0 111.873 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -157.47 157.98 30.41 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.113 1.765 . . . . 0.0 110.521 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -44.63 131.56 9.87 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.98 3.787 . . . . 0.0 115.94 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -152.56 137.8 17.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.921 1.689 . . . . 0.0 109.243 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 73.0 m -58.45 -23.62 58.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.74 0.816 . . . . 0.0 112.958 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 83.8 m -104.36 121.87 44.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.412 1.085 . . . . 0.0 110.755 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.82 145.83 29.53 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.056 1.342 . . . . 0.0 111.225 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.68 144.91 17.57 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.864 1.697 . . . . 0.0 109.563 167.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 t -132.67 121.29 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.364 1.866 . . . . 0.0 107.469 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.54 153.36 46.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.091 1.356 . . . . 0.0 112.013 -167.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.62 28.51 26.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.041 0.829 . . . . 0.0 113.607 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.94 161.65 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.381 1.472 . . . . 0.0 113.595 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.1 t -77.01 153.1 34.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.268 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.55 -16.8 63.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.442 -0.786 . . . . 0.0 112.261 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -96.2 -4.16 43.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.626 1.57 . . . . 0.0 114.528 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.9 m -65.05 138.15 58.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.643 1.177 . . . . 0.0 109.57 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -110.72 162.98 14.22 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.168 0.987 . . . . 0.0 111.464 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -57.67 -31.71 66.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.097 0.959 . . . . 0.0 111.172 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -67.32 -40.35 85.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.91 1.284 . . . . 0.0 112.066 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.49 -48.87 68.46 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.877 0.471 . . . . 0.0 110.284 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.75 -44.75 82.05 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.837 -0.539 . . . . 0.0 110.812 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.67 -44.13 97.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.213 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.05 -29.94 68.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.757 1.162 . . . . 0.0 112.922 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.95 -28.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.366 1.066 . . . . 0.0 111.894 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -100.43 -21.53 15.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.3 p -68.48 -17.7 64.24 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.383 1.447 . . . . 0.0 114.004 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -66.72 -13.49 61.39 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -97.27 -9.1 28.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.122 1.369 . . . . 0.0 113.756 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.2 -175.99 25.37 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.936 1.255 . . . . 0.0 114.837 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.34 134.83 17.72 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.428 3.419 . . . . 0.0 112.241 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 93.8 mt -124.39 125.93 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.695 1.598 . . . . 0.0 109.76 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.68 -34.75 24.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.921 1.288 . . . . 0.0 112.828 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -164.49 166.47 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.302 1.041 . . . . 0.0 112.569 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.7 t -147.55 135.75 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.901 2.08 . . . . 0.0 108.936 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.6 m -138.44 110.26 7.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.648 1.179 . . . . 0.0 111.506 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.61 144.76 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.5 t -106.17 135.87 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -127.37 155.92 42.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.36 1.464 . . . . 0.0 113.117 -170.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.98 150.96 38.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.272 1.029 . . . . 0.0 111.192 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -81.42 -23.66 37.39 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -123.64 -36.29 2.78 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.399 1.08 . . . . 0.0 112.723 -170.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.3 m -82.05 -23.62 35.74 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.685 0.794 . . . . 0.0 111.899 169.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . 0.257 90.0 mtt180 60.0 20.87 9.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.711 2.005 . . . . 0.0 115.321 169.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 46.9 ptt85 -94.29 164.76 12.9 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.059 1.743 . . . . 0.0 110.104 168.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 27.3 t -59.91 141.57 55.24 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 122.106 -0.371 . . . . 0.0 110.084 169.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -76.46 2.59 13.28 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.154 0.982 . . . . 0.0 112.681 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.54 18.95 57.77 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.517 1.056 . . . . 0.0 113.239 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -154.87 165.45 36.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.993 1.377 . . . . 0.0 113.971 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.33 173.03 17.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.786 2.034 . . . . 0.0 110.943 -169.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.64 151.83 49.74 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.245 1.418 . . . . 0.0 110.873 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.26 118.95 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.551 1.941 . . . . 0.0 108.177 -170.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -104.24 100.61 10.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.523 1.129 . . . . 0.0 110.906 -170.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -78.45 158.02 28.78 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.446 -0.783 . . . . 0.0 111.733 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -86.1 6.29 29.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.091 0.956 . . . . 0.0 113.136 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -159.16 139.69 12.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.516 1.527 . . . . 0.0 111.719 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.47 -31.59 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.984 0.914 . . . . 0.0 112.896 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.428 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 23.1 t70 -78.21 -28.82 48.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.321 0.964 . . . . 0.0 112.921 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -73.43 -28.2 61.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.515 0.726 . . . . 0.0 111.64 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.0 65.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.459 0.703 . . . . 0.0 111.371 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 55.7 mtmt -59.58 -36.29 75.95 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 120.797 -1.19 . . . . 0.0 112.492 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -62.87 -64.4 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.122 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.51 68.56 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -60.2 -32.79 71.43 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.292 1.037 . . . . 0.0 112.986 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -91.1 -22.06 20.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.539 0.736 . . . . 0.0 112.441 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -80.23 -47.32 14.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.557 1.143 . . . . 0.0 113.098 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.23 -11.43 30.29 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -171.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -66.03 112.83 4.05 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.704 -1.247 . . . . 0.0 110.925 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.22 3.42 63.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.592 1.568 . . . . 0.0 114.794 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -76.97 170.23 16.89 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.855 1.827 . . . . 0.0 112.439 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.6 137.05 44.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.719 1.208 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 24.6 tp -148.0 116.91 6.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.701 1.6 . . . . 0.0 109.602 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 54.85 33.91 20.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.339 1.456 . . . . 0.0 112.45 -170.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.88 -17.95 8.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.157 1.361 . . . . 0.0 114.313 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.0 mmt-85 -76.66 135.99 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.445 1.123 . . . . 0.0 109.748 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.38 129.48 34.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -111.12 157.78 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 111.302 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.8 152.6 45.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.883 1.673 . . . . 0.0 109.327 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -142.53 137.96 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.148 0.979 . . . . 0.0 110.838 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -156.2 162.2 40.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.413 1.485 . . . . 0.0 111.882 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.17 143.99 36.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.996 0.918 . . . . 0.0 111.685 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.4 m -67.22 129.26 39.33 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.894 -1.129 . . . . 0.0 112.703 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.9 pt -83.67 -21.65 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.302 -0.874 . . . . 0.0 112.422 171.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 12.0 p -153.81 144.81 22.77 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.905 3.282 . . . . 0.0 107.209 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -162.7 168.77 21.08 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -81.16 -48.86 1.05 Allowed Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.268 1.427 . . . . 0.0 114.774 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.78 179.0 6.37 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.778 2.986 . . . . 0.0 111.425 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -137.71 143.04 41.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.929 1.292 . . . . 0.0 112.014 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.251 1.178 0 C-N-CA 126.266 1.826 . . . . 0.0 112.135 -170.537 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.213 0 O4'-C1'-N19 111.62 3.42 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.222 1 O4'-C1'-N19 112.462 4.262 . 0.099 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.121 0 C3'-C2'-C1' 103.66 2.4 . 0.264 2o . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.253 0 O4'-C1'-N19 111.751 3.551 . 0.085 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.241 0 O4'-C1'-N19 111.111 2.911 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.301 0 O4'-C1'-N19 110.224 2.024 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.5 p 55.46 17.75 2.34 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.088 2.155 . . . . 0.0 116.505 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.3 p -164.54 156.62 16.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.46 1.504 . . . . 0.0 112.183 -173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.27 162.73 23.8 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.001 1.286 . . . . 0.0 112.981 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.0 m -148.53 151.08 34.5 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.147 1.379 . . . . 0.0 111.655 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.3 m -65.67 135.65 55.28 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.293 -0.88 . . . . 0.0 111.977 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.32 4.65 80.61 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.256 0.931 . . . . 0.0 114.752 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -62.92 129.97 42.74 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.979 1.389 . . . . 0.0 111.296 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.1 mtt85 -88.58 -1.77 58.24 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.919 1.287 . . . . 0.0 114.113 -170.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.63 148.81 34.88 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.594 1.558 . . . . 0.0 112.801 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 p30 31.69 58.25 1.17 Allowed Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 126.819 2.048 . . . . 0.0 116.338 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.72 146.86 49.53 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.538 2.826 . . . . 0.0 111.561 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -86.17 152.95 56.48 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.171 1.389 . . . . 0.0 112.604 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.96 144.32 57.08 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.249 3.299 . . . . 0.0 114.469 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -154.72 139.44 17.06 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.222 1.409 . . . . 0.0 110.359 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 58.6 m -55.67 -30.39 60.97 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.066 1.346 . . . . 0.0 112.597 170.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 t -87.59 130.8 34.63 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.178 0.991 . . . . 0.0 110.912 171.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.6 mt -118.3 145.77 44.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.327 1.851 . . . . 0.0 110.412 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.98 148.65 18.88 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.775 1.655 . . . . 0.0 110.542 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.64 130.86 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.342 1.857 . . . . 0.0 108.221 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.74 152.12 48.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.031 0.932 . . . . 0.0 111.41 -168.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.69 32.63 18.13 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 123.765 0.697 . . . . 0.0 113.668 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.5 159.52 21.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.994 1.318 . . . . 0.0 113.252 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.3 t -76.02 156.37 34.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.681 169.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.52 -19.26 63.72 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.505 -0.747 . . . . 0.0 112.127 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -94.05 -4.6 49.17 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.573 1.549 . . . . 0.0 114.282 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -66.97 132.93 48.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.465 1.106 . . . . 0.0 109.256 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.9 p -106.54 162.79 13.42 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.279 1.032 . . . . 0.0 111.153 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -60.7 -27.97 68.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.958 0.503 . . . . 0.0 111.22 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -70.94 -37.67 72.86 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.583 1.153 . . . . 0.0 112.514 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.83 -47.63 71.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.662 0.665 . . . . 0.0 110.438 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.1 -44.38 83.17 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.819 -0.55 . . . . 0.0 110.647 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -61.89 -41.68 98.18 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.419 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.17 -32.84 72.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.313 1.415 . . . . 0.0 112.689 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -77.42 -29.2 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.556 1.143 . . . . 0.0 111.933 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -99.99 -24.58 14.58 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.141 0.882 . . . . 0.0 113.364 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.9 m -69.33 -19.79 63.87 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.235 1.379 . . . . 0.0 113.693 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -70.19 -7.23 40.18 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.964 -1.085 . . . . 0.0 113.909 173.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -102.32 -5.57 24.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.456 1.502 . . . . 0.0 113.753 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.41 -175.65 24.86 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.385 1.469 . . . . 0.0 114.969 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.57 135.75 20.39 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.324 3.349 . . . . 0.0 112.476 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.51 127.71 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.767 1.627 . . . . 0.0 110.121 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.29 -32.03 19.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.933 1.293 . . . . 0.0 112.837 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -163.59 166.16 22.72 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.9 t -146.55 136.14 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 127.062 2.145 . . . . 0.0 108.161 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.8 m -133.0 110.24 10.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.037 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.0 mt -80.03 143.29 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.09 128.5 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.93 149.43 42.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.185 1.394 . . . . 0.0 112.496 -173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.57 143.08 48.41 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.939 0.895 . . . . 0.0 111.281 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -76.14 -22.93 54.88 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -119.46 -34.73 3.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.456 1.102 . . . . 0.0 112.658 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 72.3 m -83.11 -20.06 35.55 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.476 -0.765 . . . . 0.0 112.497 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 54.18 45.43 27.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.229 1.812 . . . . 0.0 112.659 170.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -138.15 156.89 47.29 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 129.336 3.054 . . . . 0.0 108.865 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.4 t -58.2 137.95 56.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.122 0.487 . . . . 0.0 111.289 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -79.22 -5.44 54.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.95 0.9 . . . . 0.0 112.773 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.17 14.63 62.01 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.777 1.18 . . . . 0.0 113.766 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.05 160.92 41.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.554 1.169 . . . . 0.0 113.148 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.93 15.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.381 1.873 . . . . 0.0 111.517 -168.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.44 152.1 42.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.404 1.482 . . . . 0.0 110.627 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.42 128.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.125 1.77 . . . . 0.0 109.071 -169.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.65 100.41 9.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.865 1.266 . . . . 0.0 111.826 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -76.78 159.06 30.43 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.576 -0.703 . . . . 0.0 111.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.27 3.72 45.58 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.954 0.902 . . . . 0.0 113.134 172.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -160.83 139.97 10.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.555 1.542 . . . . 0.0 111.67 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.79 -31.6 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.52 0.728 . . . . 0.0 112.567 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.62 -23.22 56.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.279 0.945 . . . . 0.0 113.12 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -82.52 -30.32 29.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.858 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.71 76.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.336 0.654 . . . . 0.0 111.458 169.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -61.54 -32.66 72.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.641 1.176 . . . . 0.0 112.489 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.94 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.889 0.876 . . . . 0.0 109.663 171.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.04 69.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.24 -34.27 74.86 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.932 0.893 . . . . 0.0 112.651 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -87.95 -23.62 23.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.557 0.743 . . . . 0.0 112.272 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -77.81 -45.8 23.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.51 1.124 . . . . 0.0 113.037 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.1 -12.34 21.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -65.66 112.83 3.85 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.615 -1.303 . . . . 0.0 110.861 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.17 8.58 71.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.495 1.522 . . . . 0.0 114.595 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.9 ptm -76.35 173.85 10.93 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.811 1.805 . . . . 0.0 111.523 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.61 135.16 54.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.296 1.039 . . . . 0.0 111.27 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -143.12 117.36 9.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.769 1.628 . . . . 0.0 109.224 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 29.0 t70 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.168 1.387 . . . . 0.0 112.45 -169.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.64 -5.18 65.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.648 1.118 . . . . 0.0 114.66 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.6 mmt-85 -92.05 129.62 37.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.891 1.346 . . . . 0.0 109.931 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.91 128.33 35.24 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.135 170.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -107.35 155.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 111.671 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -115.21 148.52 39.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.395 1.878 . . . . 0.0 108.64 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.8 t -144.73 136.44 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.46 1.104 . . . . 0.0 110.499 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.17 158.47 36.33 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.954 1.302 . . . . 0.0 112.438 -170.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -72.8 138.08 46.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.661 0.784 . . . . 0.0 111.822 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.3 m -72.33 130.46 40.82 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.3 pt -91.76 -14.94 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.733 1.213 . . . . 0.0 113.24 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.7 p -158.31 167.45 29.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.817 3.247 . . . . 0.0 108.416 -171.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -152.75 161.11 42.99 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -66.54 -46.39 58.32 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -83.07 158.98 15.5 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.579 2.853 . . . . 0.0 111.384 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -96.04 145.83 25.14 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.437 1.095 . . . . 0.0 113.055 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.263 1.825 . . . . 0.0 110.715 -178.859 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.351 1 O4'-C1'-N19 113.294 5.094 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.093 0 O4'-C1'-N19 111.533 3.333 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.178 0 O4'-C1'-N19 111.926 3.726 . 0.35 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 O4'-C1'-N19 111.347 3.147 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.601 0 O4'-C1'-N19 111.168 2.968 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.162 0 O4'-C1'-N19 111.624 3.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.583 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.9 p -164.55 174.91 10.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.319 1.448 . . . . 0.0 111.704 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 p -78.55 10.02 3.54 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.035 1.334 . . . . 0.0 113.839 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.42 -2.98 29.96 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.05 1.31 . . . . 0.0 115.177 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.4 p -147.83 17.68 1.12 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.827 1.651 . . . . 0.0 113.02 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.5 p -159.16 160.14 35.18 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.567 -1.333 . . . . 0.0 113.675 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.58 176.83 53.54 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.602 1.096 . . . . 0.0 113.18 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -152.88 127.68 9.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.122 0.969 . . . . 0.0 111.653 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -66.36 -20.33 66.05 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.797 1.239 . . . . 0.0 113.47 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.68 23.88 10.62 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.107 1.763 . . . . 0.0 114.386 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -171.94 63.85 0.36 Allowed Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 130.148 3.379 . . . . 0.0 110.294 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -75.4 178.95 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.593 2.862 . . . . 0.0 111.18 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -144.94 139.59 15.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.394 1.478 . . . . 0.0 110.048 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -48.26 136.95 24.69 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.575 3.517 . . . . 0.0 115.529 -171.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -156.84 141.4 16.77 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.719 1.607 . . . . 0.0 109.625 -171.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 96.4 m -58.92 -28.17 65.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.624 0.77 . . . . 0.0 112.224 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 71.8 m -87.52 124.05 33.07 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.707 1.203 . . . . 0.0 110.593 174.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -112.06 142.47 44.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.89 1.676 . . . . 0.0 110.151 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.61 145.05 17.57 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.497 1.522 . . . . 0.0 110.255 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.93 119.61 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.049 1.74 . . . . 0.0 107.814 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -126.47 158.85 35.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.406 1.482 . . . . 0.0 111.998 -167.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.56 25.03 55.11 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.127 0.87 . . . . 0.0 113.6 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.24 154.41 37.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.884 1.273 . . . . 0.0 113.342 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.8 t -72.67 143.24 48.18 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.778 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.02 -12.5 51.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -100.92 3.93 42.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.998 1.719 . . . . 0.0 114.032 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -63.46 143.04 58.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 109.806 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.5 p -110.96 159.71 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.681 0.792 . . . . 0.0 111.618 170.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.52 -30.79 67.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.889 0.876 . . . . 0.0 111.041 172.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -69.08 -38.33 78.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.748 1.219 . . . . 0.0 112.359 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -65.11 -48.05 75.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.486 0.585 . . . . 0.0 110.169 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.3 mt -59.01 -42.23 89.61 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.77 -0.581 . . . . 0.0 111.193 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.25 -45.91 92.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.107 0.867 . . . . 0.0 111.382 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -67.68 -31.32 71.21 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.406 1.457 . . . . 0.0 112.744 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.7 -29.22 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.521 1.128 . . . . 0.0 112.547 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -100.57 -27.8 13.22 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.1 p -73.31 -12.58 60.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 120.456 1.48 . . . . 0.0 114.311 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -67.64 -10.32 51.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.952 -1.092 . . . . 0.0 113.434 168.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -102.79 -7.89 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.479 1.511 . . . . 0.0 114.084 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.05 -175.95 31.35 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.597 1.094 . . . . 0.0 115.377 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.31 137.66 19.12 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.313 3.342 . . . . 0.0 112.036 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 73.4 mt -134.24 124.58 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.679 1.592 . . . . 0.0 109.902 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.2 -24.77 18.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.304 1.042 . . . . 0.0 113.557 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.38 159.73 28.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.725 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.9 t -150.83 136.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.354 2.261 . . . . 0.0 108.273 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -146.25 122.76 11.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.528 0.731 . . . . 0.0 112.024 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.62 143.96 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.363 1.065 . . . . 0.0 108.596 172.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.2 t -104.25 135.13 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.26 1.024 . . . . 0.0 110.205 -170.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -127.56 151.26 49.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.571 1.548 . . . . 0.0 112.879 -171.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -70.91 141.2 51.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.64 1.176 . . . . 0.0 111.421 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -78.22 -20.53 51.59 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -175.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -114.61 -38.74 3.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.415 1.086 . . . . 0.0 112.187 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.5 m -84.41 -16.24 43.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.802 0.841 . . . . 0.0 113.042 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 53.17 41.94 32.15 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.333 1.853 . . . . 0.0 113.323 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -134.6 153.37 52.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.077 2.551 . . . . 0.0 109.281 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.9 t -60.51 137.26 58.18 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 111.232 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -77.6 1.38 19.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.032 0.933 . . . . 0.0 112.986 173.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.65 17.21 58.77 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.431 1.015 . . . . 0.0 113.755 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -154.53 166.7 32.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.937 1.351 . . . . 0.0 114.204 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.41 171.51 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 111.056 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.47 150.7 48.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.146 1.378 . . . . 0.0 111.065 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.0 t -135.63 120.25 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.482 1.913 . . . . 0.0 108.303 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -107.17 100.69 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.57 1.148 . . . . 0.0 111.053 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.69 161.94 29.18 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.787 0.835 . . . . 0.0 111.983 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -94.13 7.61 44.6 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.289 1.036 . . . . 0.0 112.851 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.13 130.49 7.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.515 1.526 . . . . 0.0 111.571 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.26 -28.96 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.897 0.879 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.87 -24.5 48.51 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.407 1.003 . . . . 0.0 113.27 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -81.61 -29.46 33.28 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.802 0.841 . . . . 0.0 111.76 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.92 83.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.191 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -59.85 -34.38 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.283 1.033 . . . . 0.0 112.631 172.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.53 -62.85 1.22 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.773 0.829 . . . . 0.0 109.845 173.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.87 -35.2 70.64 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.27 -33.66 71.31 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.306 1.042 . . . . 0.0 112.852 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -89.05 -24.11 22.4 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.682 0.793 . . . . 0.0 112.307 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -78.79 -45.06 21.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.425 1.09 . . . . 0.0 113.152 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.1 -11.82 27.57 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.56 113.07 3.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.594 -1.316 . . . . 0.0 110.904 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.54 7.29 72.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.26 1.409 . . . . 0.0 114.733 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptm -76.22 173.16 11.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.693 1.746 . . . . 0.0 111.278 170.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -115.55 135.47 54.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.162 0.985 . . . . 0.0 111.028 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.9 tp -141.46 121.25 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 109.797 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.65 25.87 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.761 1.625 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.86 19.41 57.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.562 1.077 . . . . 0.0 114.445 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -131.7 132.12 43.66 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.544 1.538 . . . . 0.0 110.19 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.91 133.02 46.09 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.724 -0.61 . . . . 0.0 110.518 174.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.9 pt -111.0 159.0 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.887 0.875 . . . . 0.0 111.797 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -126.31 145.28 50.49 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.855 2.062 . . . . 0.0 108.857 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.36 134.46 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 118.968 0.803 . . . . 0.0 111.396 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -152.76 162.97 40.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 111.236 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -70.22 142.76 52.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.696 0.799 . . . . 0.0 111.655 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.6 m -63.47 124.07 20.38 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.276 -0.89 . . . . 0.0 112.634 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 13.0 pt -81.8 -22.06 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.86 0.864 . . . . 0.0 112.549 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.9 p -144.92 151.18 38.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.719 2.807 . . . . 0.0 107.12 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.07 155.89 37.69 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.808 0.843 . . . . 0.0 113.178 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.67 -41.6 9.73 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -172.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.6 146.1 23.84 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.093 2.529 . . . . 0.0 110.823 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -149.54 6.55 0.64 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -172.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 55.8 m . . . . . 0 C--O 1.251 1.135 0 C-N-CA 126.542 1.937 . . . . 0.0 110.77 -175.779 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.481 1 O4'-C1'-N19 114.868 6.668 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.228 0 O4'-C1'-N19 111.632 3.432 . 0.071 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 0 C4'-C3'-C2' 101.134 -1.566 . 0.165 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.079 1 O4'-C1'-N19 112.217 4.017 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.291 0 C5'-C4'-C3' 109.949 -3.701 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.1 0 C5'-C4'-C3' 111.652 -2.566 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 p -140.56 -0.34 1.57 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.8 p -169.01 144.89 3.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.023 1.329 . . . . 0.0 111.888 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.94 -61.74 2.94 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 125.326 1.441 . . . . 0.0 113.738 171.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.4 m -92.83 9.26 36.05 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.728 1.611 . . . . 0.0 112.275 172.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 69.1 m -156.92 137.97 13.57 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.924 2.09 . . . . 0.0 109.847 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.43 140.07 22.38 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.899 0.761 . . . . 0.0 111.715 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -161.98 133.2 5.22 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.411 1.084 . . . . 0.0 111.126 -173.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -2.21 21.96 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.98 26.88 4.87 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.312 1.445 . . . . 0.0 113.113 167.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 p30 178.99 58.39 0.07 OUTLIER Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 130.886 3.674 . . . . 0.0 112.505 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -78.67 -175.37 2.7 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 123.969 3.113 . . . . 0.0 111.167 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -146.95 136.8 11.95 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.868 1.267 . . . . 0.0 110.732 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.91 130.73 40.71 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.228 3.286 . . . . 0.0 113.623 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -161.04 167.67 25.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.142 1.377 . . . . 0.0 111.635 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 56.1 m -67.95 -14.15 62.73 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -171.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.7 m -98.45 128.15 44.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.447 1.099 . . . . 0.0 110.109 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.3 mt -115.44 146.76 41.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.281 1.433 . . . . 0.0 110.702 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.79 149.45 17.26 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.147 1.832 . . . . 0.0 110.614 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.6 t -136.67 129.23 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.028 2.131 . . . . 0.0 107.853 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -133.83 154.72 50.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.38 1.072 . . . . 0.0 112.684 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.45 30.21 50.26 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.056 0.836 . . . . 0.0 114.074 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.46 160.93 23.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.48 1.512 . . . . 0.0 113.521 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.1 t -72.34 155.09 40.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.013 0.925 . . . . 0.0 111.861 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.59 -17.61 62.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.457 0.703 . . . . 0.0 112.628 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -96.17 -5.55 40.31 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.083 1.353 . . . . 0.0 114.402 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.7 m -69.29 136.29 51.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.6 p -106.88 164.83 11.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.639 1.175 . . . . 0.0 111.484 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -59.26 -30.22 68.13 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.629 0.772 . . . . 0.0 111.147 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -70.61 -38.64 73.99 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.597 1.159 . . . . 0.0 112.166 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -66.36 -48.41 70.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.267 0.485 . . . . 0.0 110.341 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.0 mt -56.69 -44.79 81.83 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.815 -0.553 . . . . 0.0 110.941 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -60.97 -45.67 93.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.131 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -67.14 -29.05 68.66 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.227 1.376 . . . . 0.0 112.878 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.33 -27.68 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.44 1.096 . . . . 0.0 112.046 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -100.48 -23.73 14.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.4 p -70.39 -17.73 63.03 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.242 1.383 . . . . 0.0 113.911 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.57 -11.24 52.22 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 170.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.72 -7.14 24.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.376 1.47 . . . . 0.0 113.717 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.21 -178.47 24.82 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.221 1.391 . . . . 0.0 115.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.99 135.6 21.38 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.561 3.507 . . . . 0.0 112.668 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.47 124.26 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.062 1.745 . . . . 0.0 109.654 -174.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.12 -23.26 20.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.349 1.06 . . . . 0.0 113.493 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -161.48 162.44 30.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.0 t -151.28 135.49 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.236 2.214 . . . . 0.0 107.956 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.4 m -137.97 116.73 12.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.752 1.221 . . . . 0.0 111.393 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.84 147.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.1 t -96.95 127.68 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.111 0.964 . . . . 0.0 108.827 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.32 152.5 38.87 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.152 1.381 . . . . 0.0 112.137 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -77.28 151.55 34.99 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.343 0.657 . . . . 0.0 112.299 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -79.96 -23.67 41.48 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -122.37 -35.6 3.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.087 0.955 . . . . 0.0 112.756 -171.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 71.1 m -84.84 -23.45 29.03 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.522 -0.736 . . . . 0.0 112.428 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . 0.25 84.6 mtt180 58.42 23.57 10.77 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.47 1.908 . . . . 0.0 114.937 169.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 46.1 ptt85 -100.19 168.2 9.96 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.084 2.154 . . . . 0.0 110.097 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.5 t -58.97 141.18 54.5 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.91 0.385 . . . . 0.0 110.093 168.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -84.08 1.29 44.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.44 1.096 . . . . 0.0 112.858 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.97 8.81 62.98 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.707 1.146 . . . . 0.0 114.241 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -144.96 161.35 39.57 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.747 1.273 . . . . 0.0 113.424 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.1 13.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.051 1.74 . . . . 0.0 111.815 -168.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -145.69 156.27 43.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.999 1.72 . . . . 0.0 110.853 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.95 134.33 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.369 1.867 . . . . 0.0 109.171 -169.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.16 99.18 6.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.238 1.415 . . . . 0.0 111.078 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -79.58 158.91 27.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.02 0.928 . . . . 0.0 112.202 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.81 3.52 50.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.741 1.217 . . . . 0.0 113.063 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -157.99 137.35 11.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.563 1.545 . . . . 0.0 111.246 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.22 -32.83 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.318 0.647 . . . . 0.0 112.673 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.4 -24.42 54.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.901 0.773 . . . . 0.0 113.014 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.97 -29.15 35.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.307 1.043 . . . . 0.0 111.914 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.6 73.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.211 0.604 . . . . 0.0 110.97 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -59.78 -35.24 74.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.409 1.084 . . . . 0.0 112.502 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.22 -64.39 0.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.032 0.933 . . . . 0.0 110.015 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.11 -35.56 69.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.61 -34.5 72.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.172 0.989 . . . . 0.0 112.83 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -88.48 -24.71 22.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.611 0.764 . . . . 0.0 112.197 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -78.22 -45.57 22.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.429 1.092 . . . . 0.0 113.164 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.67 -11.43 29.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -66.02 112.98 4.12 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.611 -1.305 . . . . 0.0 111.106 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.68 8.68 73.08 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.35 1.452 . . . . 0.0 114.609 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 ptm -75.91 173.65 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.739 1.77 . . . . 0.0 111.435 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.38 134.54 54.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.204 1.002 . . . . 0.0 111.057 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.6 tp -143.7 118.87 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.51 1.524 . . . . 0.0 109.389 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 54.77 31.78 16.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.404 1.481 . . . . 0.0 112.44 -169.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.42 -4.87 66.01 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.694 1.14 . . . . 0.0 114.504 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.7 mmt-85 -92.98 130.06 38.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.933 1.367 . . . . 0.0 109.897 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.48 130.17 40.03 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.094 0.861 . . . . 0.0 109.817 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -109.08 160.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.027 0.931 . . . . 0.0 111.08 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.6 mtm-85 -127.81 156.31 42.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.481 1.112 . . . . 0.0 109.775 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.9 t -143.96 140.26 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.781 1.232 . . . . 0.0 110.962 -168.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.8 161.46 40.64 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.374 1.47 . . . . 0.0 112.151 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -72.66 137.79 46.27 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.03 0.932 . . . . 0.0 111.561 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 t -75.54 130.81 39.45 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.25 -0.906 . . . . 0.0 112.56 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.3 pt -93.4 -16.03 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.505 1.122 . . . . 0.0 113.523 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 16.7 p -154.65 161.77 41.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 129.716 3.207 . . . . 0.0 108.278 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -160.18 165.77 30.96 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.23 -52.01 50.06 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.06 151.6 39.47 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.181 2.587 . . . . 0.0 111.447 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -70.12 -18.25 63.23 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.369 1.868 . . . . 0.0 111.843 -175.391 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.235 1 O4'-C1'-N19 113.494 5.294 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.433 0 O4'-C1'-N19 111.888 3.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 0 C4'-C3'-C2' 99.96 -2.74 . 0.38 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 O5'-C5'-C4' 114.81 3.293 . 0.0 OUTLIER '7D dist 2z wannabe' 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.252 0 O4'-C1'-N19 112.066 3.866 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.058 0 C5'-C4'-C3' 110.301 -3.466 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.2 p -95.6 -2.66 47.84 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.833 1.253 . . . . 0.0 114.338 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 91.6 p -160.98 166.13 28.79 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.627 1.571 . . . . 0.0 112.084 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.51 -159.11 42.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.509 1.052 . . . . 0.0 112.962 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -160.78 153.55 21.03 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.074 1.35 . . . . 0.0 112.012 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -145.55 19.98 1.51 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.2 28.14 50.13 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 121.122 -0.986 . . . . 0.0 113.406 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -74.95 -2.86 28.99 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.477 1.511 . . . . 0.0 114.649 -171.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 72.54 9.69 5.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.892 2.477 . . . . 0.0 114.126 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.91 165.56 17.55 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.424 1.49 . . . . 0.0 111.979 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.8 m120 44.92 62.12 10.82 Favored Pre-proline 0 N--CA 1.485 1.313 0 C-N-CA 125.667 1.587 . . . . 0.0 114.655 171.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.16 168.47 24.67 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.829 3.019 . . . . 0.0 111.566 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -144.4 151.35 50.78 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 126.039 1.736 . . . . 0.0 110.49 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -50.22 140.61 33.17 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 124.536 3.491 . . . . 0.0 115.115 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -159.35 138.46 11.16 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.286 1.434 . . . . 0.0 110.245 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.7 m -57.35 -26.71 61.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.35 1.06 . . . . 0.0 112.612 170.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.9 m -90.0 114.58 26.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.555 1.542 . . . . 0.0 110.159 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.3 mt -102.17 146.94 27.25 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.627 1.171 . . . . 0.0 111.295 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.02 148.86 16.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.322 1.915 . . . . 0.0 110.47 168.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.54 124.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.192 1.797 . . . . 0.0 108.011 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -132.12 155.19 48.58 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.892 1.277 . . . . 0.0 111.91 -167.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.14 29.96 43.93 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.886 0.755 . . . . 0.0 113.398 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.79 163.84 25.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 113.168 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.8 t -76.06 154.51 35.59 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.005 168.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.0 -18.57 64.76 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.225 -0.922 . . . . 0.0 112.244 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -96.93 -1.43 45.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.846 1.658 . . . . 0.0 114.589 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 93.4 m -63.1 137.7 58.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.383 1.073 . . . . 0.0 109.611 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 p -110.34 161.64 15.43 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.861 0.864 . . . . 0.0 111.556 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.65 -27.22 68.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.336 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -69.61 -39.84 76.99 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.633 1.173 . . . . 0.0 112.251 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -65.88 -47.96 73.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.227 0.467 . . . . 0.0 110.315 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.0 mt -56.8 -44.36 81.87 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.764 -0.585 . . . . 0.0 110.921 174.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -63.17 -41.1 99.18 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.49 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.45 -31.12 69.24 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.174 1.352 . . . . 0.0 112.62 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.79 -28.91 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.374 1.07 . . . . 0.0 112.393 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -100.58 -27.47 13.39 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.1 p -71.83 -15.42 62.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.307 1.412 . . . . 0.0 114.109 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.9 -11.13 55.12 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.95 -1.094 . . . . 0.0 113.751 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -102.85 -5.18 23.86 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.302 1.441 . . . . 0.0 114.061 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.2 28.4 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.785 1.183 . . . . 0.0 115.307 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.5 135.42 18.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.313 3.342 . . . . 0.0 112.227 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.51 127.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.658 1.583 . . . . 0.0 110.187 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.91 -28.19 19.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.121 1.369 . . . . 0.0 113.325 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -162.61 167.08 23.8 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -149.38 137.16 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.448 2.299 . . . . 0.0 108.338 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.1 m -135.4 113.54 11.3 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.467 1.107 . . . . 0.0 111.635 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.34 144.97 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.294 -0.879 . . . . 0.0 108.835 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.5 t -105.51 133.51 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.338 1.055 . . . . 0.0 109.935 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -127.53 152.72 47.24 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.489 1.516 . . . . 0.0 112.958 -170.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.69 140.34 53.55 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.608 1.163 . . . . 0.0 111.535 172.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -71.87 -21.29 61.68 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.39 1.076 . . . . 0.0 113.807 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -126.72 -35.18 2.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.135 0.974 . . . . 0.0 112.781 -171.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.2 m -81.72 -15.2 55.16 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.424 -0.798 . . . . 0.0 112.844 171.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 53.58 40.23 31.15 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.357 1.863 . . . . 0.0 113.383 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -132.58 153.06 51.39 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.732 2.413 . . . . 0.0 109.476 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.2 t -59.96 137.83 57.98 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 122.013 -0.429 . . . . 0.0 111.286 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -76.89 0.45 20.87 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.654 0.781 . . . . 0.0 112.819 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.28 15.26 57.6 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 124.983 1.278 . . . . 0.0 113.721 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.53 165.15 36.02 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.948 1.356 . . . . 0.0 114.448 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.18 172.2 18.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.416 1.886 . . . . 0.0 111.509 -169.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.87 156.33 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.603 1.561 . . . . 0.0 110.908 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.84 131.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.801 2.04 . . . . 0.0 108.726 -168.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -114.79 97.5 6.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.688 1.195 . . . . 0.0 111.517 -170.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -76.57 156.89 32.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.105 0.562 . . . . 0.0 111.592 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -86.78 3.82 43.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.775 0.83 . . . . 0.0 113.189 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -160.64 143.38 13.02 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.537 1.535 . . . . 0.0 111.781 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.13 -31.72 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -74.48 -28.58 61.08 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.583 1.083 . . . . 0.0 112.859 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -75.42 -30.71 60.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.921 0.888 . . . . 0.0 111.673 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.97 -43.62 67.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.695 0.798 . . . . 0.0 111.444 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -59.33 -35.16 73.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.248 1.019 . . . . 0.0 112.419 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.17 -64.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.161 0.984 . . . . 0.0 110.163 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.3 69.54 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.41 -33.82 71.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.503 1.121 . . . . 0.0 112.845 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -89.34 -21.63 23.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.674 0.789 . . . . 0.0 112.391 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -81.17 -44.73 17.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.546 1.138 . . . . 0.0 113.071 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.7 -12.07 26.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -172.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -64.68 114.79 4.66 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.682 -1.261 . . . . 0.0 111.024 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.04 4.85 77.8 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.472 1.51 . . . . 0.0 114.695 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.4 ptm -73.25 169.18 17.63 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.839 1.82 . . . . 0.0 111.373 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -106.24 134.96 48.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.706 0.803 . . . . 0.0 110.975 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 46.7 tp -144.86 123.22 12.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.81 1.644 . . . . 0.0 109.327 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 55.25 33.57 20.93 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.099 1.36 . . . . 0.0 112.649 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.21 4.61 89.84 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.781 1.181 . . . . 0.0 114.601 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.8 mmt-85 -113.28 131.67 55.84 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.243 1.417 . . . . 0.0 110.431 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.43 131.08 44.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.91 0.777 . . . . 0.0 109.196 168.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.4 pt -110.68 160.19 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.733 0.813 . . . . 0.0 112.064 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -119.82 148.14 43.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.13 1.772 . . . . 0.0 108.919 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -141.95 135.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.316 1.047 . . . . 0.0 110.395 -172.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -156.57 165.52 36.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.222 1.409 . . . . 0.0 111.884 -170.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -80.87 141.95 34.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.371 1.068 . . . . 0.0 111.634 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.2 m -68.9 128.86 38.18 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.004 -1.06 . . . . 0.0 112.68 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.1 pt -87.73 -19.54 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.32 1.048 . . . . 0.0 112.474 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.0 p -154.02 154.17 33.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 130.302 3.441 . . . . 0.0 107.544 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -159.29 166.28 31.58 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -172.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -65.25 -53.54 39.13 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -81.53 159.66 19.49 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.416 2.744 . . . . 0.0 111.979 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -158.53 146.82 18.45 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.283 1.433 . . . . 0.0 112.298 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.362 1.865 . . . . 0.0 110.767 -178.53 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.394 0 C4'-C3'-C2' 100.417 -2.283 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 110.842 2.642 . 0.491 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 O5'-C5'-C4' 114.033 2.738 . 0.533 5z . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 0 O5'-C5'-C4' 114.145 2.818 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.283 1 O4'-C1'-N19 112.352 4.152 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.092 0 C5'-C4'-C3' 111.216 -2.856 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 m -86.51 -9.37 56.33 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.6 m -168.57 163.25 12.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.555 2.342 . . . . 0.0 110.212 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.03 -61.83 4.29 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 125.061 1.315 . . . . 0.0 112.532 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.9 m -78.69 -8.63 58.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.658 1.183 . . . . 0.0 112.663 171.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.0 m -149.23 150.3 32.37 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.526 2.331 . . . . 0.0 109.599 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.38 145.69 34.86 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.495 0.569 . . . . 0.0 112.112 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -155.07 127.61 7.93 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.589 1.155 . . . . 0.0 110.733 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -67.73 -15.11 63.48 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.38 37.65 1.0 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.519 1.528 . . . . 0.0 113.432 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -178.15 66.03 0.19 Allowed Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 129.128 2.971 . . . . 0.0 111.682 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.24 168.08 25.64 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.608 2.872 . . . . 0.0 111.304 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -155.49 141.55 12.95 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.51 1.524 . . . . 0.0 109.702 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.53 136.78 33.22 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.252 3.301 . . . . 0.0 114.742 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -155.59 150.91 26.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.413 1.485 . . . . 0.0 110.093 -172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.1 m -67.1 -5.65 14.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.119 1.368 . . . . 0.0 114.006 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.492 ' HG ' ' CB ' ' A' ' 194' ' ' SER . 27.3 p -132.51 151.82 51.77 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.703 1.201 . . . . 0.0 112.002 175.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.0 mt -126.48 151.58 47.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.893 2.077 . . . . 0.0 110.539 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.84 149.71 18.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.131 1.824 . . . . 0.0 110.496 167.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.8 129.49 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.396 1.878 . . . . 0.0 107.889 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -136.73 150.6 48.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 111.641 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.19 32.6 19.84 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.923 0.773 . . . . 0.0 113.26 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.9 mt -77.34 162.83 26.98 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.36 1.464 . . . . 0.0 113.642 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -78.91 152.52 31.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.792 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -16.75 63.31 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.427 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.57 -5.06 52.44 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.465 1.506 . . . . 0.0 114.288 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -67.71 135.42 52.71 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.476 1.111 . . . . 0.0 109.615 172.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.5 p -118.02 163.85 15.98 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.747 1.219 . . . . 0.0 110.761 172.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.77 -24.54 65.85 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.444 0.697 . . . . 0.0 111.725 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -58.02 -45.78 86.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.965 1.706 . . . . 0.0 111.774 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.92 -48.32 46.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.914 0.885 . . . . 0.0 110.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.57 -38.62 81.63 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.323 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -62.05 -45.97 91.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.239 0.927 . . . . 0.0 112.054 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.92 -31.01 69.6 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.097 1.317 . . . . 0.0 112.771 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.4 t -80.12 -30.58 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.603 1.161 . . . . 0.0 112.484 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -100.6 -25.59 14.11 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.7 p -71.29 -14.21 62.14 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.388 1.449 . . . . 0.0 113.91 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -67.2 -14.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.948 -1.095 . . . . 0.0 113.586 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.71 -8.54 34.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.009 1.324 . . . . 0.0 113.718 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -177.82 25.93 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.102 1.334 . . . . 0.0 114.65 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.98 135.48 25.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.327 3.351 . . . . 0.0 112.272 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.54 132.76 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.891 1.676 . . . . 0.0 110.504 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.81 -28.8 15.07 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.105 1.362 . . . . 0.0 113.111 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -164.3 164.45 22.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.008 0.923 . . . . 0.0 113.007 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.9 t -147.9 132.01 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.074 2.15 . . . . 0.0 107.732 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 56.6 m -132.63 104.83 6.85 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.5 mt -81.21 138.82 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 168.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.6 t -94.72 123.11 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -115.49 156.03 26.42 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.061 1.344 . . . . 0.0 112.083 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.81 161.95 28.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.877 0.871 . . . . 0.0 112.85 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -87.9 -28.39 21.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -115.81 -41.97 3.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.977 0.808 . . . . 0.0 112.793 -169.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.5 p -88.19 -23.73 23.51 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.45 0.7 . . . . 0.0 112.586 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 61.51 22.61 13.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.623 1.969 . . . . 0.0 114.088 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -79.55 159.57 26.82 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.868 2.067 . . . . 0.0 110.142 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -62.17 136.71 58.06 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.829 -0.544 . . . . 0.0 109.832 168.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -81.19 1.64 31.2 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.958 0.903 . . . . 0.0 113.032 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.38 10.18 62.41 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.626 1.107 . . . . 0.0 114.261 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -150.99 162.86 40.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.793 1.282 . . . . 0.0 113.484 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.82 172.72 17.73 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.237 1.815 . . . . 0.0 111.686 -169.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.78 155.1 46.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.823 1.649 . . . . 0.0 110.396 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.9 132.61 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.758 1.623 . . . . 0.0 109.298 -168.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.92 107.62 14.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.779 1.232 . . . . 0.0 111.996 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -85.52 157.55 20.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.411 1.085 . . . . 0.0 111.39 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -83.84 7.73 17.07 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.955 0.902 . . . . 0.0 113.18 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -160.89 143.44 12.67 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.774 1.629 . . . . 0.0 111.281 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.88 -33.8 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.525 0.73 . . . . 0.0 112.492 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.44 -25.53 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -78.91 -28.29 43.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.115 0.966 . . . . 0.0 111.968 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.6 64.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.547 0.739 . . . . 0.0 111.017 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -59.31 -36.97 76.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 0.0 112.285 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.05 -65.19 0.73 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.524 0.729 . . . . 0.0 109.944 170.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.0 65.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -61.57 -25.04 67.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.624 1.17 . . . . 0.0 113.329 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.28 4.59 36.72 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.612 1.565 . . . . 0.0 113.007 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -107.91 -52.23 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.21 1.404 . . . . 0.0 113.02 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.01 46.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -65.83 112.4 3.73 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.851 -1.156 . . . . 0.0 111.171 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.27 7.73 69.44 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.087 1.803 . . . . 0.0 114.746 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.3 ptm -75.58 162.22 28.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.75 1.775 . . . . 0.0 112.816 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.36 133.02 34.15 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.215 . . . . 0.0 110.733 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.3 tp -145.53 111.4 5.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 109.085 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.4 t70 54.36 36.23 24.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.235 1.414 . . . . 0.0 112.064 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.83 -22.01 6.14 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.287 1.422 . . . . 0.0 114.224 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -73.18 141.34 47.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.29 1.045 . . . . 0.0 110.322 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -85.3 126.05 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.2 pt -106.07 139.32 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.238 0.615 . . . . 0.0 111.294 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.11 146.78 23.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.655 1.182 . . . . 0.0 109.006 170.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -141.67 134.71 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.77 1.228 . . . . 0.0 110.097 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -156.67 159.96 38.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.909 1.284 . . . . 0.0 112.224 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -69.04 142.27 54.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.772 0.829 . . . . 0.0 112.041 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.492 ' CB ' ' HG ' ' A' ' 119' ' ' CYS . 74.8 m -65.77 119.09 10.6 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.441 -0.787 . . . . 0.0 112.291 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.2 pt -82.76 -14.92 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.288 1.035 . . . . 0.0 112.522 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 21.2 p -160.37 158.07 28.96 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 131.218 3.807 . . . . 0.0 107.192 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -152.58 150.26 29.35 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -165.25 96.71 0.84 Allowed Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 126.367 1.867 . . . . 0.0 111.448 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -87.29 -4.66 7.64 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 124.19 3.26 . . . . 0.0 113.565 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -155.19 160.9 41.23 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.016 1.326 . . . . 0.0 112.626 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 127.298 2.239 . . . . 0.0 113.772 -176.318 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.226 0 O4'-C1'-N19 111.931 3.731 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.352 0 C5'-C4'-C3' 110.84 -3.106 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.52 0 C4'-C3'-C2' 100.768 -1.932 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 C5'-C4'-C3' 110.94 -3.04 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.944 0 C4'-C3'-C2' 99.71 -2.99 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.081 0 O4'-C1'-N19 111.638 3.438 . 0.026 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.542 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.5 t -162.36 169.31 20.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.241 1.416 . . . . 0.0 111.469 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 t -167.56 -172.74 1.99 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.512 1.925 . . . . 0.0 110.737 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.42 5.09 58.09 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.252 1.406 . . . . 0.0 115.107 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.0 m -140.79 125.08 17.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.478 1.511 . . . . 0.0 109.96 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.7 m -67.69 -9.47 43.81 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -169.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.2 -3.82 88.6 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.06 1.314 . . . . 0.0 114.422 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -71.66 152.6 42.71 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.09 1.445 . . . . 0.0 112.812 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -94.0 1.84 56.18 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.85 25.65 10.78 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -159.14 66.15 2.9 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 127.978 2.511 . . . . 0.0 111.508 -175.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -75.58 167.14 27.12 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.081 2.521 . . . . 0.0 110.766 173.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -145.19 152.93 52.06 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.904 1.682 . . . . 0.0 110.195 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -49.46 134.53 32.39 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.291 3.328 . . . . 0.0 114.139 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -156.12 137.56 13.99 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.614 1.565 . . . . 0.0 109.468 -171.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 27.4 p -63.25 -20.72 65.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.469 0.708 . . . . 0.0 112.82 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.6 m -90.87 127.23 36.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.101 0.96 . . . . 0.0 110.853 169.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.49 144.22 44.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.741 1.616 . . . . 0.0 110.337 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.62 143.14 16.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.0 124.99 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.877 1.671 . . . . 0.0 107.697 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -129.01 163.99 24.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.249 1.42 . . . . 0.0 111.311 -168.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 29.93 59.56 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.471 -0.768 . . . . 0.0 113.574 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.3 mt -76.54 166.82 22.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.659 1.184 . . . . 0.0 112.924 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -85.71 151.92 23.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.039 0.936 . . . . 0.0 110.12 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.54 -18.69 65.5 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.065 -1.022 . . . . 0.0 112.327 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.39 -3.6 55.06 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.678 1.591 . . . . 0.0 114.559 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.0 m -66.8 135.27 53.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.195 0.998 . . . . 0.0 109.427 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 p -109.64 162.82 14.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.098 0.959 . . . . 0.0 111.64 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -61.08 -27.63 68.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.313 0.645 . . . . 0.0 111.297 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.01 -40.08 75.45 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.776 1.23 . . . . 0.0 112.085 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -65.97 -48.84 69.95 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.185 0.448 . . . . 0.0 110.219 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.26 -43.13 82.77 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.943 -0.473 . . . . 0.0 111.119 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.57 -49.1 79.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.733 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -66.9 -29.38 69.25 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.815 1.189 . . . . 0.0 112.944 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.53 -29.15 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.549 1.139 . . . . 0.0 112.122 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -100.64 -23.44 14.66 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.7 p -69.22 -15.84 63.47 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.287 1.403 . . . . 0.0 113.939 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.55 -15.33 63.6 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -95.07 -15.26 23.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 0.0 113.631 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.8 -175.6 32.82 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.823 1.202 . . . . 0.0 114.738 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.71 138.61 21.58 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.594 3.529 . . . . 0.0 111.955 -173.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.3 mt -130.0 123.33 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.162 1.385 . . . . 0.0 109.678 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.87 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.136 0.974 . . . . 0.0 111.771 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.86 175.07 5.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.417 1.087 . . . . 0.0 113.054 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.77 142.16 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.965 2.106 . . . . 0.0 108.785 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.5 t -139.98 118.87 12.52 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 111.67 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.72 147.4 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.731 0.812 . . . . 0.0 109.31 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.97 134.49 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 109.472 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -127.31 155.53 43.4 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.183 1.393 . . . . 0.0 113.174 -169.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.59 139.04 47.21 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.417 1.087 . . . . 0.0 111.059 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -74.68 -21.33 59.46 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -116.76 -39.31 3.31 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.989 0.915 . . . . 0.0 112.448 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.3 m -87.12 -16.22 36.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.976 0.91 . . . . 0.0 113.034 176.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 63.97 10.3 5.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.475 1.91 . . . . 0.0 114.953 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -86.67 157.49 19.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.916 2.086 . . . . 0.0 111.145 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.3 t -61.11 139.74 58.03 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.897 -0.502 . . . . 0.0 110.666 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -77.77 -0.06 25.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.833 0.853 . . . . 0.0 112.848 172.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.01 11.55 61.34 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.021 1.296 . . . . 0.0 113.833 -178.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -148.11 165.93 29.36 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.753 1.263 . . . . 0.0 114.185 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.86 169.13 25.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.813 2.045 . . . . 0.0 111.169 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -133.32 147.05 51.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.013 1.325 . . . . 0.0 110.838 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.6 t -129.32 124.82 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.708 2.003 . . . . 0.0 107.856 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.1 100.38 9.72 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.576 0.75 . . . . 0.0 110.634 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.03 156.26 31.95 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.873 -1.142 . . . . 0.0 111.489 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.93 8.11 21.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.957 0.903 . . . . 0.0 112.769 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -157.07 135.82 11.6 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.107 1.763 . . . . 0.0 110.861 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.12 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.296 0.639 . . . . 0.0 112.441 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.53 -24.66 49.91 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -172.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.44 -26.94 34.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.05 0.94 . . . . 0.0 112.0 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.64 -41.16 65.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.579 0.752 . . . . 0.0 111.355 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -59.33 -31.91 69.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 0.0 112.584 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.64 -63.58 1.04 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.257 1.023 . . . . 0.0 110.039 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -36.43 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.47 -30.1 68.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.748 1.219 . . . . 0.0 113.313 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -93.48 -22.58 18.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.942 0.897 . . . . 0.0 112.42 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -79.77 -45.54 18.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.553 1.141 . . . . 0.0 113.145 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.43 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -66.83 113.49 4.94 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.649 -1.282 . . . . 0.0 111.197 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.18 75.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.537 1.541 . . . . 0.0 114.521 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -73.94 162.71 28.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.744 1.772 . . . . 0.0 111.467 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -104.28 134.31 47.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.429 1.091 . . . . 0.0 110.943 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.8 tp -144.46 114.96 7.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.06 1.744 . . . . 0.0 109.079 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 23.71 10.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.338 1.455 . . . . 0.0 113.272 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.39 -10.89 72.98 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.72 1.629 . . . . 0.0 114.536 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -90.05 134.41 34.26 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.415 1.486 . . . . 0.0 109.756 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.77 135.95 38.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.23 0.923 . . . . 0.0 108.888 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.3 pt -106.39 152.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.042 0.937 . . . . 0.0 110.652 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -110.86 155.92 21.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.075 0.95 . . . . 0.0 109.606 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -143.76 136.45 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.424 1.09 . . . . 0.0 110.416 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -155.64 161.06 40.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.171 1.389 . . . . 0.0 111.249 -175.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -69.98 137.15 51.19 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.47 -0.769 . . . . 0.0 110.392 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 97.0 p -80.0 141.97 35.44 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.191 -0.943 . . . . 0.0 112.127 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.9 pt -84.59 3.73 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 121.054 -1.029 . . . . 0.0 112.982 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.0 p -156.58 -176.55 6.03 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 130.547 3.539 . . . . 0.0 108.726 -170.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -162.08 -177.62 5.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.185 1.794 . . . . 0.0 111.89 169.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -50.82 126.56 24.64 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.17 1.388 . . . . 0.0 112.848 -170.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.04 158.19 46.04 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.511 2.807 . . . . 0.0 111.698 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -159.88 147.47 16.74 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.557 1.543 . . . . 0.0 112.258 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.252 1.2 0 C-N-CA 126.194 1.798 . . . . 0.0 110.938 -174.949 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 O4'-C1'-N19 111.551 3.351 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.048 1 O4'-C1'-N19 112.381 4.181 . 0.01 5n . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.443 0 C4'-C3'-C2' 100.072 -2.628 . 0.143 1z . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 O5'-C5'-C4' 115.053 3.466 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 O4'-C1'-N19 110.736 2.536 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.239 0 C5'-C4'-C3' 111.644 -2.571 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -81.45 -11.04 59.36 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.6 p -164.0 -49.83 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.678 1.191 . . . . 0.0 113.062 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.15 -151.4 36.79 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.578 1.085 . . . . 0.0 113.023 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.5 m 67.45 14.41 9.61 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.738 1.615 . . . . 0.0 114.672 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.3 t -160.84 159.6 30.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.464 1.506 . . . . 0.0 111.419 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.41 143.88 31.07 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.512 1.053 . . . . 0.0 112.778 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -145.37 152.7 40.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.475 1.91 . . . . 0.0 110.032 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ptt-85 -138.69 35.79 2.21 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -169.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.38 34.95 2.99 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.761 1.624 . . . . 0.0 111.412 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -177.62 54.21 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 128.362 2.665 . . . . 0.0 113.238 -168.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -74.97 -175.72 2.5 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.607 2.872 . . . . 0.0 112.073 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -144.48 144.28 24.66 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.228 1.811 . . . . 0.0 110.095 -174.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -47.82 136.8 22.16 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 124.533 3.489 . . . . 0.0 115.452 -173.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -157.76 145.64 18.74 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.308 1.443 . . . . 0.0 110.632 -169.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 81.6 m -58.03 -29.58 65.45 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.651 1.18 . . . . 0.0 112.398 169.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.6 m -83.12 124.37 30.42 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.408 1.483 . . . . 0.0 110.298 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.1 mt -117.6 144.13 45.45 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.838 1.655 . . . . 0.0 110.615 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.16 147.71 18.66 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.784 1.659 . . . . 0.0 110.06 167.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.13 131.34 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.509 1.924 . . . . 0.0 107.851 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -138.13 139.87 39.63 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.942 0.897 . . . . 0.0 111.342 -168.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.32 26.43 6.93 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.024 0.821 . . . . 0.0 114.18 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.9 mt -74.47 162.72 28.55 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.631 1.173 . . . . 0.0 113.388 -174.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -84.67 155.88 21.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.3 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.93 -17.65 63.34 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.308 -0.87 . . . . 0.0 112.416 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -92.8 -5.05 51.95 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.846 1.658 . . . . 0.0 114.271 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.7 m -68.87 136.02 51.99 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.562 1.145 . . . . 0.0 109.548 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.1 p -118.66 162.29 18.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.598 1.159 . . . . 0.0 111.004 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.32 -27.74 66.16 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.7 0.8 . . . . 0.0 111.654 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -56.0 -46.84 78.6 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.349 1.86 . . . . 0.0 111.905 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -69.89 -46.87 64.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.93 0.892 . . . . 0.0 110.046 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.4 -41.39 84.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.182 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.19 -47.77 84.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.317 0.962 . . . . 0.0 111.11 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.5 -30.85 69.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.245 1.384 . . . . 0.0 113.014 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.7 -30.93 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.629 1.171 . . . . 0.0 112.356 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -100.44 -26.45 13.86 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -73.16 -8.99 58.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.534 1.515 . . . . 0.0 114.234 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.07 -15.54 63.79 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.857 -1.152 . . . . 0.0 113.033 168.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -94.73 -11.67 28.65 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.437 . . . . 0.0 113.621 176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.26 -178.29 29.56 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.006 1.289 . . . . 0.0 114.52 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.58 138.1 28.88 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.223 3.282 . . . . 0.0 112.114 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 55.6 mt -130.94 126.66 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.819 1.648 . . . . 0.0 110.179 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.25 -19.26 17.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -158.46 162.07 37.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.074 0.852 . . . . 0.0 113.183 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.9 t -146.5 136.21 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.013 2.125 . . . . 0.0 107.472 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -133.48 109.16 9.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 110.936 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.22 134.99 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t -88.88 103.4 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -95.1 148.91 21.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.549 1.14 . . . . 0.0 111.924 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.95 157.83 36.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.778 0.831 . . . . 0.0 112.509 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -85.99 -23.27 26.93 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -119.0 -39.97 2.88 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.517 1.127 . . . . 0.0 112.596 -169.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 79.6 p -85.61 -21.09 28.62 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.416 1.007 . . . . 0.0 112.607 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 57.04 26.26 11.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.645 1.978 . . . . 0.0 113.557 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -104.5 164.69 11.57 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 128.296 2.638 . . . . 0.0 109.49 172.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.5 t -60.56 135.75 57.85 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.742 -0.599 . . . . 0.0 110.54 172.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -78.11 -2.08 35.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.751 0.82 . . . . 0.0 112.64 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.67 11.94 60.0 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.869 1.223 . . . . 0.0 114.125 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -147.45 163.6 35.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.469 1.135 . . . . 0.0 113.186 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.07 174.23 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.159 1.784 . . . . 0.0 112.054 -168.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.41 150.04 43.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.292 1.837 . . . . 0.0 109.99 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.5 t -136.79 135.11 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.288 1.835 . . . . 0.0 108.716 -169.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -120.43 97.79 5.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.496 1.118 . . . . 0.0 112.245 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -77.73 161.9 27.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.346 0.659 . . . . 0.0 112.012 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.27 10.28 38.42 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.209 1.003 . . . . 0.0 112.799 171.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -156.72 131.35 8.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.59 1.556 . . . . 0.0 111.383 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.09 -29.17 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.939 0.896 . . . . 0.0 112.585 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.77 -28.18 44.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.239 0.927 . . . . 0.0 112.916 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.08 -30.02 55.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.514 0.726 . . . . 0.0 111.635 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.08 80.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.179 0.592 . . . . 0.0 111.419 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -60.07 -40.29 88.98 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.4 -58.08 8.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.707 0.803 . . . . 0.0 110.408 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.31 -38.63 77.48 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.13 -40.16 88.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.949 0.9 . . . . 0.0 112.222 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -81.65 -26.32 34.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.127 0.571 . . . . 0.0 112.506 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -74.83 -48.26 26.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.638 1.175 . . . . 0.0 113.286 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.31 -12.27 30.46 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -169.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -66.65 111.88 3.89 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.614 -1.304 . . . . 0.0 111.141 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.83 7.2 68.84 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.367 1.937 . . . . 0.0 114.572 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -73.76 168.65 18.96 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.68 1.74 . . . . 0.0 111.721 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.71 135.82 49.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.6 tp -145.07 117.97 8.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.145 1.778 . . . . 0.0 109.353 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 55.39 28.46 11.52 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.751 1.621 . . . . 0.0 113.42 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.38 6.96 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.721 1.153 . . . . 0.0 114.527 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -109.08 140.61 42.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.706 1.602 . . . . 0.0 110.503 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 136.63 39.09 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 168.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.9 pt -117.22 154.66 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -116.8 156.27 27.53 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.512 1.525 . . . . 0.0 109.498 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.82 137.43 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.853 1.261 . . . . 0.0 110.024 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -156.92 166.1 34.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.815 1.246 . . . . 0.0 111.853 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.79 140.29 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.234 -0.916 . . . . 0.0 112.211 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.9 m -81.45 141.13 34.18 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.68 2.33 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.912 1.285 . . . . 0.0 113.525 173.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 40.6 p -150.62 -173.33 4.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 128.791 2.837 . . . . 0.0 110.269 -170.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -154.7 168.52 26.56 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -53.24 134.2 51.23 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.19 2.596 . . . . 0.0 111.51 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.55 145.36 58.12 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.285 2.656 . . . . 0.0 111.302 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -162.27 146.33 12.07 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.532 1.533 . . . . 0.0 112.228 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.17 1.788 . . . . 0.0 110.847 -177.578 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.277 0 C5'-C4'-C3' 111.014 -2.991 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O4'-C1'-N19 111.974 3.774 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 C3'-C2'-C1' 103.677 2.419 . 0.472 5z . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.429 0 O4'-C1'-N19 111.864 3.664 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.253 1 O4'-C1'-N19 113.021 4.821 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.359 0 O5'-C5'-C4' 113.871 2.622 . 0.212 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.5 t -164.05 155.4 16.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.312 1.445 . . . . 0.0 111.151 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.9 p -79.42 -15.32 58.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.535 1.134 . . . . 0.0 113.277 171.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.61 -93.64 0.18 Allowed Glycine 0 C--N 1.343 0.962 0 C-N-CA 125.098 1.332 . . . . 0.0 111.965 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -130.37 13.27 5.54 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.79 1.636 . . . . 0.0 112.771 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.2 t -147.74 108.58 4.2 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.527 -1.358 . . . . 0.0 111.486 -175.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.27 136.95 22.13 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.193 0.901 . . . . 0.0 113.006 -172.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.02 137.95 50.09 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.153 0.981 . . . . 0.0 111.573 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -76.43 90.24 3.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.345 0.658 . . . . 0.0 110.674 -170.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.44 156.82 29.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.031 1.732 . . . . 0.0 111.146 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 39.18 61.89 5.18 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 126.011 1.725 . . . . 0.0 114.306 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.07 134.05 28.42 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.638 2.892 . . . . 0.0 110.759 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -97.04 132.95 24.81 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.175 0.99 . . . . 0.0 111.757 -173.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.52 125.35 17.53 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.521 3.481 . . . . 0.0 113.862 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -160.4 167.54 27.13 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.46 1.504 . . . . 0.0 111.512 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 71.0 m -65.26 -15.04 62.07 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -171.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.0 t -107.17 123.02 47.66 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.426 1.012 . . . . 0.0 111.061 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.04 149.48 24.52 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.836 1.654 . . . . 0.0 110.952 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.51 142.36 15.47 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.078 1.799 . . . . 0.0 110.227 167.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.98 127.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.623 1.969 . . . . 0.0 107.638 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -136.85 157.06 47.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.972 0.909 . . . . 0.0 111.386 -168.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.96 36.22 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.211 0.91 . . . . 0.0 113.675 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.24 160.29 31.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.426 1.491 . . . . 0.0 113.38 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -77.65 152.52 33.79 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 167.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.62 -18.2 65.24 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.307 -0.871 . . . . 0.0 112.726 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -100.74 -1.7 34.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.812 1.645 . . . . 0.0 114.243 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -65.85 136.41 56.13 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.615 1.166 . . . . 0.0 109.366 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.8 p -115.16 165.56 12.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.151 0.981 . . . . 0.0 111.644 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.94 -25.34 67.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.458 0.703 . . . . 0.0 111.748 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -68.61 -42.18 78.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.261 1.024 . . . . 0.0 111.461 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -66.87 -49.23 66.31 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.167 0.587 . . . . 0.0 110.386 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -58.93 -40.1 83.56 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.709 -0.619 . . . . 0.0 111.402 174.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.3 ttp-105 -59.53 -49.46 77.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.043 0.838 . . . . 0.0 111.625 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.01 -30.24 69.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.7 1.137 . . . . 0.0 113.057 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.56 -28.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.53 1.132 . . . . 0.0 112.042 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -100.67 -23.44 14.64 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.4 p -70.65 -18.3 62.85 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.363 1.438 . . . . 0.0 113.942 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -67.46 -10.51 52.18 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -101.79 -5.83 24.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.314 1.446 . . . . 0.0 113.912 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -178.16 25.7 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.951 1.262 . . . . 0.0 115.049 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.79 137.82 25.26 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.433 3.422 . . . . 0.0 112.28 -170.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.66 131.05 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.948 1.699 . . . . 0.0 110.032 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.46 -26.59 15.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.996 1.318 . . . . 0.0 113.222 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -163.41 165.23 24.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 113.077 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -146.89 133.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.837 2.055 . . . . 0.0 107.762 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.0 m -131.38 102.96 6.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.555 1.142 . . . . 0.0 110.749 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.6 mt -77.59 140.5 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t -91.31 120.71 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -111.2 143.66 41.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.53 1.132 . . . . 0.0 112.634 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -62.79 145.86 53.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.642 1.577 . . . . 0.0 111.974 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -72.09 -20.27 61.68 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -174.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -125.53 -34.61 2.65 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.113 0.965 . . . . 0.0 113.299 -170.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.6 p -94.78 -18.95 20.77 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.347 0.976 . . . . 0.0 113.38 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 59.81 16.3 5.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.92 1.688 . . . . 0.0 114.11 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.29 159.66 27.14 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.763 1.625 . . . . 0.0 109.933 169.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.0 t -57.19 136.95 56.46 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.465 -0.772 . . . . 0.0 110.49 170.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -75.46 -1.45 24.13 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.413 0.685 . . . . 0.0 112.737 173.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.13 59.54 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.646 1.593 . . . . 0.0 113.742 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -148.46 162.57 39.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.962 1.363 . . . . 0.0 114.256 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.31 172.25 17.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.761 2.024 . . . . 0.0 111.272 -169.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -138.94 155.6 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.363 1.465 . . . . 0.0 110.217 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -138.78 126.27 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.642 1.577 . . . . 0.0 109.151 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -108.51 101.19 10.37 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 111.737 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -76.75 159.76 29.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.294 1.038 . . . . 0.0 111.573 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.87 4.79 43.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.881 0.872 . . . . 0.0 113.005 171.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -159.82 136.14 8.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.368 1.467 . . . . 0.0 111.754 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.12 -30.71 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.001 0.921 . . . . 0.0 112.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.11 -23.57 51.81 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.479 1.036 . . . . 0.0 113.224 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -80.98 -29.6 35.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.788 170.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.57 81.97 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.236 0.614 . . . . 0.0 110.99 168.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.45 -31.94 71.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.31 1.044 . . . . 0.0 112.862 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.67 -64.25 0.9 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.76 0.824 . . . . 0.0 109.671 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.73 -34.96 70.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.27 -34.72 72.59 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.064 0.946 . . . . 0.0 112.883 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -88.78 -23.44 22.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.59 -45.38 19.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 113.114 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.82 31.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.33 111.32 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.698 -1.252 . . . . 0.0 111.057 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.56 8.64 70.26 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.278 1.418 . . . . 0.0 114.703 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.7 ptm -75.75 172.33 12.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.758 1.779 . . . . 0.0 111.471 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.28 135.41 54.18 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.974 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 40.0 tp -141.28 118.7 11.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.575 1.55 . . . . 0.0 109.534 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.5 t70 56.78 25.03 9.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.683 1.593 . . . . 0.0 113.417 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.08 8.6 71.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.01 1.291 . . . . 0.0 114.805 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -116.35 133.0 56.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.887 1.675 . . . . 0.0 110.614 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.43 129.69 38.94 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.819 -0.551 . . . . 0.0 110.267 173.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.9 pt -107.24 166.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.094 0.958 . . . . 0.0 111.008 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -142.54 151.15 41.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.096 1.759 . . . . 0.0 109.096 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.7 t -144.18 143.51 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.324 1.05 . . . . 0.0 112.569 -165.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -153.38 166.36 32.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.025 2.13 . . . . 0.0 111.419 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.02 149.0 48.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.522 -0.736 . . . . 0.0 111.543 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 91.6 p -79.89 124.28 28.52 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.081 -1.012 . . . . 0.0 113.374 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.0 pt -79.69 -16.94 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.609 1.164 . . . . 0.0 113.181 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.0 p -155.25 154.38 32.09 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 130.808 3.643 . . . . 0.0 106.842 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.84 148.26 23.75 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -172.14 105.63 0.35 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 127.972 2.509 . . . . 0.0 109.546 -173.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.41 156.15 58.91 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.771 2.314 . . . . 0.0 110.6 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -60.5 120.58 10.23 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.362 1.065 . . . . 0.0 112.589 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 128.778 2.831 . . . . 0.0 109.434 -176.72 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.111 1 O4'-C1'-N19 113.414 5.214 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.246 1 O4'-C1'-N19 114.771 6.571 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.287 0 O4'-C1'-N19 111.652 3.452 . 0.119 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.459 0 O5'-C5'-C4' 114.388 2.992 . 0.094 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 O4'-C1'-N19 111.097 2.897 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.001 0 O4'-C1'-N19 111.887 3.687 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.4 m 63.18 25.92 15.04 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.082 1.353 . . . . 0.0 112.83 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -74.99 -9.36 58.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.36 -171.84 54.96 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.886 1.232 . . . . 0.0 113.152 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 76.7 p -163.58 155.55 17.38 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.8 1.24 . . . . 0.0 112.574 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.8 p -169.11 174.91 5.98 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.465 1.906 . . . . 0.0 110.59 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.4 32.8 0.97 Allowed Glycine 0 N--CA 1.477 1.403 0 C-N-CA 125.455 1.503 . . . . 0.0 114.584 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -78.0 -3.41 41.9 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.615 1.966 . . . . 0.0 114.789 -175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 71.24 -1.96 2.55 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 128.437 2.695 . . . . 0.0 115.941 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.3 41.92 1.06 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.193 1.397 . . . . 0.0 111.678 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -170.11 42.79 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 127.11 2.164 . . . . 0.0 114.866 -167.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -66.45 150.98 84.06 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.487 2.125 . . . . 0.0 110.43 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.81 139.93 13.39 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.138 1.375 . . . . 0.0 110.172 -173.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.63 130.49 37.03 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.098 3.199 . . . . 0.0 113.873 -172.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -153.7 30.8 0.46 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.96 0.904 . . . . 0.0 113.11 -168.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 82.9 m 61.37 18.59 9.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.033 2.133 . . . . 0.0 114.218 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.2 t -157.52 137.4 12.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.349 1.46 . . . . 0.0 110.043 -170.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.3 mt -121.2 141.45 50.84 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.65 1.58 . . . . 0.0 110.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.23 144.73 17.42 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.482 1.515 . . . . 0.0 110.197 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.03 122.45 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.444 1.898 . . . . 0.0 107.472 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -129.23 147.58 51.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.767 1.227 . . . . 0.0 111.786 -167.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.53 31.7 11.18 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 124.071 0.843 . . . . 0.0 113.547 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.13 162.43 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.438 1.495 . . . . 0.0 113.153 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.3 t -81.83 154.62 25.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.27 0.628 . . . . 0.0 110.998 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.3 -17.38 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 112.601 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.37 -4.22 54.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.535 1.534 . . . . 0.0 114.279 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.5 m -66.81 133.59 50.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.67 1.188 . . . . 0.0 109.649 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.6 p -108.67 163.77 12.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.268 1.027 . . . . 0.0 111.546 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -61.32 -27.32 68.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.279 0.632 . . . . 0.0 111.176 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -73.69 -36.77 65.32 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.824 1.249 . . . . 0.0 112.57 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -66.07 -48.47 70.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.639 0.654 . . . . 0.0 110.28 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.95 -41.22 86.92 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.786 -0.571 . . . . 0.0 111.009 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -58.36 -50.04 75.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.867 0.758 . . . . 0.0 111.667 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.47 -29.39 68.82 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.655 1.116 . . . . 0.0 113.135 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -80.01 -29.42 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.093 0.957 . . . . 0.0 112.011 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -100.6 -22.0 15.1 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -69.19 -20.35 63.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.366 1.439 . . . . 0.0 113.799 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -67.68 -11.3 57.97 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 172.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.1 -9.38 22.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.191 1.396 . . . . 0.0 113.7 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.9 -173.09 27.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.914 1.245 . . . . 0.0 115.185 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.25 132.78 12.8 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.288 3.325 . . . . 0.0 112.758 -169.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.07 128.73 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.813 1.645 . . . . 0.0 109.367 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.04 -40.98 29.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.749 1.22 . . . . 0.0 111.872 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -169.6 173.86 6.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.993 1.717 . . . . 0.0 111.614 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.15 140.08 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.492 1.917 . . . . 0.0 108.428 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 t -142.37 116.25 9.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.253 0.621 . . . . 0.0 111.765 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.46 150.69 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.093 0.957 . . . . 0.0 109.974 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.12 132.37 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.173 0.989 . . . . 0.0 109.265 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -125.7 151.17 46.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.111 1.364 . . . . 0.0 112.867 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.32 149.31 42.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.061 0.945 . . . . 0.0 111.423 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -78.98 -24.35 43.86 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -123.4 -35.09 3.0 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.154 0.981 . . . . 0.0 113.019 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.8 m -84.52 -22.71 30.08 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.579 0.751 . . . . 0.0 112.165 170.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . 0.262 86.2 mtt180 58.84 25.02 13.06 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.385 1.874 . . . . 0.0 114.821 169.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -97.57 166.56 11.45 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.066 2.147 . . . . 0.0 110.064 168.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.9 t -58.48 140.73 53.49 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.938 -0.476 . . . . 0.0 110.049 168.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -75.6 -8.52 56.98 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 172.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 98.24 13.68 41.38 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.022 1.296 . . . . 0.0 113.94 -174.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -149.27 161.45 42.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.897 1.332 . . . . 0.0 113.633 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -161.5 174.03 14.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.582 1.953 . . . . 0.0 110.54 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -143.56 152.86 41.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.07 120.67 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.321 1.848 . . . . 0.0 108.091 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -98.81 125.59 44.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.61 1.164 . . . . 0.0 109.573 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -105.86 148.94 27.0 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.101 0.96 . . . . 0.0 112.089 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.52 -1.97 54.92 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -155.88 132.91 10.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.672 1.589 . . . . 0.0 111.062 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.47 -30.52 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.29 -17.87 60.18 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -86.78 -28.34 23.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.642 1.177 . . . . 0.0 112.076 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.01 -39.27 79.4 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.729 -0.607 . . . . 0.0 110.408 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -64.16 -23.58 67.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.706 1.202 . . . . 0.0 113.283 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.98 -64.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.776 0.83 . . . . 0.0 109.183 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -36.62 61.71 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -58.83 -31.97 68.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.188 0.995 . . . . 0.0 113.286 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -92.66 -10.53 36.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.103 0.961 . . . . 0.0 112.74 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -96.5 -49.83 4.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.896 1.278 . . . . 0.0 112.559 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.28 -16.19 40.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -63.99 115.66 5.12 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.989 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.84 6.54 76.0 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.226 1.393 . . . . 0.0 114.397 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -77.17 169.22 18.72 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.732 1.766 . . . . 0.0 111.704 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -117.22 123.96 47.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.888 0.875 . . . . 0.0 111.51 -174.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 11.5 tp -127.75 111.86 14.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.158 1.783 . . . . 0.0 109.351 -169.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.5 t70 56.31 27.27 11.62 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.081 1.353 . . . . 0.0 112.991 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.8 -1.18 80.68 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.386 1.469 . . . . 0.0 114.738 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -103.14 127.37 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.381 1.473 . . . . 0.0 110.041 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.01 128.57 36.41 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.34 155.64 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.725 0.81 . . . . 0.0 111.394 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -124.52 151.96 44.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.548 1.539 . . . . 0.0 109.245 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.1 t -141.51 136.2 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.285 1.034 . . . . 0.0 111.287 -168.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -147.25 159.27 43.85 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.357 1.863 . . . . 0.0 111.504 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -69.89 143.63 52.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.416 0.686 . . . . 0.0 111.855 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.9 m -84.28 124.31 31.1 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -172.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.8 pt -80.98 -13.78 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.272 1.029 . . . . 0.0 113.016 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 22.6 p -156.7 162.39 39.8 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 130.143 3.377 . . . . 0.0 108.399 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 160.76 39.32 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.42 -40.7 20.78 Favored Pre-proline 0 N--CA 1.48 1.038 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -61.24 157.19 41.33 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.218 3.279 . . . . 0.0 113.002 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -157.73 145.31 18.53 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.897 1.279 . . . . 0.0 112.478 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.29 1.836 . . . . 0.0 110.926 -174.641 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.177 0 O4'-C1'-N19 111.728 3.528 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 0 C5'-C4'-C3' 110.29 -3.474 . 0.028 4n . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.433 0 O4'-C1'-N19 110.764 2.564 . 0.247 3b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 0 O5'-C5'-C4' 115.161 3.543 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 P-O3'-C3' 123.34 3.033 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.153 1 O4'-C1'-N19 112.557 4.357 . 0.06 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.3 m -57.32 132.9 54.45 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.684 1.193 . . . . 0.0 112.652 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.1 m 67.21 9.17 6.75 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.869 1.668 . . . . 0.0 114.635 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.3 163.63 52.02 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.834 1.207 . . . . 0.0 113.396 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.9 m -83.67 128.11 34.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.772 0.829 . . . . 0.0 111.504 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 t -166.55 171.11 12.08 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.482 1.513 . . . . 0.0 110.979 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.66 89.19 1.14 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 173.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.88 111.52 9.11 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.731 0.812 . . . . 0.0 111.602 -173.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -86.24 -6.73 58.91 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.232 1.413 . . . . 0.0 114.197 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.3 140.85 41.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.338 1.455 . . . . 0.0 112.256 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 37.11 59.65 3.87 Favored Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 126.232 1.813 . . . . 0.0 114.555 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.14 136.71 35.38 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.482 2.788 . . . . 0.0 110.855 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.36 153.2 73.92 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.737 1.215 . . . . 0.0 112.637 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.69 140.53 56.02 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.152 3.235 . . . . 0.0 114.253 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -155.55 139.91 16.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.029 1.331 . . . . 0.0 110.231 -171.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.9 m -58.55 -28.51 65.57 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.483 1.113 . . . . 0.0 112.616 170.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 88.3 m -82.13 124.35 29.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.922 0.889 . . . . 0.0 110.224 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.2 mt -114.83 143.91 44.35 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.911 1.685 . . . . 0.0 110.475 172.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.52 148.38 18.3 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.646 1.594 . . . . 0.0 110.552 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.11 131.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.412 1.885 . . . . 0.0 107.823 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -137.36 154.87 49.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.541 1.136 . . . . 0.0 111.608 -168.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.25 30.14 38.49 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.8 0.714 . . . . 0.0 113.603 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.73 162.12 25.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.291 1.436 . . . . 0.0 113.159 -176.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -79.85 156.65 27.26 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.999 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.3 mt -70.44 -18.82 63.01 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.714 -0.616 . . . . 0.0 111.996 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.21 -4.71 51.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.727 1.611 . . . . 0.0 114.452 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.7 m -66.84 136.98 56.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.451 1.1 . . . . 0.0 109.397 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.3 p -110.22 162.56 14.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.371 1.069 . . . . 0.0 111.434 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -60.19 -29.09 68.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.673 0.789 . . . . 0.0 111.028 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.73 -37.5 79.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.458 1.103 . . . . 0.0 112.197 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.16 -48.9 66.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.358 0.527 . . . . 0.0 110.279 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.34 -43.17 88.18 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.764 -0.585 . . . . 0.0 110.897 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -57.99 -49.47 76.72 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.758 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.24 -29.73 69.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.779 1.172 . . . . 0.0 113.018 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -80.15 -29.25 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.454 1.102 . . . . 0.0 112.208 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -100.61 -24.5 14.43 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.4 p -69.34 -17.6 63.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.312 1.415 . . . . 0.0 113.913 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -67.78 -14.38 62.9 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.86 -13.02 24.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.777 1.231 . . . . 0.0 113.635 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -174.54 30.65 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.734 1.159 . . . . 0.0 114.941 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.78 140.74 23.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.563 3.509 . . . . 0.0 112.174 -171.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.26 131.9 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 0.0 110.197 -173.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 -25.55 14.97 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.203 1.401 . . . . 0.0 113.658 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -161.83 157.77 24.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.357 1.063 . . . . 0.0 112.39 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -148.27 130.4 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 127.182 2.193 . . . . 0.0 107.653 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.5 t -143.65 118.03 9.65 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.484 0.714 . . . . 0.0 111.802 -174.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.03 144.55 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 169.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t -96.94 128.96 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -121.02 151.4 39.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.408 1.483 . . . . 0.0 111.931 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -77.21 144.46 38.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.101 0.56 . . . . 0.0 111.874 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -75.26 -23.09 57.41 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -117.24 -38.27 3.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.352 1.061 . . . . 0.0 112.447 -173.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.4 m -82.33 -23.91 34.87 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.577 -0.702 . . . . 0.0 112.661 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 56.9 36.21 27.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.928 1.691 . . . . 0.0 113.694 170.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.83 164.05 19.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 128.318 2.647 . . . . 0.0 109.2 170.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.8 t -58.41 139.24 55.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.16 0.505 . . . . 0.0 111.113 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -81.38 1.93 30.69 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.437 1.095 . . . . 0.0 112.711 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.8 11.48 63.61 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.681 1.134 . . . . 0.0 114.236 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -148.99 163.68 36.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.594 1.187 . . . . 0.0 113.277 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.77 170.4 22.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.57 1.948 . . . . 0.0 111.568 -168.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -141.35 150.13 42.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.359 1.464 . . . . 0.0 111.171 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.71 127.29 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 109.347 -170.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -99.18 109.02 21.75 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.334 1.454 . . . . 0.0 111.007 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -83.29 160.99 21.59 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.342 -0.849 . . . . 0.0 111.03 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -94.88 8.72 41.8 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.064 0.946 . . . . 0.0 113.001 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -156.68 133.18 10.03 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.511 1.525 . . . . 0.0 111.241 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.03 -30.13 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.54 0.736 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -75.8 -28.52 58.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.435 1.016 . . . . 0.0 113.115 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.73 -27.46 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.225 0.61 . . . . 0.0 111.78 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.33 -41.24 70.07 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.317 0.647 . . . . 0.0 111.307 169.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -60.73 -35.71 77.03 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.196 0.999 . . . . 0.0 112.21 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.52 -63.68 1.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.021 0.928 . . . . 0.0 110.16 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.82 68.86 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.47 -36.01 79.23 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.959 0.904 . . . . 0.0 112.61 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.87 -24.4 26.7 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.515 0.726 . . . . 0.0 112.234 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -76.67 -47.12 23.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.54 1.136 . . . . 0.0 112.98 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.14 -12.43 26.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -170.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -65.62 113.38 4.19 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.517 -1.364 . . . . 0.0 110.866 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.21 8.53 71.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.235 1.398 . . . . 0.0 114.728 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -76.55 175.67 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.741 1.771 . . . . 0.0 111.485 169.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -119.72 135.37 54.86 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.254 1.021 . . . . 0.0 111.57 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.1 tp -146.07 121.33 10.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.982 1.713 . . . . 0.0 109.321 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 56.44 27.56 12.31 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.272 1.429 . . . . 0.0 112.603 -169.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.09 81.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.751 1.167 . . . . 0.0 114.355 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.48 130.29 43.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.874 1.337 . . . . 0.0 109.636 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.07 128.83 37.28 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.6 pt -108.65 159.45 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.941 0.896 . . . . 0.0 111.581 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -121.02 149.5 42.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.506 1.923 . . . . 0.0 108.938 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -145.98 137.24 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.453 1.101 . . . . 0.0 110.371 -171.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -157.15 162.82 39.37 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 112.329 -172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -73.43 138.36 45.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.454 -0.779 . . . . 0.0 111.286 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 26.7 m -75.86 139.8 41.88 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 37.5 pt -90.29 3.03 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.21 1.004 . . . . 0.0 113.257 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.6 p -155.97 -168.37 2.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 129.818 3.247 . . . . 0.0 109.376 -172.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -152.47 175.13 13.05 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.246 1.419 . . . . 0.0 112.823 169.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -60.6 140.1 92.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.247 1.419 . . . . 0.0 111.222 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.25 145.61 65.15 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.745 2.963 . . . . 0.0 112.716 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -158.95 163.18 36.73 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.076 1.351 . . . . 0.0 113.008 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.528 1.931 . . . . 0.0 112.219 -176.398 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.266 1 O4'-C1'-N19 112.582 4.382 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 O4'-C1'-N19 111.502 3.302 . 0.179 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.206 1 O4'-C1'-N19 112.293 4.093 . 0.21 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.397 0 C5'-C4'-C3' 112.089 -2.274 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 O4'-C1'-N19 112.042 3.842 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.259 0 P-O3'-C3' 122.744 2.537 . 0.165 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.036 -0.425 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.4 p 66.06 -33.41 0.18 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 129.119 2.968 . . . . 0.0 116.487 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 91.2 p -152.41 -13.19 0.18 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.381 1.472 . . . . 0.0 114.248 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -170.32 152.19 18.37 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.906 1.241 . . . . 0.0 113.252 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.0 m -158.19 155.1 28.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.541 1.936 . . . . 0.0 110.14 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.6 m -70.1 -13.71 62.33 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.9 155.16 26.4 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.659 2.075 . . . . 0.0 111.435 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -145.63 112.14 5.84 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.262 1.025 . . . . 0.0 111.571 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -74.25 -12.08 60.46 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.85 27.99 7.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.634 1.573 . . . . 0.0 113.518 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -169.2 66.33 0.61 Allowed Pre-proline 0 CA--C 1.557 1.23 0 C-N-CA 129.686 3.194 . . . . 0.0 110.793 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.34 178.93 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.06 3.174 . . . . 0.0 111.345 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -153.01 152.94 29.06 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.768 1.627 . . . . 0.0 110.929 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.2 138.32 71.73 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 124.066 3.177 . . . . 0.0 114.522 -172.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -157.57 142.84 17.03 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.911 1.284 . . . . 0.0 110.712 -170.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 71.0 m -59.0 -28.71 66.64 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.207 1.003 . . . . 0.0 112.062 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 56.1 m -86.61 127.32 34.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.804 1.242 . . . . 0.0 110.274 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -118.0 148.96 41.72 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.899 1.68 . . . . 0.0 111.049 175.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.14 147.15 16.2 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.363 1.935 . . . . 0.0 110.832 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.46 128.63 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 108.576 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -133.13 153.56 51.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.153 1.381 . . . . 0.0 111.141 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 30.94 21.11 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 123.861 0.743 . . . . 0.0 113.696 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -78.33 160.62 27.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.952 1.301 . . . . 0.0 113.4 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -81.36 151.56 27.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.488 0.715 . . . . 0.0 110.354 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.34 -16.67 64.02 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.073 -1.017 . . . . 0.0 112.819 175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -95.39 -3.17 47.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.421 1.488 . . . . 0.0 114.233 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.1 m -65.62 135.14 54.66 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.709 1.204 . . . . 0.0 109.69 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -108.04 162.68 13.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.355 1.062 . . . . 0.0 111.463 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.89 -29.35 69.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.304 0.641 . . . . 0.0 111.165 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -68.72 -38.39 80.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.501 1.12 . . . . 0.0 112.395 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -66.6 -49.8 65.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.639 0.654 . . . . 0.0 110.463 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.32 -41.37 84.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.717 -0.615 . . . . 0.0 111.09 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -62.99 -43.2 99.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.081 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.68 -33.45 74.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.185 1.357 . . . . 0.0 112.502 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.51 -28.18 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.45 1.1 . . . . 0.0 112.331 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -100.15 -23.12 14.93 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.6 m -69.15 -14.86 63.23 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.207 1.367 . . . . 0.0 113.691 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -68.17 -14.31 62.89 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.868 -1.145 . . . . 0.0 113.696 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -95.75 -13.8 23.86 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.878 1.271 . . . . 0.0 113.605 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.24 -174.58 31.91 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.099 1.333 . . . . 0.0 114.339 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.91 136.84 21.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.193 3.262 . . . . 0.0 111.934 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.1 mt -131.81 127.1 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.588 1.555 . . . . 0.0 109.789 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.87 -25.08 20.03 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.926 1.29 . . . . 0.0 113.322 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -164.28 167.33 20.02 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.12 135.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.213 2.205 . . . . 0.0 107.76 171.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.0 m -127.05 102.86 7.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.892 1.277 . . . . 0.0 110.511 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.5 mt -78.53 140.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.998 -1.064 . . . . 0.0 108.157 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.9 t -97.33 127.59 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -115.64 143.84 44.78 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.849 1.26 . . . . 0.0 112.096 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.25 139.17 58.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.577 1.151 . . . . 0.0 111.361 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -70.15 -20.56 63.14 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -117.84 -42.72 2.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.049 0.939 . . . . 0.0 112.13 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.3 m -88.28 -17.09 31.46 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.033 0.933 . . . . 0.0 113.396 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 78.5 mtm-85 64.37 8.48 4.26 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.615 1.966 . . . . 0.0 115.377 169.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -82.6 165.39 20.11 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.224 1.809 . . . . 0.0 110.574 169.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.4 t -57.5 140.91 49.42 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.868 -0.52 . . . . 0.0 110.181 168.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -77.8 0.0 25.45 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.86 0.864 . . . . 0.0 112.659 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.55 12.16 63.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.183 1.373 . . . . 0.0 113.478 -174.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -153.27 161.92 41.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 123.028 1.394 . . . . 0.0 113.811 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.69 175.02 13.67 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.575 1.95 . . . . 0.0 111.371 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.8 156.4 46.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.479 1.511 . . . . 0.0 110.101 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.9 t -139.54 136.76 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.306 1.842 . . . . 0.0 109.193 -168.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -120.5 94.21 4.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.687 1.195 . . . . 0.0 111.678 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -74.62 161.45 29.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.685 0.794 . . . . 0.0 111.96 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.28 8.85 43.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.469 1.107 . . . . 0.0 112.871 171.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -157.45 135.51 10.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.503 1.521 . . . . 0.0 111.714 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.78 -33.15 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.572 0.749 . . . . 0.0 112.633 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -73.64 -27.6 61.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.306 0.957 . . . . 0.0 112.725 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.36 -29.03 41.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.648 0.779 . . . . 0.0 111.881 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.26 -41.85 69.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.447 0.699 . . . . 0.0 111.351 169.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -59.86 -35.69 75.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.587 1.155 . . . . 0.0 112.322 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.43 -62.67 1.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.293 1.037 . . . . 0.0 110.031 171.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.37 68.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -175.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.35 -30.02 68.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.808 1.243 . . . . 0.0 113.202 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -93.14 -28.77 16.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.867 0.867 . . . . 0.0 112.178 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -74.19 -47.09 37.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.21 1.004 . . . . 0.0 113.355 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.93 -12.35 39.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.89 115.26 5.17 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.209 -0.932 . . . . 0.0 110.982 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 86.76 4.18 82.8 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.421 1.486 . . . . 0.0 114.647 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -73.84 158.91 33.65 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.73 1.765 . . . . 0.0 111.748 172.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -103.89 116.77 32.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.077 0.951 . . . . 0.0 110.724 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.6 tp -122.7 111.65 16.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.443 1.897 . . . . 0.0 109.151 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.53 23.56 9.33 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.239 1.416 . . . . 0.0 113.467 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.35 8.82 65.82 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.024 1.297 . . . . 0.0 114.699 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -115.37 134.24 55.29 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.994 1.718 . . . . 0.0 110.107 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -78.93 126.62 30.94 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 109.663 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.85 167.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.924 0.889 . . . . 0.0 111.789 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -137.23 142.41 42.06 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.728 2.011 . . . . 0.0 108.048 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -137.96 140.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.651 0.78 . . . . 0.0 111.581 -168.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -152.57 164.8 36.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.17 1.788 . . . . 0.0 111.224 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.31 141.96 41.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.347 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.4 m -75.89 135.82 40.13 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.162 -0.961 . . . . 0.0 112.855 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 8.4 pt -95.44 -6.28 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.621 1.168 . . . . 0.0 113.51 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.6 p -156.59 -170.45 3.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 129.781 3.232 . . . . 0.0 109.428 -173.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -147.49 169.85 18.66 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.342 1.457 . . . . 0.0 114.473 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.97 162.89 11.17 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.472 1.109 . . . . 0.0 112.35 171.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -60.01 146.84 95.04 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.849 3.033 . . . . 0.0 112.691 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -159.12 158.96 33.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.164 1.386 . . . . 0.0 112.824 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 C--O 1.254 1.294 0 C-N-CA 126.443 1.897 . . . . 0.0 112.163 -175.36 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.137 0 O4'-C1'-N19 111.77 3.57 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.217 0 O4'-C1'-N19 111.222 3.022 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.192 0 C5'-C4'-C3' 110.455 -3.363 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.378 0 O4'-C1'-N19 111.13 2.93 . 0.188 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.419 0 O4'-C1'-N19 111.267 3.067 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.343 0 O4'-C1'-N19 110.877 2.677 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.9 t 69.45 177.83 0.26 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.085 1.754 . . . . 0.0 113.52 -177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 87.7 p -164.89 172.99 12.16 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.346 1.859 . . . . 0.0 111.449 -176.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.37 -101.37 0.89 Allowed Glycine 0 N--CA 1.471 0.968 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.6 m -73.35 -20.01 60.88 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.4 0.68 . . . . 0.0 112.195 168.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.8 m 63.59 20.63 12.34 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.466 1.907 . . . . 0.0 115.146 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.3 136.58 20.55 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.25 0.929 . . . . 0.0 111.669 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -118.15 80.79 1.57 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.226 1.41 . . . . 0.0 109.374 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.5 mtt85 55.01 35.44 24.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.399 1.879 . . . . 0.0 112.32 -172.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.59 145.62 24.55 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.303 2.241 . . . . 0.0 109.327 -171.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 46.02 65.72 6.32 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 125.057 1.343 . . . . 0.0 113.236 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.17 179.4 6.56 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.977 3.118 . . . . 0.0 111.739 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -146.96 142.37 16.99 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.908 1.683 . . . . 0.0 109.64 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -51.52 142.44 39.2 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.119 3.213 . . . . 0.0 115.228 -174.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -154.64 139.8 17.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.46 1.504 . . . . 0.0 109.991 -172.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 87.7 m -58.62 -28.17 65.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.252 1.021 . . . . 0.0 112.532 171.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.1 t -88.94 129.69 35.58 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.398 1.079 . . . . 0.0 110.786 171.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.1 mt -118.67 146.54 44.62 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.488 1.915 . . . . 0.0 110.379 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.06 149.25 18.7 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.723 1.63 . . . . 0.0 110.955 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.47 128.46 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.505 1.922 . . . . 0.0 107.838 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -136.88 150.81 48.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.156 0.982 . . . . 0.0 112.175 -167.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.15 30.18 23.4 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 123.972 0.796 . . . . 0.0 113.383 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.09 162.87 23.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 113.349 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 t -81.81 157.8 24.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.694 0.798 . . . . 0.0 112.216 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.83 -19.91 62.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.402 0.681 . . . . 0.0 112.083 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.56 -6.38 54.77 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.447 1.499 . . . . 0.0 114.364 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.7 m -69.02 134.56 49.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.727 1.211 . . . . 0.0 109.482 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 p -108.22 162.66 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.289 1.036 . . . . 0.0 111.348 173.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -61.12 -28.65 69.25 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.075 0.55 . . . . 0.0 111.132 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -70.43 -36.73 74.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 112.53 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -67.22 -49.49 64.31 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.605 0.639 . . . . 0.0 110.289 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.54 -43.62 80.08 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.806 -0.559 . . . . 0.0 110.901 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -57.22 -50.33 73.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.657 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.11 -29.9 68.94 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.593 1.088 . . . . 0.0 113.074 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.82 -27.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.479 1.112 . . . . 0.0 112.015 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -100.51 -24.15 14.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.055 0.942 . . . . 0.0 113.488 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.3 p -69.82 -17.19 63.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.362 1.437 . . . . 0.0 113.868 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -66.86 -12.81 60.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -98.68 -8.28 26.44 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.287 1.435 . . . . 0.0 113.751 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.52 -175.55 26.81 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.982 1.277 . . . . 0.0 115.004 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.14 137.21 21.12 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 124.413 3.409 . . . . 0.0 112.248 -170.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.5 mt -128.62 131.35 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.977 1.711 . . . . 0.0 110.016 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.03 -25.18 15.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.065 1.346 . . . . 0.0 113.439 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.11 164.19 25.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.5 t -148.49 134.44 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.175 2.19 . . . . 0.0 108.056 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.9 m -132.83 110.6 10.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.36 1.064 . . . . 0.0 111.351 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.41 139.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t -90.3 108.33 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -99.51 143.86 29.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.908 1.283 . . . . 0.0 111.933 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.57 141.89 55.34 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.86 0.864 . . . . 0.0 112.641 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -69.0 -21.6 64.13 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.411 1.084 . . . . 0.0 113.768 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -124.91 -39.22 2.28 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.046 0.939 . . . . 0.0 112.33 -172.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 71.1 m -81.69 -16.59 50.79 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 173.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 78.2 mtm-85 56.41 36.67 27.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.984 1.714 . . . . 0.0 113.158 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -134.18 156.71 47.86 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.363 2.665 . . . . 0.0 109.38 -174.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.6 t -59.63 135.05 57.56 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.057 0.455 . . . . 0.0 111.117 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -81.23 2.14 29.16 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.157 0.983 . . . . 0.0 112.869 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.74 17.8 57.59 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.415 1.007 . . . . 0.0 113.95 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -153.47 162.55 41.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 122.615 1.198 . . . . 0.0 113.318 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.65 173.59 16.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.251 1.82 . . . . 0.0 111.875 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -141.17 152.4 44.63 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.784 1.633 . . . . 0.0 110.485 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 67.1 t -137.74 132.61 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.176 1.79 . . . . 0.0 108.955 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -115.89 101.67 8.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 111.509 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -78.73 160.08 27.62 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.918 0.887 . . . . 0.0 111.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -91.29 6.68 44.29 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.118 0.967 . . . . 0.0 113.017 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -158.23 134.73 9.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.398 1.479 . . . . 0.0 111.57 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.63 -29.39 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.91 0.884 . . . . 0.0 112.672 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.91 -27.37 49.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.468 1.031 . . . . 0.0 112.989 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.45 -29.2 52.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.675 0.79 . . . . 0.0 111.786 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.41 -39.5 74.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.259 0.624 . . . . 0.0 111.65 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.29 -39.1 85.71 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.112 -0.993 . . . . 0.0 111.962 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.91 -61.94 2.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.794 0.838 . . . . 0.0 110.079 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.21 -39.27 69.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -61.58 -39.18 90.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.856 0.863 . . . . 0.0 112.466 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -82.66 -25.36 33.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.276 0.63 . . . . 0.0 112.417 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -76.12 -51.84 11.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.534 1.134 . . . . 0.0 112.792 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.13 -14.19 39.36 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.1 112.6 3.45 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.521 -1.362 . . . . 0.0 111.068 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.22 8.4 68.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.47 1.509 . . . . 0.0 114.609 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -75.68 174.72 9.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.739 1.769 . . . . 0.0 111.465 169.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -120.12 135.32 55.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.248 1.019 . . . . 0.0 111.494 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -145.46 120.58 10.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.966 1.706 . . . . 0.0 109.276 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 56.53 27.47 12.36 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.424 1.489 . . . . 0.0 112.573 -169.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.58 84.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.727 1.156 . . . . 0.0 114.274 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.82 130.36 44.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.855 1.328 . . . . 0.0 109.622 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.26 130.92 42.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 122.09 -0.381 . . . . 0.0 110.171 171.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.0 pt -110.84 143.99 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.566 0.746 . . . . 0.0 111.389 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -102.35 144.41 30.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.694 1.598 . . . . 0.0 108.634 172.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.8 t -141.62 134.92 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.566 1.147 . . . . 0.0 109.911 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -156.31 158.2 37.04 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.925 1.29 . . . . 0.0 111.731 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.43 140.64 54.13 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.578 -0.701 . . . . 0.0 110.98 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.5 m -73.66 126.5 30.46 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.411 -0.806 . . . . 0.0 112.261 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 12.0 pt -86.07 -14.8 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.368 1.067 . . . . 0.0 112.762 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 15.7 p -159.21 165.02 34.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 129.98 3.312 . . . . 0.0 108.701 -172.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -152.05 159.95 43.57 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -75.57 -45.6 4.27 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.63 174.74 10.81 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.79 2.993 . . . . 0.0 111.039 175.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -135.29 141.38 45.67 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.656 1.182 . . . . 0.0 112.231 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 C--O 1.253 1.239 0 C-N-CA 126.291 1.836 . . . . 0.0 112.16 -169.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.279 1 O4'-C1'-N19 112.78 4.58 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 1 O4'-C1'-N19 112.729 4.529 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.187 0 C5'-C4'-C3' 111.407 -2.729 . 0.06 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.765 0 O4'-C4'-C3' 108.791 2.351 . 0.134 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 O4'-C1'-N19 111.058 2.858 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.095 0 O4'-C1'-N19 111.327 3.127 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.2 p -163.37 172.55 14.43 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.693 1.597 . . . . 0.0 111.388 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 89.4 p -160.68 174.06 14.53 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.756 1.222 . . . . 0.0 112.228 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.67 -111.07 3.26 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.119 0.866 . . . . 0.0 111.854 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.6 m -61.75 -11.55 12.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.905 1.682 . . . . 0.0 114.839 -175.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.1 m -68.77 -6.22 25.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.954 1.302 . . . . 0.0 114.024 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.01 49.92 4.57 Favored Glycine 0 N--CA 1.47 0.929 0 C-N-CA 124.753 1.168 . . . . 0.0 111.207 -175.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -73.49 -7.2 50.79 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -169.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 53.26 41.4 32.14 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.149 1.78 . . . . 0.0 112.68 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -136.1 146.32 46.86 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.805 1.642 . . . . 0.0 111.181 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 p30 32.8 57.94 1.42 Allowed Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 126.38 1.872 . . . . 0.0 115.993 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.89 151.41 68.31 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.768 2.979 . . . . 0.0 112.107 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -85.24 154.62 60.16 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.522 1.129 . . . . 0.0 111.773 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.44 145.26 37.49 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.184 3.256 . . . . 0.0 113.877 174.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -155.08 141.6 18.79 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.188 1.395 . . . . 0.0 110.432 -173.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 81.8 m -58.86 -28.93 66.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.616 1.166 . . . . 0.0 112.374 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.4 t -89.89 130.81 36.07 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.381 1.072 . . . . 0.0 110.755 171.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.8 mt -118.39 148.07 42.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.579 1.952 . . . . 0.0 110.593 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.1 149.61 18.0 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.132 1.825 . . . . 0.0 111.461 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.63 128.78 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.786 2.034 . . . . 0.0 108.027 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -136.05 145.42 45.99 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.304 1.042 . . . . 0.0 111.635 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 29.06 9.83 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 124.343 0.973 . . . . 0.0 114.014 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.6 mt -83.65 156.51 22.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.008 1.323 . . . . 0.0 112.874 -173.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 t -79.71 152.69 29.75 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 171.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.84 -18.86 65.59 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.481 -0.762 . . . . 0.0 112.232 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.81 -6.88 57.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.374 1.47 . . . . 0.0 114.358 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 m -74.98 130.98 40.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.3 p -104.5 165.51 11.01 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.377 1.071 . . . . 0.0 111.567 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -60.64 -29.12 69.07 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.2 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.25 -37.87 71.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.471 1.108 . . . . 0.0 112.422 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.87 -48.7 70.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.563 0.619 . . . . 0.0 110.284 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.5 mt -55.64 -43.66 76.4 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.912 -0.493 . . . . 0.0 110.865 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.42 -43.24 99.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.871 0.759 . . . . 0.0 112.366 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.3 -29.96 67.94 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.067 1.303 . . . . 0.0 112.633 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.27 -29.92 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.398 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -100.29 -24.86 14.43 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.3 p -70.97 -11.47 60.98 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.228 1.377 . . . . 0.0 114.097 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -66.61 -15.87 63.77 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.987 -1.071 . . . . 0.0 113.608 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -95.59 -14.84 23.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.85 1.26 . . . . 0.0 113.645 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.77 -177.89 33.48 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 124.878 1.227 . . . . 0.0 114.687 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.67 136.83 21.69 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 124.33 3.353 . . . . 0.0 111.931 -172.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.31 125.87 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.72 1.608 . . . . 0.0 109.755 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.65 -27.01 21.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.919 1.288 . . . . 0.0 113.176 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.08 166.19 23.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.82 137.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.972 2.109 . . . . 0.0 107.883 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -138.29 106.42 5.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.131 0.973 . . . . 0.0 111.053 -172.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.7 146.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.344 -0.847 . . . . 0.0 108.969 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.5 t -94.98 123.61 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -114.24 151.02 33.47 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.65 1.18 . . . . 0.0 112.169 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.31 148.76 43.21 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.607 0.763 . . . . 0.0 112.748 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -74.18 -21.02 60.01 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -125.41 -40.89 2.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.118 0.967 . . . . 0.0 112.701 -170.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 90.8 p -86.19 -17.03 35.93 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.394 0.997 . . . . 0.0 113.289 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.4 mtm-85 63.86 9.01 4.19 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.154 1.782 . . . . 0.0 114.686 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -88.87 166.31 14.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.212 1.405 . . . . 0.0 111.295 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.2 t -58.64 140.89 53.87 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.857 0.36 . . . . 0.0 110.088 169.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -85.04 2.76 41.81 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.322 1.049 . . . . 0.0 113.074 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.43 16.8 61.58 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.231 0.92 . . . . 0.0 113.785 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -150.2 159.5 44.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.601 1.191 . . . . 0.0 112.9 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.6 175.42 13.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.148 1.779 . . . . 0.0 111.568 -168.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -142.81 154.99 44.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.48 1.512 . . . . 0.0 110.6 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -138.42 131.65 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.213 1.805 . . . . 0.0 109.194 -168.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -114.4 96.73 5.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 0.0 111.463 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.81 158.41 32.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 111.7 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.36 0.67 53.47 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -157.13 157.46 34.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.176 1.39 . . . . 0.0 112.224 173.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.21 -26.16 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.62 -33.15 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.507 1.049 . . . . 0.0 112.874 -170.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -75.76 -23.59 55.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.562 0.745 . . . . 0.0 112.063 169.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.42 62.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.362 0.665 . . . . 0.0 111.233 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -60.03 -37.76 80.72 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.292 1.037 . . . . 0.0 111.975 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.76 -63.34 1.24 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.005 0.922 . . . . 0.0 110.195 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.98 69.75 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -60.49 -38.05 83.05 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.889 0.875 . . . . 0.0 112.464 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -83.54 -26.43 30.12 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.57 0.748 . . . . 0.0 112.128 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -76.09 -46.37 29.34 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.432 1.093 . . . . 0.0 112.973 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -91.9 -15.22 28.4 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -64.46 112.28 3.05 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.745 -1.222 . . . . 0.0 110.717 172.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.23 7.26 70.13 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.34 1.448 . . . . 0.0 114.796 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.3 ptm -74.91 172.13 12.8 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.889 1.845 . . . . 0.0 111.449 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -116.49 134.1 55.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.342 1.057 . . . . 0.0 111.242 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.2 tp -145.79 119.37 9.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.286 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.5 t70 56.94 27.69 13.53 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.529 1.532 . . . . 0.0 112.468 -169.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.43 -2.49 82.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.737 1.16 . . . . 0.0 114.175 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.81 128.16 42.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.814 1.307 . . . . 0.0 109.694 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.76 127.93 34.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.853 170.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.9 pt -108.66 154.24 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.03 0.832 . . . . 0.0 112.327 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -110.78 146.78 35.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.885 1.674 . . . . 0.0 108.697 172.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.91 139.16 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.557 1.143 . . . . 0.0 110.674 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -155.52 164.49 38.61 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.223 1.409 . . . . 0.0 112.387 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -79.74 142.81 35.09 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.199 -0.938 . . . . 0.0 111.517 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 49.9 m -75.76 134.31 40.5 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.126 -0.984 . . . . 0.0 113.592 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.6 pt -93.42 -14.2 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.696 1.198 . . . . 0.0 113.432 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.4 p -157.73 166.85 31.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 129.635 3.174 . . . . 0.0 108.586 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -152.7 165.8 34.16 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -73.03 -47.41 8.16 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.86 152.91 19.4 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.448 2.765 . . . . 0.0 111.288 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -84.0 145.4 28.54 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.008 0.923 . . . . 0.0 113.364 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 38.0 m . . . . . 0 C--O 1.252 1.234 0 C-N-CA 126.518 1.927 . . . . 0.0 110.639 177.727 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 1 O4'-C1'-N19 112.237 4.037 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.153 0 O4'-C1'-N19 111.332 3.132 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.513 0 O3'-P-O5' 99.778 -2.222 . 0.621 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 C5'-C4'-C3' 111.822 -2.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.652 0 C5'-C4'-C3' 111.399 -2.734 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.257 0 C5'-C4'-C3' 110.038 -3.642 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 m -146.0 147.34 31.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.834 1.254 . . . . 0.0 111.412 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.9 p -86.45 -3.98 59.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.642 1.177 . . . . 0.0 114.17 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.35 -170.72 20.53 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.906 1.717 . . . . 0.0 113.249 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.9 m 70.52 6.12 5.68 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.224 1.809 . . . . 0.0 114.647 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.8 t -163.93 158.93 20.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.118 1.767 . . . . 0.0 110.913 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.86 151.74 32.4 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.43 1.014 . . . . 0.0 113.011 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -159.82 130.22 5.62 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.9 1.28 . . . . 0.0 111.158 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -92.95 -6.64 48.04 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.885 1.274 . . . . 0.0 114.213 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.0 136.55 36.63 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.612 0.765 . . . . 0.0 111.268 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m120 35.76 57.87 2.88 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 126.51 1.924 . . . . 0.0 114.935 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.01 159.57 51.38 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.758 2.305 . . . . 0.0 112.573 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -67.29 145.07 98.48 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.375 0.67 . . . . 0.0 111.68 171.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -53.1 146.61 37.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.144 3.23 . . . . 0.0 114.39 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -155.18 139.03 16.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.383 1.473 . . . . 0.0 110.205 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 66.0 m -55.81 -30.65 61.72 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.944 1.297 . . . . 0.0 112.638 170.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.0 t -86.28 128.23 34.89 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.318 1.047 . . . . 0.0 110.73 171.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.59 145.44 45.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.423 1.889 . . . . 0.0 110.27 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 148.2 18.56 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.804 1.669 . . . . 0.0 110.589 168.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.77 132.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.713 2.005 . . . . 0.0 108.034 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -137.91 152.15 48.72 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.444 1.098 . . . . 0.0 111.958 -167.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.08 29.15 26.36 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.172 0.891 . . . . 0.0 113.759 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.89 159.07 29.14 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.278 1.431 . . . . 0.0 113.596 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.0 t -72.83 155.41 39.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.613 0.721 . . . . 0.0 111.878 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -70.97 -12.46 61.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.793 0.837 . . . . 0.0 112.723 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -103.86 -4.68 23.21 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.478 1.911 . . . . 0.0 114.615 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.4 m -62.61 134.95 57.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.41 1.084 . . . . 0.0 110.058 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -108.25 162.18 14.31 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.26 1.024 . . . . 0.0 111.667 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.57 -26.68 68.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.298 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.37 -36.19 66.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.161 0.984 . . . . 0.0 112.203 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.51 -50.61 68.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.748 0.704 . . . . 0.0 110.289 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.8 mt -60.15 -40.05 88.49 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.537 -0.727 . . . . 0.0 111.15 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.89 -47.44 84.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.141 0.882 . . . . 0.0 111.775 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.31 -32.59 72.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.82 1.191 . . . . 0.0 112.478 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.07 -29.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.438 1.095 . . . . 0.0 112.463 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.47 -22.97 14.84 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -68.03 -17.06 64.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.281 1.401 . . . . 0.0 113.631 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -68.08 -13.86 62.53 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.868 -1.145 . . . . 0.0 113.72 172.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -96.22 -10.82 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.93 1.292 . . . . 0.0 113.747 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.14 -173.95 28.0 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.968 1.271 . . . . 0.0 114.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.64 138.03 21.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.427 3.418 . . . . 0.0 112.147 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.5 mt -130.9 130.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.897 1.679 . . . . 0.0 109.891 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.02 -23.7 16.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.896 1.278 . . . . 0.0 113.468 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.67 162.5 29.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.83 0.852 . . . . 0.0 112.97 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.93 134.16 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.047 2.139 . . . . 0.0 107.399 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.3 t -137.08 111.18 8.34 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.529 0.732 . . . . 0.0 110.804 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.3 mt -84.82 138.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t -89.24 118.9 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -107.85 142.74 37.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.454 1.102 . . . . 0.0 112.545 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.54 140.52 58.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.835 1.254 . . . . 0.0 111.443 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -71.25 -20.19 62.26 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -173.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -117.57 -44.53 2.75 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.369 1.068 . . . . 0.0 112.043 -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 61.7 m -86.63 -17.98 32.48 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 62.42 14.38 6.87 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.222 1.809 . . . . 0.0 114.585 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -88.67 166.5 14.05 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.794 2.038 . . . . 0.0 110.132 169.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.0 t -58.44 137.26 57.44 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.108 170.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -73.73 -1.71 20.3 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.629 0.771 . . . . 0.0 112.515 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.57 6.3 59.73 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.857 1.694 . . . . 0.0 113.583 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -147.38 159.75 43.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.934 1.35 . . . . 0.0 113.971 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.54 174.77 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.446 1.898 . . . . 0.0 111.368 -169.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -143.09 153.09 42.56 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.567 1.547 . . . . 0.0 110.667 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.7 129.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.96 1.704 . . . . 0.0 108.993 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -114.15 97.94 6.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.709 1.204 . . . . 0.0 111.2 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -75.81 160.66 29.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.822 0.849 . . . . 0.0 111.807 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -92.13 7.01 44.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.154 0.982 . . . . 0.0 112.969 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.06 134.32 9.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.362 1.465 . . . . 0.0 111.483 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.91 -29.48 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 112.711 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.27 -27.26 47.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 0.977 . . . . 0.0 113.136 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -77.77 -28.27 50.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.63 0.772 . . . . 0.0 111.726 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.06 -39.5 72.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.209 0.604 . . . . 0.0 111.464 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.59 -37.51 81.57 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.055 -1.028 . . . . 0.0 112.156 172.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.85 -62.51 1.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.895 0.878 . . . . 0.0 109.976 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.98 -38.59 70.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.7 -35.36 77.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.969 0.907 . . . . 0.0 112.487 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -86.29 -25.43 25.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.453 0.701 . . . . 0.0 112.299 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -76.35 -47.94 21.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.597 1.159 . . . . 0.0 112.972 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.63 -12.09 30.19 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -66.67 110.9 3.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.626 -1.296 . . . . 0.0 111.041 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.13 6.84 68.59 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.84 1.686 . . . . 0.0 114.61 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.3 ptm -74.52 168.22 20.17 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.793 1.796 . . . . 0.0 111.453 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -111.8 133.87 53.73 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.054 0.942 . . . . 0.0 111.15 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -141.72 116.58 9.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.001 1.72 . . . . 0.0 109.153 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.17 32.27 15.6 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.22 1.408 . . . . 0.0 112.569 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.68 -1.49 82.84 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.953 -1.092 . . . . 0.0 114.756 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -96.27 133.41 40.64 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.875 1.338 . . . . 0.0 110.114 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -73.35 127.29 32.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.181 0.9 . . . . 0.0 109.146 169.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -103.64 155.9 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.737 0.815 . . . . 0.0 110.586 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -122.64 155.16 36.94 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.939 1.295 . . . . 0.0 109.587 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.5 t -144.0 139.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.763 1.225 . . . . 0.0 110.585 -169.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -155.05 158.12 38.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.253 1.421 . . . . 0.0 111.94 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -72.68 138.32 46.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.0 m -74.45 131.23 40.87 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.311 -0.868 . . . . 0.0 113.192 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 21.2 pt -90.89 -15.1 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.643 1.177 . . . . 0.0 113.167 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.8 p -156.84 161.2 39.72 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 129.657 3.183 . . . . 0.0 108.366 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.65 155.14 31.27 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 52.5 tpt85 -69.4 -43.93 24.58 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.27 145.52 10.87 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.366 2.711 . . . . 0.0 110.711 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -161.09 151.54 17.9 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.53 1.132 . . . . 0.0 112.886 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--O 1.252 1.187 0 C-N-CA 126.488 1.915 . . . . 0.0 112.086 -176.264 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.467 1 O4'-C1'-N19 112.392 4.192 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.186 0 O4'-C1'-N19 111.495 3.295 . 0.089 5n . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.292 0 O4'-C1'-N19 111.351 3.151 . 0.438 1z . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 O5'-C5'-C4' 114.918 3.37 . 0.01 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.64 0 C4'-C3'-C2' 99.921 -2.779 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.129 0 O4'-C1'-N19 111.576 3.376 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.6 p -162.36 164.22 27.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.154 1.382 . . . . 0.0 111.602 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 t -93.03 2.14 56.93 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.186 -0.946 . . . . 0.0 113.369 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -158.91 47.0 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.824 1.202 . . . . 0.0 113.074 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.1 m 71.24 -43.74 0.57 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 128.102 2.561 . . . . 0.0 114.999 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.1 m -85.89 -21.14 28.14 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.058 -1.026 . . . . 0.0 113.425 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.24 147.42 5.59 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.541 1.543 . . . . 0.0 113.842 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -165.18 148.01 8.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.446 1.898 . . . . 0.0 111.007 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.02 51.13 2.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.936 0.894 . . . . 0.0 113.07 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.27 26.25 2.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.934 1.694 . . . . 0.0 112.616 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -162.59 59.97 0.98 Allowed Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 128.452 2.701 . . . . 0.0 112.298 -170.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.46 168.82 19.44 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.64 2.893 . . . . 0.0 112.06 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -163.19 143.16 6.95 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.854 2.062 . . . . 0.0 109.277 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -44.56 131.03 9.62 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 124.521 3.481 . . . . 0.0 115.336 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -153.12 137.83 16.97 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.76 1.624 . . . . 0.0 109.712 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 59.6 m -55.9 -29.73 60.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.562 1.145 . . . . 0.0 112.513 171.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.1 t -88.86 129.13 35.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.523 1.129 . . . . 0.0 110.886 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -119.85 147.18 44.99 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.731 2.013 . . . . 0.0 110.482 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.4 150.84 17.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.993 1.758 . . . . 0.0 111.086 168.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.43 131.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.558 1.943 . . . . 0.0 108.105 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.46 151.8 47.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.404 1.082 . . . . 0.0 111.959 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.87 30.01 33.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.103 0.858 . . . . 0.0 113.422 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.29 159.23 25.91 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.408 1.483 . . . . 0.0 112.68 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 t -77.94 151.35 33.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.011 0.524 . . . . 0.0 111.737 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -16.05 63.68 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -96.98 0.84 49.5 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.974 1.709 . . . . 0.0 114.106 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.1 m -65.14 142.8 58.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.943 1.297 . . . . 0.0 109.829 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.3 p -119.87 161.11 21.39 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.901 0.88 . . . . 0.0 110.865 169.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -59.15 -24.96 63.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.828 0.851 . . . . 0.0 111.621 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -58.61 -44.44 89.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.113 1.765 . . . . 0.0 111.861 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -71.17 -45.96 62.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.021 0.928 . . . . 0.0 110.322 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.4 mt -59.42 -44.33 92.91 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.776 -0.578 . . . . 0.0 110.79 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -58.5 -47.59 83.61 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.864 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.68 -29.38 69.38 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.763 1.165 . . . . 0.0 113.163 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.6 t -79.22 -30.08 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.405 1.082 . . . . 0.0 112.371 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -100.57 -26.63 13.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.4 p -70.09 -20.07 63.22 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.357 1.435 . . . . 0.0 113.885 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.27 -11.97 58.91 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -104.11 -6.44 21.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.089 1.355 . . . . 0.0 114.329 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.13 -175.31 32.41 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.85 138.73 19.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.59 3.526 . . . . 0.0 111.986 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.14 133.33 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.85 1.66 . . . . 0.0 110.503 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.06 -22.69 14.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.254 1.421 . . . . 0.0 113.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -160.87 159.26 29.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.006 0.922 . . . . 0.0 112.696 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.1 t -152.86 132.7 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.621 2.368 . . . . 0.0 107.536 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -148.53 123.32 9.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.315 0.646 . . . . 0.0 112.234 -171.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.27 144.0 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.963 0.905 . . . . 0.0 108.681 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 t -92.01 128.4 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -115.61 140.58 49.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.105 1.362 . . . . 0.0 112.047 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.17 140.14 58.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.855 1.262 . . . . 0.0 111.683 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -72.1 -21.01 61.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -118.26 -38.15 3.23 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.407 1.083 . . . . 0.0 112.353 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.2 m -88.97 -12.13 42.38 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.993 0.917 . . . . 0.0 113.377 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 55.65 33.18 20.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.264 1.826 . . . . 0.0 114.237 170.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -133.46 163.47 29.29 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.051 2.54 . . . . 0.0 110.584 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.5 t -54.09 135.3 43.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.198 0.599 . . . . 0.0 112.014 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -77.99 -0.79 29.14 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.927 0.891 . . . . 0.0 112.708 174.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.92 10.86 64.2 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.291 1.424 . . . . 0.0 113.859 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -149.53 161.18 42.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.65 1.214 . . . . 0.0 113.786 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.68 173.79 15.54 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 111.963 -168.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.39 155.21 44.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.686 1.594 . . . . 0.0 111.47 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 88.6 t -140.93 134.15 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.659 1.984 . . . . 0.0 108.838 -169.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.29 101.88 8.3 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.087 1.355 . . . . 0.0 111.39 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.65 162.5 27.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.907 172.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -91.75 6.74 44.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.257 1.023 . . . . 0.0 112.981 171.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -159.24 137.77 10.76 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.638 1.575 . . . . 0.0 111.596 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.07 -35.88 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.637 . . . . 0.0 112.645 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.403 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 35.3 t70 -72.71 -27.49 62.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.215 0.916 . . . . 0.0 112.596 -174.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -77.4 -36.07 53.71 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.976 0.91 . . . . 0.0 111.885 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.87 90.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.258 0.623 . . . . 0.0 111.298 169.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 27.2 ttpp -65.37 -27.15 68.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.956 1.702 . . . . 0.0 112.793 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.99 -61.48 1.83 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.276 1.031 . . . . 0.0 109.431 168.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.15 67.79 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.45 -33.54 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.671 1.188 . . . . 0.0 112.842 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -88.92 -18.74 26.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.927 0.891 . . . . 0.0 112.461 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -84.64 -43.93 13.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.713 1.205 . . . . 0.0 112.948 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.87 -12.4 29.01 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -64.39 116.58 6.22 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.602 -1.311 . . . . 0.0 111.061 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.18 5.52 76.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.599 1.571 . . . . 0.0 114.872 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.2 ptm -76.24 163.1 27.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.656 1.728 . . . . 0.0 112.595 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -83.9 128.52 34.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.57 1.148 . . . . 0.0 110.189 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.9 tp -150.45 123.13 8.59 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.927 1.291 . . . . 0.0 110.175 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 55.02 31.51 16.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.541 1.536 . . . . 0.0 113.04 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.88 4.0 85.16 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.389 1.471 . . . . 0.0 114.69 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -116.96 153.36 32.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.619 1.568 . . . . 0.0 111.271 -175.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -87.9 121.62 30.54 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.6 pt -99.58 155.14 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.014 0.526 . . . . 0.0 112.044 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -112.75 144.7 41.82 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.943 1.697 . . . . 0.0 108.662 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.4 t -141.61 134.67 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.552 1.141 . . . . 0.0 109.796 -172.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -156.69 159.75 38.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.661 1.184 . . . . 0.0 112.225 -169.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.05 138.84 50.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.521 0.728 . . . . 0.0 111.281 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 67.2 m -70.62 125.79 27.8 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.494 -0.754 . . . . 0.0 112.105 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.2 pt -84.81 -16.15 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.063 0.945 . . . . 0.0 112.874 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.8 p -157.77 166.17 33.45 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 129.797 3.239 . . . . 0.0 108.397 -171.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -152.18 159.91 43.49 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -68.13 -44.38 38.07 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.78 164.81 29.6 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.205 2.603 . . . . 0.0 111.307 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -78.42 -3.61 44.17 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 128.666 2.786 . . . . 0.0 112.066 -177.43 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.4 0 O4'-C1'-N19 112.037 3.837 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.159 1 O4'-C1'-N19 113.198 4.998 . 0.147 1c . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.497 0 O5'-C5'-C4' 114.383 2.988 . 0.264 1z . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C5'-C4'-C3' 111.562 -2.626 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.346 0 O4'-C1'-N19 111.489 3.289 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.129 0 O4'-C1'-N19 111.547 3.347 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 120.763 0.316 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.28 144.31 45.91 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.239 1.816 . . . . 0.0 110.526 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.38 145.82 17.73 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.804 1.669 . . . . 0.0 110.603 167.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.45 128.75 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.81 2.044 . . . . 0.0 107.71 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -133.84 145.14 49.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.546 1.138 . . . . 0.0 111.329 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.72 9.13 44.16 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.532 1.063 . . . . 0.0 115.706 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.03 150.36 48.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.445 1.498 . . . . 0.0 114.273 -169.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.4 t -75.48 146.1 40.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.061 0.944 . . . . 0.0 110.935 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.5 -15.0 60.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.403 1.081 . . . . 0.0 113.836 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.77 -0.15 51.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.353 1.461 . . . . 0.0 113.749 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.0 m -71.65 139.41 49.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.914 1.286 . . . . 0.0 109.77 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.8 p -110.89 163.42 13.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.314 1.046 . . . . 0.0 111.451 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -59.77 -28.21 67.21 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.96 0.904 . . . . 0.0 111.137 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.13 -39.0 75.68 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.844 1.258 . . . . 0.0 112.041 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.12 -47.38 74.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.148 0.431 . . . . 0.0 110.285 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.5 mt -57.34 -46.54 83.18 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.846 -0.534 . . . . 0.0 110.882 173.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -63.44 -39.02 93.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.376 0.989 . . . . 0.0 112.707 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.4 -29.89 68.68 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.739 1.609 . . . . 0.0 112.572 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.34 -30.24 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.404 1.082 . . . . 0.0 112.253 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -100.37 -26.25 13.95 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -71.06 -14.01 62.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.344 1.429 . . . . 0.0 113.996 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -67.32 -13.49 62.04 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.016 -1.052 . . . . 0.0 113.547 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -96.98 -9.12 28.89 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.268 1.427 . . . . 0.0 113.686 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.26 -175.78 27.39 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.968 1.271 . . . . 0.0 114.882 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.41 136.01 19.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.504 3.47 . . . . 0.0 112.228 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.6 mt -128.79 122.73 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.658 1.583 . . . . 0.0 109.845 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.61 -31.32 28.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.121 0.969 . . . . 0.0 112.873 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -164.26 162.23 22.39 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.594 1.158 . . . . 0.0 112.276 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -148.0 137.06 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.112 2.165 . . . . 0.0 108.012 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.8 t -144.09 120.03 10.65 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 111.407 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -85.87 146.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.184 0.994 . . . . 0.0 108.648 172.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.6 t . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 108.778 -177.534 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.223 0 CA-C-O 119.073 -0.848 . . . . 0.0 114.181 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -144.59 160.94 40.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.628 1.214 . . . . 0.0 113.586 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.86 172.27 17.94 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.535 1.934 . . . . 0.0 111.053 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.28 149.02 40.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.768 1.227 . . . . 0.0 111.04 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.63 120.8 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.608 1.963 . . . . 0.0 108.182 -170.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -106.68 98.34 8.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.328 1.051 . . . . 0.0 111.003 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -74.66 160.97 30.13 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.479 -0.763 . . . . 0.0 111.742 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.26 6.68 41.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.171 0.988 . . . . 0.0 113.006 171.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -158.56 135.22 9.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.341 1.456 . . . . 0.0 111.748 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -68.38 -29.63 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.072 0.949 . . . . 0.0 112.746 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.63 -26.05 45.16 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.36 0.982 . . . . 0.0 113.178 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -78.71 -29.36 45.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.774 0.83 . . . . 0.0 111.677 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.65 77.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.275 0.63 . . . . 0.0 111.343 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.06 -34.02 74.23 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.99 -1.069 . . . . 0.0 112.55 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.03 -63.12 1.15 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.758 0.823 . . . . 0.0 109.758 172.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.21 70.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -61.11 -34.37 74.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.081 0.952 . . . . 0.0 112.593 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -87.81 -24.25 23.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.533 0.733 . . . . 0.0 112.31 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.43 -46.48 22.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.509 1.124 . . . . 0.0 113.074 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.91 -11.12 27.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -170.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -66.68 111.06 3.48 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 120.658 -1.276 . . . . 0.0 111.248 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.04 7.06 68.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.078 1.799 . . . . 0.0 114.627 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -74.72 168.96 18.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.713 1.757 . . . . 0.0 111.326 170.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -111.12 137.09 49.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.237 1.015 . . . . 0.0 110.974 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.06 116.8 9.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.776 1.63 . . . . 0.0 109.377 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 58.14 25.11 12.07 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.011 1.725 . . . . 0.0 113.901 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.99 2.76 68.67 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.93 1.252 . . . . 0.0 114.965 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -110.19 139.27 45.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.702 1.601 . . . . 0.0 110.516 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 138.76 47.4 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 167.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.1 pt -111.82 149.3 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.721 0.808 . . . . 0.0 110.285 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 34.5 mtm-85 -117.61 153.07 33.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 109.007 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.0 t -143.67 136.05 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.45 1.1 . . . . 0.0 110.879 -168.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -150.38 162.04 41.31 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.288 1.835 . . . . 0.0 111.484 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -69.77 142.5 53.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.849 0.86 . . . . 0.0 112.081 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 CA--C 1.544 0.728 0 O-C-N 121.33 -0.856 . . . . 0.0 112.602 177.867 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 14.8 p . . . . . 0 CA--C 1.537 0.476 0 CA-C-O 121.557 0.694 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.19 146.83 50.6 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.964 1.706 . . . . 0.0 110.889 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.47 147.48 18.55 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.838 1.685 . . . . 0.0 109.731 166.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.054 1.742 . . . . 0.0 107.832 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.69 154.23 51.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.845 0.858 . . . . 0.0 111.773 -168.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.81 34.55 30.66 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.685 0.659 . . . . 0.0 113.285 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.57 164.93 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.357 1.463 . . . . 0.0 113.203 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.6 t -83.09 153.05 25.06 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.239 0.615 . . . . 0.0 111.13 168.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.56 -15.91 62.82 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.495 -0.753 . . . . 0.0 112.386 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -95.45 -4.27 45.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.617 1.567 . . . . 0.0 114.031 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 85.2 m -67.8 133.54 49.4 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.503 1.121 . . . . 0.0 109.263 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 p -106.79 163.65 12.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -61.14 -27.58 68.49 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.093 0.557 . . . . 0.0 111.181 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.56 1.144 . . . . 0.0 112.301 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.81 -47.45 75.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.682 0.674 . . . . 0.0 110.399 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.48 -44.59 85.03 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.673 -0.642 . . . . 0.0 110.679 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -63.63 -39.71 95.05 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.013 0.824 . . . . 0.0 112.772 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.86 -28.33 65.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.36 1.436 . . . . 0.0 112.852 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.66 -33.92 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.929 0.891 . . . . 0.0 111.831 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -99.96 -24.67 14.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.2 p -71.38 -18.39 62.36 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.518 1.508 . . . . 0.0 114.112 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -69.38 -7.12 34.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.017 -1.052 . . . . 0.0 113.83 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.5 -5.1 27.48 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.107 1.363 . . . . 0.0 113.642 171.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.23 -174.92 23.06 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.602 1.573 . . . . 0.0 115.087 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.87 128.69 14.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.231 3.288 . . . . 0.0 112.642 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.0 mt -116.91 126.11 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.909 1.684 . . . . 0.0 109.281 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.54 -40.45 42.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.684 1.194 . . . . 0.0 111.859 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.51 174.41 6.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.777 1.231 . . . . 0.0 113.094 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.84 142.63 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.115 2.166 . . . . 0.0 108.524 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.6 t -137.52 118.48 14.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.467 0.707 . . . . 0.0 111.673 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 94.2 mt -82.69 142.7 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.1 t . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 123.829 0.852 . . . . 0.0 109.76 -174.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.24 0 CA-C-O 118.964 -0.909 . . . . 0.0 114.839 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.05 164.64 31.47 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.585 1.183 . . . . 0.0 113.824 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.83 171.44 20.05 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.785 2.034 . . . . 0.0 110.994 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -142.59 151.25 41.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.814 1.246 . . . . 0.0 110.906 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.3 t -131.47 126.86 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.298 1.839 . . . . 0.0 108.513 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -105.61 112.3 25.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.149 0.98 . . . . 0.0 110.441 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.65 157.96 16.67 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.322 -0.862 . . . . 0.0 111.245 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.34 -9.05 59.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -151.64 146.58 25.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.774 1.63 . . . . 0.0 111.573 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.6 -33.21 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.11 -24.57 58.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -81.42 -29.31 33.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.901 1.281 . . . . 0.0 111.801 174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.47 70.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 110.628 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -58.99 -40.03 83.6 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.16 -0.962 . . . . 0.0 112.23 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.49 -62.34 1.95 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.929 0.892 . . . . 0.0 110.242 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.83 71.68 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -63.06 -33.25 75.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.004 0.922 . . . . 0.0 112.641 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -84.49 -24.07 29.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.638 0.654 . . . . 0.0 112.703 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -82.84 -45.97 13.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.398 1.079 . . . . 0.0 113.318 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -100.25 -11.49 20.32 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.4 112.97 4.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.684 -1.26 . . . . 0.0 110.933 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.25 9.12 70.55 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.242 1.401 . . . . 0.0 114.633 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ptm -75.65 172.93 11.75 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.703 1.751 . . . . 0.0 111.502 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.24 134.66 54.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.075 0.95 . . . . 0.0 111.136 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -141.68 116.87 10.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.587 1.555 . . . . 0.0 109.239 -174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.84 25.23 10.12 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.571 1.548 . . . . 0.0 113.199 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.85 -3.55 83.01 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.395 1.474 . . . . 0.0 114.613 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.48 130.52 44.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.122 1.369 . . . . 0.0 110.15 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.4 122.25 22.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.033 0.833 . . . . 0.0 110.011 170.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -101.65 151.63 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.677 0.791 . . . . 0.0 111.631 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -106.82 149.87 26.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.317 1.847 . . . . 0.0 109.37 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.0 t -144.37 132.48 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.766 1.226 . . . . 0.0 110.224 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -156.47 154.72 30.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 112.651 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -70.01 136.18 50.13 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.362 -0.836 . . . . 0.0 112.328 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 CA--C 1.545 0.757 0 O-C-N 121.417 -0.802 . . . . 0.0 112.975 -178.071 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 C--O 1.239 0.502 0 CA-C-O 121.686 0.755 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.8 mt -127.98 148.98 50.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.346 1.858 . . . . 0.0 111.389 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.67 146.28 17.49 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 126.297 1.903 . . . . 0.0 109.57 166.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.68 123.91 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.502 1.921 . . . . 0.0 107.372 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -130.64 153.33 49.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.883 1.273 . . . . 0.0 112.735 -167.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.9 12.26 60.68 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.265 1.412 . . . . 0.0 114.502 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.33 160.77 26.54 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.31 1.844 . . . . 0.0 114.275 -169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.4 t -75.06 151.45 38.69 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.478 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -68.68 -16.11 63.73 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.549 -0.72 . . . . 0.0 112.629 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -100.58 -2.52 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.622 1.569 . . . . 0.0 114.313 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.7 m -64.9 139.77 58.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.693 1.197 . . . . 0.0 109.495 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 p -108.76 161.65 14.91 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.177 0.991 . . . . 0.0 111.471 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -59.04 -30.94 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.681 0.792 . . . . 0.0 111.136 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -67.31 -40.0 85.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.817 1.247 . . . . 0.0 112.015 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.48 -49.78 67.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.795 0.438 . . . . 0.0 110.273 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.4 -43.56 79.41 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 110.997 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -62.48 -44.74 95.65 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.352 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.31 -29.29 67.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.645 1.111 . . . . 0.0 112.872 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.88 -28.69 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.363 1.065 . . . . 0.0 112.057 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -100.16 -20.52 15.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.0 p -68.73 -16.16 63.73 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.289 1.404 . . . . 0.0 113.979 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.72 -15.34 63.46 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 171.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.54 -12.36 27.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.977 1.311 . . . . 0.0 113.586 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.28 177.84 25.48 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.008 1.289 . . . . 0.0 114.323 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.4 134.18 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 124.569 3.512 . . . . 0.0 112.332 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.7 127.45 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.93 1.692 . . . . 0.0 109.889 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.08 -25.43 17.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.228 1.411 . . . . 0.0 113.574 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -159.91 156.86 27.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.938 0.895 . . . . 0.0 112.548 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.2 t -153.05 135.85 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.131 2.173 . . . . 0.0 108.282 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -149.07 125.01 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.567 0.747 . . . . 0.0 111.79 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.3 mt -86.16 146.75 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.182 0.993 . . . . 0.0 108.846 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.469 0.478 0 C-N-CA 124.301 1.041 . . . . 0.0 109.38 -175.652 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 CA-C-O 119.145 -0.808 . . . . 0.0 113.287 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -154.54 164.57 38.5 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.841 1.305 . . . . 0.0 114.246 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.09 170.43 22.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.622 1.969 . . . . 0.0 111.449 -168.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -135.56 151.76 50.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.388 1.475 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.48 130.42 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.833 2.053 . . . . 0.0 109.046 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -119.52 113.85 21.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.031 1.333 . . . . 0.0 112.254 -170.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.23 154.79 17.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.985 0.914 . . . . 0.0 111.929 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -81.73 4.64 21.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.215 1.006 . . . . 0.0 112.841 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -155.98 129.22 8.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.081 1.752 . . . . 0.0 110.777 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.87 -27.14 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.83 -24.33 48.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.101 0.864 . . . . 0.0 113.08 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -78.85 -27.41 44.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.611 0.764 . . . . 0.0 111.734 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.24 73.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.976 0.51 . . . . 0.0 110.507 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.74 -34.66 76.22 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.013 -1.054 . . . . 0.0 112.688 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.18 -63.56 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.022 0.929 . . . . 0.0 110.045 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.83 -36.52 67.59 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.83 -38.12 77.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.059 0.943 . . . . 0.0 112.673 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.06 -21.12 27.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.547 0.739 . . . . 0.0 112.444 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -81.44 -46.51 14.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.602 1.161 . . . . 0.0 112.849 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.93 -14.59 25.82 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -64.69 111.03 2.57 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.658 -1.276 . . . . 0.0 110.76 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.82 5.82 64.16 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.47 1.509 . . . . 0.0 114.774 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.9 ptm -76.97 173.31 11.92 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.931 1.866 . . . . 0.0 111.36 169.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -118.45 137.91 52.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.28 1.032 . . . . 0.0 111.361 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.9 tp -145.8 120.46 9.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.454 1.502 . . . . 0.0 109.976 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.3 t70 57.63 23.36 9.27 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.678 1.591 . . . . 0.0 113.466 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.28 83.09 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.499 1.523 . . . . 0.0 114.625 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.72 130.24 45.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.276 1.43 . . . . 0.0 110.668 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.29 138.91 54.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 168.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 pt -115.92 143.95 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.351 0.661 . . . . 0.0 111.266 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -106.95 144.43 33.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.799 1.639 . . . . 0.0 108.297 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 t -140.3 135.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.98 0.912 . . . . 0.0 110.628 -170.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.32 162.59 39.13 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.543 1.537 . . . . 0.0 111.654 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.47 139.23 40.75 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 112.111 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.8 m . . . . . 0 CA--C 1.542 0.647 0 O-C-N 121.206 -0.934 . . . . 0.0 112.911 -177.566 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.7 mt -102.73 145.65 29.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.12 1.368 . . . . 0.0 110.452 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.02 144.95 16.13 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.879 1.704 . . . . 0.0 110.651 168.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.06 124.83 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.864 2.066 . . . . 0.0 107.634 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.03 154.71 47.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.832 1.253 . . . . 0.0 113.141 -166.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.39 18.01 61.3 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.798 1.189 . . . . 0.0 114.263 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.93 163.13 22.75 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.539 1.936 . . . . 0.0 114.237 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -80.28 149.05 30.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.828 168.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.55 -16.36 64.15 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.435 -0.791 . . . . 0.0 112.675 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -96.22 -4.39 42.54 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.449 1.5 . . . . 0.0 114.302 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -68.52 133.43 48.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.529 1.132 . . . . 0.0 109.377 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.8 p -106.3 164.16 12.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.182 0.993 . . . . 0.0 111.598 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -60.51 -29.47 69.12 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.176 0.59 . . . . 0.0 111.123 172.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -69.1 -40.16 78.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.711 1.205 . . . . 0.0 112.232 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.05 -49.47 67.53 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.187 0.449 . . . . 0.0 110.266 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.52 -42.47 78.5 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.907 -0.496 . . . . 0.0 110.978 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.61 -44.82 95.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.26 175.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.26 -32.38 72.52 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.929 1.241 . . . . 0.0 112.4 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.26 -29.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 112.273 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.16 -21.02 15.69 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 74.2 m -66.74 -17.24 64.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 120.105 1.321 . . . . 0.0 113.644 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -67.76 -14.52 63.02 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.999 -1.063 . . . . 0.0 113.829 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -97.5 -13.62 21.59 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.91 1.284 . . . . 0.0 113.857 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.81 -174.12 31.66 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.55 1.071 . . . . 0.0 114.761 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.04 136.27 16.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.437 3.425 . . . . 0.0 111.988 -171.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.5 mt -129.35 125.43 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.683 1.593 . . . . 0.0 109.742 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.16 -33.62 26.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.758 1.223 . . . . 0.0 112.669 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -166.39 170.2 13.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.254 1.021 . . . . 0.0 112.805 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.8 138.18 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.939 2.095 . . . . 0.0 108.5 175.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.0 m -138.33 109.06 6.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.256 1.022 . . . . 0.0 111.306 -171.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.89 149.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 171.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.469 0.519 0 C-N-CA 124.433 1.093 . . . . 0.0 109.61 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 CA-C-O 119.5 -0.611 . . . . 0.0 113.975 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.51 164.49 38.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.822 1.296 . . . . 0.0 113.98 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.57 172.67 17.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.21 1.804 . . . . 0.0 111.273 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.63 154.87 48.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.0 1.32 . . . . 0.0 111.233 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.8 t -134.34 121.13 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.521 1.928 . . . . 0.0 108.116 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -102.51 98.81 8.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.252 1.021 . . . . 0.0 110.552 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -76.57 161.68 28.39 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.189 -0.945 . . . . 0.0 112.174 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.18 7.94 45.12 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.547 1.139 . . . . 0.0 113.026 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -155.42 132.84 11.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.57 1.548 . . . . 0.0 111.13 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.63 -27.07 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 112.783 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.458 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 9.6 t70 -80.16 -29.74 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.189 0.904 . . . . 0.0 113.049 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.28 -30.32 60.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.26 0.624 . . . . 0.0 111.495 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.5 -43.29 77.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.352 0.661 . . . . 0.0 111.679 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 21.1 mtmt -58.03 -36.93 73.42 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.082 -1.011 . . . . 0.0 112.674 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.71 -57.31 4.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.196 0.599 . . . . 0.0 110.878 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.65 67.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.977 -1.077 . . . . 0.0 112.93 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -55.9 -47.23 77.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.819 1.248 . . . . 0.0 112.293 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -27.96 37.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.359 0.663 . . . . 0.0 111.675 -174.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -71.36 -52.41 18.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.937 1.695 . . . . 0.0 113.374 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.74 -14.12 37.96 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -64.22 111.0 2.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.766 -1.209 . . . . 0.0 111.144 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.78 8.13 65.69 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.628 1.585 . . . . 0.0 114.646 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -75.76 173.11 11.54 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.793 1.796 . . . . 0.0 111.457 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.07 136.64 53.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.214 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.4 tp -145.47 118.99 9.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.5 1.52 . . . . 0.0 109.531 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 58.13 22.74 9.39 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.422 1.489 . . . . 0.0 113.428 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.81 -5.77 83.27 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.633 1.587 . . . . 0.0 114.605 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.56 130.36 41.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.336 1.454 . . . . 0.0 110.707 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.52 131.44 43.29 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.3 pt -110.94 152.64 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.946 0.898 . . . . 0.0 110.225 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -122.75 153.13 39.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.485 1.114 . . . . 0.0 109.489 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -142.79 137.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.575 -167.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -150.18 169.84 20.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.643 1.977 . . . . 0.0 111.54 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -78.31 142.29 37.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.347 1.059 . . . . 0.0 112.003 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 178.725 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 83.8 m . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.996 0.427 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.82 145.83 29.53 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.056 1.342 . . . . 0.0 111.225 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.68 144.91 17.57 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.864 1.697 . . . . 0.0 109.563 167.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 t -132.67 121.29 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.364 1.866 . . . . 0.0 107.469 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.54 153.36 46.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.091 1.356 . . . . 0.0 112.013 -167.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.62 28.51 26.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.041 0.829 . . . . 0.0 113.607 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.94 161.65 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.381 1.472 . . . . 0.0 113.595 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.1 t -77.01 153.1 34.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.268 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.55 -16.8 63.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.442 -0.786 . . . . 0.0 112.261 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -96.2 -4.16 43.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.626 1.57 . . . . 0.0 114.528 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.9 m -65.05 138.15 58.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.643 1.177 . . . . 0.0 109.57 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -110.72 162.98 14.22 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.168 0.987 . . . . 0.0 111.464 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -57.67 -31.71 66.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.097 0.959 . . . . 0.0 111.172 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -67.32 -40.35 85.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.91 1.284 . . . . 0.0 112.066 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.49 -48.87 68.46 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.877 0.471 . . . . 0.0 110.284 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.75 -44.75 82.05 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.837 -0.539 . . . . 0.0 110.812 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.67 -44.13 97.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.213 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.05 -29.94 68.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.757 1.162 . . . . 0.0 112.922 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.95 -28.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.366 1.066 . . . . 0.0 111.894 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -100.43 -21.53 15.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.3 p -68.48 -17.7 64.24 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.383 1.447 . . . . 0.0 114.004 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -66.72 -13.49 61.39 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -97.27 -9.1 28.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.122 1.369 . . . . 0.0 113.756 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.2 -175.99 25.37 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.936 1.255 . . . . 0.0 114.837 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.34 134.83 17.72 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.428 3.419 . . . . 0.0 112.241 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 93.8 mt -124.39 125.93 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.695 1.598 . . . . 0.0 109.76 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.68 -34.75 24.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.921 1.288 . . . . 0.0 112.828 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -164.49 166.47 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.302 1.041 . . . . 0.0 112.569 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.7 t -147.55 135.75 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.901 2.08 . . . . 0.0 108.936 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.6 m -138.44 110.26 7.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.648 1.179 . . . . 0.0 111.506 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.61 144.76 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 -174.01 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.872 0 CA-C-O 119.189 -0.784 . . . . 0.0 113.239 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -154.87 165.45 36.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.993 1.377 . . . . 0.0 113.971 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.33 173.03 17.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.786 2.034 . . . . 0.0 110.943 -169.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.64 151.83 49.74 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.245 1.418 . . . . 0.0 110.873 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.26 118.95 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.551 1.941 . . . . 0.0 108.177 -170.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -104.24 100.61 10.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.523 1.129 . . . . 0.0 110.906 -170.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -78.45 158.02 28.78 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.446 -0.783 . . . . 0.0 111.733 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -86.1 6.29 29.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.091 0.956 . . . . 0.0 113.136 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -159.16 139.69 12.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.516 1.527 . . . . 0.0 111.719 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.47 -31.59 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.984 0.914 . . . . 0.0 112.896 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.449 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 23.1 t70 -78.21 -28.82 48.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.321 0.964 . . . . 0.0 112.921 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -73.43 -28.2 61.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.515 0.726 . . . . 0.0 111.64 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.0 65.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.459 0.703 . . . . 0.0 111.371 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 55.7 mtmt -59.58 -36.29 75.95 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 120.797 -1.19 . . . . 0.0 112.492 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -62.87 -64.4 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.122 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.51 68.56 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -60.2 -32.79 71.43 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.292 1.037 . . . . 0.0 112.986 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -91.1 -22.06 20.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.539 0.736 . . . . 0.0 112.441 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -80.23 -47.32 14.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.557 1.143 . . . . 0.0 113.098 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.23 -11.43 30.29 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -171.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -66.03 112.83 4.05 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.704 -1.247 . . . . 0.0 110.925 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.22 3.42 63.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.592 1.568 . . . . 0.0 114.794 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -76.97 170.23 16.89 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.855 1.827 . . . . 0.0 112.439 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.6 137.05 44.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.719 1.208 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 24.6 tp -148.0 116.91 6.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.701 1.6 . . . . 0.0 109.602 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 54.85 33.91 20.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.339 1.456 . . . . 0.0 112.45 -170.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.88 -17.95 8.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.157 1.361 . . . . 0.0 114.313 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.0 mmt-85 -76.66 135.99 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.445 1.123 . . . . 0.0 109.748 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.38 129.48 34.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -111.12 157.78 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 111.302 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.8 152.6 45.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.883 1.673 . . . . 0.0 109.327 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -142.53 137.96 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.148 0.979 . . . . 0.0 110.838 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -156.2 162.2 40.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.413 1.485 . . . . 0.0 111.882 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.17 143.99 36.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.996 0.918 . . . . 0.0 111.685 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.477 0.882 0 O-C-N 120.894 -1.129 . . . . 0.0 112.703 179.281 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.542 0.652 0 CA-C-O 120.947 0.403 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.6 mt -118.3 145.77 44.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.327 1.851 . . . . 0.0 110.412 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.98 148.65 18.88 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.775 1.655 . . . . 0.0 110.542 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.64 130.86 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.342 1.857 . . . . 0.0 108.221 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.74 152.12 48.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.031 0.932 . . . . 0.0 111.41 -168.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.69 32.63 18.13 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 123.765 0.697 . . . . 0.0 113.668 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.5 159.52 21.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.994 1.318 . . . . 0.0 113.252 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.3 t -76.02 156.37 34.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.681 169.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.52 -19.26 63.72 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.505 -0.747 . . . . 0.0 112.127 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -94.05 -4.6 49.17 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.573 1.549 . . . . 0.0 114.282 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -66.97 132.93 48.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.465 1.106 . . . . 0.0 109.256 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.9 p -106.54 162.79 13.42 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.279 1.032 . . . . 0.0 111.153 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -60.7 -27.97 68.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.958 0.503 . . . . 0.0 111.22 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -70.94 -37.67 72.86 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.583 1.153 . . . . 0.0 112.514 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.83 -47.63 71.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.662 0.665 . . . . 0.0 110.438 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.1 -44.38 83.17 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.819 -0.55 . . . . 0.0 110.647 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -61.89 -41.68 98.18 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.419 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.17 -32.84 72.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.313 1.415 . . . . 0.0 112.689 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -77.42 -29.2 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.556 1.143 . . . . 0.0 111.933 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -99.99 -24.58 14.58 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.141 0.882 . . . . 0.0 113.364 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.9 m -69.33 -19.79 63.87 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.235 1.379 . . . . 0.0 113.693 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -70.19 -7.23 40.18 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.964 -1.085 . . . . 0.0 113.909 173.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -102.32 -5.57 24.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.456 1.502 . . . . 0.0 113.753 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.41 -175.65 24.86 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.385 1.469 . . . . 0.0 114.969 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.57 135.75 20.39 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.324 3.349 . . . . 0.0 112.476 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.51 127.71 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.767 1.627 . . . . 0.0 110.121 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.29 -32.03 19.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.933 1.293 . . . . 0.0 112.837 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -163.59 166.16 22.72 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.9 t -146.55 136.14 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 127.062 2.145 . . . . 0.0 108.161 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.8 m -133.0 110.24 10.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.037 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.0 mt -80.03 143.29 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 CA-C-O 119.293 -0.726 . . . . 0.0 113.766 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.05 160.92 41.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.554 1.169 . . . . 0.0 113.148 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.93 15.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.381 1.873 . . . . 0.0 111.517 -168.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.44 152.1 42.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.404 1.482 . . . . 0.0 110.627 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.42 128.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.125 1.77 . . . . 0.0 109.071 -169.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.65 100.41 9.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.865 1.266 . . . . 0.0 111.826 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -76.78 159.06 30.43 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.576 -0.703 . . . . 0.0 111.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.27 3.72 45.58 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.954 0.902 . . . . 0.0 113.134 172.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -160.83 139.97 10.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.555 1.542 . . . . 0.0 111.67 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.79 -31.6 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.52 0.728 . . . . 0.0 112.567 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.62 -23.22 56.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.279 0.945 . . . . 0.0 113.12 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -82.52 -30.32 29.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.858 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.71 76.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.336 0.654 . . . . 0.0 111.458 169.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -61.54 -32.66 72.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.641 1.176 . . . . 0.0 112.489 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.94 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.889 0.876 . . . . 0.0 109.663 171.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.04 69.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.24 -34.27 74.86 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.932 0.893 . . . . 0.0 112.651 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -87.95 -23.62 23.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.557 0.743 . . . . 0.0 112.272 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -77.81 -45.8 23.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.51 1.124 . . . . 0.0 113.037 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.1 -12.34 21.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -65.66 112.83 3.85 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.615 -1.303 . . . . 0.0 110.861 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.17 8.58 71.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.495 1.522 . . . . 0.0 114.595 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.9 ptm -76.35 173.85 10.93 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.811 1.805 . . . . 0.0 111.523 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.61 135.16 54.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.296 1.039 . . . . 0.0 111.27 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -143.12 117.36 9.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.769 1.628 . . . . 0.0 109.224 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 29.0 t70 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.168 1.387 . . . . 0.0 112.45 -169.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.64 -5.18 65.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.648 1.118 . . . . 0.0 114.66 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.6 mmt-85 -92.05 129.62 37.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.891 1.346 . . . . 0.0 109.931 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.91 128.33 35.24 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.135 170.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -107.35 155.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 111.671 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -115.21 148.52 39.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.395 1.878 . . . . 0.0 108.64 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.8 t -144.73 136.44 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.46 1.104 . . . . 0.0 110.499 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.17 158.47 36.33 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.954 1.302 . . . . 0.0 112.438 -170.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -72.8 138.08 46.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.661 0.784 . . . . 0.0 111.822 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 CA--C 1.544 0.731 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.217 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 CA--C 1.541 0.629 0 CA-C-O 120.922 0.391 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -112.06 142.47 44.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.89 1.676 . . . . 0.0 110.151 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.61 145.05 17.57 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.497 1.522 . . . . 0.0 110.255 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.93 119.61 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.049 1.74 . . . . 0.0 107.814 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -126.47 158.85 35.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.406 1.482 . . . . 0.0 111.998 -167.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.56 25.03 55.11 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.127 0.87 . . . . 0.0 113.6 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.24 154.41 37.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.884 1.273 . . . . 0.0 113.342 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.8 t -72.67 143.24 48.18 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.778 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.02 -12.5 51.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -100.92 3.93 42.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.998 1.719 . . . . 0.0 114.032 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -63.46 143.04 58.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 109.806 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.5 p -110.96 159.71 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.681 0.792 . . . . 0.0 111.618 170.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.52 -30.79 67.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.889 0.876 . . . . 0.0 111.041 172.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -69.08 -38.33 78.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.748 1.219 . . . . 0.0 112.359 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -65.11 -48.05 75.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.486 0.585 . . . . 0.0 110.169 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.3 mt -59.01 -42.23 89.61 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.77 -0.581 . . . . 0.0 111.193 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.25 -45.91 92.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.107 0.867 . . . . 0.0 111.382 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -67.68 -31.32 71.21 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.406 1.457 . . . . 0.0 112.744 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.7 -29.22 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.521 1.128 . . . . 0.0 112.547 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -100.57 -27.8 13.22 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.1 p -73.31 -12.58 60.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 120.456 1.48 . . . . 0.0 114.311 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -67.64 -10.32 51.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.952 -1.092 . . . . 0.0 113.434 168.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -102.79 -7.89 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.479 1.511 . . . . 0.0 114.084 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.05 -175.95 31.35 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.597 1.094 . . . . 0.0 115.377 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.31 137.66 19.12 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.313 3.342 . . . . 0.0 112.036 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 73.4 mt -134.24 124.58 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.679 1.592 . . . . 0.0 109.902 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.2 -24.77 18.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.304 1.042 . . . . 0.0 113.557 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.38 159.73 28.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.725 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.9 t -150.83 136.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.354 2.261 . . . . 0.0 108.273 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -146.25 122.76 11.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.528 0.731 . . . . 0.0 112.024 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.62 143.96 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.363 1.065 . . . . 0.0 108.596 172.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 124.26 1.024 . . . . 0.0 110.205 -170.924 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 CA-C-O 119.274 -0.737 . . . . 0.0 113.755 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -154.53 166.7 32.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.937 1.351 . . . . 0.0 114.204 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.41 171.51 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 111.056 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.47 150.7 48.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.146 1.378 . . . . 0.0 111.065 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.0 t -135.63 120.25 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.482 1.913 . . . . 0.0 108.303 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -107.17 100.69 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.57 1.148 . . . . 0.0 111.053 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.69 161.94 29.18 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.787 0.835 . . . . 0.0 111.983 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -94.13 7.61 44.6 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.289 1.036 . . . . 0.0 112.851 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.13 130.49 7.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.515 1.526 . . . . 0.0 111.571 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.26 -28.96 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.897 0.879 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.87 -24.5 48.51 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.407 1.003 . . . . 0.0 113.27 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -81.61 -29.46 33.28 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.802 0.841 . . . . 0.0 111.76 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.92 83.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.191 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -59.85 -34.38 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.283 1.033 . . . . 0.0 112.631 172.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.53 -62.85 1.22 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.773 0.829 . . . . 0.0 109.845 173.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.87 -35.2 70.64 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.27 -33.66 71.31 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.306 1.042 . . . . 0.0 112.852 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -89.05 -24.11 22.4 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.682 0.793 . . . . 0.0 112.307 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -78.79 -45.06 21.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.425 1.09 . . . . 0.0 113.152 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.1 -11.82 27.57 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.56 113.07 3.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.594 -1.316 . . . . 0.0 110.904 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.54 7.29 72.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.26 1.409 . . . . 0.0 114.733 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptm -76.22 173.16 11.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.693 1.746 . . . . 0.0 111.278 170.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -115.55 135.47 54.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.162 0.985 . . . . 0.0 111.028 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.9 tp -141.46 121.25 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 109.797 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.65 25.87 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.761 1.625 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.86 19.41 57.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.562 1.077 . . . . 0.0 114.445 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -131.7 132.12 43.66 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.544 1.538 . . . . 0.0 110.19 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.91 133.02 46.09 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.724 -0.61 . . . . 0.0 110.518 174.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.9 pt -111.0 159.0 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.887 0.875 . . . . 0.0 111.797 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -126.31 145.28 50.49 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.855 2.062 . . . . 0.0 108.857 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.36 134.46 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 118.968 0.803 . . . . 0.0 111.396 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -152.76 162.97 40.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 111.236 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -70.22 142.76 52.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.696 0.799 . . . . 0.0 111.655 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 CA--C 1.545 0.777 0 O-C-N 121.276 -0.89 . . . . 0.0 112.634 177.6 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.7 m . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.867 0.365 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.3 mt -115.44 146.76 41.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.281 1.433 . . . . 0.0 110.702 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.79 149.45 17.26 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.147 1.832 . . . . 0.0 110.614 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.6 t -136.67 129.23 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.028 2.131 . . . . 0.0 107.853 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -133.83 154.72 50.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.38 1.072 . . . . 0.0 112.684 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.45 30.21 50.26 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.056 0.836 . . . . 0.0 114.074 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.46 160.93 23.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.48 1.512 . . . . 0.0 113.521 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.1 t -72.34 155.09 40.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.013 0.925 . . . . 0.0 111.861 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.59 -17.61 62.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.457 0.703 . . . . 0.0 112.628 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -96.17 -5.55 40.31 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.083 1.353 . . . . 0.0 114.402 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.7 m -69.29 136.29 51.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.6 p -106.88 164.83 11.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.639 1.175 . . . . 0.0 111.484 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -59.26 -30.22 68.13 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.629 0.772 . . . . 0.0 111.147 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -70.61 -38.64 73.99 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.597 1.159 . . . . 0.0 112.166 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -66.36 -48.41 70.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.267 0.485 . . . . 0.0 110.341 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.0 mt -56.69 -44.79 81.83 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.815 -0.553 . . . . 0.0 110.941 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -60.97 -45.67 93.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.131 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -67.14 -29.05 68.66 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.227 1.376 . . . . 0.0 112.878 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.33 -27.68 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.44 1.096 . . . . 0.0 112.046 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -100.48 -23.73 14.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.4 p -70.39 -17.73 63.03 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.242 1.383 . . . . 0.0 113.911 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.57 -11.24 52.22 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 170.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.72 -7.14 24.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.376 1.47 . . . . 0.0 113.717 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.21 -178.47 24.82 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.221 1.391 . . . . 0.0 115.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.99 135.6 21.38 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.561 3.507 . . . . 0.0 112.668 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.47 124.26 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.062 1.745 . . . . 0.0 109.654 -174.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.12 -23.26 20.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.349 1.06 . . . . 0.0 113.493 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -161.48 162.44 30.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.0 t -151.28 135.49 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.236 2.214 . . . . 0.0 107.956 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.4 m -137.97 116.73 12.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.752 1.221 . . . . 0.0 111.393 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.84 147.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 N--CA 1.466 0.367 0 C-N-CA 124.111 0.964 . . . . 0.0 108.827 179.135 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.09 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.241 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -144.96 161.35 39.57 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.747 1.273 . . . . 0.0 113.424 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.1 13.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.051 1.74 . . . . 0.0 111.815 -168.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -145.69 156.27 43.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.999 1.72 . . . . 0.0 110.853 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.95 134.33 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.369 1.867 . . . . 0.0 109.171 -169.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.16 99.18 6.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.238 1.415 . . . . 0.0 111.078 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -79.58 158.91 27.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.02 0.928 . . . . 0.0 112.202 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.81 3.52 50.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.741 1.217 . . . . 0.0 113.063 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -157.99 137.35 11.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.563 1.545 . . . . 0.0 111.246 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.22 -32.83 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.318 0.647 . . . . 0.0 112.673 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.4 -24.42 54.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.901 0.773 . . . . 0.0 113.014 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.97 -29.15 35.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.307 1.043 . . . . 0.0 111.914 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.6 73.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.211 0.604 . . . . 0.0 110.97 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -59.78 -35.24 74.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.409 1.084 . . . . 0.0 112.502 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.22 -64.39 0.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.032 0.933 . . . . 0.0 110.015 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.11 -35.56 69.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.61 -34.5 72.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.172 0.989 . . . . 0.0 112.83 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -88.48 -24.71 22.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.611 0.764 . . . . 0.0 112.197 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -78.22 -45.57 22.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.429 1.092 . . . . 0.0 113.164 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.67 -11.43 29.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -66.02 112.98 4.12 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.611 -1.305 . . . . 0.0 111.106 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.68 8.68 73.08 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.35 1.452 . . . . 0.0 114.609 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 ptm -75.91 173.65 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.739 1.77 . . . . 0.0 111.435 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.38 134.54 54.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.204 1.002 . . . . 0.0 111.057 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.6 tp -143.7 118.87 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.51 1.524 . . . . 0.0 109.389 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 54.77 31.78 16.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.404 1.481 . . . . 0.0 112.44 -169.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.42 -4.87 66.01 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.694 1.14 . . . . 0.0 114.504 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.7 mmt-85 -92.98 130.06 38.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.933 1.367 . . . . 0.0 109.897 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.48 130.17 40.03 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.094 0.861 . . . . 0.0 109.817 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -109.08 160.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.027 0.931 . . . . 0.0 111.08 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.6 mtm-85 -127.81 156.31 42.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.481 1.112 . . . . 0.0 109.775 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.9 t -143.96 140.26 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.781 1.232 . . . . 0.0 110.962 -168.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.8 161.46 40.64 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.374 1.47 . . . . 0.0 112.151 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -72.66 137.79 46.27 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.03 0.932 . . . . 0.0 111.561 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.544 0.72 0 O-C-N 121.25 -0.906 . . . . 0.0 112.56 -174.202 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.9 m . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.3 mt -102.17 146.94 27.25 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.627 1.171 . . . . 0.0 111.295 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.02 148.86 16.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.322 1.915 . . . . 0.0 110.47 168.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.54 124.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.192 1.797 . . . . 0.0 108.011 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -132.12 155.19 48.58 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.892 1.277 . . . . 0.0 111.91 -167.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.14 29.96 43.93 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.886 0.755 . . . . 0.0 113.398 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.79 163.84 25.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 113.168 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.8 t -76.06 154.51 35.59 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.005 168.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.0 -18.57 64.76 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.225 -0.922 . . . . 0.0 112.244 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -96.93 -1.43 45.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.846 1.658 . . . . 0.0 114.589 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 93.4 m -63.1 137.7 58.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.383 1.073 . . . . 0.0 109.611 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 p -110.34 161.64 15.43 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.861 0.864 . . . . 0.0 111.556 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.65 -27.22 68.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.336 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -69.61 -39.84 76.99 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.633 1.173 . . . . 0.0 112.251 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -65.88 -47.96 73.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.227 0.467 . . . . 0.0 110.315 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.0 mt -56.8 -44.36 81.87 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.764 -0.585 . . . . 0.0 110.921 174.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -63.17 -41.1 99.18 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.49 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.45 -31.12 69.24 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.174 1.352 . . . . 0.0 112.62 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.79 -28.91 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.374 1.07 . . . . 0.0 112.393 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -100.58 -27.47 13.39 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.1 p -71.83 -15.42 62.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.307 1.412 . . . . 0.0 114.109 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.9 -11.13 55.12 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.95 -1.094 . . . . 0.0 113.751 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -102.85 -5.18 23.86 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.302 1.441 . . . . 0.0 114.061 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.2 28.4 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.785 1.183 . . . . 0.0 115.307 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.5 135.42 18.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.313 3.342 . . . . 0.0 112.227 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.51 127.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.658 1.583 . . . . 0.0 110.187 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.91 -28.19 19.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.121 1.369 . . . . 0.0 113.325 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -162.61 167.08 23.8 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -149.38 137.16 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.448 2.299 . . . . 0.0 108.338 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.1 m -135.4 113.54 11.3 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.467 1.107 . . . . 0.0 111.635 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.34 144.97 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.294 -0.879 . . . . 0.0 108.835 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.338 1.055 . . . . 0.0 109.935 -173.922 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.006 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.53 165.15 36.02 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.948 1.356 . . . . 0.0 114.448 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.18 172.2 18.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.416 1.886 . . . . 0.0 111.509 -169.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.87 156.33 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.603 1.561 . . . . 0.0 110.908 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.84 131.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.801 2.04 . . . . 0.0 108.726 -168.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -114.79 97.5 6.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.688 1.195 . . . . 0.0 111.517 -170.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -76.57 156.89 32.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.105 0.562 . . . . 0.0 111.592 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -86.78 3.82 43.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.775 0.83 . . . . 0.0 113.189 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -160.64 143.38 13.02 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.537 1.535 . . . . 0.0 111.781 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.13 -31.72 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -74.48 -28.58 61.08 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.583 1.083 . . . . 0.0 112.859 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -75.42 -30.71 60.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.921 0.888 . . . . 0.0 111.673 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.97 -43.62 67.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.695 0.798 . . . . 0.0 111.444 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -59.33 -35.16 73.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.248 1.019 . . . . 0.0 112.419 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.17 -64.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.161 0.984 . . . . 0.0 110.163 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.3 69.54 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.41 -33.82 71.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.503 1.121 . . . . 0.0 112.845 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -89.34 -21.63 23.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.674 0.789 . . . . 0.0 112.391 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -81.17 -44.73 17.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.546 1.138 . . . . 0.0 113.071 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.7 -12.07 26.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -172.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -64.68 114.79 4.66 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.682 -1.261 . . . . 0.0 111.024 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.04 4.85 77.8 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.472 1.51 . . . . 0.0 114.695 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.4 ptm -73.25 169.18 17.63 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.839 1.82 . . . . 0.0 111.373 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -106.24 134.96 48.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.706 0.803 . . . . 0.0 110.975 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 46.7 tp -144.86 123.22 12.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.81 1.644 . . . . 0.0 109.327 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 55.25 33.57 20.93 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.099 1.36 . . . . 0.0 112.649 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.21 4.61 89.84 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.781 1.181 . . . . 0.0 114.601 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.8 mmt-85 -113.28 131.67 55.84 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.243 1.417 . . . . 0.0 110.431 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.43 131.08 44.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.91 0.777 . . . . 0.0 109.196 168.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.4 pt -110.68 160.19 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.733 0.813 . . . . 0.0 112.064 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -119.82 148.14 43.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.13 1.772 . . . . 0.0 108.919 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -141.95 135.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.316 1.047 . . . . 0.0 110.395 -172.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -156.57 165.52 36.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.222 1.409 . . . . 0.0 111.884 -170.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -80.87 141.95 34.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.371 1.068 . . . . 0.0 111.634 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.475 0.797 0 O-C-N 121.004 -1.06 . . . . 0.0 112.68 -177.842 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 121.912 0.863 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.0 mt -126.48 151.58 47.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.893 2.077 . . . . 0.0 110.539 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.84 149.71 18.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.131 1.824 . . . . 0.0 110.496 167.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.8 129.49 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.396 1.878 . . . . 0.0 107.889 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -136.73 150.6 48.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 111.641 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.19 32.6 19.84 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.923 0.773 . . . . 0.0 113.26 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.9 mt -77.34 162.83 26.98 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.36 1.464 . . . . 0.0 113.642 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -78.91 152.52 31.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.792 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -16.75 63.31 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.427 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.57 -5.06 52.44 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.465 1.506 . . . . 0.0 114.288 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -67.71 135.42 52.71 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.476 1.111 . . . . 0.0 109.615 172.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.5 p -118.02 163.85 15.98 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.747 1.219 . . . . 0.0 110.761 172.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.77 -24.54 65.85 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.444 0.697 . . . . 0.0 111.725 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -58.02 -45.78 86.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.965 1.706 . . . . 0.0 111.774 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.92 -48.32 46.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.914 0.885 . . . . 0.0 110.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.57 -38.62 81.63 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.323 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -62.05 -45.97 91.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.239 0.927 . . . . 0.0 112.054 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.92 -31.01 69.6 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.097 1.317 . . . . 0.0 112.771 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.4 t -80.12 -30.58 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.603 1.161 . . . . 0.0 112.484 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -100.6 -25.59 14.11 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.7 p -71.29 -14.21 62.14 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.388 1.449 . . . . 0.0 113.91 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -67.2 -14.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.948 -1.095 . . . . 0.0 113.586 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.71 -8.54 34.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.009 1.324 . . . . 0.0 113.718 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -177.82 25.93 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.102 1.334 . . . . 0.0 114.65 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.98 135.48 25.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.327 3.351 . . . . 0.0 112.272 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.54 132.76 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.891 1.676 . . . . 0.0 110.504 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.81 -28.8 15.07 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.105 1.362 . . . . 0.0 113.111 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -164.3 164.45 22.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.008 0.923 . . . . 0.0 113.007 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.9 t -147.9 132.01 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.074 2.15 . . . . 0.0 107.732 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 56.6 m -132.63 104.83 6.85 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.5 mt -81.21 138.82 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 168.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -175.743 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.047 0 CA-C-O 119.464 -0.631 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -150.99 162.86 40.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.793 1.282 . . . . 0.0 113.484 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.82 172.72 17.73 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.237 1.815 . . . . 0.0 111.686 -169.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.78 155.1 46.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.823 1.649 . . . . 0.0 110.396 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.9 132.61 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.758 1.623 . . . . 0.0 109.298 -168.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.92 107.62 14.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.779 1.232 . . . . 0.0 111.996 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -85.52 157.55 20.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.411 1.085 . . . . 0.0 111.39 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -83.84 7.73 17.07 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.955 0.902 . . . . 0.0 113.18 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -160.89 143.44 12.67 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.774 1.629 . . . . 0.0 111.281 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.88 -33.8 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.525 0.73 . . . . 0.0 112.492 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.44 -25.53 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -78.91 -28.29 43.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.115 0.966 . . . . 0.0 111.968 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.6 64.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.547 0.739 . . . . 0.0 111.017 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -59.31 -36.97 76.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 0.0 112.285 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.05 -65.19 0.73 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.524 0.729 . . . . 0.0 109.944 170.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.0 65.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -61.57 -25.04 67.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.624 1.17 . . . . 0.0 113.329 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.28 4.59 36.72 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.612 1.565 . . . . 0.0 113.007 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -107.91 -52.23 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.21 1.404 . . . . 0.0 113.02 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.01 46.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -65.83 112.4 3.73 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.851 -1.156 . . . . 0.0 111.171 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.27 7.73 69.44 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.087 1.803 . . . . 0.0 114.746 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.3 ptm -75.58 162.22 28.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.75 1.775 . . . . 0.0 112.816 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.36 133.02 34.15 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.215 . . . . 0.0 110.733 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.3 tp -145.53 111.4 5.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 109.085 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.4 t70 54.36 36.23 24.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.235 1.414 . . . . 0.0 112.064 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.83 -22.01 6.14 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.287 1.422 . . . . 0.0 114.224 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -73.18 141.34 47.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.29 1.045 . . . . 0.0 110.322 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -85.3 126.05 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.2 pt -106.07 139.32 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.238 0.615 . . . . 0.0 111.294 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.11 146.78 23.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.655 1.182 . . . . 0.0 109.006 170.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -141.67 134.71 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.77 1.228 . . . . 0.0 110.097 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -156.67 159.96 38.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.909 1.284 . . . . 0.0 112.224 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -69.04 142.27 54.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.772 0.829 . . . . 0.0 112.041 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 CA--C 1.545 0.77 0 O-C-N 121.441 -0.787 . . . . 0.0 112.291 175.706 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 121.639 0.733 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.49 144.22 44.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.741 1.616 . . . . 0.0 110.337 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.62 143.14 16.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.0 124.99 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.877 1.671 . . . . 0.0 107.697 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -129.01 163.99 24.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.249 1.42 . . . . 0.0 111.311 -168.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 29.93 59.56 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.471 -0.768 . . . . 0.0 113.574 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.3 mt -76.54 166.82 22.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.659 1.184 . . . . 0.0 112.924 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -85.71 151.92 23.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.039 0.936 . . . . 0.0 110.12 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.54 -18.69 65.5 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.065 -1.022 . . . . 0.0 112.327 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.39 -3.6 55.06 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.678 1.591 . . . . 0.0 114.559 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.0 m -66.8 135.27 53.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.195 0.998 . . . . 0.0 109.427 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 p -109.64 162.82 14.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.098 0.959 . . . . 0.0 111.64 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -61.08 -27.63 68.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.313 0.645 . . . . 0.0 111.297 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.01 -40.08 75.45 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.776 1.23 . . . . 0.0 112.085 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -65.97 -48.84 69.95 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.185 0.448 . . . . 0.0 110.219 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.26 -43.13 82.77 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.943 -0.473 . . . . 0.0 111.119 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.57 -49.1 79.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.733 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -66.9 -29.38 69.25 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.815 1.189 . . . . 0.0 112.944 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.53 -29.15 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.549 1.139 . . . . 0.0 112.122 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -100.64 -23.44 14.66 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.7 p -69.22 -15.84 63.47 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.287 1.403 . . . . 0.0 113.939 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.55 -15.33 63.6 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -95.07 -15.26 23.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 0.0 113.631 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.8 -175.6 32.82 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.823 1.202 . . . . 0.0 114.738 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.71 138.61 21.58 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.594 3.529 . . . . 0.0 111.955 -173.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.3 mt -130.0 123.33 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.162 1.385 . . . . 0.0 109.678 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.87 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.136 0.974 . . . . 0.0 111.771 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.86 175.07 5.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.417 1.087 . . . . 0.0 113.054 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.77 142.16 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.965 2.106 . . . . 0.0 108.785 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.5 t -139.98 118.87 12.52 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 111.67 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.72 147.4 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.731 0.812 . . . . 0.0 109.31 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.469 0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 109.472 -176.353 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 CA-C-O 118.979 -0.901 . . . . 0.0 113.833 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -148.11 165.93 29.36 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.753 1.263 . . . . 0.0 114.185 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.86 169.13 25.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.813 2.045 . . . . 0.0 111.169 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -133.32 147.05 51.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.013 1.325 . . . . 0.0 110.838 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.6 t -129.32 124.82 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.708 2.003 . . . . 0.0 107.856 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.1 100.38 9.72 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.576 0.75 . . . . 0.0 110.634 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.03 156.26 31.95 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.873 -1.142 . . . . 0.0 111.489 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.93 8.11 21.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.957 0.903 . . . . 0.0 112.769 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -157.07 135.82 11.6 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.107 1.763 . . . . 0.0 110.861 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.12 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.296 0.639 . . . . 0.0 112.441 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.53 -24.66 49.91 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -172.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.44 -26.94 34.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.05 0.94 . . . . 0.0 112.0 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.64 -41.16 65.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.579 0.752 . . . . 0.0 111.355 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -59.33 -31.91 69.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 0.0 112.584 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.64 -63.58 1.04 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.257 1.023 . . . . 0.0 110.039 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -36.43 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.47 -30.1 68.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.748 1.219 . . . . 0.0 113.313 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -93.48 -22.58 18.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.942 0.897 . . . . 0.0 112.42 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -79.77 -45.54 18.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.553 1.141 . . . . 0.0 113.145 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.43 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -66.83 113.49 4.94 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.649 -1.282 . . . . 0.0 111.197 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.18 75.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.537 1.541 . . . . 0.0 114.521 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -73.94 162.71 28.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.744 1.772 . . . . 0.0 111.467 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -104.28 134.31 47.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.429 1.091 . . . . 0.0 110.943 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.8 tp -144.46 114.96 7.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.06 1.744 . . . . 0.0 109.079 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 23.71 10.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.338 1.455 . . . . 0.0 113.272 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.39 -10.89 72.98 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.72 1.629 . . . . 0.0 114.536 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -90.05 134.41 34.26 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.415 1.486 . . . . 0.0 109.756 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.77 135.95 38.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.23 0.923 . . . . 0.0 108.888 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.3 pt -106.39 152.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.042 0.937 . . . . 0.0 110.652 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -110.86 155.92 21.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.075 0.95 . . . . 0.0 109.606 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -143.76 136.45 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.424 1.09 . . . . 0.0 110.416 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -155.64 161.06 40.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.171 1.389 . . . . 0.0 111.249 -175.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -69.98 137.15 51.19 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.47 -0.769 . . . . 0.0 110.392 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 CA--C 1.544 0.745 0 O-C-N 121.191 -0.943 . . . . 0.0 112.127 178.476 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.6 m . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.1 mt -117.6 144.13 45.45 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.838 1.655 . . . . 0.0 110.615 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.16 147.71 18.66 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.784 1.659 . . . . 0.0 110.06 167.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.13 131.34 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.509 1.924 . . . . 0.0 107.851 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -138.13 139.87 39.63 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.942 0.897 . . . . 0.0 111.342 -168.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.32 26.43 6.93 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.024 0.821 . . . . 0.0 114.18 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.9 mt -74.47 162.72 28.55 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.631 1.173 . . . . 0.0 113.388 -174.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -84.67 155.88 21.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.3 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.93 -17.65 63.34 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.308 -0.87 . . . . 0.0 112.416 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -92.8 -5.05 51.95 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.846 1.658 . . . . 0.0 114.271 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.7 m -68.87 136.02 51.99 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.562 1.145 . . . . 0.0 109.548 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.1 p -118.66 162.29 18.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.598 1.159 . . . . 0.0 111.004 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.32 -27.74 66.16 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.7 0.8 . . . . 0.0 111.654 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -56.0 -46.84 78.6 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.349 1.86 . . . . 0.0 111.905 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -69.89 -46.87 64.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.93 0.892 . . . . 0.0 110.046 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.4 -41.39 84.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.182 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.19 -47.77 84.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.317 0.962 . . . . 0.0 111.11 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.5 -30.85 69.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.245 1.384 . . . . 0.0 113.014 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.7 -30.93 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.629 1.171 . . . . 0.0 112.356 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -100.44 -26.45 13.86 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -73.16 -8.99 58.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.534 1.515 . . . . 0.0 114.234 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.07 -15.54 63.79 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.857 -1.152 . . . . 0.0 113.033 168.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -94.73 -11.67 28.65 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.437 . . . . 0.0 113.621 176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.26 -178.29 29.56 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.006 1.289 . . . . 0.0 114.52 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.58 138.1 28.88 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.223 3.282 . . . . 0.0 112.114 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 55.6 mt -130.94 126.66 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.819 1.648 . . . . 0.0 110.179 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.25 -19.26 17.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -158.46 162.07 37.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.074 0.852 . . . . 0.0 113.183 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.9 t -146.5 136.21 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.013 2.125 . . . . 0.0 107.472 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -133.48 109.16 9.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 110.936 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.22 134.99 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.499 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.175 0 CA-C-O 119.254 -0.748 . . . . 0.0 114.125 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -147.45 163.6 35.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.469 1.135 . . . . 0.0 113.186 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.07 174.23 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.159 1.784 . . . . 0.0 112.054 -168.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.41 150.04 43.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.292 1.837 . . . . 0.0 109.99 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.5 t -136.79 135.11 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.288 1.835 . . . . 0.0 108.716 -169.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -120.43 97.79 5.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.496 1.118 . . . . 0.0 112.245 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -77.73 161.9 27.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.346 0.659 . . . . 0.0 112.012 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.27 10.28 38.42 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.209 1.003 . . . . 0.0 112.799 171.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -156.72 131.35 8.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.59 1.556 . . . . 0.0 111.383 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.09 -29.17 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.939 0.896 . . . . 0.0 112.585 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.77 -28.18 44.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.239 0.927 . . . . 0.0 112.916 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.08 -30.02 55.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.514 0.726 . . . . 0.0 111.635 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.08 80.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.179 0.592 . . . . 0.0 111.419 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -60.07 -40.29 88.98 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.4 -58.08 8.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.707 0.803 . . . . 0.0 110.408 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.31 -38.63 77.48 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.13 -40.16 88.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.949 0.9 . . . . 0.0 112.222 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -81.65 -26.32 34.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.127 0.571 . . . . 0.0 112.506 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -74.83 -48.26 26.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.638 1.175 . . . . 0.0 113.286 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.31 -12.27 30.46 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -169.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -66.65 111.88 3.89 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.614 -1.304 . . . . 0.0 111.141 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.83 7.2 68.84 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.367 1.937 . . . . 0.0 114.572 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -73.76 168.65 18.96 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.68 1.74 . . . . 0.0 111.721 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.71 135.82 49.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.6 tp -145.07 117.97 8.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.145 1.778 . . . . 0.0 109.353 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 55.39 28.46 11.52 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.751 1.621 . . . . 0.0 113.42 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.38 6.96 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.721 1.153 . . . . 0.0 114.527 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -109.08 140.61 42.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.706 1.602 . . . . 0.0 110.503 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 136.63 39.09 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 168.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.9 pt -117.22 154.66 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -116.8 156.27 27.53 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.512 1.525 . . . . 0.0 109.498 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.82 137.43 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.853 1.261 . . . . 0.0 110.024 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -156.92 166.1 34.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.815 1.246 . . . . 0.0 111.853 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.79 140.29 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.234 -0.916 . . . . 0.0 112.211 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.304 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.0 t . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 121.005 0.431 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.04 149.48 24.52 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.836 1.654 . . . . 0.0 110.952 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.51 142.36 15.47 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.078 1.799 . . . . 0.0 110.227 167.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.98 127.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.623 1.969 . . . . 0.0 107.638 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -136.85 157.06 47.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.972 0.909 . . . . 0.0 111.386 -168.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.96 36.22 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.211 0.91 . . . . 0.0 113.675 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.24 160.29 31.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.426 1.491 . . . . 0.0 113.38 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -77.65 152.52 33.79 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 167.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.62 -18.2 65.24 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.307 -0.871 . . . . 0.0 112.726 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -100.74 -1.7 34.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.812 1.645 . . . . 0.0 114.243 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -65.85 136.41 56.13 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.615 1.166 . . . . 0.0 109.366 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.8 p -115.16 165.56 12.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.151 0.981 . . . . 0.0 111.644 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.94 -25.34 67.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.458 0.703 . . . . 0.0 111.748 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -68.61 -42.18 78.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.261 1.024 . . . . 0.0 111.461 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -66.87 -49.23 66.31 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.167 0.587 . . . . 0.0 110.386 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -58.93 -40.1 83.56 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.709 -0.619 . . . . 0.0 111.402 174.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.3 ttp-105 -59.53 -49.46 77.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.043 0.838 . . . . 0.0 111.625 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.01 -30.24 69.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.7 1.137 . . . . 0.0 113.057 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.56 -28.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.53 1.132 . . . . 0.0 112.042 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -100.67 -23.44 14.64 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.4 p -70.65 -18.3 62.85 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.363 1.438 . . . . 0.0 113.942 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -67.46 -10.51 52.18 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -101.79 -5.83 24.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.314 1.446 . . . . 0.0 113.912 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -178.16 25.7 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.951 1.262 . . . . 0.0 115.049 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.79 137.82 25.26 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.433 3.422 . . . . 0.0 112.28 -170.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.66 131.05 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.948 1.699 . . . . 0.0 110.032 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.46 -26.59 15.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.996 1.318 . . . . 0.0 113.222 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -163.41 165.23 24.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 113.077 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -146.89 133.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.837 2.055 . . . . 0.0 107.762 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.0 m -131.38 102.96 6.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.555 1.142 . . . . 0.0 110.749 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.6 mt -77.59 140.5 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.983 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.192 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.742 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -148.46 162.57 39.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.962 1.363 . . . . 0.0 114.256 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.31 172.25 17.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.761 2.024 . . . . 0.0 111.272 -169.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -138.94 155.6 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.363 1.465 . . . . 0.0 110.217 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -138.78 126.27 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.642 1.577 . . . . 0.0 109.151 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -108.51 101.19 10.37 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 111.737 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -76.75 159.76 29.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.294 1.038 . . . . 0.0 111.573 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.87 4.79 43.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.881 0.872 . . . . 0.0 113.005 171.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -159.82 136.14 8.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.368 1.467 . . . . 0.0 111.754 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.12 -30.71 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.001 0.921 . . . . 0.0 112.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.11 -23.57 51.81 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.479 1.036 . . . . 0.0 113.224 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -80.98 -29.6 35.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.788 170.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.57 81.97 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.236 0.614 . . . . 0.0 110.99 168.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.45 -31.94 71.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.31 1.044 . . . . 0.0 112.862 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.67 -64.25 0.9 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.76 0.824 . . . . 0.0 109.671 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.73 -34.96 70.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.27 -34.72 72.59 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.064 0.946 . . . . 0.0 112.883 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -88.78 -23.44 22.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.59 -45.38 19.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 113.114 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.82 31.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.33 111.32 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.698 -1.252 . . . . 0.0 111.057 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.56 8.64 70.26 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.278 1.418 . . . . 0.0 114.703 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.7 ptm -75.75 172.33 12.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.758 1.779 . . . . 0.0 111.471 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.28 135.41 54.18 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.974 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 40.0 tp -141.28 118.7 11.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.575 1.55 . . . . 0.0 109.534 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.5 t70 56.78 25.03 9.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.683 1.593 . . . . 0.0 113.417 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.08 8.6 71.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.01 1.291 . . . . 0.0 114.805 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -116.35 133.0 56.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.887 1.675 . . . . 0.0 110.614 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.43 129.69 38.94 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.819 -0.551 . . . . 0.0 110.267 173.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.9 pt -107.24 166.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.094 0.958 . . . . 0.0 111.008 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -142.54 151.15 41.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.096 1.759 . . . . 0.0 109.096 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.7 t -144.18 143.51 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.324 1.05 . . . . 0.0 112.569 -165.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -153.38 166.36 32.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.025 2.13 . . . . 0.0 111.419 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.02 149.0 48.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.522 -0.736 . . . . 0.0 111.543 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 91.6 p . . . . . 0 CA--C 1.548 0.891 0 O-C-N 121.081 -1.012 . . . . 0.0 113.374 -176.446 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.2 t . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.3 mt -121.2 141.45 50.84 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.65 1.58 . . . . 0.0 110.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.23 144.73 17.42 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.482 1.515 . . . . 0.0 110.197 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.03 122.45 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.444 1.898 . . . . 0.0 107.472 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -129.23 147.58 51.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.767 1.227 . . . . 0.0 111.786 -167.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.53 31.7 11.18 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 124.071 0.843 . . . . 0.0 113.547 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.13 162.43 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.438 1.495 . . . . 0.0 113.153 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.3 t -81.83 154.62 25.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.27 0.628 . . . . 0.0 110.998 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.3 -17.38 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 112.601 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.37 -4.22 54.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.535 1.534 . . . . 0.0 114.279 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.5 m -66.81 133.59 50.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.67 1.188 . . . . 0.0 109.649 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.6 p -108.67 163.77 12.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.268 1.027 . . . . 0.0 111.546 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -61.32 -27.32 68.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.279 0.632 . . . . 0.0 111.176 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -73.69 -36.77 65.32 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.824 1.249 . . . . 0.0 112.57 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -66.07 -48.47 70.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.639 0.654 . . . . 0.0 110.28 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.95 -41.22 86.92 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.786 -0.571 . . . . 0.0 111.009 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -58.36 -50.04 75.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.867 0.758 . . . . 0.0 111.667 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.47 -29.39 68.82 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.655 1.116 . . . . 0.0 113.135 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -80.01 -29.42 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.093 0.957 . . . . 0.0 112.011 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -100.6 -22.0 15.1 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -69.19 -20.35 63.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.366 1.439 . . . . 0.0 113.799 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -67.68 -11.3 57.97 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 172.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.1 -9.38 22.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.191 1.396 . . . . 0.0 113.7 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.9 -173.09 27.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.914 1.245 . . . . 0.0 115.185 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.25 132.78 12.8 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.288 3.325 . . . . 0.0 112.758 -169.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.07 128.73 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.813 1.645 . . . . 0.0 109.367 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.04 -40.98 29.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.749 1.22 . . . . 0.0 111.872 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -169.6 173.86 6.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.993 1.717 . . . . 0.0 111.614 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.15 140.08 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.492 1.917 . . . . 0.0 108.428 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 t -142.37 116.25 9.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.253 0.621 . . . . 0.0 111.765 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.46 150.69 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.093 0.957 . . . . 0.0 109.974 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.467 0.398 0 C-N-CA 124.173 0.989 . . . . 0.0 109.265 177.184 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.168 0 CA-C-O 119.168 -0.796 . . . . 0.0 113.94 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -149.27 161.45 42.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.897 1.332 . . . . 0.0 113.633 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -161.5 174.03 14.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.582 1.953 . . . . 0.0 110.54 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -143.56 152.86 41.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.07 120.67 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.321 1.848 . . . . 0.0 108.091 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -98.81 125.59 44.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.61 1.164 . . . . 0.0 109.573 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -105.86 148.94 27.0 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.101 0.96 . . . . 0.0 112.089 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.52 -1.97 54.92 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -155.88 132.91 10.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.672 1.589 . . . . 0.0 111.062 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.47 -30.52 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.29 -17.87 60.18 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -86.78 -28.34 23.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.642 1.177 . . . . 0.0 112.076 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.01 -39.27 79.4 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.729 -0.607 . . . . 0.0 110.408 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -64.16 -23.58 67.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.706 1.202 . . . . 0.0 113.283 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.98 -64.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.776 0.83 . . . . 0.0 109.183 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -36.62 61.71 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -58.83 -31.97 68.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.188 0.995 . . . . 0.0 113.286 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -92.66 -10.53 36.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.103 0.961 . . . . 0.0 112.74 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -96.5 -49.83 4.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.896 1.278 . . . . 0.0 112.559 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.28 -16.19 40.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -63.99 115.66 5.12 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.989 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.84 6.54 76.0 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.226 1.393 . . . . 0.0 114.397 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -77.17 169.22 18.72 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.732 1.766 . . . . 0.0 111.704 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -117.22 123.96 47.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.888 0.875 . . . . 0.0 111.51 -174.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 11.5 tp -127.75 111.86 14.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.158 1.783 . . . . 0.0 109.351 -169.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.5 t70 56.31 27.27 11.62 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.081 1.353 . . . . 0.0 112.991 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.8 -1.18 80.68 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.386 1.469 . . . . 0.0 114.738 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -103.14 127.37 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.381 1.473 . . . . 0.0 110.041 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.01 128.57 36.41 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.34 155.64 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.725 0.81 . . . . 0.0 111.394 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -124.52 151.96 44.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.548 1.539 . . . . 0.0 109.245 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.1 t -141.51 136.2 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.285 1.034 . . . . 0.0 111.287 -168.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -147.25 159.27 43.85 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.357 1.863 . . . . 0.0 111.504 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -69.89 143.63 52.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.416 0.686 . . . . 0.0 111.855 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -172.939 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 88.3 m . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 120.738 0.304 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.2 mt -114.83 143.91 44.35 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.911 1.685 . . . . 0.0 110.475 172.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.52 148.38 18.3 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.646 1.594 . . . . 0.0 110.552 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.11 131.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.412 1.885 . . . . 0.0 107.823 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -137.36 154.87 49.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.541 1.136 . . . . 0.0 111.608 -168.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.25 30.14 38.49 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.8 0.714 . . . . 0.0 113.603 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.73 162.12 25.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.291 1.436 . . . . 0.0 113.159 -176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -79.85 156.65 27.26 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.999 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.3 mt -70.44 -18.82 63.01 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.714 -0.616 . . . . 0.0 111.996 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.21 -4.71 51.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.727 1.611 . . . . 0.0 114.452 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.7 m -66.84 136.98 56.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.451 1.1 . . . . 0.0 109.397 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.3 p -110.22 162.56 14.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.371 1.069 . . . . 0.0 111.434 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -60.19 -29.09 68.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.673 0.789 . . . . 0.0 111.028 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.73 -37.5 79.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.458 1.103 . . . . 0.0 112.197 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.16 -48.9 66.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.358 0.527 . . . . 0.0 110.279 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.34 -43.17 88.18 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.764 -0.585 . . . . 0.0 110.897 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -57.99 -49.47 76.72 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.758 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.24 -29.73 69.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.779 1.172 . . . . 0.0 113.018 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -80.15 -29.25 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.454 1.102 . . . . 0.0 112.208 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -100.61 -24.5 14.43 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.4 p -69.34 -17.6 63.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.312 1.415 . . . . 0.0 113.913 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -67.78 -14.38 62.9 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.86 -13.02 24.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.777 1.231 . . . . 0.0 113.635 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -174.54 30.65 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.734 1.159 . . . . 0.0 114.941 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.78 140.74 23.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.563 3.509 . . . . 0.0 112.174 -171.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.26 131.9 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 0.0 110.197 -173.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 -25.55 14.97 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.203 1.401 . . . . 0.0 113.658 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -161.83 157.77 24.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.357 1.063 . . . . 0.0 112.39 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -148.27 130.4 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 127.182 2.193 . . . . 0.0 107.653 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.5 t -143.65 118.03 9.65 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.484 0.714 . . . . 0.0 111.802 -174.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.03 144.55 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 169.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -177.881 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.016 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.236 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -148.99 163.68 36.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.594 1.187 . . . . 0.0 113.277 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.77 170.4 22.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.57 1.948 . . . . 0.0 111.568 -168.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -141.35 150.13 42.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.359 1.464 . . . . 0.0 111.171 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.71 127.29 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 109.347 -170.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -99.18 109.02 21.75 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.334 1.454 . . . . 0.0 111.007 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -83.29 160.99 21.59 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.342 -0.849 . . . . 0.0 111.03 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -94.88 8.72 41.8 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.064 0.946 . . . . 0.0 113.001 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -156.68 133.18 10.03 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.511 1.525 . . . . 0.0 111.241 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.03 -30.13 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.54 0.736 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -75.8 -28.52 58.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.435 1.016 . . . . 0.0 113.115 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.73 -27.46 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.225 0.61 . . . . 0.0 111.78 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.33 -41.24 70.07 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.317 0.647 . . . . 0.0 111.307 169.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -60.73 -35.71 77.03 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.196 0.999 . . . . 0.0 112.21 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.52 -63.68 1.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.021 0.928 . . . . 0.0 110.16 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.82 68.86 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.47 -36.01 79.23 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.959 0.904 . . . . 0.0 112.61 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.87 -24.4 26.7 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.515 0.726 . . . . 0.0 112.234 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -76.67 -47.12 23.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.54 1.136 . . . . 0.0 112.98 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.14 -12.43 26.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -170.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -65.62 113.38 4.19 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.517 -1.364 . . . . 0.0 110.866 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.21 8.53 71.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.235 1.398 . . . . 0.0 114.728 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -76.55 175.67 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.741 1.771 . . . . 0.0 111.485 169.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -119.72 135.37 54.86 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.254 1.021 . . . . 0.0 111.57 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.1 tp -146.07 121.33 10.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.982 1.713 . . . . 0.0 109.321 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 56.44 27.56 12.31 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.272 1.429 . . . . 0.0 112.603 -169.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.09 81.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.751 1.167 . . . . 0.0 114.355 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.48 130.29 43.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.874 1.337 . . . . 0.0 109.636 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.07 128.83 37.28 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.6 pt -108.65 159.45 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.941 0.896 . . . . 0.0 111.581 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -121.02 149.5 42.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.506 1.923 . . . . 0.0 108.938 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -145.98 137.24 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.453 1.101 . . . . 0.0 110.371 -171.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -157.15 162.82 39.37 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 112.329 -172.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -73.43 138.36 45.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.454 -0.779 . . . . 0.0 111.286 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 56.1 m . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -118.0 148.96 41.72 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.899 1.68 . . . . 0.0 111.049 175.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.14 147.15 16.2 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.363 1.935 . . . . 0.0 110.832 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.46 128.63 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 108.576 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -133.13 153.56 51.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.153 1.381 . . . . 0.0 111.141 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 30.94 21.11 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 123.861 0.743 . . . . 0.0 113.696 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -78.33 160.62 27.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.952 1.301 . . . . 0.0 113.4 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -81.36 151.56 27.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.488 0.715 . . . . 0.0 110.354 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.34 -16.67 64.02 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.073 -1.017 . . . . 0.0 112.819 175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -95.39 -3.17 47.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.421 1.488 . . . . 0.0 114.233 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.1 m -65.62 135.14 54.66 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.709 1.204 . . . . 0.0 109.69 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -108.04 162.68 13.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.355 1.062 . . . . 0.0 111.463 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.89 -29.35 69.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.304 0.641 . . . . 0.0 111.165 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -68.72 -38.39 80.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.501 1.12 . . . . 0.0 112.395 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -66.6 -49.8 65.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.639 0.654 . . . . 0.0 110.463 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.32 -41.37 84.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.717 -0.615 . . . . 0.0 111.09 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -62.99 -43.2 99.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.081 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.68 -33.45 74.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.185 1.357 . . . . 0.0 112.502 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.51 -28.18 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.45 1.1 . . . . 0.0 112.331 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -100.15 -23.12 14.93 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.6 m -69.15 -14.86 63.23 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.207 1.367 . . . . 0.0 113.691 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -68.17 -14.31 62.89 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.868 -1.145 . . . . 0.0 113.696 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -95.75 -13.8 23.86 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.878 1.271 . . . . 0.0 113.605 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.24 -174.58 31.91 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.099 1.333 . . . . 0.0 114.339 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.91 136.84 21.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.193 3.262 . . . . 0.0 111.934 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.1 mt -131.81 127.1 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.588 1.555 . . . . 0.0 109.789 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.87 -25.08 20.03 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.926 1.29 . . . . 0.0 113.322 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -164.28 167.33 20.02 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.12 135.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.213 2.205 . . . . 0.0 107.76 171.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.0 m -127.05 102.86 7.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.892 1.277 . . . . 0.0 110.511 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.5 mt -78.53 140.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.998 -1.064 . . . . 0.0 108.157 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.4 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.104 0 CA-C-O 119.137 -0.813 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -153.27 161.92 41.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 123.028 1.394 . . . . 0.0 113.811 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.69 175.02 13.67 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.575 1.95 . . . . 0.0 111.371 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.8 156.4 46.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.479 1.511 . . . . 0.0 110.101 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.9 t -139.54 136.76 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.306 1.842 . . . . 0.0 109.193 -168.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -120.5 94.21 4.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.687 1.195 . . . . 0.0 111.678 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -74.62 161.45 29.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.685 0.794 . . . . 0.0 111.96 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.28 8.85 43.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.469 1.107 . . . . 0.0 112.871 171.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -157.45 135.51 10.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.503 1.521 . . . . 0.0 111.714 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.78 -33.15 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.572 0.749 . . . . 0.0 112.633 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -73.64 -27.6 61.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.306 0.957 . . . . 0.0 112.725 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.36 -29.03 41.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.648 0.779 . . . . 0.0 111.881 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.26 -41.85 69.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.447 0.699 . . . . 0.0 111.351 169.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -59.86 -35.69 75.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.587 1.155 . . . . 0.0 112.322 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.43 -62.67 1.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.293 1.037 . . . . 0.0 110.031 171.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.37 68.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -175.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.35 -30.02 68.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.808 1.243 . . . . 0.0 113.202 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -93.14 -28.77 16.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.867 0.867 . . . . 0.0 112.178 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -74.19 -47.09 37.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.21 1.004 . . . . 0.0 113.355 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.93 -12.35 39.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.89 115.26 5.17 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.209 -0.932 . . . . 0.0 110.982 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 86.76 4.18 82.8 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.421 1.486 . . . . 0.0 114.647 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -73.84 158.91 33.65 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.73 1.765 . . . . 0.0 111.748 172.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -103.89 116.77 32.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.077 0.951 . . . . 0.0 110.724 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.6 tp -122.7 111.65 16.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.443 1.897 . . . . 0.0 109.151 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.53 23.56 9.33 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.239 1.416 . . . . 0.0 113.467 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.35 8.82 65.82 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.024 1.297 . . . . 0.0 114.699 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -115.37 134.24 55.29 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.994 1.718 . . . . 0.0 110.107 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -78.93 126.62 30.94 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 109.663 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.85 167.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.924 0.889 . . . . 0.0 111.789 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -137.23 142.41 42.06 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.728 2.011 . . . . 0.0 108.048 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -137.96 140.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.651 0.78 . . . . 0.0 111.581 -168.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -152.57 164.8 36.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.17 1.788 . . . . 0.0 111.224 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.31 141.96 41.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.347 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 CA--C 1.54 0.587 0 O-C-N 121.162 -0.961 . . . . 0.0 112.855 -178.989 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.1 t . . . . . 0 CA--C 1.543 0.703 0 CA-C-O 121.072 0.463 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.1 mt -118.67 146.54 44.62 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.488 1.915 . . . . 0.0 110.379 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.06 149.25 18.7 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.723 1.63 . . . . 0.0 110.955 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.47 128.46 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.505 1.922 . . . . 0.0 107.838 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -136.88 150.81 48.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.156 0.982 . . . . 0.0 112.175 -167.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.15 30.18 23.4 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 123.972 0.796 . . . . 0.0 113.383 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.09 162.87 23.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 113.349 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 t -81.81 157.8 24.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.694 0.798 . . . . 0.0 112.216 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.83 -19.91 62.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.402 0.681 . . . . 0.0 112.083 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.56 -6.38 54.77 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.447 1.499 . . . . 0.0 114.364 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.7 m -69.02 134.56 49.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.727 1.211 . . . . 0.0 109.482 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 p -108.22 162.66 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.289 1.036 . . . . 0.0 111.348 173.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -61.12 -28.65 69.25 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.075 0.55 . . . . 0.0 111.132 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -70.43 -36.73 74.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 112.53 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -67.22 -49.49 64.31 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.605 0.639 . . . . 0.0 110.289 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.54 -43.62 80.08 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.806 -0.559 . . . . 0.0 110.901 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -57.22 -50.33 73.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.657 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.11 -29.9 68.94 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.593 1.088 . . . . 0.0 113.074 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.82 -27.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.479 1.112 . . . . 0.0 112.015 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -100.51 -24.15 14.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.055 0.942 . . . . 0.0 113.488 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.3 p -69.82 -17.19 63.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.362 1.437 . . . . 0.0 113.868 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -66.86 -12.81 60.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -98.68 -8.28 26.44 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.287 1.435 . . . . 0.0 113.751 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.52 -175.55 26.81 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.982 1.277 . . . . 0.0 115.004 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.14 137.21 21.12 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 124.413 3.409 . . . . 0.0 112.248 -170.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.5 mt -128.62 131.35 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.977 1.711 . . . . 0.0 110.016 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.03 -25.18 15.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.065 1.346 . . . . 0.0 113.439 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.11 164.19 25.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.5 t -148.49 134.44 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.175 2.19 . . . . 0.0 108.056 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.9 m -132.83 110.6 10.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.36 1.064 . . . . 0.0 111.351 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.41 139.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.513 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.95 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -153.47 162.55 41.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 122.615 1.198 . . . . 0.0 113.318 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.65 173.59 16.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.251 1.82 . . . . 0.0 111.875 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -141.17 152.4 44.63 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.784 1.633 . . . . 0.0 110.485 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 67.1 t -137.74 132.61 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.176 1.79 . . . . 0.0 108.955 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -115.89 101.67 8.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 111.509 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -78.73 160.08 27.62 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.918 0.887 . . . . 0.0 111.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -91.29 6.68 44.29 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.118 0.967 . . . . 0.0 113.017 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -158.23 134.73 9.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.398 1.479 . . . . 0.0 111.57 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.63 -29.39 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.91 0.884 . . . . 0.0 112.672 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.91 -27.37 49.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.468 1.031 . . . . 0.0 112.989 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.45 -29.2 52.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.675 0.79 . . . . 0.0 111.786 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.41 -39.5 74.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.259 0.624 . . . . 0.0 111.65 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.29 -39.1 85.71 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.112 -0.993 . . . . 0.0 111.962 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.91 -61.94 2.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.794 0.838 . . . . 0.0 110.079 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.21 -39.27 69.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -61.58 -39.18 90.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.856 0.863 . . . . 0.0 112.466 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -82.66 -25.36 33.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.276 0.63 . . . . 0.0 112.417 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -76.12 -51.84 11.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.534 1.134 . . . . 0.0 112.792 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.13 -14.19 39.36 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.1 112.6 3.45 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.521 -1.362 . . . . 0.0 111.068 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.22 8.4 68.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.47 1.509 . . . . 0.0 114.609 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -75.68 174.72 9.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.739 1.769 . . . . 0.0 111.465 169.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -120.12 135.32 55.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.248 1.019 . . . . 0.0 111.494 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -145.46 120.58 10.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.966 1.706 . . . . 0.0 109.276 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 56.53 27.47 12.36 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.424 1.489 . . . . 0.0 112.573 -169.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.58 84.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.727 1.156 . . . . 0.0 114.274 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.82 130.36 44.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.855 1.328 . . . . 0.0 109.622 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.26 130.92 42.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 122.09 -0.381 . . . . 0.0 110.171 171.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.0 pt -110.84 143.99 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.566 0.746 . . . . 0.0 111.389 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -102.35 144.41 30.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.694 1.598 . . . . 0.0 108.634 172.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.8 t -141.62 134.92 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.566 1.147 . . . . 0.0 109.911 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -156.31 158.2 37.04 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.925 1.29 . . . . 0.0 111.731 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.43 140.64 54.13 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.578 -0.701 . . . . 0.0 110.98 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 CA--C 1.54 0.559 0 O-C-N 121.411 -0.806 . . . . 0.0 112.261 -179.503 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 120.994 0.426 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.8 mt -118.39 148.07 42.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.579 1.952 . . . . 0.0 110.593 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.1 149.61 18.0 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.132 1.825 . . . . 0.0 111.461 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.63 128.78 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.786 2.034 . . . . 0.0 108.027 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -136.05 145.42 45.99 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.304 1.042 . . . . 0.0 111.635 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 29.06 9.83 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 124.343 0.973 . . . . 0.0 114.014 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.6 mt -83.65 156.51 22.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.008 1.323 . . . . 0.0 112.874 -173.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 t -79.71 152.69 29.75 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 171.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.84 -18.86 65.59 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.481 -0.762 . . . . 0.0 112.232 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.81 -6.88 57.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.374 1.47 . . . . 0.0 114.358 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 m -74.98 130.98 40.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.3 p -104.5 165.51 11.01 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.377 1.071 . . . . 0.0 111.567 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -60.64 -29.12 69.07 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.2 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.25 -37.87 71.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.471 1.108 . . . . 0.0 112.422 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.87 -48.7 70.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.563 0.619 . . . . 0.0 110.284 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.5 mt -55.64 -43.66 76.4 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.912 -0.493 . . . . 0.0 110.865 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.42 -43.24 99.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.871 0.759 . . . . 0.0 112.366 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.3 -29.96 67.94 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.067 1.303 . . . . 0.0 112.633 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.27 -29.92 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.398 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -100.29 -24.86 14.43 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.3 p -70.97 -11.47 60.98 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.228 1.377 . . . . 0.0 114.097 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -66.61 -15.87 63.77 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.987 -1.071 . . . . 0.0 113.608 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -95.59 -14.84 23.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.85 1.26 . . . . 0.0 113.645 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.77 -177.89 33.48 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 124.878 1.227 . . . . 0.0 114.687 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.67 136.83 21.69 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 124.33 3.353 . . . . 0.0 111.931 -172.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.31 125.87 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.72 1.608 . . . . 0.0 109.755 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.65 -27.01 21.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.919 1.288 . . . . 0.0 113.176 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.08 166.19 23.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.82 137.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.972 2.109 . . . . 0.0 107.883 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -138.29 106.42 5.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.131 0.973 . . . . 0.0 111.053 -172.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.7 146.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.344 -0.847 . . . . 0.0 108.969 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.044 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.057 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -150.2 159.5 44.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.601 1.191 . . . . 0.0 112.9 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.6 175.42 13.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.148 1.779 . . . . 0.0 111.568 -168.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -142.81 154.99 44.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.48 1.512 . . . . 0.0 110.6 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -138.42 131.65 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.213 1.805 . . . . 0.0 109.194 -168.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -114.4 96.73 5.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 0.0 111.463 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.81 158.41 32.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 111.7 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.36 0.67 53.47 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -157.13 157.46 34.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.176 1.39 . . . . 0.0 112.224 173.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.21 -26.16 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.62 -33.15 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.507 1.049 . . . . 0.0 112.874 -170.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -75.76 -23.59 55.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.562 0.745 . . . . 0.0 112.063 169.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.42 62.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.362 0.665 . . . . 0.0 111.233 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -60.03 -37.76 80.72 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.292 1.037 . . . . 0.0 111.975 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.76 -63.34 1.24 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.005 0.922 . . . . 0.0 110.195 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.98 69.75 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -60.49 -38.05 83.05 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.889 0.875 . . . . 0.0 112.464 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -83.54 -26.43 30.12 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.57 0.748 . . . . 0.0 112.128 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -76.09 -46.37 29.34 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.432 1.093 . . . . 0.0 112.973 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -91.9 -15.22 28.4 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -64.46 112.28 3.05 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.745 -1.222 . . . . 0.0 110.717 172.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.23 7.26 70.13 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.34 1.448 . . . . 0.0 114.796 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.3 ptm -74.91 172.13 12.8 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.889 1.845 . . . . 0.0 111.449 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -116.49 134.1 55.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.342 1.057 . . . . 0.0 111.242 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.2 tp -145.79 119.37 9.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.286 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.5 t70 56.94 27.69 13.53 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.529 1.532 . . . . 0.0 112.468 -169.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.43 -2.49 82.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.737 1.16 . . . . 0.0 114.175 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.81 128.16 42.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.814 1.307 . . . . 0.0 109.694 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.76 127.93 34.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.853 170.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.9 pt -108.66 154.24 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.03 0.832 . . . . 0.0 112.327 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -110.78 146.78 35.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.885 1.674 . . . . 0.0 108.697 172.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.91 139.16 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.557 1.143 . . . . 0.0 110.674 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -155.52 164.49 38.61 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.223 1.409 . . . . 0.0 112.387 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -79.74 142.81 35.09 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.199 -0.938 . . . . 0.0 111.517 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.544 0.717 0 O-C-N 121.126 -0.984 . . . . 0.0 113.592 -176.981 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.543 0.691 0 CA-C-O 121.12 0.486 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.59 145.44 45.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.423 1.889 . . . . 0.0 110.27 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 148.2 18.56 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.804 1.669 . . . . 0.0 110.589 168.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.77 132.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.713 2.005 . . . . 0.0 108.034 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -137.91 152.15 48.72 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.444 1.098 . . . . 0.0 111.958 -167.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.08 29.15 26.36 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.172 0.891 . . . . 0.0 113.759 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.89 159.07 29.14 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.278 1.431 . . . . 0.0 113.596 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.0 t -72.83 155.41 39.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.613 0.721 . . . . 0.0 111.878 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -70.97 -12.46 61.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.793 0.837 . . . . 0.0 112.723 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -103.86 -4.68 23.21 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.478 1.911 . . . . 0.0 114.615 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.4 m -62.61 134.95 57.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.41 1.084 . . . . 0.0 110.058 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -108.25 162.18 14.31 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.26 1.024 . . . . 0.0 111.667 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.57 -26.68 68.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.298 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.37 -36.19 66.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.161 0.984 . . . . 0.0 112.203 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.51 -50.61 68.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.748 0.704 . . . . 0.0 110.289 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.8 mt -60.15 -40.05 88.49 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.537 -0.727 . . . . 0.0 111.15 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.89 -47.44 84.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.141 0.882 . . . . 0.0 111.775 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.31 -32.59 72.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.82 1.191 . . . . 0.0 112.478 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.07 -29.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.438 1.095 . . . . 0.0 112.463 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.47 -22.97 14.84 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -68.03 -17.06 64.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.281 1.401 . . . . 0.0 113.631 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -68.08 -13.86 62.53 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.868 -1.145 . . . . 0.0 113.72 172.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -96.22 -10.82 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.93 1.292 . . . . 0.0 113.747 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.14 -173.95 28.0 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.968 1.271 . . . . 0.0 114.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.64 138.03 21.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.427 3.418 . . . . 0.0 112.147 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.5 mt -130.9 130.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.897 1.679 . . . . 0.0 109.891 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.02 -23.7 16.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.896 1.278 . . . . 0.0 113.468 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.67 162.5 29.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.83 0.852 . . . . 0.0 112.97 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.93 134.16 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.047 2.139 . . . . 0.0 107.399 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.3 t -137.08 111.18 8.34 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.529 0.732 . . . . 0.0 110.804 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.3 mt -84.82 138.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.392 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.583 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -147.38 159.75 43.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.934 1.35 . . . . 0.0 113.971 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.54 174.77 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.446 1.898 . . . . 0.0 111.368 -169.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -143.09 153.09 42.56 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.567 1.547 . . . . 0.0 110.667 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.7 129.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.96 1.704 . . . . 0.0 108.993 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -114.15 97.94 6.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.709 1.204 . . . . 0.0 111.2 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -75.81 160.66 29.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.822 0.849 . . . . 0.0 111.807 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -92.13 7.01 44.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.154 0.982 . . . . 0.0 112.969 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.06 134.32 9.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.362 1.465 . . . . 0.0 111.483 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.91 -29.48 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 112.711 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.27 -27.26 47.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 0.977 . . . . 0.0 113.136 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -77.77 -28.27 50.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.63 0.772 . . . . 0.0 111.726 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.06 -39.5 72.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.209 0.604 . . . . 0.0 111.464 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.59 -37.51 81.57 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.055 -1.028 . . . . 0.0 112.156 172.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.85 -62.51 1.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.895 0.878 . . . . 0.0 109.976 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.98 -38.59 70.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.7 -35.36 77.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.969 0.907 . . . . 0.0 112.487 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -86.29 -25.43 25.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.453 0.701 . . . . 0.0 112.299 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -76.35 -47.94 21.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.597 1.159 . . . . 0.0 112.972 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.63 -12.09 30.19 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -66.67 110.9 3.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.626 -1.296 . . . . 0.0 111.041 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.13 6.84 68.59 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.84 1.686 . . . . 0.0 114.61 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.3 ptm -74.52 168.22 20.17 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.793 1.796 . . . . 0.0 111.453 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -111.8 133.87 53.73 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.054 0.942 . . . . 0.0 111.15 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -141.72 116.58 9.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.001 1.72 . . . . 0.0 109.153 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.17 32.27 15.6 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.22 1.408 . . . . 0.0 112.569 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.68 -1.49 82.84 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.953 -1.092 . . . . 0.0 114.756 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -96.27 133.41 40.64 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.875 1.338 . . . . 0.0 110.114 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -73.35 127.29 32.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.181 0.9 . . . . 0.0 109.146 169.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -103.64 155.9 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.737 0.815 . . . . 0.0 110.586 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -122.64 155.16 36.94 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.939 1.295 . . . . 0.0 109.587 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.5 t -144.0 139.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.763 1.225 . . . . 0.0 110.585 -169.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -155.05 158.12 38.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.253 1.421 . . . . 0.0 111.94 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -72.68 138.32 46.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 CA--C 1.542 0.644 0 O-C-N 121.311 -0.868 . . . . 0.0 113.192 -177.222 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.546 0.789 0 CA-C-O 120.9 0.381 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -119.85 147.18 44.99 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.731 2.013 . . . . 0.0 110.482 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.4 150.84 17.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.993 1.758 . . . . 0.0 111.086 168.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.43 131.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.558 1.943 . . . . 0.0 108.105 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.46 151.8 47.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.404 1.082 . . . . 0.0 111.959 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.87 30.01 33.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.103 0.858 . . . . 0.0 113.422 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.29 159.23 25.91 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.408 1.483 . . . . 0.0 112.68 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 t -77.94 151.35 33.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.011 0.524 . . . . 0.0 111.737 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -16.05 63.68 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -96.98 0.84 49.5 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.974 1.709 . . . . 0.0 114.106 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.1 m -65.14 142.8 58.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.943 1.297 . . . . 0.0 109.829 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.3 p -119.87 161.11 21.39 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.901 0.88 . . . . 0.0 110.865 169.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -59.15 -24.96 63.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.828 0.851 . . . . 0.0 111.621 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -58.61 -44.44 89.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.113 1.765 . . . . 0.0 111.861 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -71.17 -45.96 62.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.021 0.928 . . . . 0.0 110.322 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.4 mt -59.42 -44.33 92.91 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.776 -0.578 . . . . 0.0 110.79 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -58.5 -47.59 83.61 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.864 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.68 -29.38 69.38 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.763 1.165 . . . . 0.0 113.163 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.6 t -79.22 -30.08 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.405 1.082 . . . . 0.0 112.371 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -100.57 -26.63 13.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.4 p -70.09 -20.07 63.22 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.357 1.435 . . . . 0.0 113.885 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.27 -11.97 58.91 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -104.11 -6.44 21.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.089 1.355 . . . . 0.0 114.329 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.13 -175.31 32.41 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.85 138.73 19.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.59 3.526 . . . . 0.0 111.986 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.14 133.33 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.85 1.66 . . . . 0.0 110.503 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.06 -22.69 14.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.254 1.421 . . . . 0.0 113.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -160.87 159.26 29.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.006 0.922 . . . . 0.0 112.696 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.1 t -152.86 132.7 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.621 2.368 . . . . 0.0 107.536 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -148.53 123.32 9.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.315 0.646 . . . . 0.0 112.234 -171.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.27 144.0 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.963 0.905 . . . . 0.0 108.681 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.284 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.114 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.859 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -149.53 161.18 42.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.65 1.214 . . . . 0.0 113.786 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.68 173.79 15.54 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 111.963 -168.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.39 155.21 44.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.686 1.594 . . . . 0.0 111.47 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 88.6 t -140.93 134.15 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.659 1.984 . . . . 0.0 108.838 -169.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.29 101.88 8.3 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.087 1.355 . . . . 0.0 111.39 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.65 162.5 27.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.907 172.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -91.75 6.74 44.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.257 1.023 . . . . 0.0 112.981 171.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -159.24 137.77 10.76 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.638 1.575 . . . . 0.0 111.596 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.07 -35.88 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.637 . . . . 0.0 112.645 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.71 -27.49 62.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.215 0.916 . . . . 0.0 112.596 -174.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -77.4 -36.07 53.71 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.976 0.91 . . . . 0.0 111.885 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.87 90.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.258 0.623 . . . . 0.0 111.298 169.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -65.37 -27.15 68.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.956 1.702 . . . . 0.0 112.793 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.99 -61.48 1.83 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.276 1.031 . . . . 0.0 109.431 168.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.15 67.79 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.45 -33.54 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.671 1.188 . . . . 0.0 112.842 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -88.92 -18.74 26.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.927 0.891 . . . . 0.0 112.461 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -84.64 -43.93 13.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.713 1.205 . . . . 0.0 112.948 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.87 -12.4 29.01 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -64.39 116.58 6.22 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.602 -1.311 . . . . 0.0 111.061 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.18 5.52 76.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.599 1.571 . . . . 0.0 114.872 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.2 ptm -76.24 163.1 27.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.656 1.728 . . . . 0.0 112.595 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -83.9 128.52 34.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.57 1.148 . . . . 0.0 110.189 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.9 tp -150.45 123.13 8.59 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.927 1.291 . . . . 0.0 110.175 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 55.02 31.51 16.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.541 1.536 . . . . 0.0 113.04 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.88 4.0 85.16 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.389 1.471 . . . . 0.0 114.69 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -116.96 153.36 32.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.619 1.568 . . . . 0.0 111.271 -175.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -87.9 121.62 30.54 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.6 pt -99.58 155.14 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.014 0.526 . . . . 0.0 112.044 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -112.75 144.7 41.82 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.943 1.697 . . . . 0.0 108.662 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.4 t -141.61 134.67 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.552 1.141 . . . . 0.0 109.796 -172.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -156.69 159.75 38.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.661 1.184 . . . . 0.0 112.225 -169.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.05 138.84 50.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.521 0.728 . . . . 0.0 111.281 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 CA--C 1.541 0.608 0 O-C-N 121.494 -0.754 . . . . 0.0 112.105 -179.843 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.2 m -66.7 140.54 57.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.331 1.052 . . . . 0.0 112.789 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.6 t -164.42 143.77 7.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.014 1.326 . . . . 0.0 110.884 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.28 146.19 10.73 Favored Glycine 0 N--CA 1.469 0.874 0 C-N-CA 123.857 0.741 . . . . 0.0 114.368 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.9 m -58.76 125.47 23.6 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.793 1.237 . . . . 0.0 111.692 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.4 m 68.03 -7.89 0.6 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.549 1.94 . . . . 0.0 114.725 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.46 -34.63 10.2 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.201 1.381 . . . . 0.0 111.747 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -67.07 138.31 57.05 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.044 0.937 . . . . 0.0 110.396 169.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -127.8 17.21 6.84 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -170.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.65 36.41 4.62 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.018 1.727 . . . . 0.0 112.039 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -176.99 60.52 0.17 Allowed Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 128.446 2.698 . . . . 0.0 111.836 -169.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.9 176.33 10.27 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.281 3.321 . . . . 0.0 112.062 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -150.16 151.93 32.67 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.745 1.618 . . . . 0.0 111.237 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -45.87 134.93 14.04 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.263 3.975 . . . . 0.0 116.801 -168.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -158.41 141.56 14.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.496 1.918 . . . . 0.0 109.591 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 61.5 m -55.78 -31.74 62.87 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.659 1.183 . . . . 0.0 112.508 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.8 m -85.04 131.33 34.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.288 1.035 . . . . 0.0 110.7 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.28 144.31 45.91 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.239 1.816 . . . . 0.0 110.526 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.38 145.82 17.73 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.804 1.669 . . . . 0.0 110.603 167.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.45 128.75 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.81 2.044 . . . . 0.0 107.71 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -133.84 145.14 49.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.546 1.138 . . . . 0.0 111.329 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.72 9.13 44.16 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.532 1.063 . . . . 0.0 115.706 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.03 150.36 48.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.445 1.498 . . . . 0.0 114.273 -169.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.4 t -75.48 146.1 40.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.061 0.944 . . . . 0.0 110.935 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.5 -15.0 60.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.403 1.081 . . . . 0.0 113.836 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.77 -0.15 51.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.353 1.461 . . . . 0.0 113.749 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.0 m -71.65 139.41 49.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.914 1.286 . . . . 0.0 109.77 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.8 p -110.89 163.42 13.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.314 1.046 . . . . 0.0 111.451 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -59.77 -28.21 67.21 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.96 0.904 . . . . 0.0 111.137 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.13 -39.0 75.68 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.844 1.258 . . . . 0.0 112.041 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.12 -47.38 74.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.148 0.431 . . . . 0.0 110.285 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.5 mt -57.34 -46.54 83.18 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.846 -0.534 . . . . 0.0 110.882 173.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -63.44 -39.02 93.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.376 0.989 . . . . 0.0 112.707 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.4 -29.89 68.68 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.739 1.609 . . . . 0.0 112.572 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.34 -30.24 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.404 1.082 . . . . 0.0 112.253 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -100.37 -26.25 13.95 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -71.06 -14.01 62.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.344 1.429 . . . . 0.0 113.996 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -67.32 -13.49 62.04 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.016 -1.052 . . . . 0.0 113.547 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -96.98 -9.12 28.89 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.268 1.427 . . . . 0.0 113.686 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.26 -175.78 27.39 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.968 1.271 . . . . 0.0 114.882 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.41 136.01 19.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.504 3.47 . . . . 0.0 112.228 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.6 mt -128.79 122.73 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.658 1.583 . . . . 0.0 109.845 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.61 -31.32 28.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.121 0.969 . . . . 0.0 112.873 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -164.26 162.23 22.39 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.594 1.158 . . . . 0.0 112.276 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -148.0 137.06 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.112 2.165 . . . . 0.0 108.012 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.8 t -144.09 120.03 10.65 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 111.407 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -85.87 146.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.184 0.994 . . . . 0.0 108.648 172.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.6 t -97.47 129.06 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 108.778 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.14 154.73 37.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.889 1.276 . . . . 0.0 113.662 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -71.9 140.24 49.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.277 1.431 . . . . 0.0 112.107 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -77.23 -22.16 52.69 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -104.19 -27.75 11.86 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.092 0.86 . . . . 0.0 112.898 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 100.0 p -120.93 -12.59 8.75 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 61.82 15.54 7.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.036 1.734 . . . . 0.0 114.386 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -74.64 153.06 39.11 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.46 1.504 . . . . 0.0 110.292 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.8 t -61.34 142.89 56.58 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.708 -0.62 . . . . 0.0 111.103 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -84.64 -1.39 55.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.181 0.993 . . . . 0.0 112.772 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.92 7.72 62.43 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.15 1.357 . . . . 0.0 114.181 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -144.59 160.94 40.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.628 1.214 . . . . 0.0 113.586 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.86 172.27 17.94 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.535 1.934 . . . . 0.0 111.053 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.28 149.02 40.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.768 1.227 . . . . 0.0 111.04 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.63 120.8 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.608 1.963 . . . . 0.0 108.182 -170.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -106.68 98.34 8.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.328 1.051 . . . . 0.0 111.003 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -74.66 160.97 30.13 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.479 -0.763 . . . . 0.0 111.742 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.26 6.68 41.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.171 0.988 . . . . 0.0 113.006 171.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -158.56 135.22 9.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.341 1.456 . . . . 0.0 111.748 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -68.38 -29.63 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.072 0.949 . . . . 0.0 112.746 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.63 -26.05 45.16 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.36 0.982 . . . . 0.0 113.178 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -78.71 -29.36 45.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.774 0.83 . . . . 0.0 111.677 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.65 77.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.275 0.63 . . . . 0.0 111.343 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.06 -34.02 74.23 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.99 -1.069 . . . . 0.0 112.55 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.03 -63.12 1.15 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.758 0.823 . . . . 0.0 109.758 172.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.21 70.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -61.11 -34.37 74.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.081 0.952 . . . . 0.0 112.593 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -87.81 -24.25 23.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.533 0.733 . . . . 0.0 112.31 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.43 -46.48 22.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.509 1.124 . . . . 0.0 113.074 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.91 -11.12 27.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -170.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -66.68 111.06 3.48 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 120.658 -1.276 . . . . 0.0 111.248 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.04 7.06 68.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.078 1.799 . . . . 0.0 114.627 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -74.72 168.96 18.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.713 1.757 . . . . 0.0 111.326 170.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -111.12 137.09 49.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.237 1.015 . . . . 0.0 110.974 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.06 116.8 9.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.776 1.63 . . . . 0.0 109.377 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 58.14 25.11 12.07 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.011 1.725 . . . . 0.0 113.901 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.99 2.76 68.67 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.93 1.252 . . . . 0.0 114.965 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -110.19 139.27 45.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.702 1.601 . . . . 0.0 110.516 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 138.76 47.4 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 167.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.1 pt -111.82 149.3 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.721 0.808 . . . . 0.0 110.285 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 34.5 mtm-85 -117.61 153.07 33.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 109.007 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.0 t -143.67 136.05 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.45 1.1 . . . . 0.0 110.879 -168.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -150.38 162.04 41.31 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.288 1.835 . . . . 0.0 111.484 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -69.77 142.5 53.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.849 0.86 . . . . 0.0 112.081 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.0 m -66.54 125.93 27.27 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.33 -0.856 . . . . 0.0 112.602 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.8 pt -83.19 -19.87 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.246 1.019 . . . . 0.0 112.477 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.8 p -156.48 155.97 32.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 130.724 3.61 . . . . 0.0 107.323 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.49 158.91 34.97 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -70.65 -40.46 10.82 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -58.59 150.17 71.18 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.332 3.355 . . . . 0.0 113.349 170.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -160.99 146.76 14.51 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.381 1.473 . . . . 0.0 112.098 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.05 1.74 . . . . 0.0 110.859 -174.39 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.257 1 O4'-C1'-N19 112.597 4.397 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 C3'-C2'-C1' 103.46 2.177 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 O4'-C4'-C3' 108.411 2.08 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 O5'-C5'-C4' 114.717 3.226 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.55 0 C4'-C3'-C2' 99.662 -3.038 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.014 0 O4'-C1'-N19 111.76 3.56 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.8 m -138.03 12.45 2.86 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -170.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.5 m -163.53 155.24 17.15 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.402 1.881 . . . . 0.0 110.992 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.09 -71.6 2.6 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.769 1.176 . . . . 0.0 111.993 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.0 p -167.89 147.43 4.85 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.026 1.731 . . . . 0.0 111.675 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 m -171.29 146.92 2.4 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.68 1.992 . . . . 0.0 110.709 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -95.81 144.49 17.28 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.659 1.123 . . . . 0.0 111.82 173.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -158.8 148.95 19.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.295 1.438 . . . . 0.0 112.213 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 ttm105 -75.56 31.77 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.689 1.996 . . . . 0.0 115.384 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.79 172.7 7.21 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.85 1.26 . . . . 0.0 111.627 172.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -51.04 119.16 11.57 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 124.045 0.938 . . . . 0.0 112.448 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -85.32 -175.16 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.902 3.068 . . . . 0.0 111.754 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -149.02 160.54 34.84 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 126.53 1.932 . . . . 0.0 110.615 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.3 138.49 46.01 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.27 3.313 . . . . 0.0 115.319 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -154.94 156.98 37.04 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.686 1.594 . . . . 0.0 110.384 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.83 10.6 0.49 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.599 1.559 . . . . 0.0 114.42 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 14.8 p -152.87 150.64 29.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.092 1.357 . . . . 0.0 111.442 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.19 146.83 50.6 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.964 1.706 . . . . 0.0 110.889 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.47 147.48 18.55 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.838 1.685 . . . . 0.0 109.731 166.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.054 1.742 . . . . 0.0 107.832 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.69 154.23 51.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.845 0.858 . . . . 0.0 111.773 -168.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.81 34.55 30.66 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.685 0.659 . . . . 0.0 113.285 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.57 164.93 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.357 1.463 . . . . 0.0 113.203 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.6 t -83.09 153.05 25.06 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.239 0.615 . . . . 0.0 111.13 168.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.56 -15.91 62.82 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.495 -0.753 . . . . 0.0 112.386 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -95.45 -4.27 45.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.617 1.567 . . . . 0.0 114.031 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 85.2 m -67.8 133.54 49.4 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.503 1.121 . . . . 0.0 109.263 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 p -106.79 163.65 12.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -61.14 -27.58 68.49 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.093 0.557 . . . . 0.0 111.181 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.56 1.144 . . . . 0.0 112.301 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.81 -47.45 75.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.682 0.674 . . . . 0.0 110.399 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.48 -44.59 85.03 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.673 -0.642 . . . . 0.0 110.679 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -63.63 -39.71 95.05 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.013 0.824 . . . . 0.0 112.772 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.86 -28.33 65.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.36 1.436 . . . . 0.0 112.852 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.66 -33.92 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.929 0.891 . . . . 0.0 111.831 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -99.96 -24.67 14.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.2 p -71.38 -18.39 62.36 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.518 1.508 . . . . 0.0 114.112 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -69.38 -7.12 34.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.017 -1.052 . . . . 0.0 113.83 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.5 -5.1 27.48 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.107 1.363 . . . . 0.0 113.642 171.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.23 -174.92 23.06 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.602 1.573 . . . . 0.0 115.087 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.87 128.69 14.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.231 3.288 . . . . 0.0 112.642 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.0 mt -116.91 126.11 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.909 1.684 . . . . 0.0 109.281 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.54 -40.45 42.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.684 1.194 . . . . 0.0 111.859 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.51 174.41 6.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.777 1.231 . . . . 0.0 113.094 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.84 142.63 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.115 2.166 . . . . 0.0 108.524 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.6 t -137.52 118.48 14.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.467 0.707 . . . . 0.0 111.673 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 94.2 mt -82.69 142.7 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.1 t -92.82 128.76 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.829 0.852 . . . . 0.0 109.76 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -125.44 153.62 43.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.327 1.451 . . . . 0.0 112.927 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.63 150.83 48.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.408 1.083 . . . . 0.0 111.565 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -81.18 -20.95 40.11 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -127.36 -39.67 1.86 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.972 0.909 . . . . 0.0 112.708 -170.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 67.9 m -82.36 -20.44 37.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.457 0.703 . . . . 0.0 112.132 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 58.56 21.79 9.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.487 1.915 . . . . 0.0 114.044 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -76.88 147.68 36.91 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 128.365 2.666 . . . . 0.0 110.804 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.1 t -69.07 134.76 49.81 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -87.29 -2.08 58.37 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 96.09 6.6 58.96 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 125.102 1.334 . . . . 0.0 114.839 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.05 164.64 31.47 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.585 1.183 . . . . 0.0 113.824 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.83 171.44 20.05 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.785 2.034 . . . . 0.0 110.994 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -142.59 151.25 41.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.814 1.246 . . . . 0.0 110.906 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.3 t -131.47 126.86 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.298 1.839 . . . . 0.0 108.513 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -105.61 112.3 25.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.149 0.98 . . . . 0.0 110.441 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.65 157.96 16.67 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.322 -0.862 . . . . 0.0 111.245 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.34 -9.05 59.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -151.64 146.58 25.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.774 1.63 . . . . 0.0 111.573 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.6 -33.21 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.11 -24.57 58.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -81.42 -29.31 33.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.901 1.281 . . . . 0.0 111.801 174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.47 70.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 110.628 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -58.99 -40.03 83.6 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.16 -0.962 . . . . 0.0 112.23 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.49 -62.34 1.95 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.929 0.892 . . . . 0.0 110.242 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.83 71.68 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -63.06 -33.25 75.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.004 0.922 . . . . 0.0 112.641 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -84.49 -24.07 29.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.638 0.654 . . . . 0.0 112.703 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -82.84 -45.97 13.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.398 1.079 . . . . 0.0 113.318 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -100.25 -11.49 20.32 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.4 112.97 4.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.684 -1.26 . . . . 0.0 110.933 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.25 9.12 70.55 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.242 1.401 . . . . 0.0 114.633 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ptm -75.65 172.93 11.75 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.703 1.751 . . . . 0.0 111.502 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.24 134.66 54.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.075 0.95 . . . . 0.0 111.136 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -141.68 116.87 10.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.587 1.555 . . . . 0.0 109.239 -174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.84 25.23 10.12 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.571 1.548 . . . . 0.0 113.199 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.85 -3.55 83.01 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.395 1.474 . . . . 0.0 114.613 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.48 130.52 44.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.122 1.369 . . . . 0.0 110.15 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.4 122.25 22.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.033 0.833 . . . . 0.0 110.011 170.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -101.65 151.63 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.677 0.791 . . . . 0.0 111.631 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -106.82 149.87 26.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.317 1.847 . . . . 0.0 109.37 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.0 t -144.37 132.48 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.766 1.226 . . . . 0.0 110.224 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -156.47 154.72 30.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 112.651 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -70.01 136.18 50.13 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.362 -0.836 . . . . 0.0 112.328 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.3 m -68.84 126.94 31.33 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.417 -0.802 . . . . 0.0 112.975 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.5 pt -83.2 -19.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.084 0.954 . . . . 0.0 113.138 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.9 p -155.48 158.13 38.03 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 129.998 3.319 . . . . 0.0 107.508 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.77 159.05 41.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 -176.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 6.4 tpp85 -63.47 -50.54 72.88 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.921 1.689 . . . . 0.0 114.776 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.09 149.84 47.1 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.226 2.617 . . . . 0.0 111.397 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -151.97 2.6 0.37 Allowed 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -174.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.461 1.905 . . . . 0.0 111.812 -173.265 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.128 0 O4'-C1'-N19 111.795 3.595 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.245 1 O4'-C1'-N19 115.624 7.424 . 0.191 2z . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.117 1 O4'-C1'-N19 112.318 4.118 . 0.028 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.351 0 O4'-C1'-N19 111.21 3.01 . 0.133 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.592 0 O4'-C1'-N19 111.633 3.433 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.43 -1.942 0 O4'-C1'-N19 112.151 3.951 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.5 t -163.26 150.78 13.03 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.289 1.436 . . . . 0.0 111.171 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.7 p -81.65 -11.57 59.04 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.406 1.082 . . . . 0.0 113.363 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.52 31.01 2.45 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.703 1.62 . . . . 0.0 114.61 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.3 p -82.62 -20.22 36.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.7 p -169.22 158.62 8.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.97 1.708 . . . . 0.0 111.595 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.53 104.45 1.68 Allowed Glycine 0 N--CA 1.47 0.926 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -152.58 20.36 0.62 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -169.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 58.88 32.56 22.35 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.916 1.686 . . . . 0.0 114.346 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.64 33.61 2.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.611 1.565 . . . . 0.0 112.035 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -174.73 39.34 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 128.297 2.639 . . . . 0.0 114.799 -169.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.43 162.44 40.65 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.472 2.781 . . . . 0.0 112.14 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -157.81 143.44 12.46 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.608 1.563 . . . . 0.0 110.314 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.86 136.07 58.98 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.143 3.228 . . . . 0.0 114.003 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -149.22 28.48 0.82 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.176 0.99 . . . . 0.0 112.883 -168.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.411 ' H ' HG23 ' A' ' 169' ' ' VAL . 58.2 m 68.11 1.36 2.77 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.429 2.292 . . . . 0.0 114.73 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.7 p -156.79 154.44 29.94 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.044 1.338 . . . . 0.0 112.088 -172.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.8 mt -127.98 148.98 50.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.346 1.858 . . . . 0.0 111.389 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.67 146.28 17.49 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 126.297 1.903 . . . . 0.0 109.57 166.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.68 123.91 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.502 1.921 . . . . 0.0 107.372 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -130.64 153.33 49.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.883 1.273 . . . . 0.0 112.735 -167.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.9 12.26 60.68 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.265 1.412 . . . . 0.0 114.502 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.33 160.77 26.54 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.31 1.844 . . . . 0.0 114.275 -169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.4 t -75.06 151.45 38.69 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.478 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -68.68 -16.11 63.73 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.549 -0.72 . . . . 0.0 112.629 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -100.58 -2.52 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.622 1.569 . . . . 0.0 114.313 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.7 m -64.9 139.77 58.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.693 1.197 . . . . 0.0 109.495 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 p -108.76 161.65 14.91 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.177 0.991 . . . . 0.0 111.471 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -59.04 -30.94 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.681 0.792 . . . . 0.0 111.136 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -67.31 -40.0 85.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.817 1.247 . . . . 0.0 112.015 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.48 -49.78 67.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.795 0.438 . . . . 0.0 110.273 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.4 -43.56 79.41 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 110.997 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -62.48 -44.74 95.65 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.352 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.31 -29.29 67.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.645 1.111 . . . . 0.0 112.872 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.88 -28.69 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.363 1.065 . . . . 0.0 112.057 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -100.16 -20.52 15.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.0 p -68.73 -16.16 63.73 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.289 1.404 . . . . 0.0 113.979 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.72 -15.34 63.46 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 171.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.54 -12.36 27.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.977 1.311 . . . . 0.0 113.586 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.28 177.84 25.48 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.008 1.289 . . . . 0.0 114.323 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.4 134.18 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 124.569 3.512 . . . . 0.0 112.332 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.7 127.45 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.93 1.692 . . . . 0.0 109.889 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.08 -25.43 17.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.228 1.411 . . . . 0.0 113.574 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -159.91 156.86 27.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.938 0.895 . . . . 0.0 112.548 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.2 t -153.05 135.85 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.131 2.173 . . . . 0.0 108.282 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -149.07 125.01 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.567 0.747 . . . . 0.0 111.79 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.3 mt -86.16 146.75 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.182 0.993 . . . . 0.0 108.846 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.74 132.55 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.301 1.041 . . . . 0.0 109.38 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -124.69 153.51 42.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.992 1.317 . . . . 0.0 113.112 -170.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.85 141.32 53.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.257 1.423 . . . . 0.0 111.366 172.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -75.54 -20.31 58.75 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -113.45 -38.28 4.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.385 1.074 . . . . 0.0 112.853 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 60.0 p -94.51 -17.85 22.02 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 62.89 12.46 5.8 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.406 1.882 . . . . 0.0 114.081 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.76 154.47 31.94 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.326 1.45 . . . . 0.0 110.308 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.1 t -61.68 141.33 57.9 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.558 -0.714 . . . . 0.0 110.82 172.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -75.92 0.22 19.12 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.879 0.872 . . . . 0.0 112.754 170.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.04 18.86 55.15 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.955 1.264 . . . . 0.0 113.287 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -154.54 164.57 38.5 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.841 1.305 . . . . 0.0 114.246 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.09 170.43 22.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.622 1.969 . . . . 0.0 111.449 -168.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -135.56 151.76 50.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.388 1.475 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.48 130.42 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.833 2.053 . . . . 0.0 109.046 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -119.52 113.85 21.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.031 1.333 . . . . 0.0 112.254 -170.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.23 154.79 17.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.985 0.914 . . . . 0.0 111.929 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -81.73 4.64 21.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.215 1.006 . . . . 0.0 112.841 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -155.98 129.22 8.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.081 1.752 . . . . 0.0 110.777 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 118' ' ' CYS . 7.7 p -66.87 -27.14 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.83 -24.33 48.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.101 0.864 . . . . 0.0 113.08 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -78.85 -27.41 44.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.611 0.764 . . . . 0.0 111.734 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.24 73.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.976 0.51 . . . . 0.0 110.507 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.74 -34.66 76.22 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.013 -1.054 . . . . 0.0 112.688 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.18 -63.56 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.022 0.929 . . . . 0.0 110.045 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.83 -36.52 67.59 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.83 -38.12 77.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.059 0.943 . . . . 0.0 112.673 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.06 -21.12 27.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.547 0.739 . . . . 0.0 112.444 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -81.44 -46.51 14.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.602 1.161 . . . . 0.0 112.849 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.93 -14.59 25.82 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -64.69 111.03 2.57 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.658 -1.276 . . . . 0.0 110.76 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.82 5.82 64.16 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.47 1.509 . . . . 0.0 114.774 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.9 ptm -76.97 173.31 11.92 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.931 1.866 . . . . 0.0 111.36 169.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -118.45 137.91 52.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.28 1.032 . . . . 0.0 111.361 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.9 tp -145.8 120.46 9.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.454 1.502 . . . . 0.0 109.976 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.3 t70 57.63 23.36 9.27 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.678 1.591 . . . . 0.0 113.466 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.28 83.09 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.499 1.523 . . . . 0.0 114.625 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.72 130.24 45.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.276 1.43 . . . . 0.0 110.668 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.29 138.91 54.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 168.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 pt -115.92 143.95 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.351 0.661 . . . . 0.0 111.266 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -106.95 144.43 33.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.799 1.639 . . . . 0.0 108.297 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 t -140.3 135.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.98 0.912 . . . . 0.0 110.628 -170.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.32 162.59 39.13 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.543 1.537 . . . . 0.0 111.654 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.47 139.23 40.75 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 112.111 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.8 m -70.06 126.86 30.92 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.206 -0.934 . . . . 0.0 112.911 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 6.4 pt -86.12 -0.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.5 p -155.19 -163.64 1.59 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 129.24 3.016 . . . . 0.0 109.322 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -150.88 169.3 22.05 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.921 1.288 . . . . 0.0 113.861 169.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.9 159.37 55.25 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.119 0.968 . . . . 0.0 112.572 171.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -70.77 149.18 60.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.377 2.718 . . . . 0.0 113.28 -171.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 68.2 -16.82 0.18 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 127.799 2.44 . . . . 0.0 117.0 169.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.58 1.552 . . . . 0.0 113.358 -178.422 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.429 1 O4'-C1'-N19 112.555 4.355 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.197 0 C4'-C3'-C2' 100.009 -2.691 . 0.134 5n . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.266 0 O4'-C1'-N19 110.444 2.244 . 0.612 1z . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.222 0 O4'-C1'-N19 111.094 2.894 . 0.169 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 C5'-C4'-C3' 110.813 -3.125 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 0 C5'-C4'-C3' 110.795 -3.137 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.541 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.6 p -164.13 170.83 15.88 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.205 1.402 . . . . 0.0 111.802 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.1 m -74.35 3.12 7.88 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.0 -11.17 84.96 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.902 1.239 . . . . 0.0 115.206 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.8 t -162.32 133.8 5.24 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.941 1.296 . . . . 0.0 111.361 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.3 p -167.43 144.55 4.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.456 1.502 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -99.84 -11.1 44.54 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 124.647 1.117 . . . . 0.0 114.677 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -66.82 142.61 57.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.848 1.259 . . . . 0.0 111.248 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 78.14 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.415 1.086 . . . . 0.0 111.849 170.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.98 37.92 0.18 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.073 2.149 . . . . 0.0 111.708 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -168.52 34.38 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 126.707 2.003 . . . . 0.0 115.855 -168.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.04 149.69 88.94 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.134 2.556 . . . . 0.0 112.335 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -151.94 153.09 31.05 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 126.204 1.802 . . . . 0.0 110.639 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -38.1 125.17 0.77 Allowed 'Trans proline' 0 C--N 1.355 0.909 1 C-N-CA 125.97 4.447 . . . . 0.0 116.896 -168.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -156.97 137.38 12.98 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.409 1.884 . . . . 0.0 109.43 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.9 m -59.48 -28.26 66.85 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.096 0.958 . . . . 0.0 112.697 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 81.7 m -85.33 117.17 24.1 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.123 0.969 . . . . 0.0 110.058 171.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.7 mt -102.73 145.65 29.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.12 1.368 . . . . 0.0 110.452 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.02 144.95 16.13 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.879 1.704 . . . . 0.0 110.651 168.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.06 124.83 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.864 2.066 . . . . 0.0 107.634 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.03 154.71 47.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.832 1.253 . . . . 0.0 113.141 -166.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.39 18.01 61.3 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.798 1.189 . . . . 0.0 114.263 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.93 163.13 22.75 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.539 1.936 . . . . 0.0 114.237 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -80.28 149.05 30.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.828 168.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.55 -16.36 64.15 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.435 -0.791 . . . . 0.0 112.675 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -96.22 -4.39 42.54 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.449 1.5 . . . . 0.0 114.302 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -68.52 133.43 48.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.529 1.132 . . . . 0.0 109.377 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.8 p -106.3 164.16 12.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.182 0.993 . . . . 0.0 111.598 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -60.51 -29.47 69.12 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.176 0.59 . . . . 0.0 111.123 172.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -69.1 -40.16 78.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.711 1.205 . . . . 0.0 112.232 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.05 -49.47 67.53 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.187 0.449 . . . . 0.0 110.266 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.52 -42.47 78.5 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.907 -0.496 . . . . 0.0 110.978 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.61 -44.82 95.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.26 175.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.26 -32.38 72.52 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.929 1.241 . . . . 0.0 112.4 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.26 -29.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 112.273 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.16 -21.02 15.69 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 74.2 m -66.74 -17.24 64.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 120.105 1.321 . . . . 0.0 113.644 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -67.76 -14.52 63.02 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.999 -1.063 . . . . 0.0 113.829 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -97.5 -13.62 21.59 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.91 1.284 . . . . 0.0 113.857 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.81 -174.12 31.66 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.55 1.071 . . . . 0.0 114.761 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.04 136.27 16.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.437 3.425 . . . . 0.0 111.988 -171.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.5 mt -129.35 125.43 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.683 1.593 . . . . 0.0 109.742 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.16 -33.62 26.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.758 1.223 . . . . 0.0 112.669 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -166.39 170.2 13.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.254 1.021 . . . . 0.0 112.805 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.8 138.18 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.939 2.095 . . . . 0.0 108.5 175.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.0 m -138.33 109.06 6.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.256 1.022 . . . . 0.0 111.306 -171.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.89 149.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 171.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t -103.84 133.08 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.433 1.093 . . . . 0.0 109.61 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -128.24 153.73 46.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.191 1.396 . . . . 0.0 113.456 -169.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.41 138.83 49.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.787 1.235 . . . . 0.0 111.155 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -74.42 -21.31 59.68 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -118.0 -38.16 3.28 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.337 1.055 . . . . 0.0 112.463 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.9 m -83.84 -14.15 51.97 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.785 0.834 . . . . 0.0 113.177 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 54.08 38.71 29.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.273 1.829 . . . . 0.0 113.476 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -131.32 153.52 49.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.606 2.362 . . . . 0.0 109.53 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.3 t -60.09 138.19 57.94 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.05 -0.406 . . . . 0.0 111.474 -177.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -76.89 0.62 20.23 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.807 0.843 . . . . 0.0 112.939 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.47 13.58 53.38 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.28 1.419 . . . . 0.0 113.975 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.51 164.49 38.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.822 1.296 . . . . 0.0 113.98 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.57 172.67 17.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.21 1.804 . . . . 0.0 111.273 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.63 154.87 48.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.0 1.32 . . . . 0.0 111.233 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.8 t -134.34 121.13 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.521 1.928 . . . . 0.0 108.116 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -102.51 98.81 8.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.252 1.021 . . . . 0.0 110.552 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -76.57 161.68 28.39 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.189 -0.945 . . . . 0.0 112.174 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.18 7.94 45.12 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.547 1.139 . . . . 0.0 113.026 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -155.42 132.84 11.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.57 1.548 . . . . 0.0 111.13 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.63 -27.07 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 112.783 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.458 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 9.6 t70 -80.16 -29.74 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.189 0.904 . . . . 0.0 113.049 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.28 -30.32 60.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.26 0.624 . . . . 0.0 111.495 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.5 -43.29 77.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.352 0.661 . . . . 0.0 111.679 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 21.1 mtmt -58.03 -36.93 73.42 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.082 -1.011 . . . . 0.0 112.674 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.71 -57.31 4.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.196 0.599 . . . . 0.0 110.878 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.65 67.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.977 -1.077 . . . . 0.0 112.93 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -55.9 -47.23 77.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.819 1.248 . . . . 0.0 112.293 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -27.96 37.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.359 0.663 . . . . 0.0 111.675 -174.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -71.36 -52.41 18.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.937 1.695 . . . . 0.0 113.374 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.74 -14.12 37.96 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -64.22 111.0 2.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.766 -1.209 . . . . 0.0 111.144 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.78 8.13 65.69 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.628 1.585 . . . . 0.0 114.646 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -75.76 173.11 11.54 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.793 1.796 . . . . 0.0 111.457 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.07 136.64 53.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.214 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.4 tp -145.47 118.99 9.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.5 1.52 . . . . 0.0 109.531 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 58.13 22.74 9.39 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.422 1.489 . . . . 0.0 113.428 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.81 -5.77 83.27 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.633 1.587 . . . . 0.0 114.605 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.56 130.36 41.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.336 1.454 . . . . 0.0 110.707 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.52 131.44 43.29 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.3 pt -110.94 152.64 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.946 0.898 . . . . 0.0 110.225 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -122.75 153.13 39.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.485 1.114 . . . . 0.0 109.489 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -142.79 137.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.575 -167.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -150.18 169.84 20.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.643 1.977 . . . . 0.0 111.54 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -78.31 142.29 37.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.347 1.059 . . . . 0.0 112.003 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.3 t -64.69 138.78 58.59 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 6.7 pt -96.16 -21.28 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.672 1.189 . . . . 0.0 113.665 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.5 p -161.4 146.01 13.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.472 2.709 . . . . 0.0 108.404 -171.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -152.44 165.78 33.99 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -170.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -69.07 -48.57 27.36 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.26 145.33 24.06 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.142 2.561 . . . . 0.0 111.064 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -72.51 -14.51 61.67 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 129.201 3.0 . . . . 0.0 114.1 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.345 1 O4'-C1'-N19 113.99 5.79 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.209 0 O4'-C1'-N19 111.655 3.455 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 0 O4'-C1'-N19 110.449 2.249 . 0.403 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 O5'-C5'-C4' 114.455 3.039 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.104 0 O4'-C1'-N19 112.05 3.85 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.292 0 C5'-C4'-C3' 112.142 -2.239 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -64.05 -27.15 68.91 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -171.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -72.92 -16.62 61.55 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.011 0.924 . . . . 0.0 113.292 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.4 -42.08 3.28 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.443 1.497 . . . . 0.0 112.299 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.4 m -148.17 115.97 6.37 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.479 1.112 . . . . 0.0 111.782 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.6 p -167.72 172.68 9.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.885 1.674 . . . . 0.0 111.419 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.16 11.5 60.44 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.723 1.154 . . . . 0.0 114.041 172.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -57.76 128.09 35.31 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.675 1.238 . . . . 0.0 110.773 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -97.23 2.39 50.85 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.566 1.546 . . . . 0.0 114.792 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.45 47.87 0.98 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.897 1.679 . . . . 0.0 113.268 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -169.07 32.02 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.546 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -167.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.55 155.95 65.23 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.65 2.234 . . . . 0.0 111.873 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -157.47 157.98 30.41 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.113 1.765 . . . . 0.0 110.521 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -44.63 131.56 9.87 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.98 3.787 . . . . 0.0 115.94 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -152.56 137.8 17.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.921 1.689 . . . . 0.0 109.243 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 73.0 m -58.45 -23.62 58.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.74 0.816 . . . . 0.0 112.958 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 83.8 m -104.36 121.87 44.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.412 1.085 . . . . 0.0 110.755 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.82 145.83 29.53 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.056 1.342 . . . . 0.0 111.225 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.68 144.91 17.57 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.864 1.697 . . . . 0.0 109.563 167.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 t -132.67 121.29 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.364 1.866 . . . . 0.0 107.469 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.54 153.36 46.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.091 1.356 . . . . 0.0 112.013 -167.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.62 28.51 26.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.041 0.829 . . . . 0.0 113.607 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.94 161.65 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.381 1.472 . . . . 0.0 113.595 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.1 t -77.01 153.1 34.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.268 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.55 -16.8 63.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.442 -0.786 . . . . 0.0 112.261 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -96.2 -4.16 43.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.626 1.57 . . . . 0.0 114.528 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.9 m -65.05 138.15 58.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.643 1.177 . . . . 0.0 109.57 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -110.72 162.98 14.22 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.168 0.987 . . . . 0.0 111.464 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -57.67 -31.71 66.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.097 0.959 . . . . 0.0 111.172 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -67.32 -40.35 85.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.91 1.284 . . . . 0.0 112.066 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.49 -48.87 68.46 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.877 0.471 . . . . 0.0 110.284 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.75 -44.75 82.05 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.837 -0.539 . . . . 0.0 110.812 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.67 -44.13 97.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.213 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.05 -29.94 68.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.757 1.162 . . . . 0.0 112.922 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.95 -28.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.366 1.066 . . . . 0.0 111.894 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -100.43 -21.53 15.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.3 p -68.48 -17.7 64.24 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.383 1.447 . . . . 0.0 114.004 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -66.72 -13.49 61.39 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -97.27 -9.1 28.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.122 1.369 . . . . 0.0 113.756 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.2 -175.99 25.37 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.936 1.255 . . . . 0.0 114.837 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.34 134.83 17.72 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.428 3.419 . . . . 0.0 112.241 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 93.8 mt -124.39 125.93 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.695 1.598 . . . . 0.0 109.76 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.68 -34.75 24.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.921 1.288 . . . . 0.0 112.828 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -164.49 166.47 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.302 1.041 . . . . 0.0 112.569 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.7 t -147.55 135.75 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.901 2.08 . . . . 0.0 108.936 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.6 m -138.44 110.26 7.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.648 1.179 . . . . 0.0 111.506 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.61 144.76 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.5 t -106.17 135.87 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -127.37 155.92 42.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.36 1.464 . . . . 0.0 113.117 -170.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.98 150.96 38.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.272 1.029 . . . . 0.0 111.192 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -81.42 -23.66 37.39 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -123.64 -36.29 2.78 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.399 1.08 . . . . 0.0 112.723 -170.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.3 m -82.05 -23.62 35.74 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.685 0.794 . . . . 0.0 111.899 169.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . 0.257 90.0 mtt180 60.0 20.87 9.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.711 2.005 . . . . 0.0 115.321 169.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 46.9 ptt85 -94.29 164.76 12.9 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.059 1.743 . . . . 0.0 110.104 168.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 27.3 t -59.91 141.57 55.24 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 122.106 -0.371 . . . . 0.0 110.084 169.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -76.46 2.59 13.28 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.154 0.982 . . . . 0.0 112.681 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.54 18.95 57.77 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.517 1.056 . . . . 0.0 113.239 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -154.87 165.45 36.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.993 1.377 . . . . 0.0 113.971 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.33 173.03 17.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.786 2.034 . . . . 0.0 110.943 -169.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.64 151.83 49.74 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.245 1.418 . . . . 0.0 110.873 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.26 118.95 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.551 1.941 . . . . 0.0 108.177 -170.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -104.24 100.61 10.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.523 1.129 . . . . 0.0 110.906 -170.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -78.45 158.02 28.78 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.446 -0.783 . . . . 0.0 111.733 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -86.1 6.29 29.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.091 0.956 . . . . 0.0 113.136 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -159.16 139.69 12.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.516 1.527 . . . . 0.0 111.719 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.47 -31.59 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.984 0.914 . . . . 0.0 112.896 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.449 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 23.1 t70 -78.21 -28.82 48.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.321 0.964 . . . . 0.0 112.921 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -73.43 -28.2 61.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.515 0.726 . . . . 0.0 111.64 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.0 65.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.459 0.703 . . . . 0.0 111.371 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 55.7 mtmt -59.58 -36.29 75.95 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 120.797 -1.19 . . . . 0.0 112.492 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -62.87 -64.4 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.122 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.51 68.56 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -60.2 -32.79 71.43 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.292 1.037 . . . . 0.0 112.986 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -91.1 -22.06 20.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.539 0.736 . . . . 0.0 112.441 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -80.23 -47.32 14.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.557 1.143 . . . . 0.0 113.098 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.23 -11.43 30.29 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -171.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -66.03 112.83 4.05 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.704 -1.247 . . . . 0.0 110.925 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.22 3.42 63.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.592 1.568 . . . . 0.0 114.794 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -76.97 170.23 16.89 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.855 1.827 . . . . 0.0 112.439 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.6 137.05 44.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.719 1.208 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 24.6 tp -148.0 116.91 6.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.701 1.6 . . . . 0.0 109.602 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 54.85 33.91 20.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.339 1.456 . . . . 0.0 112.45 -170.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.88 -17.95 8.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.157 1.361 . . . . 0.0 114.313 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.0 mmt-85 -76.66 135.99 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.445 1.123 . . . . 0.0 109.748 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.38 129.48 34.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -111.12 157.78 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 111.302 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.8 152.6 45.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.883 1.673 . . . . 0.0 109.327 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -142.53 137.96 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.148 0.979 . . . . 0.0 110.838 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -156.2 162.2 40.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.413 1.485 . . . . 0.0 111.882 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.17 143.99 36.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.996 0.918 . . . . 0.0 111.685 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.4 m -67.22 129.26 39.33 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.894 -1.129 . . . . 0.0 112.703 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.9 pt -83.67 -21.65 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.302 -0.874 . . . . 0.0 112.422 171.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 12.0 p -153.81 144.81 22.77 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.905 3.282 . . . . 0.0 107.209 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -162.7 168.77 21.08 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -81.16 -48.86 1.05 Allowed Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.268 1.427 . . . . 0.0 114.774 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.78 179.0 6.37 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.778 2.986 . . . . 0.0 111.425 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -137.71 143.04 41.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.929 1.292 . . . . 0.0 112.014 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.251 1.178 0 C-N-CA 126.266 1.826 . . . . 0.0 112.135 -170.537 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.213 0 O4'-C1'-N19 111.62 3.42 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.222 1 O4'-C1'-N19 112.462 4.262 . 0.099 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.121 0 C3'-C2'-C1' 103.66 2.4 . 0.264 2o . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.253 0 O4'-C1'-N19 111.751 3.551 . 0.085 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.241 0 O4'-C1'-N19 111.111 2.911 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.301 0 O4'-C1'-N19 110.224 2.024 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.5 p 55.46 17.75 2.34 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.088 2.155 . . . . 0.0 116.505 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.3 p -164.54 156.62 16.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.46 1.504 . . . . 0.0 112.183 -173.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.27 162.73 23.8 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.001 1.286 . . . . 0.0 112.981 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.0 m -148.53 151.08 34.5 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.147 1.379 . . . . 0.0 111.655 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.3 m -65.67 135.65 55.28 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.293 -0.88 . . . . 0.0 111.977 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.32 4.65 80.61 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.256 0.931 . . . . 0.0 114.752 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -62.92 129.97 42.74 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.979 1.389 . . . . 0.0 111.296 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.1 mtt85 -88.58 -1.77 58.24 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.919 1.287 . . . . 0.0 114.113 -170.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.63 148.81 34.88 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.594 1.558 . . . . 0.0 112.801 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 p30 31.69 58.25 1.17 Allowed Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 126.819 2.048 . . . . 0.0 116.338 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.72 146.86 49.53 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.538 2.826 . . . . 0.0 111.561 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -86.17 152.95 56.48 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.171 1.389 . . . . 0.0 112.604 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.96 144.32 57.08 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.249 3.299 . . . . 0.0 114.469 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -154.72 139.44 17.06 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.222 1.409 . . . . 0.0 110.359 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 58.6 m -55.67 -30.39 60.97 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.066 1.346 . . . . 0.0 112.597 170.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 t -87.59 130.8 34.63 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.178 0.991 . . . . 0.0 110.912 171.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.6 mt -118.3 145.77 44.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.327 1.851 . . . . 0.0 110.412 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.98 148.65 18.88 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.775 1.655 . . . . 0.0 110.542 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.64 130.86 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.342 1.857 . . . . 0.0 108.221 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.74 152.12 48.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.031 0.932 . . . . 0.0 111.41 -168.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.69 32.63 18.13 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 123.765 0.697 . . . . 0.0 113.668 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.5 159.52 21.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.994 1.318 . . . . 0.0 113.252 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.3 t -76.02 156.37 34.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.681 169.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.52 -19.26 63.72 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.505 -0.747 . . . . 0.0 112.127 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -94.05 -4.6 49.17 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.573 1.549 . . . . 0.0 114.282 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -66.97 132.93 48.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.465 1.106 . . . . 0.0 109.256 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.9 p -106.54 162.79 13.42 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.279 1.032 . . . . 0.0 111.153 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -60.7 -27.97 68.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.958 0.503 . . . . 0.0 111.22 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -70.94 -37.67 72.86 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.583 1.153 . . . . 0.0 112.514 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.83 -47.63 71.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.662 0.665 . . . . 0.0 110.438 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.1 -44.38 83.17 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.819 -0.55 . . . . 0.0 110.647 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -61.89 -41.68 98.18 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.419 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.17 -32.84 72.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.313 1.415 . . . . 0.0 112.689 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -77.42 -29.2 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.556 1.143 . . . . 0.0 111.933 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -99.99 -24.58 14.58 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.141 0.882 . . . . 0.0 113.364 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.9 m -69.33 -19.79 63.87 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.235 1.379 . . . . 0.0 113.693 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -70.19 -7.23 40.18 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.964 -1.085 . . . . 0.0 113.909 173.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -102.32 -5.57 24.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.456 1.502 . . . . 0.0 113.753 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.41 -175.65 24.86 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.385 1.469 . . . . 0.0 114.969 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.57 135.75 20.39 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.324 3.349 . . . . 0.0 112.476 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.51 127.71 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.767 1.627 . . . . 0.0 110.121 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.29 -32.03 19.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.933 1.293 . . . . 0.0 112.837 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -163.59 166.16 22.72 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.9 t -146.55 136.14 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 127.062 2.145 . . . . 0.0 108.161 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.8 m -133.0 110.24 10.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.037 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.0 mt -80.03 143.29 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.09 128.5 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.93 149.43 42.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.185 1.394 . . . . 0.0 112.496 -173.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.57 143.08 48.41 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.939 0.895 . . . . 0.0 111.281 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -76.14 -22.93 54.88 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -119.46 -34.73 3.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.456 1.102 . . . . 0.0 112.658 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 72.3 m -83.11 -20.06 35.55 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.476 -0.765 . . . . 0.0 112.497 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 54.18 45.43 27.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.229 1.812 . . . . 0.0 112.659 170.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -138.15 156.89 47.29 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 129.336 3.054 . . . . 0.0 108.865 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.4 t -58.2 137.95 56.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.122 0.487 . . . . 0.0 111.289 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -79.22 -5.44 54.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.95 0.9 . . . . 0.0 112.773 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.17 14.63 62.01 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.777 1.18 . . . . 0.0 113.766 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.05 160.92 41.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.554 1.169 . . . . 0.0 113.148 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.93 15.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.381 1.873 . . . . 0.0 111.517 -168.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.44 152.1 42.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.404 1.482 . . . . 0.0 110.627 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.42 128.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.125 1.77 . . . . 0.0 109.071 -169.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.65 100.41 9.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.865 1.266 . . . . 0.0 111.826 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -76.78 159.06 30.43 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.576 -0.703 . . . . 0.0 111.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.27 3.72 45.58 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.954 0.902 . . . . 0.0 113.134 172.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -160.83 139.97 10.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.555 1.542 . . . . 0.0 111.67 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.79 -31.6 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.52 0.728 . . . . 0.0 112.567 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.62 -23.22 56.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.279 0.945 . . . . 0.0 113.12 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -82.52 -30.32 29.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.858 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.71 76.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.336 0.654 . . . . 0.0 111.458 169.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -61.54 -32.66 72.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.641 1.176 . . . . 0.0 112.489 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.94 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.889 0.876 . . . . 0.0 109.663 171.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.04 69.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.24 -34.27 74.86 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.932 0.893 . . . . 0.0 112.651 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -87.95 -23.62 23.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.557 0.743 . . . . 0.0 112.272 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -77.81 -45.8 23.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.51 1.124 . . . . 0.0 113.037 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.1 -12.34 21.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -65.66 112.83 3.85 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.615 -1.303 . . . . 0.0 110.861 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.17 8.58 71.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.495 1.522 . . . . 0.0 114.595 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.9 ptm -76.35 173.85 10.93 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.811 1.805 . . . . 0.0 111.523 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.61 135.16 54.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.296 1.039 . . . . 0.0 111.27 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -143.12 117.36 9.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.769 1.628 . . . . 0.0 109.224 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 29.0 t70 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.168 1.387 . . . . 0.0 112.45 -169.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.64 -5.18 65.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.648 1.118 . . . . 0.0 114.66 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.6 mmt-85 -92.05 129.62 37.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.891 1.346 . . . . 0.0 109.931 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.91 128.33 35.24 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.135 170.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -107.35 155.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 111.671 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -115.21 148.52 39.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.395 1.878 . . . . 0.0 108.64 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.8 t -144.73 136.44 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.46 1.104 . . . . 0.0 110.499 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.17 158.47 36.33 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.954 1.302 . . . . 0.0 112.438 -170.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -72.8 138.08 46.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.661 0.784 . . . . 0.0 111.822 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.3 m -72.33 130.46 40.82 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.3 pt -91.76 -14.94 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.733 1.213 . . . . 0.0 113.24 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.7 p -158.31 167.45 29.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.817 3.247 . . . . 0.0 108.416 -171.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -152.75 161.11 42.99 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -66.54 -46.39 58.32 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -83.07 158.98 15.5 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.579 2.853 . . . . 0.0 111.384 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -96.04 145.83 25.14 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.437 1.095 . . . . 0.0 113.055 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.263 1.825 . . . . 0.0 110.715 -178.859 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.351 1 O4'-C1'-N19 113.294 5.094 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.093 0 O4'-C1'-N19 111.533 3.333 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.178 0 O4'-C1'-N19 111.926 3.726 . 0.35 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 O4'-C1'-N19 111.347 3.147 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.601 0 O4'-C1'-N19 111.168 2.968 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.162 0 O4'-C1'-N19 111.624 3.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.583 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.9 p -164.55 174.91 10.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.319 1.448 . . . . 0.0 111.704 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 p -78.55 10.02 3.54 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.035 1.334 . . . . 0.0 113.839 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.42 -2.98 29.96 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.05 1.31 . . . . 0.0 115.177 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.4 p -147.83 17.68 1.12 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.827 1.651 . . . . 0.0 113.02 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.5 p -159.16 160.14 35.18 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.567 -1.333 . . . . 0.0 113.675 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.58 176.83 53.54 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.602 1.096 . . . . 0.0 113.18 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -152.88 127.68 9.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.122 0.969 . . . . 0.0 111.653 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -66.36 -20.33 66.05 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.797 1.239 . . . . 0.0 113.47 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.68 23.88 10.62 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.107 1.763 . . . . 0.0 114.386 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -171.94 63.85 0.36 Allowed Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 130.148 3.379 . . . . 0.0 110.294 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -75.4 178.95 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.593 2.862 . . . . 0.0 111.18 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -144.94 139.59 15.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.394 1.478 . . . . 0.0 110.048 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -48.26 136.95 24.69 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.575 3.517 . . . . 0.0 115.529 -171.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -156.84 141.4 16.77 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.719 1.607 . . . . 0.0 109.625 -171.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 96.4 m -58.92 -28.17 65.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.624 0.77 . . . . 0.0 112.224 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 71.8 m -87.52 124.05 33.07 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.707 1.203 . . . . 0.0 110.593 174.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -112.06 142.47 44.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.89 1.676 . . . . 0.0 110.151 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.61 145.05 17.57 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.497 1.522 . . . . 0.0 110.255 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.93 119.61 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.049 1.74 . . . . 0.0 107.814 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -126.47 158.85 35.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.406 1.482 . . . . 0.0 111.998 -167.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.56 25.03 55.11 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.127 0.87 . . . . 0.0 113.6 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.24 154.41 37.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.884 1.273 . . . . 0.0 113.342 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.8 t -72.67 143.24 48.18 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.778 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.02 -12.5 51.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -100.92 3.93 42.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.998 1.719 . . . . 0.0 114.032 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -63.46 143.04 58.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 109.806 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.5 p -110.96 159.71 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.681 0.792 . . . . 0.0 111.618 170.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.52 -30.79 67.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.889 0.876 . . . . 0.0 111.041 172.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -69.08 -38.33 78.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.748 1.219 . . . . 0.0 112.359 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -65.11 -48.05 75.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.486 0.585 . . . . 0.0 110.169 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.3 mt -59.01 -42.23 89.61 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.77 -0.581 . . . . 0.0 111.193 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.25 -45.91 92.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.107 0.867 . . . . 0.0 111.382 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -67.68 -31.32 71.21 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.406 1.457 . . . . 0.0 112.744 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.7 -29.22 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.521 1.128 . . . . 0.0 112.547 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -100.57 -27.8 13.22 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.1 p -73.31 -12.58 60.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 120.456 1.48 . . . . 0.0 114.311 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -67.64 -10.32 51.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.952 -1.092 . . . . 0.0 113.434 168.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -102.79 -7.89 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.479 1.511 . . . . 0.0 114.084 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.05 -175.95 31.35 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.597 1.094 . . . . 0.0 115.377 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.31 137.66 19.12 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.313 3.342 . . . . 0.0 112.036 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 73.4 mt -134.24 124.58 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.679 1.592 . . . . 0.0 109.902 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.2 -24.77 18.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.304 1.042 . . . . 0.0 113.557 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.38 159.73 28.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.725 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.9 t -150.83 136.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.354 2.261 . . . . 0.0 108.273 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -146.25 122.76 11.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.528 0.731 . . . . 0.0 112.024 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.62 143.96 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.363 1.065 . . . . 0.0 108.596 172.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.2 t -104.25 135.13 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.26 1.024 . . . . 0.0 110.205 -170.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -127.56 151.26 49.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.571 1.548 . . . . 0.0 112.879 -171.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -70.91 141.2 51.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.64 1.176 . . . . 0.0 111.421 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -78.22 -20.53 51.59 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -175.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -114.61 -38.74 3.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.415 1.086 . . . . 0.0 112.187 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.5 m -84.41 -16.24 43.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.802 0.841 . . . . 0.0 113.042 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 53.17 41.94 32.15 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.333 1.853 . . . . 0.0 113.323 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -134.6 153.37 52.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.077 2.551 . . . . 0.0 109.281 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.9 t -60.51 137.26 58.18 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 111.232 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -77.6 1.38 19.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.032 0.933 . . . . 0.0 112.986 173.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.65 17.21 58.77 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.431 1.015 . . . . 0.0 113.755 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -154.53 166.7 32.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.937 1.351 . . . . 0.0 114.204 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.41 171.51 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 111.056 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.47 150.7 48.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.146 1.378 . . . . 0.0 111.065 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.0 t -135.63 120.25 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.482 1.913 . . . . 0.0 108.303 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -107.17 100.69 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.57 1.148 . . . . 0.0 111.053 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.69 161.94 29.18 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.787 0.835 . . . . 0.0 111.983 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -94.13 7.61 44.6 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.289 1.036 . . . . 0.0 112.851 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.13 130.49 7.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.515 1.526 . . . . 0.0 111.571 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.26 -28.96 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.897 0.879 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.87 -24.5 48.51 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.407 1.003 . . . . 0.0 113.27 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -81.61 -29.46 33.28 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.802 0.841 . . . . 0.0 111.76 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.92 83.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.191 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -59.85 -34.38 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.283 1.033 . . . . 0.0 112.631 172.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.53 -62.85 1.22 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.773 0.829 . . . . 0.0 109.845 173.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.87 -35.2 70.64 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.27 -33.66 71.31 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.306 1.042 . . . . 0.0 112.852 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -89.05 -24.11 22.4 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.682 0.793 . . . . 0.0 112.307 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -78.79 -45.06 21.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.425 1.09 . . . . 0.0 113.152 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.1 -11.82 27.57 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.56 113.07 3.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.594 -1.316 . . . . 0.0 110.904 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.54 7.29 72.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.26 1.409 . . . . 0.0 114.733 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptm -76.22 173.16 11.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.693 1.746 . . . . 0.0 111.278 170.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -115.55 135.47 54.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.162 0.985 . . . . 0.0 111.028 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.9 tp -141.46 121.25 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 109.797 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.65 25.87 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.761 1.625 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.86 19.41 57.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.562 1.077 . . . . 0.0 114.445 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -131.7 132.12 43.66 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.544 1.538 . . . . 0.0 110.19 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.91 133.02 46.09 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.724 -0.61 . . . . 0.0 110.518 174.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.9 pt -111.0 159.0 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.887 0.875 . . . . 0.0 111.797 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -126.31 145.28 50.49 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.855 2.062 . . . . 0.0 108.857 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.36 134.46 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 118.968 0.803 . . . . 0.0 111.396 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -152.76 162.97 40.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 111.236 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -70.22 142.76 52.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.696 0.799 . . . . 0.0 111.655 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.6 m -63.47 124.07 20.38 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.276 -0.89 . . . . 0.0 112.634 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 13.0 pt -81.8 -22.06 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.86 0.864 . . . . 0.0 112.549 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.9 p -144.92 151.18 38.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.719 2.807 . . . . 0.0 107.12 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.07 155.89 37.69 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.808 0.843 . . . . 0.0 113.178 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.67 -41.6 9.73 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -172.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.6 146.1 23.84 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.093 2.529 . . . . 0.0 110.823 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -149.54 6.55 0.64 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -172.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 55.8 m . . . . . 0 C--O 1.251 1.135 0 C-N-CA 126.542 1.937 . . . . 0.0 110.77 -175.779 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.481 1 O4'-C1'-N19 114.868 6.668 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.228 0 O4'-C1'-N19 111.632 3.432 . 0.071 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 0 C4'-C3'-C2' 101.134 -1.566 . 0.165 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.079 1 O4'-C1'-N19 112.217 4.017 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.291 0 C5'-C4'-C3' 109.949 -3.701 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.1 0 C5'-C4'-C3' 111.652 -2.566 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.482 ' N ' ' HG ' ' A' ' 108' ' ' SER . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 p -140.56 -0.34 1.57 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.8 p -169.01 144.89 3.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.023 1.329 . . . . 0.0 111.888 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.94 -61.74 2.94 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 125.326 1.441 . . . . 0.0 113.738 171.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.4 m -92.83 9.26 36.05 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.728 1.611 . . . . 0.0 112.275 172.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.482 ' HG ' ' N ' ' A' ' 103' ' ' GLY . 69.1 m -156.92 137.97 13.57 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.924 2.09 . . . . 0.0 109.847 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.43 140.07 22.38 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.899 0.761 . . . . 0.0 111.715 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -161.98 133.2 5.22 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.411 1.084 . . . . 0.0 111.126 -173.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -2.21 21.96 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.98 26.88 4.87 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.312 1.445 . . . . 0.0 113.113 167.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 p30 178.99 58.39 0.07 OUTLIER Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 130.886 3.674 . . . . 0.0 112.505 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -78.67 -175.37 2.7 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 123.969 3.113 . . . . 0.0 111.167 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -146.95 136.8 11.95 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.868 1.267 . . . . 0.0 110.732 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.91 130.73 40.71 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.228 3.286 . . . . 0.0 113.623 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -161.04 167.67 25.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.142 1.377 . . . . 0.0 111.635 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 56.1 m -67.95 -14.15 62.73 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -171.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.7 m -98.45 128.15 44.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.447 1.099 . . . . 0.0 110.109 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.3 mt -115.44 146.76 41.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.281 1.433 . . . . 0.0 110.702 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.79 149.45 17.26 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.147 1.832 . . . . 0.0 110.614 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.6 t -136.67 129.23 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.028 2.131 . . . . 0.0 107.853 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -133.83 154.72 50.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.38 1.072 . . . . 0.0 112.684 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.45 30.21 50.26 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.056 0.836 . . . . 0.0 114.074 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.46 160.93 23.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.48 1.512 . . . . 0.0 113.521 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.1 t -72.34 155.09 40.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.013 0.925 . . . . 0.0 111.861 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.59 -17.61 62.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.457 0.703 . . . . 0.0 112.628 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -96.17 -5.55 40.31 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.083 1.353 . . . . 0.0 114.402 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.7 m -69.29 136.29 51.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.6 p -106.88 164.83 11.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.639 1.175 . . . . 0.0 111.484 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -59.26 -30.22 68.13 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.629 0.772 . . . . 0.0 111.147 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -70.61 -38.64 73.99 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.597 1.159 . . . . 0.0 112.166 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -66.36 -48.41 70.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.267 0.485 . . . . 0.0 110.341 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.0 mt -56.69 -44.79 81.83 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.815 -0.553 . . . . 0.0 110.941 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -60.97 -45.67 93.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.131 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -67.14 -29.05 68.66 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.227 1.376 . . . . 0.0 112.878 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.33 -27.68 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.44 1.096 . . . . 0.0 112.046 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -100.48 -23.73 14.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.4 p -70.39 -17.73 63.03 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.242 1.383 . . . . 0.0 113.911 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.57 -11.24 52.22 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 170.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.72 -7.14 24.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.376 1.47 . . . . 0.0 113.717 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.21 -178.47 24.82 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.221 1.391 . . . . 0.0 115.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.99 135.6 21.38 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.561 3.507 . . . . 0.0 112.668 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.47 124.26 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.062 1.745 . . . . 0.0 109.654 -174.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.12 -23.26 20.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.349 1.06 . . . . 0.0 113.493 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -161.48 162.44 30.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.0 t -151.28 135.49 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.236 2.214 . . . . 0.0 107.956 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.4 m -137.97 116.73 12.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.752 1.221 . . . . 0.0 111.393 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.84 147.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.1 t -96.95 127.68 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.111 0.964 . . . . 0.0 108.827 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.32 152.5 38.87 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.152 1.381 . . . . 0.0 112.137 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -77.28 151.55 34.99 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.343 0.657 . . . . 0.0 112.299 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -79.96 -23.67 41.48 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -122.37 -35.6 3.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.087 0.955 . . . . 0.0 112.756 -171.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 71.1 m -84.84 -23.45 29.03 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.522 -0.736 . . . . 0.0 112.428 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . 0.25 84.6 mtt180 58.42 23.57 10.77 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.47 1.908 . . . . 0.0 114.937 169.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 46.1 ptt85 -100.19 168.2 9.96 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.084 2.154 . . . . 0.0 110.097 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.5 t -58.97 141.18 54.5 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.91 0.385 . . . . 0.0 110.093 168.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -84.08 1.29 44.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.44 1.096 . . . . 0.0 112.858 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.97 8.81 62.98 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.707 1.146 . . . . 0.0 114.241 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -144.96 161.35 39.57 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.747 1.273 . . . . 0.0 113.424 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.1 13.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.051 1.74 . . . . 0.0 111.815 -168.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -145.69 156.27 43.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.999 1.72 . . . . 0.0 110.853 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.95 134.33 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.369 1.867 . . . . 0.0 109.171 -169.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.16 99.18 6.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.238 1.415 . . . . 0.0 111.078 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -79.58 158.91 27.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.02 0.928 . . . . 0.0 112.202 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.81 3.52 50.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.741 1.217 . . . . 0.0 113.063 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -157.99 137.35 11.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.563 1.545 . . . . 0.0 111.246 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.22 -32.83 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.318 0.647 . . . . 0.0 112.673 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.4 -24.42 54.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.901 0.773 . . . . 0.0 113.014 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.97 -29.15 35.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.307 1.043 . . . . 0.0 111.914 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.6 73.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.211 0.604 . . . . 0.0 110.97 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -59.78 -35.24 74.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.409 1.084 . . . . 0.0 112.502 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.22 -64.39 0.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.032 0.933 . . . . 0.0 110.015 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.11 -35.56 69.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.61 -34.5 72.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.172 0.989 . . . . 0.0 112.83 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -88.48 -24.71 22.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.611 0.764 . . . . 0.0 112.197 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -78.22 -45.57 22.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.429 1.092 . . . . 0.0 113.164 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.67 -11.43 29.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -66.02 112.98 4.12 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.611 -1.305 . . . . 0.0 111.106 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.68 8.68 73.08 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.35 1.452 . . . . 0.0 114.609 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 ptm -75.91 173.65 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.739 1.77 . . . . 0.0 111.435 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.38 134.54 54.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.204 1.002 . . . . 0.0 111.057 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.6 tp -143.7 118.87 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.51 1.524 . . . . 0.0 109.389 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 54.77 31.78 16.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.404 1.481 . . . . 0.0 112.44 -169.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.42 -4.87 66.01 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.694 1.14 . . . . 0.0 114.504 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.7 mmt-85 -92.98 130.06 38.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.933 1.367 . . . . 0.0 109.897 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.48 130.17 40.03 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.094 0.861 . . . . 0.0 109.817 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -109.08 160.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.027 0.931 . . . . 0.0 111.08 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.6 mtm-85 -127.81 156.31 42.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.481 1.112 . . . . 0.0 109.775 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.9 t -143.96 140.26 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.781 1.232 . . . . 0.0 110.962 -168.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.8 161.46 40.64 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.374 1.47 . . . . 0.0 112.151 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -72.66 137.79 46.27 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.03 0.932 . . . . 0.0 111.561 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 t -75.54 130.81 39.45 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.25 -0.906 . . . . 0.0 112.56 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.3 pt -93.4 -16.03 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.505 1.122 . . . . 0.0 113.523 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 16.7 p -154.65 161.77 41.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 129.716 3.207 . . . . 0.0 108.278 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -160.18 165.77 30.96 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.23 -52.01 50.06 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.06 151.6 39.47 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.181 2.587 . . . . 0.0 111.447 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -70.12 -18.25 63.23 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.369 1.868 . . . . 0.0 111.843 -175.391 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.235 1 O4'-C1'-N19 113.494 5.294 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.433 0 O4'-C1'-N19 111.888 3.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 0 C4'-C3'-C2' 99.96 -2.74 . 0.38 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 O5'-C5'-C4' 114.81 3.293 . 0.0 OUTLIER '7D dist 2z wannabe' 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.252 0 O4'-C1'-N19 112.066 3.866 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.058 0 C5'-C4'-C3' 110.301 -3.466 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.2 p -95.6 -2.66 47.84 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.833 1.253 . . . . 0.0 114.338 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 91.6 p -160.98 166.13 28.79 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.627 1.571 . . . . 0.0 112.084 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.51 -159.11 42.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.509 1.052 . . . . 0.0 112.962 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -160.78 153.55 21.03 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.074 1.35 . . . . 0.0 112.012 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -145.55 19.98 1.51 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.2 28.14 50.13 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 121.122 -0.986 . . . . 0.0 113.406 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -74.95 -2.86 28.99 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.477 1.511 . . . . 0.0 114.649 -171.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 72.54 9.69 5.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.892 2.477 . . . . 0.0 114.126 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.91 165.56 17.55 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.424 1.49 . . . . 0.0 111.979 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.8 m120 44.92 62.12 10.82 Favored Pre-proline 0 N--CA 1.485 1.313 0 C-N-CA 125.667 1.587 . . . . 0.0 114.655 171.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.16 168.47 24.67 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.829 3.019 . . . . 0.0 111.566 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -144.4 151.35 50.78 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 126.039 1.736 . . . . 0.0 110.49 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -50.22 140.61 33.17 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 124.536 3.491 . . . . 0.0 115.115 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -159.35 138.46 11.16 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.286 1.434 . . . . 0.0 110.245 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.7 m -57.35 -26.71 61.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.35 1.06 . . . . 0.0 112.612 170.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.9 m -90.0 114.58 26.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.555 1.542 . . . . 0.0 110.159 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.3 mt -102.17 146.94 27.25 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.627 1.171 . . . . 0.0 111.295 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.02 148.86 16.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.322 1.915 . . . . 0.0 110.47 168.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.54 124.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.192 1.797 . . . . 0.0 108.011 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -132.12 155.19 48.58 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.892 1.277 . . . . 0.0 111.91 -167.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.14 29.96 43.93 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.886 0.755 . . . . 0.0 113.398 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.79 163.84 25.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 113.168 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.8 t -76.06 154.51 35.59 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.005 168.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.0 -18.57 64.76 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.225 -0.922 . . . . 0.0 112.244 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -96.93 -1.43 45.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.846 1.658 . . . . 0.0 114.589 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 93.4 m -63.1 137.7 58.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.383 1.073 . . . . 0.0 109.611 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 p -110.34 161.64 15.43 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.861 0.864 . . . . 0.0 111.556 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.65 -27.22 68.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.336 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -69.61 -39.84 76.99 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.633 1.173 . . . . 0.0 112.251 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -65.88 -47.96 73.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.227 0.467 . . . . 0.0 110.315 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.0 mt -56.8 -44.36 81.87 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.764 -0.585 . . . . 0.0 110.921 174.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -63.17 -41.1 99.18 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.49 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.45 -31.12 69.24 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.174 1.352 . . . . 0.0 112.62 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.79 -28.91 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.374 1.07 . . . . 0.0 112.393 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -100.58 -27.47 13.39 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.1 p -71.83 -15.42 62.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.307 1.412 . . . . 0.0 114.109 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.9 -11.13 55.12 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.95 -1.094 . . . . 0.0 113.751 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -102.85 -5.18 23.86 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.302 1.441 . . . . 0.0 114.061 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.2 28.4 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.785 1.183 . . . . 0.0 115.307 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.5 135.42 18.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.313 3.342 . . . . 0.0 112.227 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.51 127.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.658 1.583 . . . . 0.0 110.187 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.91 -28.19 19.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.121 1.369 . . . . 0.0 113.325 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -162.61 167.08 23.8 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -149.38 137.16 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.448 2.299 . . . . 0.0 108.338 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.1 m -135.4 113.54 11.3 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.467 1.107 . . . . 0.0 111.635 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.34 144.97 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.294 -0.879 . . . . 0.0 108.835 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.5 t -105.51 133.51 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.338 1.055 . . . . 0.0 109.935 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -127.53 152.72 47.24 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.489 1.516 . . . . 0.0 112.958 -170.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.69 140.34 53.55 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.608 1.163 . . . . 0.0 111.535 172.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -71.87 -21.29 61.68 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.39 1.076 . . . . 0.0 113.807 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -126.72 -35.18 2.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.135 0.974 . . . . 0.0 112.781 -171.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.2 m -81.72 -15.2 55.16 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.424 -0.798 . . . . 0.0 112.844 171.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 53.58 40.23 31.15 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.357 1.863 . . . . 0.0 113.383 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -132.58 153.06 51.39 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.732 2.413 . . . . 0.0 109.476 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.2 t -59.96 137.83 57.98 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 122.013 -0.429 . . . . 0.0 111.286 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -76.89 0.45 20.87 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.654 0.781 . . . . 0.0 112.819 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.28 15.26 57.6 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 124.983 1.278 . . . . 0.0 113.721 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.53 165.15 36.02 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.948 1.356 . . . . 0.0 114.448 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.18 172.2 18.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.416 1.886 . . . . 0.0 111.509 -169.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.87 156.33 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.603 1.561 . . . . 0.0 110.908 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.84 131.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.801 2.04 . . . . 0.0 108.726 -168.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -114.79 97.5 6.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.688 1.195 . . . . 0.0 111.517 -170.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -76.57 156.89 32.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.105 0.562 . . . . 0.0 111.592 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -86.78 3.82 43.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.775 0.83 . . . . 0.0 113.189 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -160.64 143.38 13.02 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.537 1.535 . . . . 0.0 111.781 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.13 -31.72 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -74.48 -28.58 61.08 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.583 1.083 . . . . 0.0 112.859 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -75.42 -30.71 60.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.921 0.888 . . . . 0.0 111.673 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.97 -43.62 67.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.695 0.798 . . . . 0.0 111.444 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -59.33 -35.16 73.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.248 1.019 . . . . 0.0 112.419 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.17 -64.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.161 0.984 . . . . 0.0 110.163 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.3 69.54 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.41 -33.82 71.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.503 1.121 . . . . 0.0 112.845 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -89.34 -21.63 23.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.674 0.789 . . . . 0.0 112.391 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -81.17 -44.73 17.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.546 1.138 . . . . 0.0 113.071 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.7 -12.07 26.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -172.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -64.68 114.79 4.66 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.682 -1.261 . . . . 0.0 111.024 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.04 4.85 77.8 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.472 1.51 . . . . 0.0 114.695 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.4 ptm -73.25 169.18 17.63 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.839 1.82 . . . . 0.0 111.373 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -106.24 134.96 48.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.706 0.803 . . . . 0.0 110.975 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 46.7 tp -144.86 123.22 12.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.81 1.644 . . . . 0.0 109.327 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 55.25 33.57 20.93 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.099 1.36 . . . . 0.0 112.649 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.21 4.61 89.84 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.781 1.181 . . . . 0.0 114.601 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.8 mmt-85 -113.28 131.67 55.84 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.243 1.417 . . . . 0.0 110.431 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.43 131.08 44.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.91 0.777 . . . . 0.0 109.196 168.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.4 pt -110.68 160.19 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.733 0.813 . . . . 0.0 112.064 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -119.82 148.14 43.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.13 1.772 . . . . 0.0 108.919 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -141.95 135.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.316 1.047 . . . . 0.0 110.395 -172.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -156.57 165.52 36.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.222 1.409 . . . . 0.0 111.884 -170.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -80.87 141.95 34.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.371 1.068 . . . . 0.0 111.634 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.2 m -68.9 128.86 38.18 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.004 -1.06 . . . . 0.0 112.68 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.1 pt -87.73 -19.54 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.32 1.048 . . . . 0.0 112.474 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.0 p -154.02 154.17 33.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 130.302 3.441 . . . . 0.0 107.544 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -159.29 166.28 31.58 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -172.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -65.25 -53.54 39.13 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -81.53 159.66 19.49 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.416 2.744 . . . . 0.0 111.979 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -158.53 146.82 18.45 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.283 1.433 . . . . 0.0 112.298 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.362 1.865 . . . . 0.0 110.767 -178.53 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.394 0 C4'-C3'-C2' 100.417 -2.283 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 110.842 2.642 . 0.491 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 O5'-C5'-C4' 114.033 2.738 . 0.533 5z . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 0 O5'-C5'-C4' 114.145 2.818 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.283 1 O4'-C1'-N19 112.352 4.152 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.092 0 C5'-C4'-C3' 111.216 -2.856 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 m -86.51 -9.37 56.33 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.6 m -168.57 163.25 12.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.555 2.342 . . . . 0.0 110.212 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.03 -61.83 4.29 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 125.061 1.315 . . . . 0.0 112.532 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.9 m -78.69 -8.63 58.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.658 1.183 . . . . 0.0 112.663 171.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.0 m -149.23 150.3 32.37 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.526 2.331 . . . . 0.0 109.599 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.38 145.69 34.86 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.495 0.569 . . . . 0.0 112.112 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -155.07 127.61 7.93 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.589 1.155 . . . . 0.0 110.733 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -67.73 -15.11 63.48 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.38 37.65 1.0 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.519 1.528 . . . . 0.0 113.432 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -178.15 66.03 0.19 Allowed Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 129.128 2.971 . . . . 0.0 111.682 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.24 168.08 25.64 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.608 2.872 . . . . 0.0 111.304 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -155.49 141.55 12.95 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.51 1.524 . . . . 0.0 109.702 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.53 136.78 33.22 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.252 3.301 . . . . 0.0 114.742 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -155.59 150.91 26.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.413 1.485 . . . . 0.0 110.093 -172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.1 m -67.1 -5.65 14.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.119 1.368 . . . . 0.0 114.006 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 27.3 p -132.51 151.82 51.77 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.703 1.201 . . . . 0.0 112.002 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.0 mt -126.48 151.58 47.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.893 2.077 . . . . 0.0 110.539 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.84 149.71 18.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.131 1.824 . . . . 0.0 110.496 167.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.8 129.49 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.396 1.878 . . . . 0.0 107.889 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -136.73 150.6 48.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 111.641 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.19 32.6 19.84 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.923 0.773 . . . . 0.0 113.26 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.9 mt -77.34 162.83 26.98 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.36 1.464 . . . . 0.0 113.642 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -78.91 152.52 31.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.792 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -16.75 63.31 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.427 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.57 -5.06 52.44 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.465 1.506 . . . . 0.0 114.288 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -67.71 135.42 52.71 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.476 1.111 . . . . 0.0 109.615 172.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.5 p -118.02 163.85 15.98 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.747 1.219 . . . . 0.0 110.761 172.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.77 -24.54 65.85 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.444 0.697 . . . . 0.0 111.725 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -58.02 -45.78 86.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.965 1.706 . . . . 0.0 111.774 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.92 -48.32 46.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.914 0.885 . . . . 0.0 110.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.57 -38.62 81.63 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.323 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -62.05 -45.97 91.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.239 0.927 . . . . 0.0 112.054 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.92 -31.01 69.6 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.097 1.317 . . . . 0.0 112.771 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.4 t -80.12 -30.58 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.603 1.161 . . . . 0.0 112.484 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -100.6 -25.59 14.11 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.7 p -71.29 -14.21 62.14 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.388 1.449 . . . . 0.0 113.91 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -67.2 -14.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.948 -1.095 . . . . 0.0 113.586 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.71 -8.54 34.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.009 1.324 . . . . 0.0 113.718 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -177.82 25.93 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.102 1.334 . . . . 0.0 114.65 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.98 135.48 25.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.327 3.351 . . . . 0.0 112.272 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.54 132.76 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.891 1.676 . . . . 0.0 110.504 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.81 -28.8 15.07 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.105 1.362 . . . . 0.0 113.111 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -164.3 164.45 22.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.008 0.923 . . . . 0.0 113.007 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.9 t -147.9 132.01 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.074 2.15 . . . . 0.0 107.732 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 56.6 m -132.63 104.83 6.85 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.5 mt -81.21 138.82 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 168.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.6 t -94.72 123.11 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -115.49 156.03 26.42 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.061 1.344 . . . . 0.0 112.083 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.81 161.95 28.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.877 0.871 . . . . 0.0 112.85 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -87.9 -28.39 21.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -115.81 -41.97 3.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.977 0.808 . . . . 0.0 112.793 -169.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.5 p -88.19 -23.73 23.51 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.45 0.7 . . . . 0.0 112.586 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 61.51 22.61 13.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.623 1.969 . . . . 0.0 114.088 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -79.55 159.57 26.82 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.868 2.067 . . . . 0.0 110.142 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -62.17 136.71 58.06 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.829 -0.544 . . . . 0.0 109.832 168.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -81.19 1.64 31.2 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.958 0.903 . . . . 0.0 113.032 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.38 10.18 62.41 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.626 1.107 . . . . 0.0 114.261 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -150.99 162.86 40.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.793 1.282 . . . . 0.0 113.484 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.82 172.72 17.73 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.237 1.815 . . . . 0.0 111.686 -169.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.78 155.1 46.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.823 1.649 . . . . 0.0 110.396 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.9 132.61 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.758 1.623 . . . . 0.0 109.298 -168.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.92 107.62 14.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.779 1.232 . . . . 0.0 111.996 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -85.52 157.55 20.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.411 1.085 . . . . 0.0 111.39 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -83.84 7.73 17.07 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.955 0.902 . . . . 0.0 113.18 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -160.89 143.44 12.67 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.774 1.629 . . . . 0.0 111.281 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.88 -33.8 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.525 0.73 . . . . 0.0 112.492 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.44 -25.53 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -78.91 -28.29 43.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.115 0.966 . . . . 0.0 111.968 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.6 64.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.547 0.739 . . . . 0.0 111.017 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -59.31 -36.97 76.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 0.0 112.285 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.05 -65.19 0.73 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.524 0.729 . . . . 0.0 109.944 170.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.0 65.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -61.57 -25.04 67.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.624 1.17 . . . . 0.0 113.329 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.28 4.59 36.72 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.612 1.565 . . . . 0.0 113.007 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -107.91 -52.23 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.21 1.404 . . . . 0.0 113.02 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.01 46.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -65.83 112.4 3.73 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.851 -1.156 . . . . 0.0 111.171 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.27 7.73 69.44 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.087 1.803 . . . . 0.0 114.746 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.3 ptm -75.58 162.22 28.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.75 1.775 . . . . 0.0 112.816 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.36 133.02 34.15 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.215 . . . . 0.0 110.733 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.3 tp -145.53 111.4 5.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 109.085 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.4 t70 54.36 36.23 24.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.235 1.414 . . . . 0.0 112.064 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.83 -22.01 6.14 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.287 1.422 . . . . 0.0 114.224 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -73.18 141.34 47.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.29 1.045 . . . . 0.0 110.322 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -85.3 126.05 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.2 pt -106.07 139.32 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.238 0.615 . . . . 0.0 111.294 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.11 146.78 23.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.655 1.182 . . . . 0.0 109.006 170.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -141.67 134.71 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.77 1.228 . . . . 0.0 110.097 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -156.67 159.96 38.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.909 1.284 . . . . 0.0 112.224 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -69.04 142.27 54.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.772 0.829 . . . . 0.0 112.041 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.8 m -65.77 119.09 10.6 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.441 -0.787 . . . . 0.0 112.291 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.2 pt -82.76 -14.92 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.288 1.035 . . . . 0.0 112.522 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 21.2 p -160.37 158.07 28.96 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 131.218 3.807 . . . . 0.0 107.192 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -152.58 150.26 29.35 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -165.25 96.71 0.84 Allowed Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 126.367 1.867 . . . . 0.0 111.448 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -87.29 -4.66 7.64 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 124.19 3.26 . . . . 0.0 113.565 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -155.19 160.9 41.23 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.016 1.326 . . . . 0.0 112.626 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 127.298 2.239 . . . . 0.0 113.772 -176.318 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.226 0 O4'-C1'-N19 111.931 3.731 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.352 0 C5'-C4'-C3' 110.84 -3.106 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.52 0 C4'-C3'-C2' 100.768 -1.932 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 C5'-C4'-C3' 110.94 -3.04 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.944 0 C4'-C3'-C2' 99.71 -2.99 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.081 0 O4'-C1'-N19 111.638 3.438 . 0.026 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.542 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.5 t -162.36 169.31 20.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.241 1.416 . . . . 0.0 111.469 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 t -167.56 -172.74 1.99 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.512 1.925 . . . . 0.0 110.737 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.42 5.09 58.09 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.252 1.406 . . . . 0.0 115.107 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.0 m -140.79 125.08 17.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.478 1.511 . . . . 0.0 109.96 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.7 m -67.69 -9.47 43.81 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -169.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.2 -3.82 88.6 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.06 1.314 . . . . 0.0 114.422 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -71.66 152.6 42.71 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.09 1.445 . . . . 0.0 112.812 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -94.0 1.84 56.18 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.85 25.65 10.78 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -159.14 66.15 2.9 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 127.978 2.511 . . . . 0.0 111.508 -175.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -75.58 167.14 27.12 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.081 2.521 . . . . 0.0 110.766 173.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -145.19 152.93 52.06 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.904 1.682 . . . . 0.0 110.195 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -49.46 134.53 32.39 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.291 3.328 . . . . 0.0 114.139 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -156.12 137.56 13.99 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.614 1.565 . . . . 0.0 109.468 -171.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 27.4 p -63.25 -20.72 65.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.469 0.708 . . . . 0.0 112.82 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.6 m -90.87 127.23 36.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.101 0.96 . . . . 0.0 110.853 169.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.49 144.22 44.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.741 1.616 . . . . 0.0 110.337 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.62 143.14 16.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.0 124.99 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.877 1.671 . . . . 0.0 107.697 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -129.01 163.99 24.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.249 1.42 . . . . 0.0 111.311 -168.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 29.93 59.56 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.471 -0.768 . . . . 0.0 113.574 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.3 mt -76.54 166.82 22.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.659 1.184 . . . . 0.0 112.924 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -85.71 151.92 23.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.039 0.936 . . . . 0.0 110.12 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.54 -18.69 65.5 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.065 -1.022 . . . . 0.0 112.327 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.39 -3.6 55.06 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.678 1.591 . . . . 0.0 114.559 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.0 m -66.8 135.27 53.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.195 0.998 . . . . 0.0 109.427 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 p -109.64 162.82 14.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.098 0.959 . . . . 0.0 111.64 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -61.08 -27.63 68.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.313 0.645 . . . . 0.0 111.297 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.01 -40.08 75.45 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.776 1.23 . . . . 0.0 112.085 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -65.97 -48.84 69.95 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.185 0.448 . . . . 0.0 110.219 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.26 -43.13 82.77 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.943 -0.473 . . . . 0.0 111.119 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.57 -49.1 79.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.733 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -66.9 -29.38 69.25 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.815 1.189 . . . . 0.0 112.944 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.53 -29.15 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.549 1.139 . . . . 0.0 112.122 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -100.64 -23.44 14.66 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.7 p -69.22 -15.84 63.47 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.287 1.403 . . . . 0.0 113.939 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.55 -15.33 63.6 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -95.07 -15.26 23.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 0.0 113.631 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.8 -175.6 32.82 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.823 1.202 . . . . 0.0 114.738 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.71 138.61 21.58 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.594 3.529 . . . . 0.0 111.955 -173.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.3 mt -130.0 123.33 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.162 1.385 . . . . 0.0 109.678 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.87 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.136 0.974 . . . . 0.0 111.771 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.86 175.07 5.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.417 1.087 . . . . 0.0 113.054 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.77 142.16 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.965 2.106 . . . . 0.0 108.785 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.5 t -139.98 118.87 12.52 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 111.67 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.72 147.4 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.731 0.812 . . . . 0.0 109.31 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.97 134.49 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 109.472 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -127.31 155.53 43.4 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.183 1.393 . . . . 0.0 113.174 -169.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.59 139.04 47.21 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.417 1.087 . . . . 0.0 111.059 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -74.68 -21.33 59.46 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -116.76 -39.31 3.31 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.989 0.915 . . . . 0.0 112.448 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.3 m -87.12 -16.22 36.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.976 0.91 . . . . 0.0 113.034 176.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 63.97 10.3 5.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.475 1.91 . . . . 0.0 114.953 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -86.67 157.49 19.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.916 2.086 . . . . 0.0 111.145 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.3 t -61.11 139.74 58.03 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.897 -0.502 . . . . 0.0 110.666 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -77.77 -0.06 25.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.833 0.853 . . . . 0.0 112.848 172.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.01 11.55 61.34 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.021 1.296 . . . . 0.0 113.833 -178.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -148.11 165.93 29.36 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.753 1.263 . . . . 0.0 114.185 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.86 169.13 25.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.813 2.045 . . . . 0.0 111.169 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -133.32 147.05 51.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.013 1.325 . . . . 0.0 110.838 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.6 t -129.32 124.82 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.708 2.003 . . . . 0.0 107.856 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.1 100.38 9.72 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.576 0.75 . . . . 0.0 110.634 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.03 156.26 31.95 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.873 -1.142 . . . . 0.0 111.489 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.93 8.11 21.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.957 0.903 . . . . 0.0 112.769 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -157.07 135.82 11.6 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.107 1.763 . . . . 0.0 110.861 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.12 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.296 0.639 . . . . 0.0 112.441 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.53 -24.66 49.91 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -172.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.44 -26.94 34.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.05 0.94 . . . . 0.0 112.0 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.64 -41.16 65.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.579 0.752 . . . . 0.0 111.355 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -59.33 -31.91 69.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 0.0 112.584 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.64 -63.58 1.04 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.257 1.023 . . . . 0.0 110.039 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -36.43 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.47 -30.1 68.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.748 1.219 . . . . 0.0 113.313 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -93.48 -22.58 18.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.942 0.897 . . . . 0.0 112.42 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -79.77 -45.54 18.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.553 1.141 . . . . 0.0 113.145 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.43 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -66.83 113.49 4.94 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.649 -1.282 . . . . 0.0 111.197 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.18 75.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.537 1.541 . . . . 0.0 114.521 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -73.94 162.71 28.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.744 1.772 . . . . 0.0 111.467 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -104.28 134.31 47.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.429 1.091 . . . . 0.0 110.943 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.8 tp -144.46 114.96 7.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.06 1.744 . . . . 0.0 109.079 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 23.71 10.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.338 1.455 . . . . 0.0 113.272 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.39 -10.89 72.98 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.72 1.629 . . . . 0.0 114.536 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -90.05 134.41 34.26 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.415 1.486 . . . . 0.0 109.756 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.77 135.95 38.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.23 0.923 . . . . 0.0 108.888 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.3 pt -106.39 152.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.042 0.937 . . . . 0.0 110.652 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -110.86 155.92 21.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.075 0.95 . . . . 0.0 109.606 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -143.76 136.45 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.424 1.09 . . . . 0.0 110.416 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -155.64 161.06 40.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.171 1.389 . . . . 0.0 111.249 -175.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -69.98 137.15 51.19 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.47 -0.769 . . . . 0.0 110.392 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 97.0 p -80.0 141.97 35.44 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.191 -0.943 . . . . 0.0 112.127 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.9 pt -84.59 3.73 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 121.054 -1.029 . . . . 0.0 112.982 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.0 p -156.58 -176.55 6.03 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 130.547 3.539 . . . . 0.0 108.726 -170.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -162.08 -177.62 5.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.185 1.794 . . . . 0.0 111.89 169.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -50.82 126.56 24.64 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.17 1.388 . . . . 0.0 112.848 -170.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.04 158.19 46.04 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.511 2.807 . . . . 0.0 111.698 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -159.88 147.47 16.74 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.557 1.543 . . . . 0.0 112.258 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.252 1.2 0 C-N-CA 126.194 1.798 . . . . 0.0 110.938 -174.949 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 O4'-C1'-N19 111.551 3.351 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.048 1 O4'-C1'-N19 112.381 4.181 . 0.01 5n . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.443 0 C4'-C3'-C2' 100.072 -2.628 . 0.143 1z . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 O5'-C5'-C4' 115.053 3.466 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 O4'-C1'-N19 110.736 2.536 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.239 0 C5'-C4'-C3' 111.644 -2.571 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -81.45 -11.04 59.36 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.6 p -164.0 -49.83 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.678 1.191 . . . . 0.0 113.062 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.15 -151.4 36.79 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.578 1.085 . . . . 0.0 113.023 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.5 m 67.45 14.41 9.61 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.738 1.615 . . . . 0.0 114.672 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.3 t -160.84 159.6 30.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.464 1.506 . . . . 0.0 111.419 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.41 143.88 31.07 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.512 1.053 . . . . 0.0 112.778 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -145.37 152.7 40.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.475 1.91 . . . . 0.0 110.032 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ptt-85 -138.69 35.79 2.21 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -169.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.38 34.95 2.99 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.761 1.624 . . . . 0.0 111.412 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -177.62 54.21 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 128.362 2.665 . . . . 0.0 113.238 -168.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -74.97 -175.72 2.5 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.607 2.872 . . . . 0.0 112.073 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -144.48 144.28 24.66 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.228 1.811 . . . . 0.0 110.095 -174.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -47.82 136.8 22.16 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 124.533 3.489 . . . . 0.0 115.452 -173.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -157.76 145.64 18.74 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.308 1.443 . . . . 0.0 110.632 -169.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 81.6 m -58.03 -29.58 65.45 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.651 1.18 . . . . 0.0 112.398 169.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.6 m -83.12 124.37 30.42 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.408 1.483 . . . . 0.0 110.298 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.1 mt -117.6 144.13 45.45 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.838 1.655 . . . . 0.0 110.615 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.16 147.71 18.66 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.784 1.659 . . . . 0.0 110.06 167.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.13 131.34 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.509 1.924 . . . . 0.0 107.851 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -138.13 139.87 39.63 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.942 0.897 . . . . 0.0 111.342 -168.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.32 26.43 6.93 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.024 0.821 . . . . 0.0 114.18 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.9 mt -74.47 162.72 28.55 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.631 1.173 . . . . 0.0 113.388 -174.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -84.67 155.88 21.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.3 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.93 -17.65 63.34 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.308 -0.87 . . . . 0.0 112.416 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -92.8 -5.05 51.95 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.846 1.658 . . . . 0.0 114.271 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.7 m -68.87 136.02 51.99 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.562 1.145 . . . . 0.0 109.548 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.1 p -118.66 162.29 18.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.598 1.159 . . . . 0.0 111.004 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.32 -27.74 66.16 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.7 0.8 . . . . 0.0 111.654 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -56.0 -46.84 78.6 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.349 1.86 . . . . 0.0 111.905 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -69.89 -46.87 64.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.93 0.892 . . . . 0.0 110.046 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.4 -41.39 84.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.182 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.19 -47.77 84.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.317 0.962 . . . . 0.0 111.11 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.5 -30.85 69.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.245 1.384 . . . . 0.0 113.014 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.7 -30.93 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.629 1.171 . . . . 0.0 112.356 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -100.44 -26.45 13.86 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -73.16 -8.99 58.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.534 1.515 . . . . 0.0 114.234 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.07 -15.54 63.79 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.857 -1.152 . . . . 0.0 113.033 168.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -94.73 -11.67 28.65 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.437 . . . . 0.0 113.621 176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.26 -178.29 29.56 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.006 1.289 . . . . 0.0 114.52 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.58 138.1 28.88 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.223 3.282 . . . . 0.0 112.114 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 55.6 mt -130.94 126.66 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.819 1.648 . . . . 0.0 110.179 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.25 -19.26 17.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -158.46 162.07 37.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.074 0.852 . . . . 0.0 113.183 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.9 t -146.5 136.21 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.013 2.125 . . . . 0.0 107.472 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -133.48 109.16 9.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 110.936 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.22 134.99 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t -88.88 103.4 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -95.1 148.91 21.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.549 1.14 . . . . 0.0 111.924 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.95 157.83 36.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.778 0.831 . . . . 0.0 112.509 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -85.99 -23.27 26.93 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -119.0 -39.97 2.88 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.517 1.127 . . . . 0.0 112.596 -169.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 79.6 p -85.61 -21.09 28.62 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.416 1.007 . . . . 0.0 112.607 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 57.04 26.26 11.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.645 1.978 . . . . 0.0 113.557 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -104.5 164.69 11.57 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 128.296 2.638 . . . . 0.0 109.49 172.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.5 t -60.56 135.75 57.85 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.742 -0.599 . . . . 0.0 110.54 172.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -78.11 -2.08 35.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.751 0.82 . . . . 0.0 112.64 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.67 11.94 60.0 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.869 1.223 . . . . 0.0 114.125 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -147.45 163.6 35.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.469 1.135 . . . . 0.0 113.186 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.07 174.23 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.159 1.784 . . . . 0.0 112.054 -168.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.41 150.04 43.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.292 1.837 . . . . 0.0 109.99 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.5 t -136.79 135.11 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.288 1.835 . . . . 0.0 108.716 -169.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -120.43 97.79 5.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.496 1.118 . . . . 0.0 112.245 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -77.73 161.9 27.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.346 0.659 . . . . 0.0 112.012 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.27 10.28 38.42 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.209 1.003 . . . . 0.0 112.799 171.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -156.72 131.35 8.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.59 1.556 . . . . 0.0 111.383 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.09 -29.17 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.939 0.896 . . . . 0.0 112.585 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.77 -28.18 44.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.239 0.927 . . . . 0.0 112.916 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.08 -30.02 55.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.514 0.726 . . . . 0.0 111.635 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.08 80.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.179 0.592 . . . . 0.0 111.419 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -60.07 -40.29 88.98 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.4 -58.08 8.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.707 0.803 . . . . 0.0 110.408 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.31 -38.63 77.48 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.13 -40.16 88.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.949 0.9 . . . . 0.0 112.222 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -81.65 -26.32 34.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.127 0.571 . . . . 0.0 112.506 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -74.83 -48.26 26.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.638 1.175 . . . . 0.0 113.286 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.31 -12.27 30.46 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -169.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -66.65 111.88 3.89 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.614 -1.304 . . . . 0.0 111.141 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.83 7.2 68.84 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.367 1.937 . . . . 0.0 114.572 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -73.76 168.65 18.96 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.68 1.74 . . . . 0.0 111.721 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.71 135.82 49.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.6 tp -145.07 117.97 8.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.145 1.778 . . . . 0.0 109.353 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 55.39 28.46 11.52 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.751 1.621 . . . . 0.0 113.42 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.38 6.96 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.721 1.153 . . . . 0.0 114.527 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -109.08 140.61 42.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.706 1.602 . . . . 0.0 110.503 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 136.63 39.09 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 168.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.9 pt -117.22 154.66 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -116.8 156.27 27.53 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.512 1.525 . . . . 0.0 109.498 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.82 137.43 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.853 1.261 . . . . 0.0 110.024 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -156.92 166.1 34.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.815 1.246 . . . . 0.0 111.853 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.79 140.29 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.234 -0.916 . . . . 0.0 112.211 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.9 m -81.45 141.13 34.18 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.68 2.33 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.912 1.285 . . . . 0.0 113.525 173.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 40.6 p -150.62 -173.33 4.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 128.791 2.837 . . . . 0.0 110.269 -170.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -154.7 168.52 26.56 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -53.24 134.2 51.23 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.19 2.596 . . . . 0.0 111.51 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.55 145.36 58.12 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.285 2.656 . . . . 0.0 111.302 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -162.27 146.33 12.07 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.532 1.533 . . . . 0.0 112.228 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.17 1.788 . . . . 0.0 110.847 -177.578 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.277 0 C5'-C4'-C3' 111.014 -2.991 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O4'-C1'-N19 111.974 3.774 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 C3'-C2'-C1' 103.677 2.419 . 0.472 5z . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.429 0 O4'-C1'-N19 111.864 3.664 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.253 1 O4'-C1'-N19 113.021 4.821 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.359 0 O5'-C5'-C4' 113.871 2.622 . 0.212 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.5 t -164.05 155.4 16.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.312 1.445 . . . . 0.0 111.151 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.9 p -79.42 -15.32 58.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.535 1.134 . . . . 0.0 113.277 171.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.61 -93.64 0.18 Allowed Glycine 0 C--N 1.343 0.962 0 C-N-CA 125.098 1.332 . . . . 0.0 111.965 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -130.37 13.27 5.54 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.79 1.636 . . . . 0.0 112.771 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.2 t -147.74 108.58 4.2 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.527 -1.358 . . . . 0.0 111.486 -175.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.27 136.95 22.13 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.193 0.901 . . . . 0.0 113.006 -172.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.02 137.95 50.09 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.153 0.981 . . . . 0.0 111.573 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -76.43 90.24 3.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.345 0.658 . . . . 0.0 110.674 -170.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.44 156.82 29.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.031 1.732 . . . . 0.0 111.146 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 39.18 61.89 5.18 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 126.011 1.725 . . . . 0.0 114.306 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.07 134.05 28.42 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.638 2.892 . . . . 0.0 110.759 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -97.04 132.95 24.81 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.175 0.99 . . . . 0.0 111.757 -173.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.52 125.35 17.53 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.521 3.481 . . . . 0.0 113.862 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -160.4 167.54 27.13 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.46 1.504 . . . . 0.0 111.512 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 71.0 m -65.26 -15.04 62.07 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -171.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.0 t -107.17 123.02 47.66 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.426 1.012 . . . . 0.0 111.061 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.04 149.48 24.52 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.836 1.654 . . . . 0.0 110.952 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.51 142.36 15.47 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.078 1.799 . . . . 0.0 110.227 167.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.98 127.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.623 1.969 . . . . 0.0 107.638 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -136.85 157.06 47.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.972 0.909 . . . . 0.0 111.386 -168.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.96 36.22 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.211 0.91 . . . . 0.0 113.675 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.24 160.29 31.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.426 1.491 . . . . 0.0 113.38 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -77.65 152.52 33.79 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 167.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.62 -18.2 65.24 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.307 -0.871 . . . . 0.0 112.726 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -100.74 -1.7 34.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.812 1.645 . . . . 0.0 114.243 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -65.85 136.41 56.13 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.615 1.166 . . . . 0.0 109.366 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.8 p -115.16 165.56 12.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.151 0.981 . . . . 0.0 111.644 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.94 -25.34 67.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.458 0.703 . . . . 0.0 111.748 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -68.61 -42.18 78.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.261 1.024 . . . . 0.0 111.461 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -66.87 -49.23 66.31 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.167 0.587 . . . . 0.0 110.386 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -58.93 -40.1 83.56 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.709 -0.619 . . . . 0.0 111.402 174.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.3 ttp-105 -59.53 -49.46 77.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.043 0.838 . . . . 0.0 111.625 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.01 -30.24 69.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.7 1.137 . . . . 0.0 113.057 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.56 -28.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.53 1.132 . . . . 0.0 112.042 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -100.67 -23.44 14.64 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.4 p -70.65 -18.3 62.85 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.363 1.438 . . . . 0.0 113.942 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -67.46 -10.51 52.18 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -101.79 -5.83 24.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.314 1.446 . . . . 0.0 113.912 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -178.16 25.7 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.951 1.262 . . . . 0.0 115.049 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.79 137.82 25.26 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.433 3.422 . . . . 0.0 112.28 -170.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.66 131.05 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.948 1.699 . . . . 0.0 110.032 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.46 -26.59 15.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.996 1.318 . . . . 0.0 113.222 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -163.41 165.23 24.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 113.077 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -146.89 133.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.837 2.055 . . . . 0.0 107.762 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.0 m -131.38 102.96 6.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.555 1.142 . . . . 0.0 110.749 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.6 mt -77.59 140.5 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t -91.31 120.71 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -111.2 143.66 41.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.53 1.132 . . . . 0.0 112.634 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -62.79 145.86 53.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.642 1.577 . . . . 0.0 111.974 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -72.09 -20.27 61.68 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -174.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -125.53 -34.61 2.65 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.113 0.965 . . . . 0.0 113.299 -170.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.6 p -94.78 -18.95 20.77 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.347 0.976 . . . . 0.0 113.38 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 59.81 16.3 5.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.92 1.688 . . . . 0.0 114.11 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.29 159.66 27.14 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.763 1.625 . . . . 0.0 109.933 169.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.0 t -57.19 136.95 56.46 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.465 -0.772 . . . . 0.0 110.49 170.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -75.46 -1.45 24.13 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.413 0.685 . . . . 0.0 112.737 173.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.13 59.54 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.646 1.593 . . . . 0.0 113.742 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -148.46 162.57 39.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.962 1.363 . . . . 0.0 114.256 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.31 172.25 17.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.761 2.024 . . . . 0.0 111.272 -169.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -138.94 155.6 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.363 1.465 . . . . 0.0 110.217 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -138.78 126.27 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.642 1.577 . . . . 0.0 109.151 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -108.51 101.19 10.37 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 111.737 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -76.75 159.76 29.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.294 1.038 . . . . 0.0 111.573 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.87 4.79 43.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.881 0.872 . . . . 0.0 113.005 171.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -159.82 136.14 8.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.368 1.467 . . . . 0.0 111.754 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.12 -30.71 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.001 0.921 . . . . 0.0 112.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.11 -23.57 51.81 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.479 1.036 . . . . 0.0 113.224 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -80.98 -29.6 35.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.788 170.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.57 81.97 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.236 0.614 . . . . 0.0 110.99 168.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.45 -31.94 71.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.31 1.044 . . . . 0.0 112.862 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.67 -64.25 0.9 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.76 0.824 . . . . 0.0 109.671 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.73 -34.96 70.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.27 -34.72 72.59 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.064 0.946 . . . . 0.0 112.883 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -88.78 -23.44 22.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.59 -45.38 19.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 113.114 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.82 31.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.33 111.32 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.698 -1.252 . . . . 0.0 111.057 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.56 8.64 70.26 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.278 1.418 . . . . 0.0 114.703 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.7 ptm -75.75 172.33 12.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.758 1.779 . . . . 0.0 111.471 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.28 135.41 54.18 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.974 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 40.0 tp -141.28 118.7 11.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.575 1.55 . . . . 0.0 109.534 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.5 t70 56.78 25.03 9.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.683 1.593 . . . . 0.0 113.417 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.08 8.6 71.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.01 1.291 . . . . 0.0 114.805 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -116.35 133.0 56.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.887 1.675 . . . . 0.0 110.614 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.43 129.69 38.94 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.819 -0.551 . . . . 0.0 110.267 173.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.9 pt -107.24 166.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.094 0.958 . . . . 0.0 111.008 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -142.54 151.15 41.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.096 1.759 . . . . 0.0 109.096 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.7 t -144.18 143.51 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.324 1.05 . . . . 0.0 112.569 -165.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -153.38 166.36 32.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.025 2.13 . . . . 0.0 111.419 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.02 149.0 48.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.522 -0.736 . . . . 0.0 111.543 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 91.6 p -79.89 124.28 28.52 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.081 -1.012 . . . . 0.0 113.374 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.0 pt -79.69 -16.94 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.609 1.164 . . . . 0.0 113.181 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.0 p -155.25 154.38 32.09 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 130.808 3.643 . . . . 0.0 106.842 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.84 148.26 23.75 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -172.14 105.63 0.35 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 127.972 2.509 . . . . 0.0 109.546 -173.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.41 156.15 58.91 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.771 2.314 . . . . 0.0 110.6 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -60.5 120.58 10.23 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.362 1.065 . . . . 0.0 112.589 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 128.778 2.831 . . . . 0.0 109.434 -176.72 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.111 1 O4'-C1'-N19 113.414 5.214 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.246 1 O4'-C1'-N19 114.771 6.571 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.287 0 O4'-C1'-N19 111.652 3.452 . 0.119 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.459 0 O5'-C5'-C4' 114.388 2.992 . 0.094 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 O4'-C1'-N19 111.097 2.897 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.001 0 O4'-C1'-N19 111.887 3.687 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.4 m 63.18 25.92 15.04 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.082 1.353 . . . . 0.0 112.83 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -74.99 -9.36 58.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.36 -171.84 54.96 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.886 1.232 . . . . 0.0 113.152 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 76.7 p -163.58 155.55 17.38 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.8 1.24 . . . . 0.0 112.574 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.8 p -169.11 174.91 5.98 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.465 1.906 . . . . 0.0 110.59 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.4 32.8 0.97 Allowed Glycine 0 N--CA 1.477 1.403 0 C-N-CA 125.455 1.503 . . . . 0.0 114.584 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -78.0 -3.41 41.9 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.615 1.966 . . . . 0.0 114.789 -175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 71.24 -1.96 2.55 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 128.437 2.695 . . . . 0.0 115.941 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.3 41.92 1.06 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.193 1.397 . . . . 0.0 111.678 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -170.11 42.79 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 127.11 2.164 . . . . 0.0 114.866 -167.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -66.45 150.98 84.06 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.487 2.125 . . . . 0.0 110.43 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.81 139.93 13.39 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.138 1.375 . . . . 0.0 110.172 -173.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.63 130.49 37.03 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.098 3.199 . . . . 0.0 113.873 -172.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -153.7 30.8 0.46 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.96 0.904 . . . . 0.0 113.11 -168.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 82.9 m 61.37 18.59 9.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.033 2.133 . . . . 0.0 114.218 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.2 t -157.52 137.4 12.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.349 1.46 . . . . 0.0 110.043 -170.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.3 mt -121.2 141.45 50.84 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.65 1.58 . . . . 0.0 110.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.23 144.73 17.42 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.482 1.515 . . . . 0.0 110.197 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.03 122.45 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.444 1.898 . . . . 0.0 107.472 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -129.23 147.58 51.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.767 1.227 . . . . 0.0 111.786 -167.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.53 31.7 11.18 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 124.071 0.843 . . . . 0.0 113.547 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.13 162.43 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.438 1.495 . . . . 0.0 113.153 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.3 t -81.83 154.62 25.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.27 0.628 . . . . 0.0 110.998 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.3 -17.38 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 112.601 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.37 -4.22 54.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.535 1.534 . . . . 0.0 114.279 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.5 m -66.81 133.59 50.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.67 1.188 . . . . 0.0 109.649 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.6 p -108.67 163.77 12.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.268 1.027 . . . . 0.0 111.546 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -61.32 -27.32 68.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.279 0.632 . . . . 0.0 111.176 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -73.69 -36.77 65.32 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.824 1.249 . . . . 0.0 112.57 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -66.07 -48.47 70.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.639 0.654 . . . . 0.0 110.28 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.95 -41.22 86.92 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.786 -0.571 . . . . 0.0 111.009 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -58.36 -50.04 75.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.867 0.758 . . . . 0.0 111.667 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.47 -29.39 68.82 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.655 1.116 . . . . 0.0 113.135 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -80.01 -29.42 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.093 0.957 . . . . 0.0 112.011 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -100.6 -22.0 15.1 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -69.19 -20.35 63.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.366 1.439 . . . . 0.0 113.799 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -67.68 -11.3 57.97 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 172.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.1 -9.38 22.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.191 1.396 . . . . 0.0 113.7 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.9 -173.09 27.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.914 1.245 . . . . 0.0 115.185 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.25 132.78 12.8 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.288 3.325 . . . . 0.0 112.758 -169.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.07 128.73 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.813 1.645 . . . . 0.0 109.367 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.04 -40.98 29.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.749 1.22 . . . . 0.0 111.872 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -169.6 173.86 6.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.993 1.717 . . . . 0.0 111.614 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.15 140.08 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.492 1.917 . . . . 0.0 108.428 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 t -142.37 116.25 9.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.253 0.621 . . . . 0.0 111.765 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.46 150.69 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.093 0.957 . . . . 0.0 109.974 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.12 132.37 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.173 0.989 . . . . 0.0 109.265 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -125.7 151.17 46.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.111 1.364 . . . . 0.0 112.867 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.32 149.31 42.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.061 0.945 . . . . 0.0 111.423 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -78.98 -24.35 43.86 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -123.4 -35.09 3.0 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.154 0.981 . . . . 0.0 113.019 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.8 m -84.52 -22.71 30.08 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.579 0.751 . . . . 0.0 112.165 170.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . 0.262 86.2 mtt180 58.84 25.02 13.06 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.385 1.874 . . . . 0.0 114.821 169.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -97.57 166.56 11.45 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.066 2.147 . . . . 0.0 110.064 168.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.9 t -58.48 140.73 53.49 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.938 -0.476 . . . . 0.0 110.049 168.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -75.6 -8.52 56.98 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 172.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 98.24 13.68 41.38 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.022 1.296 . . . . 0.0 113.94 -174.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -149.27 161.45 42.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.897 1.332 . . . . 0.0 113.633 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -161.5 174.03 14.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.582 1.953 . . . . 0.0 110.54 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -143.56 152.86 41.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.07 120.67 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.321 1.848 . . . . 0.0 108.091 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -98.81 125.59 44.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.61 1.164 . . . . 0.0 109.573 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -105.86 148.94 27.0 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.101 0.96 . . . . 0.0 112.089 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.52 -1.97 54.92 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -155.88 132.91 10.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.672 1.589 . . . . 0.0 111.062 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.47 -30.52 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.29 -17.87 60.18 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -86.78 -28.34 23.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.642 1.177 . . . . 0.0 112.076 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.01 -39.27 79.4 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.729 -0.607 . . . . 0.0 110.408 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -64.16 -23.58 67.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.706 1.202 . . . . 0.0 113.283 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.98 -64.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.776 0.83 . . . . 0.0 109.183 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -36.62 61.71 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -58.83 -31.97 68.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.188 0.995 . . . . 0.0 113.286 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -92.66 -10.53 36.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.103 0.961 . . . . 0.0 112.74 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -96.5 -49.83 4.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.896 1.278 . . . . 0.0 112.559 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.28 -16.19 40.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -63.99 115.66 5.12 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.989 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.84 6.54 76.0 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.226 1.393 . . . . 0.0 114.397 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -77.17 169.22 18.72 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.732 1.766 . . . . 0.0 111.704 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -117.22 123.96 47.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.888 0.875 . . . . 0.0 111.51 -174.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 11.5 tp -127.75 111.86 14.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.158 1.783 . . . . 0.0 109.351 -169.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.5 t70 56.31 27.27 11.62 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.081 1.353 . . . . 0.0 112.991 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.8 -1.18 80.68 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.386 1.469 . . . . 0.0 114.738 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -103.14 127.37 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.381 1.473 . . . . 0.0 110.041 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.01 128.57 36.41 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.34 155.64 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.725 0.81 . . . . 0.0 111.394 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -124.52 151.96 44.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.548 1.539 . . . . 0.0 109.245 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.1 t -141.51 136.2 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.285 1.034 . . . . 0.0 111.287 -168.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -147.25 159.27 43.85 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.357 1.863 . . . . 0.0 111.504 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -69.89 143.63 52.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.416 0.686 . . . . 0.0 111.855 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.9 m -84.28 124.31 31.1 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -172.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.8 pt -80.98 -13.78 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.272 1.029 . . . . 0.0 113.016 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 22.6 p -156.7 162.39 39.8 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 130.143 3.377 . . . . 0.0 108.399 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 160.76 39.32 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.42 -40.7 20.78 Favored Pre-proline 0 N--CA 1.48 1.038 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -61.24 157.19 41.33 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.218 3.279 . . . . 0.0 113.002 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -157.73 145.31 18.53 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.897 1.279 . . . . 0.0 112.478 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.29 1.836 . . . . 0.0 110.926 -174.641 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.177 0 O4'-C1'-N19 111.728 3.528 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 0 C5'-C4'-C3' 110.29 -3.474 . 0.028 4n . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.433 0 O4'-C1'-N19 110.764 2.564 . 0.247 3b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 0 O5'-C5'-C4' 115.161 3.543 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 P-O3'-C3' 123.34 3.033 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.153 1 O4'-C1'-N19 112.557 4.357 . 0.06 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.3 m -57.32 132.9 54.45 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.684 1.193 . . . . 0.0 112.652 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.1 m 67.21 9.17 6.75 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.869 1.668 . . . . 0.0 114.635 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.3 163.63 52.02 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.834 1.207 . . . . 0.0 113.396 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.9 m -83.67 128.11 34.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.772 0.829 . . . . 0.0 111.504 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 t -166.55 171.11 12.08 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.482 1.513 . . . . 0.0 110.979 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.66 89.19 1.14 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 173.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.88 111.52 9.11 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.731 0.812 . . . . 0.0 111.602 -173.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -86.24 -6.73 58.91 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.232 1.413 . . . . 0.0 114.197 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.3 140.85 41.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.338 1.455 . . . . 0.0 112.256 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 37.11 59.65 3.87 Favored Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 126.232 1.813 . . . . 0.0 114.555 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.14 136.71 35.38 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.482 2.788 . . . . 0.0 110.855 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.36 153.2 73.92 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.737 1.215 . . . . 0.0 112.637 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.69 140.53 56.02 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.152 3.235 . . . . 0.0 114.253 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -155.55 139.91 16.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.029 1.331 . . . . 0.0 110.231 -171.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.9 m -58.55 -28.51 65.57 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.483 1.113 . . . . 0.0 112.616 170.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 88.3 m -82.13 124.35 29.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.922 0.889 . . . . 0.0 110.224 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.2 mt -114.83 143.91 44.35 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.911 1.685 . . . . 0.0 110.475 172.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.52 148.38 18.3 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.646 1.594 . . . . 0.0 110.552 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.11 131.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.412 1.885 . . . . 0.0 107.823 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -137.36 154.87 49.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.541 1.136 . . . . 0.0 111.608 -168.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.25 30.14 38.49 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.8 0.714 . . . . 0.0 113.603 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.73 162.12 25.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.291 1.436 . . . . 0.0 113.159 -176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -79.85 156.65 27.26 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.999 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.3 mt -70.44 -18.82 63.01 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.714 -0.616 . . . . 0.0 111.996 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.21 -4.71 51.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.727 1.611 . . . . 0.0 114.452 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.7 m -66.84 136.98 56.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.451 1.1 . . . . 0.0 109.397 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.3 p -110.22 162.56 14.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.371 1.069 . . . . 0.0 111.434 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -60.19 -29.09 68.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.673 0.789 . . . . 0.0 111.028 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.73 -37.5 79.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.458 1.103 . . . . 0.0 112.197 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.16 -48.9 66.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.358 0.527 . . . . 0.0 110.279 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.34 -43.17 88.18 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.764 -0.585 . . . . 0.0 110.897 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -57.99 -49.47 76.72 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.758 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.24 -29.73 69.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.779 1.172 . . . . 0.0 113.018 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -80.15 -29.25 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.454 1.102 . . . . 0.0 112.208 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -100.61 -24.5 14.43 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.4 p -69.34 -17.6 63.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.312 1.415 . . . . 0.0 113.913 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -67.78 -14.38 62.9 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.86 -13.02 24.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.777 1.231 . . . . 0.0 113.635 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -174.54 30.65 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.734 1.159 . . . . 0.0 114.941 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.78 140.74 23.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.563 3.509 . . . . 0.0 112.174 -171.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.26 131.9 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 0.0 110.197 -173.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 -25.55 14.97 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.203 1.401 . . . . 0.0 113.658 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -161.83 157.77 24.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.357 1.063 . . . . 0.0 112.39 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -148.27 130.4 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 127.182 2.193 . . . . 0.0 107.653 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.5 t -143.65 118.03 9.65 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.484 0.714 . . . . 0.0 111.802 -174.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.03 144.55 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 169.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t -96.94 128.96 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -121.02 151.4 39.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.408 1.483 . . . . 0.0 111.931 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -77.21 144.46 38.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.101 0.56 . . . . 0.0 111.874 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -75.26 -23.09 57.41 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -117.24 -38.27 3.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.352 1.061 . . . . 0.0 112.447 -173.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.4 m -82.33 -23.91 34.87 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.577 -0.702 . . . . 0.0 112.661 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 56.9 36.21 27.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.928 1.691 . . . . 0.0 113.694 170.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.83 164.05 19.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 128.318 2.647 . . . . 0.0 109.2 170.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.8 t -58.41 139.24 55.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.16 0.505 . . . . 0.0 111.113 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -81.38 1.93 30.69 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.437 1.095 . . . . 0.0 112.711 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.8 11.48 63.61 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.681 1.134 . . . . 0.0 114.236 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -148.99 163.68 36.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.594 1.187 . . . . 0.0 113.277 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.77 170.4 22.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.57 1.948 . . . . 0.0 111.568 -168.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -141.35 150.13 42.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.359 1.464 . . . . 0.0 111.171 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.71 127.29 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 109.347 -170.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -99.18 109.02 21.75 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.334 1.454 . . . . 0.0 111.007 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -83.29 160.99 21.59 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.342 -0.849 . . . . 0.0 111.03 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -94.88 8.72 41.8 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.064 0.946 . . . . 0.0 113.001 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -156.68 133.18 10.03 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.511 1.525 . . . . 0.0 111.241 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.03 -30.13 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.54 0.736 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -75.8 -28.52 58.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.435 1.016 . . . . 0.0 113.115 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.73 -27.46 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.225 0.61 . . . . 0.0 111.78 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.33 -41.24 70.07 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.317 0.647 . . . . 0.0 111.307 169.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -60.73 -35.71 77.03 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.196 0.999 . . . . 0.0 112.21 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.52 -63.68 1.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.021 0.928 . . . . 0.0 110.16 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.82 68.86 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.47 -36.01 79.23 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.959 0.904 . . . . 0.0 112.61 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.87 -24.4 26.7 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.515 0.726 . . . . 0.0 112.234 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -76.67 -47.12 23.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.54 1.136 . . . . 0.0 112.98 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.14 -12.43 26.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -170.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -65.62 113.38 4.19 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.517 -1.364 . . . . 0.0 110.866 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.21 8.53 71.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.235 1.398 . . . . 0.0 114.728 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -76.55 175.67 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.741 1.771 . . . . 0.0 111.485 169.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -119.72 135.37 54.86 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.254 1.021 . . . . 0.0 111.57 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.1 tp -146.07 121.33 10.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.982 1.713 . . . . 0.0 109.321 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 56.44 27.56 12.31 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.272 1.429 . . . . 0.0 112.603 -169.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.09 81.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.751 1.167 . . . . 0.0 114.355 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.48 130.29 43.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.874 1.337 . . . . 0.0 109.636 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.07 128.83 37.28 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.6 pt -108.65 159.45 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.941 0.896 . . . . 0.0 111.581 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -121.02 149.5 42.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.506 1.923 . . . . 0.0 108.938 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -145.98 137.24 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.453 1.101 . . . . 0.0 110.371 -171.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -157.15 162.82 39.37 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 112.329 -172.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -73.43 138.36 45.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.454 -0.779 . . . . 0.0 111.286 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 26.7 m -75.86 139.8 41.88 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 37.5 pt -90.29 3.03 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.21 1.004 . . . . 0.0 113.257 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.6 p -155.97 -168.37 2.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 129.818 3.247 . . . . 0.0 109.376 -172.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -152.47 175.13 13.05 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.246 1.419 . . . . 0.0 112.823 169.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -60.6 140.1 92.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.247 1.419 . . . . 0.0 111.222 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.25 145.61 65.15 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.745 2.963 . . . . 0.0 112.716 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -158.95 163.18 36.73 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.076 1.351 . . . . 0.0 113.008 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.528 1.931 . . . . 0.0 112.219 -176.398 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.266 1 O4'-C1'-N19 112.582 4.382 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 O4'-C1'-N19 111.502 3.302 . 0.179 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.206 1 O4'-C1'-N19 112.293 4.093 . 0.21 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.397 0 C5'-C4'-C3' 112.089 -2.274 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 O4'-C1'-N19 112.042 3.842 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.259 0 P-O3'-C3' 122.744 2.537 . 0.165 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.036 -0.425 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.4 p 66.06 -33.41 0.18 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 129.119 2.968 . . . . 0.0 116.487 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 91.2 p -152.41 -13.19 0.18 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.381 1.472 . . . . 0.0 114.248 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -170.32 152.19 18.37 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.906 1.241 . . . . 0.0 113.252 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.0 m -158.19 155.1 28.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.541 1.936 . . . . 0.0 110.14 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.6 m -70.1 -13.71 62.33 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.9 155.16 26.4 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.659 2.075 . . . . 0.0 111.435 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -145.63 112.14 5.84 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.262 1.025 . . . . 0.0 111.571 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -74.25 -12.08 60.46 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.85 27.99 7.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.634 1.573 . . . . 0.0 113.518 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -169.2 66.33 0.61 Allowed Pre-proline 0 CA--C 1.557 1.23 0 C-N-CA 129.686 3.194 . . . . 0.0 110.793 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.34 178.93 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.06 3.174 . . . . 0.0 111.345 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -153.01 152.94 29.06 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.768 1.627 . . . . 0.0 110.929 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.2 138.32 71.73 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 124.066 3.177 . . . . 0.0 114.522 -172.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -157.57 142.84 17.03 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.911 1.284 . . . . 0.0 110.712 -170.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 71.0 m -59.0 -28.71 66.64 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.207 1.003 . . . . 0.0 112.062 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 56.1 m -86.61 127.32 34.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.804 1.242 . . . . 0.0 110.274 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -118.0 148.96 41.72 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.899 1.68 . . . . 0.0 111.049 175.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.14 147.15 16.2 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.363 1.935 . . . . 0.0 110.832 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.46 128.63 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 108.576 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -133.13 153.56 51.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.153 1.381 . . . . 0.0 111.141 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 30.94 21.11 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 123.861 0.743 . . . . 0.0 113.696 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -78.33 160.62 27.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.952 1.301 . . . . 0.0 113.4 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -81.36 151.56 27.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.488 0.715 . . . . 0.0 110.354 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.34 -16.67 64.02 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.073 -1.017 . . . . 0.0 112.819 175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -95.39 -3.17 47.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.421 1.488 . . . . 0.0 114.233 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.1 m -65.62 135.14 54.66 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.709 1.204 . . . . 0.0 109.69 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -108.04 162.68 13.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.355 1.062 . . . . 0.0 111.463 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.89 -29.35 69.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.304 0.641 . . . . 0.0 111.165 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -68.72 -38.39 80.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.501 1.12 . . . . 0.0 112.395 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -66.6 -49.8 65.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.639 0.654 . . . . 0.0 110.463 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.32 -41.37 84.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.717 -0.615 . . . . 0.0 111.09 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -62.99 -43.2 99.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.081 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.68 -33.45 74.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.185 1.357 . . . . 0.0 112.502 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.51 -28.18 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.45 1.1 . . . . 0.0 112.331 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -100.15 -23.12 14.93 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.6 m -69.15 -14.86 63.23 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.207 1.367 . . . . 0.0 113.691 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -68.17 -14.31 62.89 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.868 -1.145 . . . . 0.0 113.696 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -95.75 -13.8 23.86 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.878 1.271 . . . . 0.0 113.605 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.24 -174.58 31.91 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.099 1.333 . . . . 0.0 114.339 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.91 136.84 21.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.193 3.262 . . . . 0.0 111.934 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.1 mt -131.81 127.1 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.588 1.555 . . . . 0.0 109.789 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.87 -25.08 20.03 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.926 1.29 . . . . 0.0 113.322 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -164.28 167.33 20.02 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.12 135.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.213 2.205 . . . . 0.0 107.76 171.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.0 m -127.05 102.86 7.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.892 1.277 . . . . 0.0 110.511 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.5 mt -78.53 140.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.998 -1.064 . . . . 0.0 108.157 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.9 t -97.33 127.59 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -115.64 143.84 44.78 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.849 1.26 . . . . 0.0 112.096 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.25 139.17 58.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.577 1.151 . . . . 0.0 111.361 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -70.15 -20.56 63.14 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -117.84 -42.72 2.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.049 0.939 . . . . 0.0 112.13 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.3 m -88.28 -17.09 31.46 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.033 0.933 . . . . 0.0 113.396 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 78.5 mtm-85 64.37 8.48 4.26 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.615 1.966 . . . . 0.0 115.377 169.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -82.6 165.39 20.11 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.224 1.809 . . . . 0.0 110.574 169.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.4 t -57.5 140.91 49.42 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.868 -0.52 . . . . 0.0 110.181 168.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -77.8 0.0 25.45 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.86 0.864 . . . . 0.0 112.659 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.55 12.16 63.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.183 1.373 . . . . 0.0 113.478 -174.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -153.27 161.92 41.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 123.028 1.394 . . . . 0.0 113.811 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.69 175.02 13.67 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.575 1.95 . . . . 0.0 111.371 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.8 156.4 46.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.479 1.511 . . . . 0.0 110.101 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.9 t -139.54 136.76 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.306 1.842 . . . . 0.0 109.193 -168.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -120.5 94.21 4.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.687 1.195 . . . . 0.0 111.678 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -74.62 161.45 29.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.685 0.794 . . . . 0.0 111.96 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.28 8.85 43.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.469 1.107 . . . . 0.0 112.871 171.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -157.45 135.51 10.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.503 1.521 . . . . 0.0 111.714 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.78 -33.15 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.572 0.749 . . . . 0.0 112.633 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -73.64 -27.6 61.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.306 0.957 . . . . 0.0 112.725 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.36 -29.03 41.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.648 0.779 . . . . 0.0 111.881 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.26 -41.85 69.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.447 0.699 . . . . 0.0 111.351 169.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -59.86 -35.69 75.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.587 1.155 . . . . 0.0 112.322 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.43 -62.67 1.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.293 1.037 . . . . 0.0 110.031 171.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.37 68.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -175.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.35 -30.02 68.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.808 1.243 . . . . 0.0 113.202 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -93.14 -28.77 16.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.867 0.867 . . . . 0.0 112.178 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -74.19 -47.09 37.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.21 1.004 . . . . 0.0 113.355 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.93 -12.35 39.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.89 115.26 5.17 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.209 -0.932 . . . . 0.0 110.982 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 86.76 4.18 82.8 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.421 1.486 . . . . 0.0 114.647 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -73.84 158.91 33.65 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.73 1.765 . . . . 0.0 111.748 172.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -103.89 116.77 32.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.077 0.951 . . . . 0.0 110.724 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.6 tp -122.7 111.65 16.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.443 1.897 . . . . 0.0 109.151 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.53 23.56 9.33 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.239 1.416 . . . . 0.0 113.467 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.35 8.82 65.82 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.024 1.297 . . . . 0.0 114.699 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -115.37 134.24 55.29 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.994 1.718 . . . . 0.0 110.107 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -78.93 126.62 30.94 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 109.663 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.85 167.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.924 0.889 . . . . 0.0 111.789 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -137.23 142.41 42.06 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.728 2.011 . . . . 0.0 108.048 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -137.96 140.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.651 0.78 . . . . 0.0 111.581 -168.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -152.57 164.8 36.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.17 1.788 . . . . 0.0 111.224 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.31 141.96 41.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.347 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.4 m -75.89 135.82 40.13 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.162 -0.961 . . . . 0.0 112.855 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 8.4 pt -95.44 -6.28 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.621 1.168 . . . . 0.0 113.51 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.6 p -156.59 -170.45 3.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 129.781 3.232 . . . . 0.0 109.428 -173.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -147.49 169.85 18.66 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.342 1.457 . . . . 0.0 114.473 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.97 162.89 11.17 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.472 1.109 . . . . 0.0 112.35 171.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -60.01 146.84 95.04 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.849 3.033 . . . . 0.0 112.691 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -159.12 158.96 33.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.164 1.386 . . . . 0.0 112.824 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 C--O 1.254 1.294 0 C-N-CA 126.443 1.897 . . . . 0.0 112.163 -175.36 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.137 0 O4'-C1'-N19 111.77 3.57 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.217 0 O4'-C1'-N19 111.222 3.022 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.192 0 C5'-C4'-C3' 110.455 -3.363 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.378 0 O4'-C1'-N19 111.13 2.93 . 0.188 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.419 0 O4'-C1'-N19 111.267 3.067 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.343 0 O4'-C1'-N19 110.877 2.677 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.9 t 69.45 177.83 0.26 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.085 1.754 . . . . 0.0 113.52 -177.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 87.7 p -164.89 172.99 12.16 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.346 1.859 . . . . 0.0 111.449 -176.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.37 -101.37 0.89 Allowed Glycine 0 N--CA 1.471 0.968 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.6 m -73.35 -20.01 60.88 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.4 0.68 . . . . 0.0 112.195 168.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.8 m 63.59 20.63 12.34 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.466 1.907 . . . . 0.0 115.146 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.3 136.58 20.55 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.25 0.929 . . . . 0.0 111.669 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -118.15 80.79 1.57 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.226 1.41 . . . . 0.0 109.374 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.5 mtt85 55.01 35.44 24.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.399 1.879 . . . . 0.0 112.32 -172.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.59 145.62 24.55 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.303 2.241 . . . . 0.0 109.327 -171.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 46.02 65.72 6.32 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 125.057 1.343 . . . . 0.0 113.236 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.17 179.4 6.56 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.977 3.118 . . . . 0.0 111.739 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -146.96 142.37 16.99 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.908 1.683 . . . . 0.0 109.64 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -51.52 142.44 39.2 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.119 3.213 . . . . 0.0 115.228 -174.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -154.64 139.8 17.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.46 1.504 . . . . 0.0 109.991 -172.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 87.7 m -58.62 -28.17 65.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.252 1.021 . . . . 0.0 112.532 171.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.1 t -88.94 129.69 35.58 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.398 1.079 . . . . 0.0 110.786 171.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.1 mt -118.67 146.54 44.62 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.488 1.915 . . . . 0.0 110.379 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.06 149.25 18.7 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.723 1.63 . . . . 0.0 110.955 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.47 128.46 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.505 1.922 . . . . 0.0 107.838 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -136.88 150.81 48.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.156 0.982 . . . . 0.0 112.175 -167.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.15 30.18 23.4 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 123.972 0.796 . . . . 0.0 113.383 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.09 162.87 23.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 113.349 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 t -81.81 157.8 24.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.694 0.798 . . . . 0.0 112.216 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.83 -19.91 62.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.402 0.681 . . . . 0.0 112.083 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.56 -6.38 54.77 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.447 1.499 . . . . 0.0 114.364 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.7 m -69.02 134.56 49.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.727 1.211 . . . . 0.0 109.482 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 p -108.22 162.66 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.289 1.036 . . . . 0.0 111.348 173.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -61.12 -28.65 69.25 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.075 0.55 . . . . 0.0 111.132 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -70.43 -36.73 74.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 112.53 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -67.22 -49.49 64.31 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.605 0.639 . . . . 0.0 110.289 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.54 -43.62 80.08 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.806 -0.559 . . . . 0.0 110.901 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -57.22 -50.33 73.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.657 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.11 -29.9 68.94 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.593 1.088 . . . . 0.0 113.074 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.82 -27.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.479 1.112 . . . . 0.0 112.015 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -100.51 -24.15 14.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.055 0.942 . . . . 0.0 113.488 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.3 p -69.82 -17.19 63.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.362 1.437 . . . . 0.0 113.868 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -66.86 -12.81 60.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -98.68 -8.28 26.44 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.287 1.435 . . . . 0.0 113.751 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.52 -175.55 26.81 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.982 1.277 . . . . 0.0 115.004 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.14 137.21 21.12 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 124.413 3.409 . . . . 0.0 112.248 -170.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.5 mt -128.62 131.35 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.977 1.711 . . . . 0.0 110.016 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.03 -25.18 15.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.065 1.346 . . . . 0.0 113.439 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.11 164.19 25.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.5 t -148.49 134.44 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.175 2.19 . . . . 0.0 108.056 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.9 m -132.83 110.6 10.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.36 1.064 . . . . 0.0 111.351 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.41 139.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t -90.3 108.33 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -99.51 143.86 29.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.908 1.283 . . . . 0.0 111.933 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.57 141.89 55.34 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.86 0.864 . . . . 0.0 112.641 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -69.0 -21.6 64.13 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.411 1.084 . . . . 0.0 113.768 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -124.91 -39.22 2.28 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.046 0.939 . . . . 0.0 112.33 -172.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 71.1 m -81.69 -16.59 50.79 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 173.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 78.2 mtm-85 56.41 36.67 27.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.984 1.714 . . . . 0.0 113.158 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -134.18 156.71 47.86 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.363 2.665 . . . . 0.0 109.38 -174.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.6 t -59.63 135.05 57.56 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.057 0.455 . . . . 0.0 111.117 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -81.23 2.14 29.16 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.157 0.983 . . . . 0.0 112.869 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.74 17.8 57.59 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.415 1.007 . . . . 0.0 113.95 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.405 ' CD1' " H4'" ' B' ' 4' ' ' ' G' . 53.7 p90 -153.47 162.55 41.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 122.615 1.198 . . . . 0.0 113.318 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.65 173.59 16.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.251 1.82 . . . . 0.0 111.875 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -141.17 152.4 44.63 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.784 1.633 . . . . 0.0 110.485 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 67.1 t -137.74 132.61 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.176 1.79 . . . . 0.0 108.955 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -115.89 101.67 8.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 111.509 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -78.73 160.08 27.62 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.918 0.887 . . . . 0.0 111.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -91.29 6.68 44.29 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.118 0.967 . . . . 0.0 113.017 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -158.23 134.73 9.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.398 1.479 . . . . 0.0 111.57 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.63 -29.39 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.91 0.884 . . . . 0.0 112.672 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.91 -27.37 49.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.468 1.031 . . . . 0.0 112.989 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.45 -29.2 52.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.675 0.79 . . . . 0.0 111.786 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.41 -39.5 74.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.259 0.624 . . . . 0.0 111.65 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.29 -39.1 85.71 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.112 -0.993 . . . . 0.0 111.962 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.91 -61.94 2.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.794 0.838 . . . . 0.0 110.079 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.21 -39.27 69.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -61.58 -39.18 90.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.856 0.863 . . . . 0.0 112.466 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -82.66 -25.36 33.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.276 0.63 . . . . 0.0 112.417 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -76.12 -51.84 11.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.534 1.134 . . . . 0.0 112.792 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.13 -14.19 39.36 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.1 112.6 3.45 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.521 -1.362 . . . . 0.0 111.068 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.22 8.4 68.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.47 1.509 . . . . 0.0 114.609 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -75.68 174.72 9.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.739 1.769 . . . . 0.0 111.465 169.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -120.12 135.32 55.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.248 1.019 . . . . 0.0 111.494 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -145.46 120.58 10.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.966 1.706 . . . . 0.0 109.276 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 56.53 27.47 12.36 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.424 1.489 . . . . 0.0 112.573 -169.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.58 84.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.727 1.156 . . . . 0.0 114.274 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.82 130.36 44.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.855 1.328 . . . . 0.0 109.622 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.26 130.92 42.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 122.09 -0.381 . . . . 0.0 110.171 171.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.0 pt -110.84 143.99 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.566 0.746 . . . . 0.0 111.389 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -102.35 144.41 30.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.694 1.598 . . . . 0.0 108.634 172.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.8 t -141.62 134.92 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.566 1.147 . . . . 0.0 109.911 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -156.31 158.2 37.04 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.925 1.29 . . . . 0.0 111.731 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.43 140.64 54.13 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.578 -0.701 . . . . 0.0 110.98 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.5 m -73.66 126.5 30.46 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.411 -0.806 . . . . 0.0 112.261 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 12.0 pt -86.07 -14.8 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.368 1.067 . . . . 0.0 112.762 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 15.7 p -159.21 165.02 34.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 129.98 3.312 . . . . 0.0 108.701 -172.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -152.05 159.95 43.57 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -75.57 -45.6 4.27 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.63 174.74 10.81 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.79 2.993 . . . . 0.0 111.039 175.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -135.29 141.38 45.67 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.656 1.182 . . . . 0.0 112.231 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 C--O 1.253 1.239 0 C-N-CA 126.291 1.836 . . . . 0.0 112.16 -169.904 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.279 1 O4'-C1'-N19 112.78 4.58 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 1 O4'-C1'-N19 112.729 4.529 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.187 0 C5'-C4'-C3' 111.407 -2.729 . 0.06 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.405 " H4'" ' CD1' ' A' ' 161' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.765 0 O4'-C4'-C3' 108.791 2.351 . 0.134 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 O4'-C1'-N19 111.058 2.858 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.095 0 O4'-C1'-N19 111.327 3.127 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.2 p -163.37 172.55 14.43 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.693 1.597 . . . . 0.0 111.388 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 89.4 p -160.68 174.06 14.53 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.756 1.222 . . . . 0.0 112.228 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.67 -111.07 3.26 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.119 0.866 . . . . 0.0 111.854 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.6 m -61.75 -11.55 12.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.905 1.682 . . . . 0.0 114.839 -175.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.1 m -68.77 -6.22 25.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.954 1.302 . . . . 0.0 114.024 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.01 49.92 4.57 Favored Glycine 0 N--CA 1.47 0.929 0 C-N-CA 124.753 1.168 . . . . 0.0 111.207 -175.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -73.49 -7.2 50.79 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -169.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 53.26 41.4 32.14 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.149 1.78 . . . . 0.0 112.68 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -136.1 146.32 46.86 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.805 1.642 . . . . 0.0 111.181 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 p30 32.8 57.94 1.42 Allowed Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 126.38 1.872 . . . . 0.0 115.993 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.89 151.41 68.31 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.768 2.979 . . . . 0.0 112.107 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -85.24 154.62 60.16 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.522 1.129 . . . . 0.0 111.773 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.44 145.26 37.49 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.184 3.256 . . . . 0.0 113.877 174.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -155.08 141.6 18.79 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.188 1.395 . . . . 0.0 110.432 -173.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 81.8 m -58.86 -28.93 66.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.616 1.166 . . . . 0.0 112.374 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.4 t -89.89 130.81 36.07 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.381 1.072 . . . . 0.0 110.755 171.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.8 mt -118.39 148.07 42.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.579 1.952 . . . . 0.0 110.593 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.1 149.61 18.0 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.132 1.825 . . . . 0.0 111.461 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.63 128.78 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.786 2.034 . . . . 0.0 108.027 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -136.05 145.42 45.99 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.304 1.042 . . . . 0.0 111.635 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 29.06 9.83 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 124.343 0.973 . . . . 0.0 114.014 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.6 mt -83.65 156.51 22.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.008 1.323 . . . . 0.0 112.874 -173.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 t -79.71 152.69 29.75 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 171.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.84 -18.86 65.59 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.481 -0.762 . . . . 0.0 112.232 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.81 -6.88 57.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.374 1.47 . . . . 0.0 114.358 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 m -74.98 130.98 40.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.3 p -104.5 165.51 11.01 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.377 1.071 . . . . 0.0 111.567 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -60.64 -29.12 69.07 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.2 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.25 -37.87 71.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.471 1.108 . . . . 0.0 112.422 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.87 -48.7 70.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.563 0.619 . . . . 0.0 110.284 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.5 mt -55.64 -43.66 76.4 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.912 -0.493 . . . . 0.0 110.865 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.42 -43.24 99.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.871 0.759 . . . . 0.0 112.366 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.3 -29.96 67.94 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.067 1.303 . . . . 0.0 112.633 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.27 -29.92 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.398 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -100.29 -24.86 14.43 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.3 p -70.97 -11.47 60.98 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.228 1.377 . . . . 0.0 114.097 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -66.61 -15.87 63.77 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.987 -1.071 . . . . 0.0 113.608 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -95.59 -14.84 23.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.85 1.26 . . . . 0.0 113.645 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.77 -177.89 33.48 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 124.878 1.227 . . . . 0.0 114.687 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.67 136.83 21.69 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 124.33 3.353 . . . . 0.0 111.931 -172.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.31 125.87 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.72 1.608 . . . . 0.0 109.755 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.65 -27.01 21.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.919 1.288 . . . . 0.0 113.176 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.08 166.19 23.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.82 137.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.972 2.109 . . . . 0.0 107.883 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -138.29 106.42 5.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.131 0.973 . . . . 0.0 111.053 -172.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.7 146.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.344 -0.847 . . . . 0.0 108.969 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.5 t -94.98 123.61 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -114.24 151.02 33.47 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.65 1.18 . . . . 0.0 112.169 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.31 148.76 43.21 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.607 0.763 . . . . 0.0 112.748 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -74.18 -21.02 60.01 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -125.41 -40.89 2.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.118 0.967 . . . . 0.0 112.701 -170.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 90.8 p -86.19 -17.03 35.93 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.394 0.997 . . . . 0.0 113.289 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.4 mtm-85 63.86 9.01 4.19 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.154 1.782 . . . . 0.0 114.686 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -88.87 166.31 14.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.212 1.405 . . . . 0.0 111.295 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.2 t -58.64 140.89 53.87 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.857 0.36 . . . . 0.0 110.088 169.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -85.04 2.76 41.81 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.322 1.049 . . . . 0.0 113.074 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.43 16.8 61.58 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.231 0.92 . . . . 0.0 113.785 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -150.2 159.5 44.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.601 1.191 . . . . 0.0 112.9 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.6 175.42 13.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.148 1.779 . . . . 0.0 111.568 -168.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -142.81 154.99 44.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.48 1.512 . . . . 0.0 110.6 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -138.42 131.65 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.213 1.805 . . . . 0.0 109.194 -168.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -114.4 96.73 5.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 0.0 111.463 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.81 158.41 32.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 111.7 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.36 0.67 53.47 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -157.13 157.46 34.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.176 1.39 . . . . 0.0 112.224 173.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.21 -26.16 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.62 -33.15 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.507 1.049 . . . . 0.0 112.874 -170.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -75.76 -23.59 55.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.562 0.745 . . . . 0.0 112.063 169.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.42 62.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.362 0.665 . . . . 0.0 111.233 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -60.03 -37.76 80.72 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.292 1.037 . . . . 0.0 111.975 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.76 -63.34 1.24 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.005 0.922 . . . . 0.0 110.195 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.98 69.75 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -60.49 -38.05 83.05 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.889 0.875 . . . . 0.0 112.464 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -83.54 -26.43 30.12 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.57 0.748 . . . . 0.0 112.128 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -76.09 -46.37 29.34 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.432 1.093 . . . . 0.0 112.973 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -91.9 -15.22 28.4 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -64.46 112.28 3.05 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.745 -1.222 . . . . 0.0 110.717 172.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.23 7.26 70.13 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.34 1.448 . . . . 0.0 114.796 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.3 ptm -74.91 172.13 12.8 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.889 1.845 . . . . 0.0 111.449 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -116.49 134.1 55.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.342 1.057 . . . . 0.0 111.242 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.2 tp -145.79 119.37 9.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.286 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.5 t70 56.94 27.69 13.53 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.529 1.532 . . . . 0.0 112.468 -169.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.43 -2.49 82.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.737 1.16 . . . . 0.0 114.175 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.81 128.16 42.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.814 1.307 . . . . 0.0 109.694 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.76 127.93 34.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.853 170.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.9 pt -108.66 154.24 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.03 0.832 . . . . 0.0 112.327 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -110.78 146.78 35.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.885 1.674 . . . . 0.0 108.697 172.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.91 139.16 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.557 1.143 . . . . 0.0 110.674 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -155.52 164.49 38.61 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.223 1.409 . . . . 0.0 112.387 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -79.74 142.81 35.09 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.199 -0.938 . . . . 0.0 111.517 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 49.9 m -75.76 134.31 40.5 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.126 -0.984 . . . . 0.0 113.592 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.6 pt -93.42 -14.2 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.696 1.198 . . . . 0.0 113.432 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.4 p -157.73 166.85 31.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 129.635 3.174 . . . . 0.0 108.586 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -152.7 165.8 34.16 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -73.03 -47.41 8.16 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.86 152.91 19.4 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.448 2.765 . . . . 0.0 111.288 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -84.0 145.4 28.54 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.008 0.923 . . . . 0.0 113.364 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 38.0 m . . . . . 0 C--O 1.252 1.234 0 C-N-CA 126.518 1.927 . . . . 0.0 110.639 177.727 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 1 O4'-C1'-N19 112.237 4.037 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.153 0 O4'-C1'-N19 111.332 3.132 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.513 0 O3'-P-O5' 99.778 -2.222 . 0.621 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 C5'-C4'-C3' 111.822 -2.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.652 0 C5'-C4'-C3' 111.399 -2.734 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.257 0 C5'-C4'-C3' 110.038 -3.642 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 m -146.0 147.34 31.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.834 1.254 . . . . 0.0 111.412 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.9 p -86.45 -3.98 59.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.642 1.177 . . . . 0.0 114.17 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.35 -170.72 20.53 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.906 1.717 . . . . 0.0 113.249 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.9 m 70.52 6.12 5.68 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.224 1.809 . . . . 0.0 114.647 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.8 t -163.93 158.93 20.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.118 1.767 . . . . 0.0 110.913 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.86 151.74 32.4 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.43 1.014 . . . . 0.0 113.011 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -159.82 130.22 5.62 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.9 1.28 . . . . 0.0 111.158 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -92.95 -6.64 48.04 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.885 1.274 . . . . 0.0 114.213 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.0 136.55 36.63 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.612 0.765 . . . . 0.0 111.268 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m120 35.76 57.87 2.88 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 126.51 1.924 . . . . 0.0 114.935 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.01 159.57 51.38 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.758 2.305 . . . . 0.0 112.573 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -67.29 145.07 98.48 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.375 0.67 . . . . 0.0 111.68 171.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -53.1 146.61 37.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.144 3.23 . . . . 0.0 114.39 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -155.18 139.03 16.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.383 1.473 . . . . 0.0 110.205 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 66.0 m -55.81 -30.65 61.72 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.944 1.297 . . . . 0.0 112.638 170.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.0 t -86.28 128.23 34.89 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.318 1.047 . . . . 0.0 110.73 171.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.59 145.44 45.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.423 1.889 . . . . 0.0 110.27 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 148.2 18.56 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.804 1.669 . . . . 0.0 110.589 168.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.77 132.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.713 2.005 . . . . 0.0 108.034 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -137.91 152.15 48.72 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.444 1.098 . . . . 0.0 111.958 -167.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.08 29.15 26.36 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.172 0.891 . . . . 0.0 113.759 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.89 159.07 29.14 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.278 1.431 . . . . 0.0 113.596 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.0 t -72.83 155.41 39.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.613 0.721 . . . . 0.0 111.878 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -70.97 -12.46 61.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.793 0.837 . . . . 0.0 112.723 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -103.86 -4.68 23.21 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.478 1.911 . . . . 0.0 114.615 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.4 m -62.61 134.95 57.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.41 1.084 . . . . 0.0 110.058 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -108.25 162.18 14.31 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.26 1.024 . . . . 0.0 111.667 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.57 -26.68 68.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.298 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.37 -36.19 66.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.161 0.984 . . . . 0.0 112.203 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.51 -50.61 68.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.748 0.704 . . . . 0.0 110.289 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.8 mt -60.15 -40.05 88.49 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.537 -0.727 . . . . 0.0 111.15 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.89 -47.44 84.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.141 0.882 . . . . 0.0 111.775 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.31 -32.59 72.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.82 1.191 . . . . 0.0 112.478 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.07 -29.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.438 1.095 . . . . 0.0 112.463 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.47 -22.97 14.84 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -68.03 -17.06 64.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.281 1.401 . . . . 0.0 113.631 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -68.08 -13.86 62.53 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.868 -1.145 . . . . 0.0 113.72 172.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -96.22 -10.82 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.93 1.292 . . . . 0.0 113.747 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.14 -173.95 28.0 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.968 1.271 . . . . 0.0 114.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.64 138.03 21.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.427 3.418 . . . . 0.0 112.147 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.5 mt -130.9 130.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.897 1.679 . . . . 0.0 109.891 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.02 -23.7 16.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.896 1.278 . . . . 0.0 113.468 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.67 162.5 29.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.83 0.852 . . . . 0.0 112.97 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.93 134.16 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.047 2.139 . . . . 0.0 107.399 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.3 t -137.08 111.18 8.34 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.529 0.732 . . . . 0.0 110.804 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.3 mt -84.82 138.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t -89.24 118.9 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -107.85 142.74 37.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.454 1.102 . . . . 0.0 112.545 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.54 140.52 58.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.835 1.254 . . . . 0.0 111.443 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -71.25 -20.19 62.26 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -173.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -117.57 -44.53 2.75 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.369 1.068 . . . . 0.0 112.043 -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 61.7 m -86.63 -17.98 32.48 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 62.42 14.38 6.87 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.222 1.809 . . . . 0.0 114.585 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -88.67 166.5 14.05 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.794 2.038 . . . . 0.0 110.132 169.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.0 t -58.44 137.26 57.44 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.108 170.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -73.73 -1.71 20.3 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.629 0.771 . . . . 0.0 112.515 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.57 6.3 59.73 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.857 1.694 . . . . 0.0 113.583 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -147.38 159.75 43.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.934 1.35 . . . . 0.0 113.971 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.54 174.77 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.446 1.898 . . . . 0.0 111.368 -169.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -143.09 153.09 42.56 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.567 1.547 . . . . 0.0 110.667 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.7 129.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.96 1.704 . . . . 0.0 108.993 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -114.15 97.94 6.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.709 1.204 . . . . 0.0 111.2 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -75.81 160.66 29.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.822 0.849 . . . . 0.0 111.807 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -92.13 7.01 44.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.154 0.982 . . . . 0.0 112.969 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.06 134.32 9.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.362 1.465 . . . . 0.0 111.483 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.91 -29.48 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 112.711 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.27 -27.26 47.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 0.977 . . . . 0.0 113.136 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -77.77 -28.27 50.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.63 0.772 . . . . 0.0 111.726 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.06 -39.5 72.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.209 0.604 . . . . 0.0 111.464 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.59 -37.51 81.57 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.055 -1.028 . . . . 0.0 112.156 172.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.85 -62.51 1.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.895 0.878 . . . . 0.0 109.976 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.98 -38.59 70.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.7 -35.36 77.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.969 0.907 . . . . 0.0 112.487 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -86.29 -25.43 25.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.453 0.701 . . . . 0.0 112.299 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -76.35 -47.94 21.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.597 1.159 . . . . 0.0 112.972 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.63 -12.09 30.19 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -66.67 110.9 3.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.626 -1.296 . . . . 0.0 111.041 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.13 6.84 68.59 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.84 1.686 . . . . 0.0 114.61 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.3 ptm -74.52 168.22 20.17 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.793 1.796 . . . . 0.0 111.453 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -111.8 133.87 53.73 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.054 0.942 . . . . 0.0 111.15 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -141.72 116.58 9.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.001 1.72 . . . . 0.0 109.153 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.17 32.27 15.6 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.22 1.408 . . . . 0.0 112.569 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.68 -1.49 82.84 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.953 -1.092 . . . . 0.0 114.756 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -96.27 133.41 40.64 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.875 1.338 . . . . 0.0 110.114 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -73.35 127.29 32.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.181 0.9 . . . . 0.0 109.146 169.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -103.64 155.9 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.737 0.815 . . . . 0.0 110.586 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -122.64 155.16 36.94 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.939 1.295 . . . . 0.0 109.587 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.5 t -144.0 139.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.763 1.225 . . . . 0.0 110.585 -169.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -155.05 158.12 38.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.253 1.421 . . . . 0.0 111.94 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -72.68 138.32 46.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.0 m -74.45 131.23 40.87 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.311 -0.868 . . . . 0.0 113.192 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 21.2 pt -90.89 -15.1 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.643 1.177 . . . . 0.0 113.167 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.8 p -156.84 161.2 39.72 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 129.657 3.183 . . . . 0.0 108.366 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.65 155.14 31.27 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 52.5 tpt85 -69.4 -43.93 24.58 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.27 145.52 10.87 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.366 2.711 . . . . 0.0 110.711 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -161.09 151.54 17.9 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.53 1.132 . . . . 0.0 112.886 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--O 1.252 1.187 0 C-N-CA 126.488 1.915 . . . . 0.0 112.086 -176.264 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.467 1 O4'-C1'-N19 112.392 4.192 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.46 " H2'" " H2'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.427 -2.186 0 O4'-C1'-N19 111.495 3.295 . 0.089 5n . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.46 " H2'" " H2'" ' B' ' 2' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.54 2.292 0 O4'-C1'-N19 111.351 3.151 . 0.438 1z . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 O5'-C5'-C4' 114.918 3.37 . 0.01 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.64 0 C4'-C3'-C2' 99.921 -2.779 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.129 0 O4'-C1'-N19 111.576 3.376 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.6 p -162.36 164.22 27.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.154 1.382 . . . . 0.0 111.602 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 t -93.03 2.14 56.93 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.186 -0.946 . . . . 0.0 113.369 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -158.91 47.0 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.824 1.202 . . . . 0.0 113.074 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.1 m 71.24 -43.74 0.57 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 128.102 2.561 . . . . 0.0 114.999 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.1 m -85.89 -21.14 28.14 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.058 -1.026 . . . . 0.0 113.425 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.24 147.42 5.59 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.541 1.543 . . . . 0.0 113.842 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -165.18 148.01 8.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.446 1.898 . . . . 0.0 111.007 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.02 51.13 2.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.936 0.894 . . . . 0.0 113.07 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.27 26.25 2.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.934 1.694 . . . . 0.0 112.616 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -162.59 59.97 0.98 Allowed Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 128.452 2.701 . . . . 0.0 112.298 -170.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.46 168.82 19.44 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.64 2.893 . . . . 0.0 112.06 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -163.19 143.16 6.95 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.854 2.062 . . . . 0.0 109.277 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -44.56 131.03 9.62 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 124.521 3.481 . . . . 0.0 115.336 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -153.12 137.83 16.97 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.76 1.624 . . . . 0.0 109.712 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 59.6 m -55.9 -29.73 60.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.562 1.145 . . . . 0.0 112.513 171.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.1 t -88.86 129.13 35.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.523 1.129 . . . . 0.0 110.886 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -119.85 147.18 44.99 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.731 2.013 . . . . 0.0 110.482 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.4 150.84 17.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.993 1.758 . . . . 0.0 111.086 168.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.43 131.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.558 1.943 . . . . 0.0 108.105 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.46 151.8 47.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.404 1.082 . . . . 0.0 111.959 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.87 30.01 33.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.103 0.858 . . . . 0.0 113.422 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.29 159.23 25.91 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.408 1.483 . . . . 0.0 112.68 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 t -77.94 151.35 33.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.011 0.524 . . . . 0.0 111.737 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -16.05 63.68 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -96.98 0.84 49.5 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.974 1.709 . . . . 0.0 114.106 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.1 m -65.14 142.8 58.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.943 1.297 . . . . 0.0 109.829 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.3 p -119.87 161.11 21.39 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.901 0.88 . . . . 0.0 110.865 169.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -59.15 -24.96 63.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.828 0.851 . . . . 0.0 111.621 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -58.61 -44.44 89.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.113 1.765 . . . . 0.0 111.861 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -71.17 -45.96 62.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.021 0.928 . . . . 0.0 110.322 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.4 mt -59.42 -44.33 92.91 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.776 -0.578 . . . . 0.0 110.79 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -58.5 -47.59 83.61 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.864 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.68 -29.38 69.38 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.763 1.165 . . . . 0.0 113.163 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.6 t -79.22 -30.08 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.405 1.082 . . . . 0.0 112.371 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -100.57 -26.63 13.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.4 p -70.09 -20.07 63.22 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.357 1.435 . . . . 0.0 113.885 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.27 -11.97 58.91 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -104.11 -6.44 21.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.089 1.355 . . . . 0.0 114.329 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.13 -175.31 32.41 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.85 138.73 19.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.59 3.526 . . . . 0.0 111.986 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.14 133.33 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.85 1.66 . . . . 0.0 110.503 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.06 -22.69 14.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.254 1.421 . . . . 0.0 113.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -160.87 159.26 29.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.006 0.922 . . . . 0.0 112.696 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.1 t -152.86 132.7 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.621 2.368 . . . . 0.0 107.536 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -148.53 123.32 9.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.315 0.646 . . . . 0.0 112.234 -171.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.27 144.0 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.963 0.905 . . . . 0.0 108.681 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 t -92.01 128.4 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -115.61 140.58 49.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.105 1.362 . . . . 0.0 112.047 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.17 140.14 58.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.855 1.262 . . . . 0.0 111.683 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -72.1 -21.01 61.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -118.26 -38.15 3.23 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.407 1.083 . . . . 0.0 112.353 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.2 m -88.97 -12.13 42.38 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.993 0.917 . . . . 0.0 113.377 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 55.65 33.18 20.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.264 1.826 . . . . 0.0 114.237 170.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -133.46 163.47 29.29 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.051 2.54 . . . . 0.0 110.584 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.5 t -54.09 135.3 43.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.198 0.599 . . . . 0.0 112.014 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -77.99 -0.79 29.14 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.927 0.891 . . . . 0.0 112.708 174.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.92 10.86 64.2 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.291 1.424 . . . . 0.0 113.859 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -149.53 161.18 42.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.65 1.214 . . . . 0.0 113.786 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.68 173.79 15.54 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 111.963 -168.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.39 155.21 44.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.686 1.594 . . . . 0.0 111.47 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 88.6 t -140.93 134.15 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.659 1.984 . . . . 0.0 108.838 -169.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.29 101.88 8.3 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.087 1.355 . . . . 0.0 111.39 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.65 162.5 27.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.907 172.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -91.75 6.74 44.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.257 1.023 . . . . 0.0 112.981 171.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -159.24 137.77 10.76 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.638 1.575 . . . . 0.0 111.596 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.07 -35.88 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.637 . . . . 0.0 112.645 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.71 -27.49 62.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.215 0.916 . . . . 0.0 112.596 -174.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -77.4 -36.07 53.71 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.976 0.91 . . . . 0.0 111.885 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.87 90.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.258 0.623 . . . . 0.0 111.298 169.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -65.37 -27.15 68.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.956 1.702 . . . . 0.0 112.793 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.99 -61.48 1.83 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.276 1.031 . . . . 0.0 109.431 168.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.15 67.79 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.45 -33.54 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.671 1.188 . . . . 0.0 112.842 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -88.92 -18.74 26.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.927 0.891 . . . . 0.0 112.461 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -84.64 -43.93 13.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.713 1.205 . . . . 0.0 112.948 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.87 -12.4 29.01 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -64.39 116.58 6.22 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.602 -1.311 . . . . 0.0 111.061 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.18 5.52 76.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.599 1.571 . . . . 0.0 114.872 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.2 ptm -76.24 163.1 27.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.656 1.728 . . . . 0.0 112.595 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -83.9 128.52 34.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.57 1.148 . . . . 0.0 110.189 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.9 tp -150.45 123.13 8.59 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.927 1.291 . . . . 0.0 110.175 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 55.02 31.51 16.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.541 1.536 . . . . 0.0 113.04 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.88 4.0 85.16 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.389 1.471 . . . . 0.0 114.69 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -116.96 153.36 32.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.619 1.568 . . . . 0.0 111.271 -175.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -87.9 121.62 30.54 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.6 pt -99.58 155.14 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.014 0.526 . . . . 0.0 112.044 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -112.75 144.7 41.82 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.943 1.697 . . . . 0.0 108.662 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.4 t -141.61 134.67 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.552 1.141 . . . . 0.0 109.796 -172.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -156.69 159.75 38.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.661 1.184 . . . . 0.0 112.225 -169.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.05 138.84 50.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.521 0.728 . . . . 0.0 111.281 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 67.2 m -70.62 125.79 27.8 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.494 -0.754 . . . . 0.0 112.105 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.2 pt -84.81 -16.15 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.063 0.945 . . . . 0.0 112.874 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.8 p -157.77 166.17 33.45 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 129.797 3.239 . . . . 0.0 108.397 -171.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -152.18 159.91 43.49 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -68.13 -44.38 38.07 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.78 164.81 29.6 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.205 2.603 . . . . 0.0 111.307 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -78.42 -3.61 44.17 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 128.666 2.786 . . . . 0.0 112.066 -177.43 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.4 0 O4'-C1'-N19 112.037 3.837 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.159 1 O4'-C1'-N19 113.198 4.998 . 0.147 1c . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.497 0 O5'-C5'-C4' 114.383 2.988 . 0.264 1z . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C5'-C4'-C3' 111.562 -2.626 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.346 0 O4'-C1'-N19 111.489 3.289 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.129 0 O4'-C1'-N19 111.547 3.347 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 120.763 0.316 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.28 144.31 45.91 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.239 1.816 . . . . 0.0 110.526 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.38 145.82 17.73 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.804 1.669 . . . . 0.0 110.603 167.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.45 128.75 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.81 2.044 . . . . 0.0 107.71 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -133.84 145.14 49.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.546 1.138 . . . . 0.0 111.329 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.72 9.13 44.16 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.532 1.063 . . . . 0.0 115.706 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.03 150.36 48.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.445 1.498 . . . . 0.0 114.273 -169.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.4 t -75.48 146.1 40.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.061 0.944 . . . . 0.0 110.935 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.5 -15.0 60.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.403 1.081 . . . . 0.0 113.836 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.77 -0.15 51.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.353 1.461 . . . . 0.0 113.749 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.0 m -71.65 139.41 49.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.914 1.286 . . . . 0.0 109.77 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.8 p -110.89 163.42 13.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.314 1.046 . . . . 0.0 111.451 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -59.77 -28.21 67.21 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.96 0.904 . . . . 0.0 111.137 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.13 -39.0 75.68 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.844 1.258 . . . . 0.0 112.041 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.12 -47.38 74.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.148 0.431 . . . . 0.0 110.285 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.5 mt -57.34 -46.54 83.18 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.846 -0.534 . . . . 0.0 110.882 173.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -63.44 -39.02 93.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.376 0.989 . . . . 0.0 112.707 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.4 -29.89 68.68 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.739 1.609 . . . . 0.0 112.572 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.34 -30.24 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.404 1.082 . . . . 0.0 112.253 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -100.37 -26.25 13.95 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -71.06 -14.01 62.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.344 1.429 . . . . 0.0 113.996 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -67.32 -13.49 62.04 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.016 -1.052 . . . . 0.0 113.547 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -96.98 -9.12 28.89 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.268 1.427 . . . . 0.0 113.686 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.26 -175.78 27.39 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.968 1.271 . . . . 0.0 114.882 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.41 136.01 19.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.504 3.47 . . . . 0.0 112.228 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.6 mt -128.79 122.73 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.658 1.583 . . . . 0.0 109.845 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.61 -31.32 28.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.121 0.969 . . . . 0.0 112.873 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -164.26 162.23 22.39 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.594 1.158 . . . . 0.0 112.276 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -148.0 137.06 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.112 2.165 . . . . 0.0 108.012 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.8 t -144.09 120.03 10.65 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 111.407 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -85.87 146.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.184 0.994 . . . . 0.0 108.648 172.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.6 t . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 108.778 -177.534 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.223 0 CA-C-O 119.073 -0.848 . . . . 0.0 114.181 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -144.59 160.94 40.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.628 1.214 . . . . 0.0 113.586 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.86 172.27 17.94 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.535 1.934 . . . . 0.0 111.053 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.28 149.02 40.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.768 1.227 . . . . 0.0 111.04 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.63 120.8 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.608 1.963 . . . . 0.0 108.182 -170.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -106.68 98.34 8.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.328 1.051 . . . . 0.0 111.003 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -74.66 160.97 30.13 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.479 -0.763 . . . . 0.0 111.742 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.26 6.68 41.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.171 0.988 . . . . 0.0 113.006 171.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -158.56 135.22 9.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.341 1.456 . . . . 0.0 111.748 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -68.38 -29.63 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.072 0.949 . . . . 0.0 112.746 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.63 -26.05 45.16 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.36 0.982 . . . . 0.0 113.178 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -78.71 -29.36 45.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.774 0.83 . . . . 0.0 111.677 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.65 77.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.275 0.63 . . . . 0.0 111.343 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.06 -34.02 74.23 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.99 -1.069 . . . . 0.0 112.55 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.03 -63.12 1.15 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.758 0.823 . . . . 0.0 109.758 172.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.21 70.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -61.11 -34.37 74.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.081 0.952 . . . . 0.0 112.593 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -87.81 -24.25 23.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.533 0.733 . . . . 0.0 112.31 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.43 -46.48 22.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.509 1.124 . . . . 0.0 113.074 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.91 -11.12 27.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -170.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -66.68 111.06 3.48 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 120.658 -1.276 . . . . 0.0 111.248 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.04 7.06 68.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.078 1.799 . . . . 0.0 114.627 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -74.72 168.96 18.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.713 1.757 . . . . 0.0 111.326 170.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -111.12 137.09 49.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.237 1.015 . . . . 0.0 110.974 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.06 116.8 9.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.776 1.63 . . . . 0.0 109.377 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 58.14 25.11 12.07 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.011 1.725 . . . . 0.0 113.901 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.99 2.76 68.67 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.93 1.252 . . . . 0.0 114.965 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -110.19 139.27 45.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.702 1.601 . . . . 0.0 110.516 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 138.76 47.4 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 167.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.1 pt -111.82 149.3 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.721 0.808 . . . . 0.0 110.285 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 34.5 mtm-85 -117.61 153.07 33.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 109.007 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.0 t -143.67 136.05 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.45 1.1 . . . . 0.0 110.879 -168.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -150.38 162.04 41.31 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.288 1.835 . . . . 0.0 111.484 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -69.77 142.5 53.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.849 0.86 . . . . 0.0 112.081 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 CA--C 1.544 0.728 0 O-C-N 121.33 -0.856 . . . . 0.0 112.602 177.867 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 14.8 p . . . . . 0 CA--C 1.537 0.476 0 CA-C-O 121.557 0.694 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.19 146.83 50.6 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.964 1.706 . . . . 0.0 110.889 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.47 147.48 18.55 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.838 1.685 . . . . 0.0 109.731 166.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.054 1.742 . . . . 0.0 107.832 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.69 154.23 51.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.845 0.858 . . . . 0.0 111.773 -168.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.81 34.55 30.66 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.685 0.659 . . . . 0.0 113.285 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.57 164.93 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.357 1.463 . . . . 0.0 113.203 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.6 t -83.09 153.05 25.06 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.239 0.615 . . . . 0.0 111.13 168.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.56 -15.91 62.82 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.495 -0.753 . . . . 0.0 112.386 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -95.45 -4.27 45.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.617 1.567 . . . . 0.0 114.031 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 85.2 m -67.8 133.54 49.4 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.503 1.121 . . . . 0.0 109.263 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 p -106.79 163.65 12.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -61.14 -27.58 68.49 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.093 0.557 . . . . 0.0 111.181 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.56 1.144 . . . . 0.0 112.301 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.81 -47.45 75.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.682 0.674 . . . . 0.0 110.399 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.48 -44.59 85.03 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.673 -0.642 . . . . 0.0 110.679 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -63.63 -39.71 95.05 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.013 0.824 . . . . 0.0 112.772 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.86 -28.33 65.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.36 1.436 . . . . 0.0 112.852 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.66 -33.92 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.929 0.891 . . . . 0.0 111.831 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -99.96 -24.67 14.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.2 p -71.38 -18.39 62.36 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.518 1.508 . . . . 0.0 114.112 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -69.38 -7.12 34.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.017 -1.052 . . . . 0.0 113.83 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.5 -5.1 27.48 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.107 1.363 . . . . 0.0 113.642 171.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.23 -174.92 23.06 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.602 1.573 . . . . 0.0 115.087 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.87 128.69 14.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.231 3.288 . . . . 0.0 112.642 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.0 mt -116.91 126.11 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.909 1.684 . . . . 0.0 109.281 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.54 -40.45 42.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.684 1.194 . . . . 0.0 111.859 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.51 174.41 6.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.777 1.231 . . . . 0.0 113.094 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.84 142.63 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.115 2.166 . . . . 0.0 108.524 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.6 t -137.52 118.48 14.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.467 0.707 . . . . 0.0 111.673 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 94.2 mt -82.69 142.7 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.1 t . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 123.829 0.852 . . . . 0.0 109.76 -174.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.24 0 CA-C-O 118.964 -0.909 . . . . 0.0 114.839 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.05 164.64 31.47 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.585 1.183 . . . . 0.0 113.824 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.83 171.44 20.05 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.785 2.034 . . . . 0.0 110.994 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -142.59 151.25 41.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.814 1.246 . . . . 0.0 110.906 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.3 t -131.47 126.86 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.298 1.839 . . . . 0.0 108.513 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -105.61 112.3 25.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.149 0.98 . . . . 0.0 110.441 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.65 157.96 16.67 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.322 -0.862 . . . . 0.0 111.245 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.34 -9.05 59.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -151.64 146.58 25.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.774 1.63 . . . . 0.0 111.573 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.6 -33.21 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.11 -24.57 58.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -81.42 -29.31 33.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.901 1.281 . . . . 0.0 111.801 174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.47 70.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 110.628 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -58.99 -40.03 83.6 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.16 -0.962 . . . . 0.0 112.23 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.49 -62.34 1.95 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.929 0.892 . . . . 0.0 110.242 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.83 71.68 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -63.06 -33.25 75.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.004 0.922 . . . . 0.0 112.641 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -84.49 -24.07 29.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.638 0.654 . . . . 0.0 112.703 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -82.84 -45.97 13.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.398 1.079 . . . . 0.0 113.318 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -100.25 -11.49 20.32 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.4 112.97 4.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.684 -1.26 . . . . 0.0 110.933 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.25 9.12 70.55 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.242 1.401 . . . . 0.0 114.633 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ptm -75.65 172.93 11.75 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.703 1.751 . . . . 0.0 111.502 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.24 134.66 54.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.075 0.95 . . . . 0.0 111.136 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -141.68 116.87 10.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.587 1.555 . . . . 0.0 109.239 -174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.84 25.23 10.12 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.571 1.548 . . . . 0.0 113.199 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.85 -3.55 83.01 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.395 1.474 . . . . 0.0 114.613 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.48 130.52 44.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.122 1.369 . . . . 0.0 110.15 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.4 122.25 22.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.033 0.833 . . . . 0.0 110.011 170.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -101.65 151.63 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.677 0.791 . . . . 0.0 111.631 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -106.82 149.87 26.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.317 1.847 . . . . 0.0 109.37 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.0 t -144.37 132.48 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.766 1.226 . . . . 0.0 110.224 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -156.47 154.72 30.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 112.651 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -70.01 136.18 50.13 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.362 -0.836 . . . . 0.0 112.328 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 CA--C 1.545 0.757 0 O-C-N 121.417 -0.802 . . . . 0.0 112.975 -178.071 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 C--O 1.239 0.502 0 CA-C-O 121.686 0.755 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.8 mt -127.98 148.98 50.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.346 1.858 . . . . 0.0 111.389 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.67 146.28 17.49 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 126.297 1.903 . . . . 0.0 109.57 166.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.68 123.91 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.502 1.921 . . . . 0.0 107.372 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -130.64 153.33 49.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.883 1.273 . . . . 0.0 112.735 -167.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.9 12.26 60.68 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.265 1.412 . . . . 0.0 114.502 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.33 160.77 26.54 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.31 1.844 . . . . 0.0 114.275 -169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.4 t -75.06 151.45 38.69 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.478 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -68.68 -16.11 63.73 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.549 -0.72 . . . . 0.0 112.629 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -100.58 -2.52 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.622 1.569 . . . . 0.0 114.313 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.7 m -64.9 139.77 58.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.693 1.197 . . . . 0.0 109.495 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 p -108.76 161.65 14.91 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.177 0.991 . . . . 0.0 111.471 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -59.04 -30.94 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.681 0.792 . . . . 0.0 111.136 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -67.31 -40.0 85.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.817 1.247 . . . . 0.0 112.015 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.48 -49.78 67.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.795 0.438 . . . . 0.0 110.273 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.4 -43.56 79.41 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 110.997 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -62.48 -44.74 95.65 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.352 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.31 -29.29 67.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.645 1.111 . . . . 0.0 112.872 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.88 -28.69 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.363 1.065 . . . . 0.0 112.057 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -100.16 -20.52 15.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.0 p -68.73 -16.16 63.73 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.289 1.404 . . . . 0.0 113.979 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.72 -15.34 63.46 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 171.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.54 -12.36 27.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.977 1.311 . . . . 0.0 113.586 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.28 177.84 25.48 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.008 1.289 . . . . 0.0 114.323 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.4 134.18 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 124.569 3.512 . . . . 0.0 112.332 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.7 127.45 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.93 1.692 . . . . 0.0 109.889 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.08 -25.43 17.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.228 1.411 . . . . 0.0 113.574 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -159.91 156.86 27.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.938 0.895 . . . . 0.0 112.548 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.2 t -153.05 135.85 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.131 2.173 . . . . 0.0 108.282 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -149.07 125.01 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.567 0.747 . . . . 0.0 111.79 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.3 mt -86.16 146.75 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.182 0.993 . . . . 0.0 108.846 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.469 0.478 0 C-N-CA 124.301 1.041 . . . . 0.0 109.38 -175.652 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 CA-C-O 119.145 -0.808 . . . . 0.0 113.287 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -154.54 164.57 38.5 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.841 1.305 . . . . 0.0 114.246 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.09 170.43 22.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.622 1.969 . . . . 0.0 111.449 -168.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -135.56 151.76 50.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.388 1.475 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.48 130.42 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.833 2.053 . . . . 0.0 109.046 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -119.52 113.85 21.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.031 1.333 . . . . 0.0 112.254 -170.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.23 154.79 17.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.985 0.914 . . . . 0.0 111.929 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -81.73 4.64 21.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.215 1.006 . . . . 0.0 112.841 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -155.98 129.22 8.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.081 1.752 . . . . 0.0 110.777 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.87 -27.14 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.83 -24.33 48.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.101 0.864 . . . . 0.0 113.08 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -78.85 -27.41 44.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.611 0.764 . . . . 0.0 111.734 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.24 73.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.976 0.51 . . . . 0.0 110.507 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.74 -34.66 76.22 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.013 -1.054 . . . . 0.0 112.688 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.18 -63.56 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.022 0.929 . . . . 0.0 110.045 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.83 -36.52 67.59 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.83 -38.12 77.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.059 0.943 . . . . 0.0 112.673 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.06 -21.12 27.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.547 0.739 . . . . 0.0 112.444 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -81.44 -46.51 14.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.602 1.161 . . . . 0.0 112.849 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.93 -14.59 25.82 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -64.69 111.03 2.57 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.658 -1.276 . . . . 0.0 110.76 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.82 5.82 64.16 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.47 1.509 . . . . 0.0 114.774 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.9 ptm -76.97 173.31 11.92 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.931 1.866 . . . . 0.0 111.36 169.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -118.45 137.91 52.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.28 1.032 . . . . 0.0 111.361 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.9 tp -145.8 120.46 9.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.454 1.502 . . . . 0.0 109.976 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.3 t70 57.63 23.36 9.27 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.678 1.591 . . . . 0.0 113.466 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.28 83.09 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.499 1.523 . . . . 0.0 114.625 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.72 130.24 45.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.276 1.43 . . . . 0.0 110.668 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.29 138.91 54.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 168.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 pt -115.92 143.95 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.351 0.661 . . . . 0.0 111.266 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -106.95 144.43 33.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.799 1.639 . . . . 0.0 108.297 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 t -140.3 135.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.98 0.912 . . . . 0.0 110.628 -170.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.32 162.59 39.13 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.543 1.537 . . . . 0.0 111.654 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.47 139.23 40.75 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 112.111 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.8 m . . . . . 0 CA--C 1.542 0.647 0 O-C-N 121.206 -0.934 . . . . 0.0 112.911 -177.566 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.7 mt -102.73 145.65 29.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.12 1.368 . . . . 0.0 110.452 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.02 144.95 16.13 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.879 1.704 . . . . 0.0 110.651 168.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.06 124.83 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.864 2.066 . . . . 0.0 107.634 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.03 154.71 47.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.832 1.253 . . . . 0.0 113.141 -166.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.39 18.01 61.3 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.798 1.189 . . . . 0.0 114.263 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.93 163.13 22.75 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.539 1.936 . . . . 0.0 114.237 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -80.28 149.05 30.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.828 168.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.55 -16.36 64.15 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.435 -0.791 . . . . 0.0 112.675 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -96.22 -4.39 42.54 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.449 1.5 . . . . 0.0 114.302 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -68.52 133.43 48.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.529 1.132 . . . . 0.0 109.377 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.8 p -106.3 164.16 12.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.182 0.993 . . . . 0.0 111.598 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -60.51 -29.47 69.12 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.176 0.59 . . . . 0.0 111.123 172.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -69.1 -40.16 78.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.711 1.205 . . . . 0.0 112.232 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.05 -49.47 67.53 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.187 0.449 . . . . 0.0 110.266 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.52 -42.47 78.5 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.907 -0.496 . . . . 0.0 110.978 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.61 -44.82 95.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.26 175.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.26 -32.38 72.52 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.929 1.241 . . . . 0.0 112.4 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.26 -29.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 112.273 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.16 -21.02 15.69 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 74.2 m -66.74 -17.24 64.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 120.105 1.321 . . . . 0.0 113.644 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -67.76 -14.52 63.02 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.999 -1.063 . . . . 0.0 113.829 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -97.5 -13.62 21.59 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.91 1.284 . . . . 0.0 113.857 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.81 -174.12 31.66 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.55 1.071 . . . . 0.0 114.761 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.04 136.27 16.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.437 3.425 . . . . 0.0 111.988 -171.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.5 mt -129.35 125.43 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.683 1.593 . . . . 0.0 109.742 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.16 -33.62 26.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.758 1.223 . . . . 0.0 112.669 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -166.39 170.2 13.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.254 1.021 . . . . 0.0 112.805 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.8 138.18 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.939 2.095 . . . . 0.0 108.5 175.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.0 m -138.33 109.06 6.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.256 1.022 . . . . 0.0 111.306 -171.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.89 149.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 171.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.469 0.519 0 C-N-CA 124.433 1.093 . . . . 0.0 109.61 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 CA-C-O 119.5 -0.611 . . . . 0.0 113.975 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.51 164.49 38.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.822 1.296 . . . . 0.0 113.98 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.57 172.67 17.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.21 1.804 . . . . 0.0 111.273 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.63 154.87 48.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.0 1.32 . . . . 0.0 111.233 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.8 t -134.34 121.13 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.521 1.928 . . . . 0.0 108.116 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -102.51 98.81 8.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.252 1.021 . . . . 0.0 110.552 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -76.57 161.68 28.39 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.189 -0.945 . . . . 0.0 112.174 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.18 7.94 45.12 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.547 1.139 . . . . 0.0 113.026 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -155.42 132.84 11.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.57 1.548 . . . . 0.0 111.13 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.63 -27.07 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 112.783 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.458 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 9.6 t70 -80.16 -29.74 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.189 0.904 . . . . 0.0 113.049 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.28 -30.32 60.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.26 0.624 . . . . 0.0 111.495 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.5 -43.29 77.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.352 0.661 . . . . 0.0 111.679 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 21.1 mtmt -58.03 -36.93 73.42 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.082 -1.011 . . . . 0.0 112.674 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.71 -57.31 4.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.196 0.599 . . . . 0.0 110.878 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.65 67.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.977 -1.077 . . . . 0.0 112.93 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -55.9 -47.23 77.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.819 1.248 . . . . 0.0 112.293 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -27.96 37.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.359 0.663 . . . . 0.0 111.675 -174.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -71.36 -52.41 18.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.937 1.695 . . . . 0.0 113.374 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.74 -14.12 37.96 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -64.22 111.0 2.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.766 -1.209 . . . . 0.0 111.144 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.78 8.13 65.69 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.628 1.585 . . . . 0.0 114.646 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -75.76 173.11 11.54 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.793 1.796 . . . . 0.0 111.457 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.07 136.64 53.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.214 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.4 tp -145.47 118.99 9.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.5 1.52 . . . . 0.0 109.531 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 58.13 22.74 9.39 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.422 1.489 . . . . 0.0 113.428 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.81 -5.77 83.27 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.633 1.587 . . . . 0.0 114.605 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.56 130.36 41.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.336 1.454 . . . . 0.0 110.707 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.52 131.44 43.29 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.3 pt -110.94 152.64 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.946 0.898 . . . . 0.0 110.225 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -122.75 153.13 39.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.485 1.114 . . . . 0.0 109.489 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -142.79 137.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.575 -167.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -150.18 169.84 20.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.643 1.977 . . . . 0.0 111.54 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -78.31 142.29 37.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.347 1.059 . . . . 0.0 112.003 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 178.725 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 83.8 m . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.996 0.427 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.82 145.83 29.53 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.056 1.342 . . . . 0.0 111.225 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.68 144.91 17.57 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.864 1.697 . . . . 0.0 109.563 167.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 t -132.67 121.29 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.364 1.866 . . . . 0.0 107.469 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.54 153.36 46.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.091 1.356 . . . . 0.0 112.013 -167.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.62 28.51 26.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.041 0.829 . . . . 0.0 113.607 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.94 161.65 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.381 1.472 . . . . 0.0 113.595 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.1 t -77.01 153.1 34.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.268 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.55 -16.8 63.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.442 -0.786 . . . . 0.0 112.261 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -96.2 -4.16 43.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.626 1.57 . . . . 0.0 114.528 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.9 m -65.05 138.15 58.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.643 1.177 . . . . 0.0 109.57 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -110.72 162.98 14.22 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.168 0.987 . . . . 0.0 111.464 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -57.67 -31.71 66.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.097 0.959 . . . . 0.0 111.172 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -67.32 -40.35 85.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.91 1.284 . . . . 0.0 112.066 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.49 -48.87 68.46 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.877 0.471 . . . . 0.0 110.284 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.75 -44.75 82.05 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.837 -0.539 . . . . 0.0 110.812 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.67 -44.13 97.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.213 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.05 -29.94 68.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.757 1.162 . . . . 0.0 112.922 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.95 -28.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.366 1.066 . . . . 0.0 111.894 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -100.43 -21.53 15.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.3 p -68.48 -17.7 64.24 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.383 1.447 . . . . 0.0 114.004 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -66.72 -13.49 61.39 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -97.27 -9.1 28.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.122 1.369 . . . . 0.0 113.756 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.2 -175.99 25.37 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.936 1.255 . . . . 0.0 114.837 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.34 134.83 17.72 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.428 3.419 . . . . 0.0 112.241 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 93.8 mt -124.39 125.93 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.695 1.598 . . . . 0.0 109.76 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.68 -34.75 24.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.921 1.288 . . . . 0.0 112.828 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -164.49 166.47 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.302 1.041 . . . . 0.0 112.569 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.7 t -147.55 135.75 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.901 2.08 . . . . 0.0 108.936 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.6 m -138.44 110.26 7.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.648 1.179 . . . . 0.0 111.506 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.61 144.76 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 -174.01 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.872 0 CA-C-O 119.189 -0.784 . . . . 0.0 113.239 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -154.87 165.45 36.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.993 1.377 . . . . 0.0 113.971 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.33 173.03 17.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.786 2.034 . . . . 0.0 110.943 -169.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.64 151.83 49.74 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.245 1.418 . . . . 0.0 110.873 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.26 118.95 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.551 1.941 . . . . 0.0 108.177 -170.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -104.24 100.61 10.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.523 1.129 . . . . 0.0 110.906 -170.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -78.45 158.02 28.78 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.446 -0.783 . . . . 0.0 111.733 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -86.1 6.29 29.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.091 0.956 . . . . 0.0 113.136 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -159.16 139.69 12.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.516 1.527 . . . . 0.0 111.719 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.47 -31.59 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.984 0.914 . . . . 0.0 112.896 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.449 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 23.1 t70 -78.21 -28.82 48.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.321 0.964 . . . . 0.0 112.921 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -73.43 -28.2 61.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.515 0.726 . . . . 0.0 111.64 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.0 65.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.459 0.703 . . . . 0.0 111.371 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 55.7 mtmt -59.58 -36.29 75.95 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 120.797 -1.19 . . . . 0.0 112.492 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -62.87 -64.4 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.122 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.51 68.56 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -60.2 -32.79 71.43 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.292 1.037 . . . . 0.0 112.986 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -91.1 -22.06 20.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.539 0.736 . . . . 0.0 112.441 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -80.23 -47.32 14.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.557 1.143 . . . . 0.0 113.098 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.23 -11.43 30.29 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -171.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -66.03 112.83 4.05 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.704 -1.247 . . . . 0.0 110.925 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.22 3.42 63.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.592 1.568 . . . . 0.0 114.794 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -76.97 170.23 16.89 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.855 1.827 . . . . 0.0 112.439 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.6 137.05 44.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.719 1.208 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 24.6 tp -148.0 116.91 6.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.701 1.6 . . . . 0.0 109.602 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 54.85 33.91 20.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.339 1.456 . . . . 0.0 112.45 -170.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.88 -17.95 8.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.157 1.361 . . . . 0.0 114.313 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.0 mmt-85 -76.66 135.99 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.445 1.123 . . . . 0.0 109.748 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.38 129.48 34.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -111.12 157.78 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 111.302 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.8 152.6 45.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.883 1.673 . . . . 0.0 109.327 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -142.53 137.96 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.148 0.979 . . . . 0.0 110.838 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -156.2 162.2 40.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.413 1.485 . . . . 0.0 111.882 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.17 143.99 36.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.996 0.918 . . . . 0.0 111.685 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.477 0.882 0 O-C-N 120.894 -1.129 . . . . 0.0 112.703 179.281 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.542 0.652 0 CA-C-O 120.947 0.403 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.6 mt -118.3 145.77 44.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.327 1.851 . . . . 0.0 110.412 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.98 148.65 18.88 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.775 1.655 . . . . 0.0 110.542 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.64 130.86 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.342 1.857 . . . . 0.0 108.221 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.74 152.12 48.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.031 0.932 . . . . 0.0 111.41 -168.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.69 32.63 18.13 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 123.765 0.697 . . . . 0.0 113.668 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.5 159.52 21.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.994 1.318 . . . . 0.0 113.252 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.3 t -76.02 156.37 34.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.681 169.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.52 -19.26 63.72 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.505 -0.747 . . . . 0.0 112.127 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -94.05 -4.6 49.17 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.573 1.549 . . . . 0.0 114.282 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -66.97 132.93 48.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.465 1.106 . . . . 0.0 109.256 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.9 p -106.54 162.79 13.42 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.279 1.032 . . . . 0.0 111.153 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -60.7 -27.97 68.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.958 0.503 . . . . 0.0 111.22 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -70.94 -37.67 72.86 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.583 1.153 . . . . 0.0 112.514 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.83 -47.63 71.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.662 0.665 . . . . 0.0 110.438 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.1 -44.38 83.17 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.819 -0.55 . . . . 0.0 110.647 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -61.89 -41.68 98.18 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.419 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.17 -32.84 72.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.313 1.415 . . . . 0.0 112.689 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -77.42 -29.2 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.556 1.143 . . . . 0.0 111.933 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -99.99 -24.58 14.58 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.141 0.882 . . . . 0.0 113.364 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.9 m -69.33 -19.79 63.87 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.235 1.379 . . . . 0.0 113.693 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -70.19 -7.23 40.18 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.964 -1.085 . . . . 0.0 113.909 173.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -102.32 -5.57 24.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.456 1.502 . . . . 0.0 113.753 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.41 -175.65 24.86 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.385 1.469 . . . . 0.0 114.969 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.57 135.75 20.39 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.324 3.349 . . . . 0.0 112.476 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.51 127.71 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.767 1.627 . . . . 0.0 110.121 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.29 -32.03 19.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.933 1.293 . . . . 0.0 112.837 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -163.59 166.16 22.72 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.9 t -146.55 136.14 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 127.062 2.145 . . . . 0.0 108.161 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.8 m -133.0 110.24 10.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.037 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.0 mt -80.03 143.29 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 CA-C-O 119.293 -0.726 . . . . 0.0 113.766 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.05 160.92 41.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.554 1.169 . . . . 0.0 113.148 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.93 15.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.381 1.873 . . . . 0.0 111.517 -168.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.44 152.1 42.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.404 1.482 . . . . 0.0 110.627 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.42 128.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.125 1.77 . . . . 0.0 109.071 -169.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.65 100.41 9.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.865 1.266 . . . . 0.0 111.826 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -76.78 159.06 30.43 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.576 -0.703 . . . . 0.0 111.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.27 3.72 45.58 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.954 0.902 . . . . 0.0 113.134 172.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -160.83 139.97 10.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.555 1.542 . . . . 0.0 111.67 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.79 -31.6 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.52 0.728 . . . . 0.0 112.567 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.62 -23.22 56.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.279 0.945 . . . . 0.0 113.12 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -82.52 -30.32 29.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.858 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.71 76.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.336 0.654 . . . . 0.0 111.458 169.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -61.54 -32.66 72.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.641 1.176 . . . . 0.0 112.489 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.94 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.889 0.876 . . . . 0.0 109.663 171.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.04 69.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.24 -34.27 74.86 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.932 0.893 . . . . 0.0 112.651 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -87.95 -23.62 23.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.557 0.743 . . . . 0.0 112.272 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -77.81 -45.8 23.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.51 1.124 . . . . 0.0 113.037 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.1 -12.34 21.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -65.66 112.83 3.85 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.615 -1.303 . . . . 0.0 110.861 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.17 8.58 71.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.495 1.522 . . . . 0.0 114.595 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.9 ptm -76.35 173.85 10.93 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.811 1.805 . . . . 0.0 111.523 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.61 135.16 54.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.296 1.039 . . . . 0.0 111.27 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -143.12 117.36 9.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.769 1.628 . . . . 0.0 109.224 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 29.0 t70 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.168 1.387 . . . . 0.0 112.45 -169.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.64 -5.18 65.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.648 1.118 . . . . 0.0 114.66 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.6 mmt-85 -92.05 129.62 37.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.891 1.346 . . . . 0.0 109.931 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.91 128.33 35.24 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.135 170.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -107.35 155.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 111.671 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -115.21 148.52 39.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.395 1.878 . . . . 0.0 108.64 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.8 t -144.73 136.44 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.46 1.104 . . . . 0.0 110.499 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.17 158.47 36.33 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.954 1.302 . . . . 0.0 112.438 -170.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -72.8 138.08 46.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.661 0.784 . . . . 0.0 111.822 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 CA--C 1.544 0.731 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.217 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 CA--C 1.541 0.629 0 CA-C-O 120.922 0.391 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -112.06 142.47 44.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.89 1.676 . . . . 0.0 110.151 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.61 145.05 17.57 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.497 1.522 . . . . 0.0 110.255 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.93 119.61 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.049 1.74 . . . . 0.0 107.814 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -126.47 158.85 35.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.406 1.482 . . . . 0.0 111.998 -167.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.56 25.03 55.11 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.127 0.87 . . . . 0.0 113.6 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.24 154.41 37.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.884 1.273 . . . . 0.0 113.342 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.8 t -72.67 143.24 48.18 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.778 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.02 -12.5 51.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -100.92 3.93 42.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.998 1.719 . . . . 0.0 114.032 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -63.46 143.04 58.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 109.806 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.5 p -110.96 159.71 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.681 0.792 . . . . 0.0 111.618 170.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.52 -30.79 67.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.889 0.876 . . . . 0.0 111.041 172.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -69.08 -38.33 78.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.748 1.219 . . . . 0.0 112.359 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -65.11 -48.05 75.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.486 0.585 . . . . 0.0 110.169 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.3 mt -59.01 -42.23 89.61 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.77 -0.581 . . . . 0.0 111.193 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.25 -45.91 92.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.107 0.867 . . . . 0.0 111.382 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -67.68 -31.32 71.21 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.406 1.457 . . . . 0.0 112.744 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.7 -29.22 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.521 1.128 . . . . 0.0 112.547 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -100.57 -27.8 13.22 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.1 p -73.31 -12.58 60.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 120.456 1.48 . . . . 0.0 114.311 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -67.64 -10.32 51.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.952 -1.092 . . . . 0.0 113.434 168.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -102.79 -7.89 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.479 1.511 . . . . 0.0 114.084 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.05 -175.95 31.35 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.597 1.094 . . . . 0.0 115.377 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.31 137.66 19.12 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.313 3.342 . . . . 0.0 112.036 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 73.4 mt -134.24 124.58 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.679 1.592 . . . . 0.0 109.902 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.2 -24.77 18.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.304 1.042 . . . . 0.0 113.557 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.38 159.73 28.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.725 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.9 t -150.83 136.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.354 2.261 . . . . 0.0 108.273 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -146.25 122.76 11.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.528 0.731 . . . . 0.0 112.024 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.62 143.96 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.363 1.065 . . . . 0.0 108.596 172.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 124.26 1.024 . . . . 0.0 110.205 -170.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 CA-C-O 119.274 -0.737 . . . . 0.0 113.755 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -154.53 166.7 32.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.937 1.351 . . . . 0.0 114.204 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.41 171.51 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 111.056 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.47 150.7 48.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.146 1.378 . . . . 0.0 111.065 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.0 t -135.63 120.25 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.482 1.913 . . . . 0.0 108.303 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -107.17 100.69 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.57 1.148 . . . . 0.0 111.053 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.69 161.94 29.18 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.787 0.835 . . . . 0.0 111.983 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -94.13 7.61 44.6 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.289 1.036 . . . . 0.0 112.851 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.13 130.49 7.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.515 1.526 . . . . 0.0 111.571 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.26 -28.96 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.897 0.879 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.87 -24.5 48.51 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.407 1.003 . . . . 0.0 113.27 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -81.61 -29.46 33.28 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.802 0.841 . . . . 0.0 111.76 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.92 83.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.191 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -59.85 -34.38 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.283 1.033 . . . . 0.0 112.631 172.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.53 -62.85 1.22 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.773 0.829 . . . . 0.0 109.845 173.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.87 -35.2 70.64 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.27 -33.66 71.31 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.306 1.042 . . . . 0.0 112.852 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -89.05 -24.11 22.4 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.682 0.793 . . . . 0.0 112.307 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -78.79 -45.06 21.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.425 1.09 . . . . 0.0 113.152 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.1 -11.82 27.57 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.56 113.07 3.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.594 -1.316 . . . . 0.0 110.904 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.54 7.29 72.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.26 1.409 . . . . 0.0 114.733 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptm -76.22 173.16 11.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.693 1.746 . . . . 0.0 111.278 170.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -115.55 135.47 54.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.162 0.985 . . . . 0.0 111.028 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.9 tp -141.46 121.25 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 109.797 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.65 25.87 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.761 1.625 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.86 19.41 57.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.562 1.077 . . . . 0.0 114.445 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -131.7 132.12 43.66 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.544 1.538 . . . . 0.0 110.19 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.91 133.02 46.09 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.724 -0.61 . . . . 0.0 110.518 174.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.9 pt -111.0 159.0 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.887 0.875 . . . . 0.0 111.797 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -126.31 145.28 50.49 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.855 2.062 . . . . 0.0 108.857 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.36 134.46 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 118.968 0.803 . . . . 0.0 111.396 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -152.76 162.97 40.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 111.236 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -70.22 142.76 52.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.696 0.799 . . . . 0.0 111.655 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 CA--C 1.545 0.777 0 O-C-N 121.276 -0.89 . . . . 0.0 112.634 177.6 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.7 m . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.867 0.365 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.3 mt -115.44 146.76 41.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.281 1.433 . . . . 0.0 110.702 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.79 149.45 17.26 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.147 1.832 . . . . 0.0 110.614 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.6 t -136.67 129.23 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.028 2.131 . . . . 0.0 107.853 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -133.83 154.72 50.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.38 1.072 . . . . 0.0 112.684 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.45 30.21 50.26 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.056 0.836 . . . . 0.0 114.074 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.46 160.93 23.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.48 1.512 . . . . 0.0 113.521 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.1 t -72.34 155.09 40.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.013 0.925 . . . . 0.0 111.861 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.59 -17.61 62.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.457 0.703 . . . . 0.0 112.628 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -96.17 -5.55 40.31 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.083 1.353 . . . . 0.0 114.402 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.7 m -69.29 136.29 51.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.6 p -106.88 164.83 11.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.639 1.175 . . . . 0.0 111.484 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -59.26 -30.22 68.13 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.629 0.772 . . . . 0.0 111.147 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -70.61 -38.64 73.99 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.597 1.159 . . . . 0.0 112.166 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -66.36 -48.41 70.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.267 0.485 . . . . 0.0 110.341 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.0 mt -56.69 -44.79 81.83 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.815 -0.553 . . . . 0.0 110.941 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -60.97 -45.67 93.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.131 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -67.14 -29.05 68.66 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.227 1.376 . . . . 0.0 112.878 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.33 -27.68 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.44 1.096 . . . . 0.0 112.046 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -100.48 -23.73 14.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.4 p -70.39 -17.73 63.03 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.242 1.383 . . . . 0.0 113.911 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.57 -11.24 52.22 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 170.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.72 -7.14 24.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.376 1.47 . . . . 0.0 113.717 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.21 -178.47 24.82 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.221 1.391 . . . . 0.0 115.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.99 135.6 21.38 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.561 3.507 . . . . 0.0 112.668 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.47 124.26 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.062 1.745 . . . . 0.0 109.654 -174.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.12 -23.26 20.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.349 1.06 . . . . 0.0 113.493 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -161.48 162.44 30.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.0 t -151.28 135.49 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.236 2.214 . . . . 0.0 107.956 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.4 m -137.97 116.73 12.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.752 1.221 . . . . 0.0 111.393 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.84 147.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 N--CA 1.466 0.367 0 C-N-CA 124.111 0.964 . . . . 0.0 108.827 179.135 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.09 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.241 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -144.96 161.35 39.57 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.747 1.273 . . . . 0.0 113.424 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.1 13.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.051 1.74 . . . . 0.0 111.815 -168.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -145.69 156.27 43.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.999 1.72 . . . . 0.0 110.853 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.95 134.33 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.369 1.867 . . . . 0.0 109.171 -169.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.16 99.18 6.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.238 1.415 . . . . 0.0 111.078 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -79.58 158.91 27.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.02 0.928 . . . . 0.0 112.202 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.81 3.52 50.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.741 1.217 . . . . 0.0 113.063 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -157.99 137.35 11.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.563 1.545 . . . . 0.0 111.246 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.22 -32.83 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.318 0.647 . . . . 0.0 112.673 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.4 -24.42 54.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.901 0.773 . . . . 0.0 113.014 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.97 -29.15 35.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.307 1.043 . . . . 0.0 111.914 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.6 73.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.211 0.604 . . . . 0.0 110.97 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -59.78 -35.24 74.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.409 1.084 . . . . 0.0 112.502 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.22 -64.39 0.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.032 0.933 . . . . 0.0 110.015 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.11 -35.56 69.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.61 -34.5 72.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.172 0.989 . . . . 0.0 112.83 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -88.48 -24.71 22.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.611 0.764 . . . . 0.0 112.197 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -78.22 -45.57 22.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.429 1.092 . . . . 0.0 113.164 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.67 -11.43 29.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -66.02 112.98 4.12 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.611 -1.305 . . . . 0.0 111.106 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.68 8.68 73.08 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.35 1.452 . . . . 0.0 114.609 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 ptm -75.91 173.65 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.739 1.77 . . . . 0.0 111.435 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.38 134.54 54.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.204 1.002 . . . . 0.0 111.057 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.6 tp -143.7 118.87 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.51 1.524 . . . . 0.0 109.389 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 54.77 31.78 16.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.404 1.481 . . . . 0.0 112.44 -169.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.42 -4.87 66.01 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.694 1.14 . . . . 0.0 114.504 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.7 mmt-85 -92.98 130.06 38.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.933 1.367 . . . . 0.0 109.897 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.48 130.17 40.03 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.094 0.861 . . . . 0.0 109.817 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -109.08 160.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.027 0.931 . . . . 0.0 111.08 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.6 mtm-85 -127.81 156.31 42.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.481 1.112 . . . . 0.0 109.775 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.9 t -143.96 140.26 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.781 1.232 . . . . 0.0 110.962 -168.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.8 161.46 40.64 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.374 1.47 . . . . 0.0 112.151 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -72.66 137.79 46.27 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.03 0.932 . . . . 0.0 111.561 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.544 0.72 0 O-C-N 121.25 -0.906 . . . . 0.0 112.56 -174.202 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.9 m . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.3 mt -102.17 146.94 27.25 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.627 1.171 . . . . 0.0 111.295 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.02 148.86 16.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.322 1.915 . . . . 0.0 110.47 168.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.54 124.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.192 1.797 . . . . 0.0 108.011 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -132.12 155.19 48.58 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.892 1.277 . . . . 0.0 111.91 -167.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.14 29.96 43.93 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.886 0.755 . . . . 0.0 113.398 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.79 163.84 25.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 113.168 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.8 t -76.06 154.51 35.59 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.005 168.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.0 -18.57 64.76 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.225 -0.922 . . . . 0.0 112.244 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -96.93 -1.43 45.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.846 1.658 . . . . 0.0 114.589 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 93.4 m -63.1 137.7 58.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.383 1.073 . . . . 0.0 109.611 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 p -110.34 161.64 15.43 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.861 0.864 . . . . 0.0 111.556 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.65 -27.22 68.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.336 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -69.61 -39.84 76.99 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.633 1.173 . . . . 0.0 112.251 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -65.88 -47.96 73.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.227 0.467 . . . . 0.0 110.315 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.0 mt -56.8 -44.36 81.87 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.764 -0.585 . . . . 0.0 110.921 174.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -63.17 -41.1 99.18 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.49 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.45 -31.12 69.24 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.174 1.352 . . . . 0.0 112.62 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.79 -28.91 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.374 1.07 . . . . 0.0 112.393 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -100.58 -27.47 13.39 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.1 p -71.83 -15.42 62.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.307 1.412 . . . . 0.0 114.109 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.9 -11.13 55.12 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.95 -1.094 . . . . 0.0 113.751 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -102.85 -5.18 23.86 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.302 1.441 . . . . 0.0 114.061 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.2 28.4 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.785 1.183 . . . . 0.0 115.307 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.5 135.42 18.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.313 3.342 . . . . 0.0 112.227 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.51 127.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.658 1.583 . . . . 0.0 110.187 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.91 -28.19 19.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.121 1.369 . . . . 0.0 113.325 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -162.61 167.08 23.8 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -149.38 137.16 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.448 2.299 . . . . 0.0 108.338 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.1 m -135.4 113.54 11.3 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.467 1.107 . . . . 0.0 111.635 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.34 144.97 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.294 -0.879 . . . . 0.0 108.835 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.338 1.055 . . . . 0.0 109.935 -173.922 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.006 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.53 165.15 36.02 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.948 1.356 . . . . 0.0 114.448 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.18 172.2 18.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.416 1.886 . . . . 0.0 111.509 -169.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.87 156.33 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.603 1.561 . . . . 0.0 110.908 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.84 131.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.801 2.04 . . . . 0.0 108.726 -168.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -114.79 97.5 6.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.688 1.195 . . . . 0.0 111.517 -170.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -76.57 156.89 32.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.105 0.562 . . . . 0.0 111.592 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -86.78 3.82 43.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.775 0.83 . . . . 0.0 113.189 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -160.64 143.38 13.02 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.537 1.535 . . . . 0.0 111.781 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.13 -31.72 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -74.48 -28.58 61.08 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.583 1.083 . . . . 0.0 112.859 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -75.42 -30.71 60.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.921 0.888 . . . . 0.0 111.673 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.97 -43.62 67.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.695 0.798 . . . . 0.0 111.444 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -59.33 -35.16 73.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.248 1.019 . . . . 0.0 112.419 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.17 -64.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.161 0.984 . . . . 0.0 110.163 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.3 69.54 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.41 -33.82 71.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.503 1.121 . . . . 0.0 112.845 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -89.34 -21.63 23.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.674 0.789 . . . . 0.0 112.391 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -81.17 -44.73 17.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.546 1.138 . . . . 0.0 113.071 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.7 -12.07 26.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -172.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -64.68 114.79 4.66 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.682 -1.261 . . . . 0.0 111.024 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.04 4.85 77.8 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.472 1.51 . . . . 0.0 114.695 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.4 ptm -73.25 169.18 17.63 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.839 1.82 . . . . 0.0 111.373 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -106.24 134.96 48.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.706 0.803 . . . . 0.0 110.975 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 46.7 tp -144.86 123.22 12.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.81 1.644 . . . . 0.0 109.327 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 55.25 33.57 20.93 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.099 1.36 . . . . 0.0 112.649 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.21 4.61 89.84 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.781 1.181 . . . . 0.0 114.601 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.8 mmt-85 -113.28 131.67 55.84 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.243 1.417 . . . . 0.0 110.431 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.43 131.08 44.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.91 0.777 . . . . 0.0 109.196 168.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.4 pt -110.68 160.19 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.733 0.813 . . . . 0.0 112.064 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -119.82 148.14 43.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.13 1.772 . . . . 0.0 108.919 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -141.95 135.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.316 1.047 . . . . 0.0 110.395 -172.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -156.57 165.52 36.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.222 1.409 . . . . 0.0 111.884 -170.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -80.87 141.95 34.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.371 1.068 . . . . 0.0 111.634 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.475 0.797 0 O-C-N 121.004 -1.06 . . . . 0.0 112.68 -177.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 121.912 0.863 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.0 mt -126.48 151.58 47.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.893 2.077 . . . . 0.0 110.539 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.84 149.71 18.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.131 1.824 . . . . 0.0 110.496 167.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.8 129.49 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.396 1.878 . . . . 0.0 107.889 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -136.73 150.6 48.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 111.641 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.19 32.6 19.84 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.923 0.773 . . . . 0.0 113.26 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.9 mt -77.34 162.83 26.98 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.36 1.464 . . . . 0.0 113.642 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -78.91 152.52 31.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.792 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -16.75 63.31 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.427 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.57 -5.06 52.44 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.465 1.506 . . . . 0.0 114.288 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -67.71 135.42 52.71 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.476 1.111 . . . . 0.0 109.615 172.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.5 p -118.02 163.85 15.98 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.747 1.219 . . . . 0.0 110.761 172.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.77 -24.54 65.85 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.444 0.697 . . . . 0.0 111.725 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -58.02 -45.78 86.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.965 1.706 . . . . 0.0 111.774 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.92 -48.32 46.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.914 0.885 . . . . 0.0 110.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.57 -38.62 81.63 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.323 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -62.05 -45.97 91.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.239 0.927 . . . . 0.0 112.054 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.92 -31.01 69.6 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.097 1.317 . . . . 0.0 112.771 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.4 t -80.12 -30.58 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.603 1.161 . . . . 0.0 112.484 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -100.6 -25.59 14.11 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.7 p -71.29 -14.21 62.14 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.388 1.449 . . . . 0.0 113.91 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -67.2 -14.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.948 -1.095 . . . . 0.0 113.586 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.71 -8.54 34.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.009 1.324 . . . . 0.0 113.718 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -177.82 25.93 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.102 1.334 . . . . 0.0 114.65 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.98 135.48 25.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.327 3.351 . . . . 0.0 112.272 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.54 132.76 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.891 1.676 . . . . 0.0 110.504 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.81 -28.8 15.07 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.105 1.362 . . . . 0.0 113.111 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -164.3 164.45 22.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.008 0.923 . . . . 0.0 113.007 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.9 t -147.9 132.01 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.074 2.15 . . . . 0.0 107.732 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 56.6 m -132.63 104.83 6.85 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.5 mt -81.21 138.82 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 168.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -175.743 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.047 0 CA-C-O 119.464 -0.631 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -150.99 162.86 40.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.793 1.282 . . . . 0.0 113.484 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.82 172.72 17.73 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.237 1.815 . . . . 0.0 111.686 -169.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.78 155.1 46.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.823 1.649 . . . . 0.0 110.396 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.9 132.61 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.758 1.623 . . . . 0.0 109.298 -168.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.92 107.62 14.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.779 1.232 . . . . 0.0 111.996 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -85.52 157.55 20.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.411 1.085 . . . . 0.0 111.39 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -83.84 7.73 17.07 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.955 0.902 . . . . 0.0 113.18 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -160.89 143.44 12.67 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.774 1.629 . . . . 0.0 111.281 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.88 -33.8 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.525 0.73 . . . . 0.0 112.492 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.44 -25.53 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -78.91 -28.29 43.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.115 0.966 . . . . 0.0 111.968 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.6 64.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.547 0.739 . . . . 0.0 111.017 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -59.31 -36.97 76.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 0.0 112.285 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.05 -65.19 0.73 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.524 0.729 . . . . 0.0 109.944 170.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.0 65.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -61.57 -25.04 67.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.624 1.17 . . . . 0.0 113.329 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.28 4.59 36.72 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.612 1.565 . . . . 0.0 113.007 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -107.91 -52.23 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.21 1.404 . . . . 0.0 113.02 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.01 46.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -65.83 112.4 3.73 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.851 -1.156 . . . . 0.0 111.171 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.27 7.73 69.44 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.087 1.803 . . . . 0.0 114.746 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.3 ptm -75.58 162.22 28.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.75 1.775 . . . . 0.0 112.816 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.36 133.02 34.15 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.215 . . . . 0.0 110.733 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.3 tp -145.53 111.4 5.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 109.085 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.4 t70 54.36 36.23 24.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.235 1.414 . . . . 0.0 112.064 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.83 -22.01 6.14 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.287 1.422 . . . . 0.0 114.224 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -73.18 141.34 47.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.29 1.045 . . . . 0.0 110.322 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -85.3 126.05 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.2 pt -106.07 139.32 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.238 0.615 . . . . 0.0 111.294 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.11 146.78 23.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.655 1.182 . . . . 0.0 109.006 170.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -141.67 134.71 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.77 1.228 . . . . 0.0 110.097 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -156.67 159.96 38.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.909 1.284 . . . . 0.0 112.224 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -69.04 142.27 54.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.772 0.829 . . . . 0.0 112.041 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 CA--C 1.545 0.77 0 O-C-N 121.441 -0.787 . . . . 0.0 112.291 175.706 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 121.639 0.733 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.49 144.22 44.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.741 1.616 . . . . 0.0 110.337 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.62 143.14 16.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.0 124.99 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.877 1.671 . . . . 0.0 107.697 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -129.01 163.99 24.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.249 1.42 . . . . 0.0 111.311 -168.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 29.93 59.56 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.471 -0.768 . . . . 0.0 113.574 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.3 mt -76.54 166.82 22.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.659 1.184 . . . . 0.0 112.924 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -85.71 151.92 23.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.039 0.936 . . . . 0.0 110.12 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.54 -18.69 65.5 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.065 -1.022 . . . . 0.0 112.327 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.39 -3.6 55.06 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.678 1.591 . . . . 0.0 114.559 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.0 m -66.8 135.27 53.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.195 0.998 . . . . 0.0 109.427 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 p -109.64 162.82 14.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.098 0.959 . . . . 0.0 111.64 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -61.08 -27.63 68.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.313 0.645 . . . . 0.0 111.297 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.01 -40.08 75.45 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.776 1.23 . . . . 0.0 112.085 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -65.97 -48.84 69.95 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.185 0.448 . . . . 0.0 110.219 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.26 -43.13 82.77 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.943 -0.473 . . . . 0.0 111.119 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.57 -49.1 79.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.733 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -66.9 -29.38 69.25 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.815 1.189 . . . . 0.0 112.944 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.53 -29.15 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.549 1.139 . . . . 0.0 112.122 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -100.64 -23.44 14.66 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.7 p -69.22 -15.84 63.47 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.287 1.403 . . . . 0.0 113.939 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.55 -15.33 63.6 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -95.07 -15.26 23.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 0.0 113.631 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.8 -175.6 32.82 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.823 1.202 . . . . 0.0 114.738 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.71 138.61 21.58 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.594 3.529 . . . . 0.0 111.955 -173.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.3 mt -130.0 123.33 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.162 1.385 . . . . 0.0 109.678 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.87 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.136 0.974 . . . . 0.0 111.771 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.86 175.07 5.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.417 1.087 . . . . 0.0 113.054 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.77 142.16 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.965 2.106 . . . . 0.0 108.785 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.5 t -139.98 118.87 12.52 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 111.67 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.72 147.4 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.731 0.812 . . . . 0.0 109.31 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.469 0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 109.472 -176.353 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 CA-C-O 118.979 -0.901 . . . . 0.0 113.833 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -148.11 165.93 29.36 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.753 1.263 . . . . 0.0 114.185 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.86 169.13 25.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.813 2.045 . . . . 0.0 111.169 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -133.32 147.05 51.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.013 1.325 . . . . 0.0 110.838 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.6 t -129.32 124.82 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.708 2.003 . . . . 0.0 107.856 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.1 100.38 9.72 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.576 0.75 . . . . 0.0 110.634 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.03 156.26 31.95 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.873 -1.142 . . . . 0.0 111.489 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.93 8.11 21.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.957 0.903 . . . . 0.0 112.769 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -157.07 135.82 11.6 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.107 1.763 . . . . 0.0 110.861 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.12 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.296 0.639 . . . . 0.0 112.441 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.53 -24.66 49.91 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -172.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.44 -26.94 34.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.05 0.94 . . . . 0.0 112.0 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.64 -41.16 65.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.579 0.752 . . . . 0.0 111.355 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -59.33 -31.91 69.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 0.0 112.584 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.64 -63.58 1.04 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.257 1.023 . . . . 0.0 110.039 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -36.43 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.47 -30.1 68.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.748 1.219 . . . . 0.0 113.313 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -93.48 -22.58 18.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.942 0.897 . . . . 0.0 112.42 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -79.77 -45.54 18.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.553 1.141 . . . . 0.0 113.145 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.43 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -66.83 113.49 4.94 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.649 -1.282 . . . . 0.0 111.197 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.18 75.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.537 1.541 . . . . 0.0 114.521 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -73.94 162.71 28.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.744 1.772 . . . . 0.0 111.467 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -104.28 134.31 47.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.429 1.091 . . . . 0.0 110.943 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.8 tp -144.46 114.96 7.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.06 1.744 . . . . 0.0 109.079 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 23.71 10.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.338 1.455 . . . . 0.0 113.272 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.39 -10.89 72.98 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.72 1.629 . . . . 0.0 114.536 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -90.05 134.41 34.26 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.415 1.486 . . . . 0.0 109.756 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.77 135.95 38.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.23 0.923 . . . . 0.0 108.888 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.3 pt -106.39 152.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.042 0.937 . . . . 0.0 110.652 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -110.86 155.92 21.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.075 0.95 . . . . 0.0 109.606 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -143.76 136.45 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.424 1.09 . . . . 0.0 110.416 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -155.64 161.06 40.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.171 1.389 . . . . 0.0 111.249 -175.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -69.98 137.15 51.19 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.47 -0.769 . . . . 0.0 110.392 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 CA--C 1.544 0.745 0 O-C-N 121.191 -0.943 . . . . 0.0 112.127 178.476 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.6 m . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.1 mt -117.6 144.13 45.45 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.838 1.655 . . . . 0.0 110.615 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.16 147.71 18.66 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.784 1.659 . . . . 0.0 110.06 167.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.13 131.34 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.509 1.924 . . . . 0.0 107.851 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -138.13 139.87 39.63 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.942 0.897 . . . . 0.0 111.342 -168.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.32 26.43 6.93 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.024 0.821 . . . . 0.0 114.18 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.9 mt -74.47 162.72 28.55 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.631 1.173 . . . . 0.0 113.388 -174.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -84.67 155.88 21.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.3 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.93 -17.65 63.34 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.308 -0.87 . . . . 0.0 112.416 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -92.8 -5.05 51.95 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.846 1.658 . . . . 0.0 114.271 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.7 m -68.87 136.02 51.99 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.562 1.145 . . . . 0.0 109.548 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.1 p -118.66 162.29 18.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.598 1.159 . . . . 0.0 111.004 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.32 -27.74 66.16 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.7 0.8 . . . . 0.0 111.654 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -56.0 -46.84 78.6 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.349 1.86 . . . . 0.0 111.905 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -69.89 -46.87 64.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.93 0.892 . . . . 0.0 110.046 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.4 -41.39 84.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.182 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.19 -47.77 84.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.317 0.962 . . . . 0.0 111.11 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.5 -30.85 69.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.245 1.384 . . . . 0.0 113.014 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.7 -30.93 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.629 1.171 . . . . 0.0 112.356 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -100.44 -26.45 13.86 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -73.16 -8.99 58.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.534 1.515 . . . . 0.0 114.234 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.07 -15.54 63.79 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.857 -1.152 . . . . 0.0 113.033 168.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -94.73 -11.67 28.65 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.437 . . . . 0.0 113.621 176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.26 -178.29 29.56 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.006 1.289 . . . . 0.0 114.52 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.58 138.1 28.88 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.223 3.282 . . . . 0.0 112.114 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 55.6 mt -130.94 126.66 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.819 1.648 . . . . 0.0 110.179 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.25 -19.26 17.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -158.46 162.07 37.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.074 0.852 . . . . 0.0 113.183 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.9 t -146.5 136.21 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.013 2.125 . . . . 0.0 107.472 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -133.48 109.16 9.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 110.936 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.22 134.99 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.499 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.175 0 CA-C-O 119.254 -0.748 . . . . 0.0 114.125 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -147.45 163.6 35.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.469 1.135 . . . . 0.0 113.186 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.07 174.23 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.159 1.784 . . . . 0.0 112.054 -168.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.41 150.04 43.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.292 1.837 . . . . 0.0 109.99 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.5 t -136.79 135.11 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.288 1.835 . . . . 0.0 108.716 -169.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -120.43 97.79 5.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.496 1.118 . . . . 0.0 112.245 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -77.73 161.9 27.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.346 0.659 . . . . 0.0 112.012 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.27 10.28 38.42 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.209 1.003 . . . . 0.0 112.799 171.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -156.72 131.35 8.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.59 1.556 . . . . 0.0 111.383 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.09 -29.17 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.939 0.896 . . . . 0.0 112.585 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.77 -28.18 44.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.239 0.927 . . . . 0.0 112.916 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.08 -30.02 55.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.514 0.726 . . . . 0.0 111.635 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.08 80.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.179 0.592 . . . . 0.0 111.419 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -60.07 -40.29 88.98 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.4 -58.08 8.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.707 0.803 . . . . 0.0 110.408 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.31 -38.63 77.48 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.13 -40.16 88.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.949 0.9 . . . . 0.0 112.222 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -81.65 -26.32 34.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.127 0.571 . . . . 0.0 112.506 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -74.83 -48.26 26.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.638 1.175 . . . . 0.0 113.286 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.31 -12.27 30.46 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -169.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -66.65 111.88 3.89 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.614 -1.304 . . . . 0.0 111.141 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.83 7.2 68.84 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.367 1.937 . . . . 0.0 114.572 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -73.76 168.65 18.96 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.68 1.74 . . . . 0.0 111.721 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.71 135.82 49.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.6 tp -145.07 117.97 8.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.145 1.778 . . . . 0.0 109.353 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 55.39 28.46 11.52 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.751 1.621 . . . . 0.0 113.42 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.38 6.96 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.721 1.153 . . . . 0.0 114.527 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -109.08 140.61 42.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.706 1.602 . . . . 0.0 110.503 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 136.63 39.09 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 168.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.9 pt -117.22 154.66 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -116.8 156.27 27.53 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.512 1.525 . . . . 0.0 109.498 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.82 137.43 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.853 1.261 . . . . 0.0 110.024 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -156.92 166.1 34.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.815 1.246 . . . . 0.0 111.853 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.79 140.29 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.234 -0.916 . . . . 0.0 112.211 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.304 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.0 t . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 121.005 0.431 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.04 149.48 24.52 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.836 1.654 . . . . 0.0 110.952 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.51 142.36 15.47 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.078 1.799 . . . . 0.0 110.227 167.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.98 127.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.623 1.969 . . . . 0.0 107.638 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -136.85 157.06 47.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.972 0.909 . . . . 0.0 111.386 -168.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.96 36.22 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.211 0.91 . . . . 0.0 113.675 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.24 160.29 31.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.426 1.491 . . . . 0.0 113.38 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -77.65 152.52 33.79 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 167.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.62 -18.2 65.24 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.307 -0.871 . . . . 0.0 112.726 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -100.74 -1.7 34.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.812 1.645 . . . . 0.0 114.243 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -65.85 136.41 56.13 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.615 1.166 . . . . 0.0 109.366 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.8 p -115.16 165.56 12.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.151 0.981 . . . . 0.0 111.644 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.94 -25.34 67.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.458 0.703 . . . . 0.0 111.748 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -68.61 -42.18 78.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.261 1.024 . . . . 0.0 111.461 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -66.87 -49.23 66.31 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.167 0.587 . . . . 0.0 110.386 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -58.93 -40.1 83.56 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.709 -0.619 . . . . 0.0 111.402 174.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.3 ttp-105 -59.53 -49.46 77.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.043 0.838 . . . . 0.0 111.625 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.01 -30.24 69.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.7 1.137 . . . . 0.0 113.057 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.56 -28.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.53 1.132 . . . . 0.0 112.042 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -100.67 -23.44 14.64 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.4 p -70.65 -18.3 62.85 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.363 1.438 . . . . 0.0 113.942 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -67.46 -10.51 52.18 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -101.79 -5.83 24.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.314 1.446 . . . . 0.0 113.912 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -178.16 25.7 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.951 1.262 . . . . 0.0 115.049 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.79 137.82 25.26 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.433 3.422 . . . . 0.0 112.28 -170.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.66 131.05 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.948 1.699 . . . . 0.0 110.032 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.46 -26.59 15.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.996 1.318 . . . . 0.0 113.222 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -163.41 165.23 24.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 113.077 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -146.89 133.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.837 2.055 . . . . 0.0 107.762 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.0 m -131.38 102.96 6.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.555 1.142 . . . . 0.0 110.749 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.6 mt -77.59 140.5 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.192 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.742 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -148.46 162.57 39.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.962 1.363 . . . . 0.0 114.256 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.31 172.25 17.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.761 2.024 . . . . 0.0 111.272 -169.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -138.94 155.6 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.363 1.465 . . . . 0.0 110.217 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -138.78 126.27 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.642 1.577 . . . . 0.0 109.151 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -108.51 101.19 10.37 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 111.737 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -76.75 159.76 29.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.294 1.038 . . . . 0.0 111.573 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.87 4.79 43.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.881 0.872 . . . . 0.0 113.005 171.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -159.82 136.14 8.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.368 1.467 . . . . 0.0 111.754 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.12 -30.71 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.001 0.921 . . . . 0.0 112.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.11 -23.57 51.81 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.479 1.036 . . . . 0.0 113.224 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -80.98 -29.6 35.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.788 170.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.57 81.97 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.236 0.614 . . . . 0.0 110.99 168.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.45 -31.94 71.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.31 1.044 . . . . 0.0 112.862 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.67 -64.25 0.9 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.76 0.824 . . . . 0.0 109.671 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.73 -34.96 70.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.27 -34.72 72.59 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.064 0.946 . . . . 0.0 112.883 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -88.78 -23.44 22.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.59 -45.38 19.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 113.114 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.82 31.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.33 111.32 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.698 -1.252 . . . . 0.0 111.057 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.56 8.64 70.26 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.278 1.418 . . . . 0.0 114.703 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.7 ptm -75.75 172.33 12.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.758 1.779 . . . . 0.0 111.471 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.28 135.41 54.18 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.974 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 40.0 tp -141.28 118.7 11.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.575 1.55 . . . . 0.0 109.534 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.5 t70 56.78 25.03 9.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.683 1.593 . . . . 0.0 113.417 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.08 8.6 71.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.01 1.291 . . . . 0.0 114.805 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -116.35 133.0 56.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.887 1.675 . . . . 0.0 110.614 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.43 129.69 38.94 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.819 -0.551 . . . . 0.0 110.267 173.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.9 pt -107.24 166.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.094 0.958 . . . . 0.0 111.008 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -142.54 151.15 41.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.096 1.759 . . . . 0.0 109.096 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.7 t -144.18 143.51 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.324 1.05 . . . . 0.0 112.569 -165.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -153.38 166.36 32.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.025 2.13 . . . . 0.0 111.419 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.02 149.0 48.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.522 -0.736 . . . . 0.0 111.543 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 91.6 p . . . . . 0 CA--C 1.548 0.891 0 O-C-N 121.081 -1.012 . . . . 0.0 113.374 -176.446 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.2 t . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.3 mt -121.2 141.45 50.84 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.65 1.58 . . . . 0.0 110.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.23 144.73 17.42 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.482 1.515 . . . . 0.0 110.197 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.03 122.45 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.444 1.898 . . . . 0.0 107.472 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -129.23 147.58 51.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.767 1.227 . . . . 0.0 111.786 -167.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.53 31.7 11.18 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 124.071 0.843 . . . . 0.0 113.547 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.13 162.43 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.438 1.495 . . . . 0.0 113.153 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.3 t -81.83 154.62 25.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.27 0.628 . . . . 0.0 110.998 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.3 -17.38 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 112.601 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.37 -4.22 54.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.535 1.534 . . . . 0.0 114.279 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.5 m -66.81 133.59 50.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.67 1.188 . . . . 0.0 109.649 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.6 p -108.67 163.77 12.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.268 1.027 . . . . 0.0 111.546 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -61.32 -27.32 68.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.279 0.632 . . . . 0.0 111.176 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -73.69 -36.77 65.32 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.824 1.249 . . . . 0.0 112.57 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -66.07 -48.47 70.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.639 0.654 . . . . 0.0 110.28 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.95 -41.22 86.92 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.786 -0.571 . . . . 0.0 111.009 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -58.36 -50.04 75.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.867 0.758 . . . . 0.0 111.667 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.47 -29.39 68.82 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.655 1.116 . . . . 0.0 113.135 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -80.01 -29.42 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.093 0.957 . . . . 0.0 112.011 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -100.6 -22.0 15.1 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -69.19 -20.35 63.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.366 1.439 . . . . 0.0 113.799 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -67.68 -11.3 57.97 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 172.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.1 -9.38 22.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.191 1.396 . . . . 0.0 113.7 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.9 -173.09 27.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.914 1.245 . . . . 0.0 115.185 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.25 132.78 12.8 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.288 3.325 . . . . 0.0 112.758 -169.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.07 128.73 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.813 1.645 . . . . 0.0 109.367 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.04 -40.98 29.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.749 1.22 . . . . 0.0 111.872 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -169.6 173.86 6.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.993 1.717 . . . . 0.0 111.614 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.15 140.08 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.492 1.917 . . . . 0.0 108.428 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 t -142.37 116.25 9.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.253 0.621 . . . . 0.0 111.765 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.46 150.69 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.093 0.957 . . . . 0.0 109.974 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.467 0.398 0 C-N-CA 124.173 0.989 . . . . 0.0 109.265 177.184 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.168 0 CA-C-O 119.168 -0.796 . . . . 0.0 113.94 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -149.27 161.45 42.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.897 1.332 . . . . 0.0 113.633 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -161.5 174.03 14.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.582 1.953 . . . . 0.0 110.54 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -143.56 152.86 41.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.07 120.67 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.321 1.848 . . . . 0.0 108.091 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -98.81 125.59 44.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.61 1.164 . . . . 0.0 109.573 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -105.86 148.94 27.0 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.101 0.96 . . . . 0.0 112.089 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.52 -1.97 54.92 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -155.88 132.91 10.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.672 1.589 . . . . 0.0 111.062 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.47 -30.52 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.29 -17.87 60.18 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -86.78 -28.34 23.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.642 1.177 . . . . 0.0 112.076 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.01 -39.27 79.4 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.729 -0.607 . . . . 0.0 110.408 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -64.16 -23.58 67.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.706 1.202 . . . . 0.0 113.283 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.98 -64.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.776 0.83 . . . . 0.0 109.183 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -36.62 61.71 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -58.83 -31.97 68.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.188 0.995 . . . . 0.0 113.286 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -92.66 -10.53 36.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.103 0.961 . . . . 0.0 112.74 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -96.5 -49.83 4.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.896 1.278 . . . . 0.0 112.559 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.28 -16.19 40.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -63.99 115.66 5.12 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.989 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.84 6.54 76.0 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.226 1.393 . . . . 0.0 114.397 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -77.17 169.22 18.72 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.732 1.766 . . . . 0.0 111.704 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -117.22 123.96 47.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.888 0.875 . . . . 0.0 111.51 -174.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 11.5 tp -127.75 111.86 14.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.158 1.783 . . . . 0.0 109.351 -169.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.5 t70 56.31 27.27 11.62 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.081 1.353 . . . . 0.0 112.991 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.8 -1.18 80.68 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.386 1.469 . . . . 0.0 114.738 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -103.14 127.37 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.381 1.473 . . . . 0.0 110.041 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.01 128.57 36.41 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.34 155.64 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.725 0.81 . . . . 0.0 111.394 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -124.52 151.96 44.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.548 1.539 . . . . 0.0 109.245 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.1 t -141.51 136.2 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.285 1.034 . . . . 0.0 111.287 -168.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -147.25 159.27 43.85 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.357 1.863 . . . . 0.0 111.504 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -69.89 143.63 52.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.416 0.686 . . . . 0.0 111.855 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -172.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 88.3 m . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 120.738 0.304 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.2 mt -114.83 143.91 44.35 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.911 1.685 . . . . 0.0 110.475 172.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.52 148.38 18.3 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.646 1.594 . . . . 0.0 110.552 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.11 131.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.412 1.885 . . . . 0.0 107.823 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -137.36 154.87 49.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.541 1.136 . . . . 0.0 111.608 -168.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.25 30.14 38.49 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.8 0.714 . . . . 0.0 113.603 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.73 162.12 25.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.291 1.436 . . . . 0.0 113.159 -176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -79.85 156.65 27.26 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.999 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.3 mt -70.44 -18.82 63.01 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.714 -0.616 . . . . 0.0 111.996 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.21 -4.71 51.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.727 1.611 . . . . 0.0 114.452 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.7 m -66.84 136.98 56.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.451 1.1 . . . . 0.0 109.397 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.3 p -110.22 162.56 14.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.371 1.069 . . . . 0.0 111.434 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -60.19 -29.09 68.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.673 0.789 . . . . 0.0 111.028 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.73 -37.5 79.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.458 1.103 . . . . 0.0 112.197 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.16 -48.9 66.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.358 0.527 . . . . 0.0 110.279 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.34 -43.17 88.18 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.764 -0.585 . . . . 0.0 110.897 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -57.99 -49.47 76.72 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.758 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.24 -29.73 69.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.779 1.172 . . . . 0.0 113.018 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -80.15 -29.25 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.454 1.102 . . . . 0.0 112.208 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -100.61 -24.5 14.43 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.4 p -69.34 -17.6 63.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.312 1.415 . . . . 0.0 113.913 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -67.78 -14.38 62.9 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.86 -13.02 24.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.777 1.231 . . . . 0.0 113.635 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -174.54 30.65 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.734 1.159 . . . . 0.0 114.941 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.78 140.74 23.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.563 3.509 . . . . 0.0 112.174 -171.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.26 131.9 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 0.0 110.197 -173.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 -25.55 14.97 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.203 1.401 . . . . 0.0 113.658 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -161.83 157.77 24.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.357 1.063 . . . . 0.0 112.39 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -148.27 130.4 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 127.182 2.193 . . . . 0.0 107.653 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.5 t -143.65 118.03 9.65 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.484 0.714 . . . . 0.0 111.802 -174.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.03 144.55 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 169.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -177.881 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.016 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.236 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -148.99 163.68 36.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.594 1.187 . . . . 0.0 113.277 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.77 170.4 22.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.57 1.948 . . . . 0.0 111.568 -168.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -141.35 150.13 42.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.359 1.464 . . . . 0.0 111.171 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.71 127.29 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 109.347 -170.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -99.18 109.02 21.75 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.334 1.454 . . . . 0.0 111.007 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -83.29 160.99 21.59 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.342 -0.849 . . . . 0.0 111.03 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -94.88 8.72 41.8 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.064 0.946 . . . . 0.0 113.001 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -156.68 133.18 10.03 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.511 1.525 . . . . 0.0 111.241 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.03 -30.13 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.54 0.736 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -75.8 -28.52 58.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.435 1.016 . . . . 0.0 113.115 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.73 -27.46 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.225 0.61 . . . . 0.0 111.78 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.33 -41.24 70.07 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.317 0.647 . . . . 0.0 111.307 169.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -60.73 -35.71 77.03 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.196 0.999 . . . . 0.0 112.21 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.52 -63.68 1.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.021 0.928 . . . . 0.0 110.16 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.82 68.86 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.47 -36.01 79.23 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.959 0.904 . . . . 0.0 112.61 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.87 -24.4 26.7 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.515 0.726 . . . . 0.0 112.234 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -76.67 -47.12 23.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.54 1.136 . . . . 0.0 112.98 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.14 -12.43 26.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -170.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -65.62 113.38 4.19 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.517 -1.364 . . . . 0.0 110.866 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.21 8.53 71.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.235 1.398 . . . . 0.0 114.728 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -76.55 175.67 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.741 1.771 . . . . 0.0 111.485 169.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -119.72 135.37 54.86 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.254 1.021 . . . . 0.0 111.57 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.1 tp -146.07 121.33 10.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.982 1.713 . . . . 0.0 109.321 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 56.44 27.56 12.31 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.272 1.429 . . . . 0.0 112.603 -169.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.09 81.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.751 1.167 . . . . 0.0 114.355 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.48 130.29 43.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.874 1.337 . . . . 0.0 109.636 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.07 128.83 37.28 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.6 pt -108.65 159.45 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.941 0.896 . . . . 0.0 111.581 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -121.02 149.5 42.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.506 1.923 . . . . 0.0 108.938 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -145.98 137.24 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.453 1.101 . . . . 0.0 110.371 -171.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -157.15 162.82 39.37 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 112.329 -172.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -73.43 138.36 45.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.454 -0.779 . . . . 0.0 111.286 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 56.1 m . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -118.0 148.96 41.72 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.899 1.68 . . . . 0.0 111.049 175.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.14 147.15 16.2 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.363 1.935 . . . . 0.0 110.832 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.46 128.63 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 108.576 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -133.13 153.56 51.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.153 1.381 . . . . 0.0 111.141 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 30.94 21.11 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 123.861 0.743 . . . . 0.0 113.696 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -78.33 160.62 27.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.952 1.301 . . . . 0.0 113.4 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -81.36 151.56 27.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.488 0.715 . . . . 0.0 110.354 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.34 -16.67 64.02 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.073 -1.017 . . . . 0.0 112.819 175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -95.39 -3.17 47.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.421 1.488 . . . . 0.0 114.233 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.1 m -65.62 135.14 54.66 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.709 1.204 . . . . 0.0 109.69 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -108.04 162.68 13.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.355 1.062 . . . . 0.0 111.463 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.89 -29.35 69.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.304 0.641 . . . . 0.0 111.165 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -68.72 -38.39 80.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.501 1.12 . . . . 0.0 112.395 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -66.6 -49.8 65.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.639 0.654 . . . . 0.0 110.463 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.32 -41.37 84.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.717 -0.615 . . . . 0.0 111.09 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -62.99 -43.2 99.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.081 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.68 -33.45 74.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.185 1.357 . . . . 0.0 112.502 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.51 -28.18 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.45 1.1 . . . . 0.0 112.331 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -100.15 -23.12 14.93 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.6 m -69.15 -14.86 63.23 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.207 1.367 . . . . 0.0 113.691 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -68.17 -14.31 62.89 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.868 -1.145 . . . . 0.0 113.696 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -95.75 -13.8 23.86 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.878 1.271 . . . . 0.0 113.605 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.24 -174.58 31.91 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.099 1.333 . . . . 0.0 114.339 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.91 136.84 21.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.193 3.262 . . . . 0.0 111.934 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.1 mt -131.81 127.1 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.588 1.555 . . . . 0.0 109.789 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.87 -25.08 20.03 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.926 1.29 . . . . 0.0 113.322 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -164.28 167.33 20.02 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.12 135.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.213 2.205 . . . . 0.0 107.76 171.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.0 m -127.05 102.86 7.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.892 1.277 . . . . 0.0 110.511 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.5 mt -78.53 140.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.998 -1.064 . . . . 0.0 108.157 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.4 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.104 0 CA-C-O 119.137 -0.813 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -153.27 161.92 41.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 123.028 1.394 . . . . 0.0 113.811 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.69 175.02 13.67 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.575 1.95 . . . . 0.0 111.371 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.8 156.4 46.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.479 1.511 . . . . 0.0 110.101 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.9 t -139.54 136.76 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.306 1.842 . . . . 0.0 109.193 -168.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -120.5 94.21 4.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.687 1.195 . . . . 0.0 111.678 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -74.62 161.45 29.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.685 0.794 . . . . 0.0 111.96 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.28 8.85 43.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.469 1.107 . . . . 0.0 112.871 171.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -157.45 135.51 10.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.503 1.521 . . . . 0.0 111.714 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.78 -33.15 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.572 0.749 . . . . 0.0 112.633 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -73.64 -27.6 61.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.306 0.957 . . . . 0.0 112.725 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.36 -29.03 41.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.648 0.779 . . . . 0.0 111.881 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.26 -41.85 69.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.447 0.699 . . . . 0.0 111.351 169.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -59.86 -35.69 75.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.587 1.155 . . . . 0.0 112.322 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.43 -62.67 1.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.293 1.037 . . . . 0.0 110.031 171.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.37 68.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -175.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.35 -30.02 68.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.808 1.243 . . . . 0.0 113.202 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -93.14 -28.77 16.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.867 0.867 . . . . 0.0 112.178 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -74.19 -47.09 37.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.21 1.004 . . . . 0.0 113.355 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.93 -12.35 39.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.89 115.26 5.17 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.209 -0.932 . . . . 0.0 110.982 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 86.76 4.18 82.8 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.421 1.486 . . . . 0.0 114.647 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -73.84 158.91 33.65 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.73 1.765 . . . . 0.0 111.748 172.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -103.89 116.77 32.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.077 0.951 . . . . 0.0 110.724 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.6 tp -122.7 111.65 16.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.443 1.897 . . . . 0.0 109.151 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.53 23.56 9.33 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.239 1.416 . . . . 0.0 113.467 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.35 8.82 65.82 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.024 1.297 . . . . 0.0 114.699 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -115.37 134.24 55.29 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.994 1.718 . . . . 0.0 110.107 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -78.93 126.62 30.94 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 109.663 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.85 167.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.924 0.889 . . . . 0.0 111.789 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -137.23 142.41 42.06 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.728 2.011 . . . . 0.0 108.048 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -137.96 140.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.651 0.78 . . . . 0.0 111.581 -168.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -152.57 164.8 36.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.17 1.788 . . . . 0.0 111.224 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.31 141.96 41.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.347 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 CA--C 1.54 0.587 0 O-C-N 121.162 -0.961 . . . . 0.0 112.855 -178.989 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.1 t . . . . . 0 CA--C 1.543 0.703 0 CA-C-O 121.072 0.463 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.1 mt -118.67 146.54 44.62 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.488 1.915 . . . . 0.0 110.379 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.06 149.25 18.7 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.723 1.63 . . . . 0.0 110.955 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.47 128.46 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.505 1.922 . . . . 0.0 107.838 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -136.88 150.81 48.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.156 0.982 . . . . 0.0 112.175 -167.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.15 30.18 23.4 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 123.972 0.796 . . . . 0.0 113.383 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.09 162.87 23.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 113.349 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 t -81.81 157.8 24.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.694 0.798 . . . . 0.0 112.216 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.83 -19.91 62.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.402 0.681 . . . . 0.0 112.083 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.56 -6.38 54.77 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.447 1.499 . . . . 0.0 114.364 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.7 m -69.02 134.56 49.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.727 1.211 . . . . 0.0 109.482 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 p -108.22 162.66 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.289 1.036 . . . . 0.0 111.348 173.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -61.12 -28.65 69.25 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.075 0.55 . . . . 0.0 111.132 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -70.43 -36.73 74.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 112.53 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -67.22 -49.49 64.31 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.605 0.639 . . . . 0.0 110.289 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.54 -43.62 80.08 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.806 -0.559 . . . . 0.0 110.901 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -57.22 -50.33 73.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.657 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.11 -29.9 68.94 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.593 1.088 . . . . 0.0 113.074 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.82 -27.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.479 1.112 . . . . 0.0 112.015 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -100.51 -24.15 14.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.055 0.942 . . . . 0.0 113.488 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.3 p -69.82 -17.19 63.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.362 1.437 . . . . 0.0 113.868 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -66.86 -12.81 60.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -98.68 -8.28 26.44 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.287 1.435 . . . . 0.0 113.751 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.52 -175.55 26.81 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.982 1.277 . . . . 0.0 115.004 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.14 137.21 21.12 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 124.413 3.409 . . . . 0.0 112.248 -170.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.5 mt -128.62 131.35 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.977 1.711 . . . . 0.0 110.016 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.03 -25.18 15.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.065 1.346 . . . . 0.0 113.439 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.11 164.19 25.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.5 t -148.49 134.44 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.175 2.19 . . . . 0.0 108.056 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.9 m -132.83 110.6 10.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.36 1.064 . . . . 0.0 111.351 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.41 139.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.513 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.95 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -153.47 162.55 41.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 122.615 1.198 . . . . 0.0 113.318 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.65 173.59 16.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.251 1.82 . . . . 0.0 111.875 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -141.17 152.4 44.63 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.784 1.633 . . . . 0.0 110.485 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 67.1 t -137.74 132.61 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.176 1.79 . . . . 0.0 108.955 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -115.89 101.67 8.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 111.509 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -78.73 160.08 27.62 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.918 0.887 . . . . 0.0 111.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -91.29 6.68 44.29 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.118 0.967 . . . . 0.0 113.017 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -158.23 134.73 9.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.398 1.479 . . . . 0.0 111.57 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.63 -29.39 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.91 0.884 . . . . 0.0 112.672 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.91 -27.37 49.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.468 1.031 . . . . 0.0 112.989 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.45 -29.2 52.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.675 0.79 . . . . 0.0 111.786 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.41 -39.5 74.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.259 0.624 . . . . 0.0 111.65 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.29 -39.1 85.71 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.112 -0.993 . . . . 0.0 111.962 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.91 -61.94 2.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.794 0.838 . . . . 0.0 110.079 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.21 -39.27 69.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -61.58 -39.18 90.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.856 0.863 . . . . 0.0 112.466 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -82.66 -25.36 33.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.276 0.63 . . . . 0.0 112.417 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -76.12 -51.84 11.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.534 1.134 . . . . 0.0 112.792 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.13 -14.19 39.36 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.1 112.6 3.45 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.521 -1.362 . . . . 0.0 111.068 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.22 8.4 68.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.47 1.509 . . . . 0.0 114.609 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -75.68 174.72 9.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.739 1.769 . . . . 0.0 111.465 169.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -120.12 135.32 55.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.248 1.019 . . . . 0.0 111.494 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -145.46 120.58 10.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.966 1.706 . . . . 0.0 109.276 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 56.53 27.47 12.36 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.424 1.489 . . . . 0.0 112.573 -169.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.58 84.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.727 1.156 . . . . 0.0 114.274 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.82 130.36 44.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.855 1.328 . . . . 0.0 109.622 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.26 130.92 42.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 122.09 -0.381 . . . . 0.0 110.171 171.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.0 pt -110.84 143.99 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.566 0.746 . . . . 0.0 111.389 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -102.35 144.41 30.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.694 1.598 . . . . 0.0 108.634 172.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.8 t -141.62 134.92 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.566 1.147 . . . . 0.0 109.911 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -156.31 158.2 37.04 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.925 1.29 . . . . 0.0 111.731 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.43 140.64 54.13 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.578 -0.701 . . . . 0.0 110.98 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 CA--C 1.54 0.559 0 O-C-N 121.411 -0.806 . . . . 0.0 112.261 -179.503 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 120.994 0.426 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.8 mt -118.39 148.07 42.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.579 1.952 . . . . 0.0 110.593 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.1 149.61 18.0 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.132 1.825 . . . . 0.0 111.461 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.63 128.78 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.786 2.034 . . . . 0.0 108.027 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -136.05 145.42 45.99 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.304 1.042 . . . . 0.0 111.635 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 29.06 9.83 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 124.343 0.973 . . . . 0.0 114.014 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.6 mt -83.65 156.51 22.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.008 1.323 . . . . 0.0 112.874 -173.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 t -79.71 152.69 29.75 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 171.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.84 -18.86 65.59 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.481 -0.762 . . . . 0.0 112.232 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.81 -6.88 57.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.374 1.47 . . . . 0.0 114.358 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 m -74.98 130.98 40.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.3 p -104.5 165.51 11.01 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.377 1.071 . . . . 0.0 111.567 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -60.64 -29.12 69.07 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.2 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.25 -37.87 71.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.471 1.108 . . . . 0.0 112.422 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.87 -48.7 70.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.563 0.619 . . . . 0.0 110.284 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.5 mt -55.64 -43.66 76.4 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.912 -0.493 . . . . 0.0 110.865 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.42 -43.24 99.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.871 0.759 . . . . 0.0 112.366 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.3 -29.96 67.94 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.067 1.303 . . . . 0.0 112.633 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.27 -29.92 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.398 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -100.29 -24.86 14.43 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.3 p -70.97 -11.47 60.98 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.228 1.377 . . . . 0.0 114.097 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -66.61 -15.87 63.77 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.987 -1.071 . . . . 0.0 113.608 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -95.59 -14.84 23.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.85 1.26 . . . . 0.0 113.645 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.77 -177.89 33.48 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 124.878 1.227 . . . . 0.0 114.687 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.67 136.83 21.69 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 124.33 3.353 . . . . 0.0 111.931 -172.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.31 125.87 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.72 1.608 . . . . 0.0 109.755 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.65 -27.01 21.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.919 1.288 . . . . 0.0 113.176 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.08 166.19 23.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.82 137.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.972 2.109 . . . . 0.0 107.883 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -138.29 106.42 5.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.131 0.973 . . . . 0.0 111.053 -172.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.7 146.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.344 -0.847 . . . . 0.0 108.969 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.044 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.057 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -150.2 159.5 44.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.601 1.191 . . . . 0.0 112.9 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.6 175.42 13.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.148 1.779 . . . . 0.0 111.568 -168.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -142.81 154.99 44.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.48 1.512 . . . . 0.0 110.6 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -138.42 131.65 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.213 1.805 . . . . 0.0 109.194 -168.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -114.4 96.73 5.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 0.0 111.463 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.81 158.41 32.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 111.7 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.36 0.67 53.47 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -157.13 157.46 34.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.176 1.39 . . . . 0.0 112.224 173.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.21 -26.16 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.62 -33.15 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.507 1.049 . . . . 0.0 112.874 -170.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -75.76 -23.59 55.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.562 0.745 . . . . 0.0 112.063 169.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.42 62.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.362 0.665 . . . . 0.0 111.233 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -60.03 -37.76 80.72 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.292 1.037 . . . . 0.0 111.975 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.76 -63.34 1.24 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.005 0.922 . . . . 0.0 110.195 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.98 69.75 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -60.49 -38.05 83.05 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.889 0.875 . . . . 0.0 112.464 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -83.54 -26.43 30.12 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.57 0.748 . . . . 0.0 112.128 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -76.09 -46.37 29.34 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.432 1.093 . . . . 0.0 112.973 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -91.9 -15.22 28.4 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -64.46 112.28 3.05 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.745 -1.222 . . . . 0.0 110.717 172.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.23 7.26 70.13 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.34 1.448 . . . . 0.0 114.796 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.3 ptm -74.91 172.13 12.8 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.889 1.845 . . . . 0.0 111.449 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -116.49 134.1 55.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.342 1.057 . . . . 0.0 111.242 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.2 tp -145.79 119.37 9.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.286 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.5 t70 56.94 27.69 13.53 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.529 1.532 . . . . 0.0 112.468 -169.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.43 -2.49 82.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.737 1.16 . . . . 0.0 114.175 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.81 128.16 42.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.814 1.307 . . . . 0.0 109.694 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.76 127.93 34.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.853 170.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.9 pt -108.66 154.24 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.03 0.832 . . . . 0.0 112.327 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -110.78 146.78 35.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.885 1.674 . . . . 0.0 108.697 172.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.91 139.16 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.557 1.143 . . . . 0.0 110.674 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -155.52 164.49 38.61 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.223 1.409 . . . . 0.0 112.387 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -79.74 142.81 35.09 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.199 -0.938 . . . . 0.0 111.517 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.544 0.717 0 O-C-N 121.126 -0.984 . . . . 0.0 113.592 -176.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.543 0.691 0 CA-C-O 121.12 0.486 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.59 145.44 45.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.423 1.889 . . . . 0.0 110.27 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 148.2 18.56 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.804 1.669 . . . . 0.0 110.589 168.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.77 132.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.713 2.005 . . . . 0.0 108.034 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -137.91 152.15 48.72 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.444 1.098 . . . . 0.0 111.958 -167.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.08 29.15 26.36 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.172 0.891 . . . . 0.0 113.759 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.89 159.07 29.14 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.278 1.431 . . . . 0.0 113.596 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.0 t -72.83 155.41 39.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.613 0.721 . . . . 0.0 111.878 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -70.97 -12.46 61.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.793 0.837 . . . . 0.0 112.723 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -103.86 -4.68 23.21 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.478 1.911 . . . . 0.0 114.615 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.4 m -62.61 134.95 57.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.41 1.084 . . . . 0.0 110.058 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -108.25 162.18 14.31 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.26 1.024 . . . . 0.0 111.667 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.57 -26.68 68.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.298 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.37 -36.19 66.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.161 0.984 . . . . 0.0 112.203 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.51 -50.61 68.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.748 0.704 . . . . 0.0 110.289 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.8 mt -60.15 -40.05 88.49 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.537 -0.727 . . . . 0.0 111.15 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.89 -47.44 84.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.141 0.882 . . . . 0.0 111.775 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.31 -32.59 72.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.82 1.191 . . . . 0.0 112.478 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.07 -29.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.438 1.095 . . . . 0.0 112.463 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.47 -22.97 14.84 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -68.03 -17.06 64.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.281 1.401 . . . . 0.0 113.631 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -68.08 -13.86 62.53 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.868 -1.145 . . . . 0.0 113.72 172.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -96.22 -10.82 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.93 1.292 . . . . 0.0 113.747 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.14 -173.95 28.0 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.968 1.271 . . . . 0.0 114.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.64 138.03 21.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.427 3.418 . . . . 0.0 112.147 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.5 mt -130.9 130.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.897 1.679 . . . . 0.0 109.891 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.02 -23.7 16.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.896 1.278 . . . . 0.0 113.468 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.67 162.5 29.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.83 0.852 . . . . 0.0 112.97 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.93 134.16 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.047 2.139 . . . . 0.0 107.399 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.3 t -137.08 111.18 8.34 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.529 0.732 . . . . 0.0 110.804 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.3 mt -84.82 138.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.392 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.583 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -147.38 159.75 43.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.934 1.35 . . . . 0.0 113.971 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.54 174.77 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.446 1.898 . . . . 0.0 111.368 -169.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -143.09 153.09 42.56 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.567 1.547 . . . . 0.0 110.667 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.7 129.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.96 1.704 . . . . 0.0 108.993 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -114.15 97.94 6.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.709 1.204 . . . . 0.0 111.2 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -75.81 160.66 29.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.822 0.849 . . . . 0.0 111.807 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -92.13 7.01 44.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.154 0.982 . . . . 0.0 112.969 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.06 134.32 9.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.362 1.465 . . . . 0.0 111.483 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.91 -29.48 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 112.711 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.27 -27.26 47.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 0.977 . . . . 0.0 113.136 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -77.77 -28.27 50.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.63 0.772 . . . . 0.0 111.726 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.06 -39.5 72.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.209 0.604 . . . . 0.0 111.464 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.59 -37.51 81.57 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.055 -1.028 . . . . 0.0 112.156 172.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.85 -62.51 1.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.895 0.878 . . . . 0.0 109.976 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.98 -38.59 70.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.7 -35.36 77.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.969 0.907 . . . . 0.0 112.487 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -86.29 -25.43 25.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.453 0.701 . . . . 0.0 112.299 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -76.35 -47.94 21.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.597 1.159 . . . . 0.0 112.972 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.63 -12.09 30.19 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -66.67 110.9 3.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.626 -1.296 . . . . 0.0 111.041 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.13 6.84 68.59 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.84 1.686 . . . . 0.0 114.61 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.3 ptm -74.52 168.22 20.17 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.793 1.796 . . . . 0.0 111.453 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -111.8 133.87 53.73 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.054 0.942 . . . . 0.0 111.15 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -141.72 116.58 9.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.001 1.72 . . . . 0.0 109.153 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.17 32.27 15.6 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.22 1.408 . . . . 0.0 112.569 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.68 -1.49 82.84 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.953 -1.092 . . . . 0.0 114.756 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -96.27 133.41 40.64 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.875 1.338 . . . . 0.0 110.114 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -73.35 127.29 32.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.181 0.9 . . . . 0.0 109.146 169.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -103.64 155.9 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.737 0.815 . . . . 0.0 110.586 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -122.64 155.16 36.94 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.939 1.295 . . . . 0.0 109.587 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.5 t -144.0 139.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.763 1.225 . . . . 0.0 110.585 -169.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -155.05 158.12 38.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.253 1.421 . . . . 0.0 111.94 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -72.68 138.32 46.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 CA--C 1.542 0.644 0 O-C-N 121.311 -0.868 . . . . 0.0 113.192 -177.222 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.546 0.789 0 CA-C-O 120.9 0.381 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -119.85 147.18 44.99 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.731 2.013 . . . . 0.0 110.482 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.4 150.84 17.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.993 1.758 . . . . 0.0 111.086 168.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.43 131.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.558 1.943 . . . . 0.0 108.105 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.46 151.8 47.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.404 1.082 . . . . 0.0 111.959 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.87 30.01 33.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.103 0.858 . . . . 0.0 113.422 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.29 159.23 25.91 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.408 1.483 . . . . 0.0 112.68 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 t -77.94 151.35 33.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.011 0.524 . . . . 0.0 111.737 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -16.05 63.68 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -96.98 0.84 49.5 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.974 1.709 . . . . 0.0 114.106 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.1 m -65.14 142.8 58.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.943 1.297 . . . . 0.0 109.829 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.3 p -119.87 161.11 21.39 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.901 0.88 . . . . 0.0 110.865 169.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -59.15 -24.96 63.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.828 0.851 . . . . 0.0 111.621 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -58.61 -44.44 89.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.113 1.765 . . . . 0.0 111.861 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -71.17 -45.96 62.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.021 0.928 . . . . 0.0 110.322 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.4 mt -59.42 -44.33 92.91 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.776 -0.578 . . . . 0.0 110.79 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -58.5 -47.59 83.61 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.864 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.68 -29.38 69.38 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.763 1.165 . . . . 0.0 113.163 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.6 t -79.22 -30.08 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.405 1.082 . . . . 0.0 112.371 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -100.57 -26.63 13.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.4 p -70.09 -20.07 63.22 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.357 1.435 . . . . 0.0 113.885 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.27 -11.97 58.91 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -104.11 -6.44 21.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.089 1.355 . . . . 0.0 114.329 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.13 -175.31 32.41 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.85 138.73 19.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.59 3.526 . . . . 0.0 111.986 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.14 133.33 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.85 1.66 . . . . 0.0 110.503 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.06 -22.69 14.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.254 1.421 . . . . 0.0 113.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -160.87 159.26 29.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.006 0.922 . . . . 0.0 112.696 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.1 t -152.86 132.7 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.621 2.368 . . . . 0.0 107.536 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -148.53 123.32 9.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.315 0.646 . . . . 0.0 112.234 -171.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.27 144.0 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.963 0.905 . . . . 0.0 108.681 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.284 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.114 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.859 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -149.53 161.18 42.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.65 1.214 . . . . 0.0 113.786 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.68 173.79 15.54 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 111.963 -168.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.39 155.21 44.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.686 1.594 . . . . 0.0 111.47 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 88.6 t -140.93 134.15 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.659 1.984 . . . . 0.0 108.838 -169.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.29 101.88 8.3 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.087 1.355 . . . . 0.0 111.39 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.65 162.5 27.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.907 172.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -91.75 6.74 44.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.257 1.023 . . . . 0.0 112.981 171.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -159.24 137.77 10.76 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.638 1.575 . . . . 0.0 111.596 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.07 -35.88 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.637 . . . . 0.0 112.645 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.71 -27.49 62.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.215 0.916 . . . . 0.0 112.596 -174.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -77.4 -36.07 53.71 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.976 0.91 . . . . 0.0 111.885 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.87 90.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.258 0.623 . . . . 0.0 111.298 169.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -65.37 -27.15 68.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.956 1.702 . . . . 0.0 112.793 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.99 -61.48 1.83 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.276 1.031 . . . . 0.0 109.431 168.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.15 67.79 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.45 -33.54 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.671 1.188 . . . . 0.0 112.842 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -88.92 -18.74 26.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.927 0.891 . . . . 0.0 112.461 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -84.64 -43.93 13.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.713 1.205 . . . . 0.0 112.948 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.87 -12.4 29.01 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -64.39 116.58 6.22 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.602 -1.311 . . . . 0.0 111.061 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.18 5.52 76.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.599 1.571 . . . . 0.0 114.872 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.2 ptm -76.24 163.1 27.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.656 1.728 . . . . 0.0 112.595 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -83.9 128.52 34.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.57 1.148 . . . . 0.0 110.189 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.9 tp -150.45 123.13 8.59 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.927 1.291 . . . . 0.0 110.175 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 55.02 31.51 16.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.541 1.536 . . . . 0.0 113.04 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.88 4.0 85.16 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.389 1.471 . . . . 0.0 114.69 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -116.96 153.36 32.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.619 1.568 . . . . 0.0 111.271 -175.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -87.9 121.62 30.54 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.6 pt -99.58 155.14 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.014 0.526 . . . . 0.0 112.044 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -112.75 144.7 41.82 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.943 1.697 . . . . 0.0 108.662 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.4 t -141.61 134.67 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.552 1.141 . . . . 0.0 109.796 -172.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -156.69 159.75 38.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.661 1.184 . . . . 0.0 112.225 -169.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.05 138.84 50.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.521 0.728 . . . . 0.0 111.281 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 CA--C 1.541 0.608 0 O-C-N 121.494 -0.754 . . . . 0.0 112.105 -179.843 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.2 m -66.7 140.54 57.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.331 1.052 . . . . 0.0 112.789 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.6 t -164.42 143.77 7.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.014 1.326 . . . . 0.0 110.884 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.28 146.19 10.73 Favored Glycine 0 N--CA 1.469 0.874 0 C-N-CA 123.857 0.741 . . . . 0.0 114.368 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.9 m -58.76 125.47 23.6 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.793 1.237 . . . . 0.0 111.692 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.4 m 68.03 -7.89 0.6 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.549 1.94 . . . . 0.0 114.725 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.46 -34.63 10.2 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.201 1.381 . . . . 0.0 111.747 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -67.07 138.31 57.05 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.044 0.937 . . . . 0.0 110.396 169.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -127.8 17.21 6.84 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -170.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.65 36.41 4.62 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.018 1.727 . . . . 0.0 112.039 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -176.99 60.52 0.17 Allowed Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 128.446 2.698 . . . . 0.0 111.836 -169.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.9 176.33 10.27 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.281 3.321 . . . . 0.0 112.062 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -150.16 151.93 32.67 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.745 1.618 . . . . 0.0 111.237 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -45.87 134.93 14.04 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.263 3.975 . . . . 0.0 116.801 -168.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -158.41 141.56 14.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.496 1.918 . . . . 0.0 109.591 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 61.5 m -55.78 -31.74 62.87 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.659 1.183 . . . . 0.0 112.508 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.8 m -85.04 131.33 34.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.288 1.035 . . . . 0.0 110.7 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.28 144.31 45.91 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.239 1.816 . . . . 0.0 110.526 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.38 145.82 17.73 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.804 1.669 . . . . 0.0 110.603 167.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.45 128.75 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.81 2.044 . . . . 0.0 107.71 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -133.84 145.14 49.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.546 1.138 . . . . 0.0 111.329 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.72 9.13 44.16 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.532 1.063 . . . . 0.0 115.706 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.03 150.36 48.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.445 1.498 . . . . 0.0 114.273 -169.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.4 t -75.48 146.1 40.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.061 0.944 . . . . 0.0 110.935 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.5 -15.0 60.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.403 1.081 . . . . 0.0 113.836 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.77 -0.15 51.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.353 1.461 . . . . 0.0 113.749 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.0 m -71.65 139.41 49.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.914 1.286 . . . . 0.0 109.77 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.8 p -110.89 163.42 13.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.314 1.046 . . . . 0.0 111.451 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -59.77 -28.21 67.21 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.96 0.904 . . . . 0.0 111.137 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.13 -39.0 75.68 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.844 1.258 . . . . 0.0 112.041 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.12 -47.38 74.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.148 0.431 . . . . 0.0 110.285 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.5 mt -57.34 -46.54 83.18 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.846 -0.534 . . . . 0.0 110.882 173.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -63.44 -39.02 93.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.376 0.989 . . . . 0.0 112.707 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.4 -29.89 68.68 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.739 1.609 . . . . 0.0 112.572 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.34 -30.24 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.404 1.082 . . . . 0.0 112.253 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -100.37 -26.25 13.95 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -71.06 -14.01 62.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.344 1.429 . . . . 0.0 113.996 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -67.32 -13.49 62.04 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.016 -1.052 . . . . 0.0 113.547 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -96.98 -9.12 28.89 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.268 1.427 . . . . 0.0 113.686 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.26 -175.78 27.39 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.968 1.271 . . . . 0.0 114.882 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.41 136.01 19.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.504 3.47 . . . . 0.0 112.228 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.6 mt -128.79 122.73 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.658 1.583 . . . . 0.0 109.845 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.61 -31.32 28.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.121 0.969 . . . . 0.0 112.873 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -164.26 162.23 22.39 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.594 1.158 . . . . 0.0 112.276 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -148.0 137.06 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.112 2.165 . . . . 0.0 108.012 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.8 t -144.09 120.03 10.65 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 111.407 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -85.87 146.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.184 0.994 . . . . 0.0 108.648 172.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.6 t -97.47 129.06 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 108.778 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.14 154.73 37.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.889 1.276 . . . . 0.0 113.662 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -71.9 140.24 49.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.277 1.431 . . . . 0.0 112.107 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -77.23 -22.16 52.69 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -104.19 -27.75 11.86 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.092 0.86 . . . . 0.0 112.898 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 100.0 p -120.93 -12.59 8.75 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 61.82 15.54 7.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.036 1.734 . . . . 0.0 114.386 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -74.64 153.06 39.11 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.46 1.504 . . . . 0.0 110.292 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.8 t -61.34 142.89 56.58 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.708 -0.62 . . . . 0.0 111.103 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -84.64 -1.39 55.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.181 0.993 . . . . 0.0 112.772 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.92 7.72 62.43 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.15 1.357 . . . . 0.0 114.181 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -144.59 160.94 40.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.628 1.214 . . . . 0.0 113.586 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.86 172.27 17.94 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.535 1.934 . . . . 0.0 111.053 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.28 149.02 40.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.768 1.227 . . . . 0.0 111.04 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.63 120.8 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.608 1.963 . . . . 0.0 108.182 -170.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -106.68 98.34 8.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.328 1.051 . . . . 0.0 111.003 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -74.66 160.97 30.13 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.479 -0.763 . . . . 0.0 111.742 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.26 6.68 41.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.171 0.988 . . . . 0.0 113.006 171.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -158.56 135.22 9.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.341 1.456 . . . . 0.0 111.748 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -68.38 -29.63 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.072 0.949 . . . . 0.0 112.746 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.63 -26.05 45.16 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.36 0.982 . . . . 0.0 113.178 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -78.71 -29.36 45.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.774 0.83 . . . . 0.0 111.677 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.65 77.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.275 0.63 . . . . 0.0 111.343 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.06 -34.02 74.23 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.99 -1.069 . . . . 0.0 112.55 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.03 -63.12 1.15 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.758 0.823 . . . . 0.0 109.758 172.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.21 70.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -61.11 -34.37 74.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.081 0.952 . . . . 0.0 112.593 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -87.81 -24.25 23.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.533 0.733 . . . . 0.0 112.31 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.43 -46.48 22.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.509 1.124 . . . . 0.0 113.074 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.91 -11.12 27.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -170.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -66.68 111.06 3.48 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 120.658 -1.276 . . . . 0.0 111.248 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.04 7.06 68.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.078 1.799 . . . . 0.0 114.627 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -74.72 168.96 18.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.713 1.757 . . . . 0.0 111.326 170.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -111.12 137.09 49.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.237 1.015 . . . . 0.0 110.974 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.06 116.8 9.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.776 1.63 . . . . 0.0 109.377 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 58.14 25.11 12.07 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.011 1.725 . . . . 0.0 113.901 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 91.99 2.76 68.67 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.93 1.252 . . . . 0.0 114.965 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -110.19 139.27 45.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.702 1.601 . . . . 0.0 110.516 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 138.76 47.4 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 167.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.1 pt -111.82 149.3 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.721 0.808 . . . . 0.0 110.285 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 34.5 mtm-85 -117.61 153.07 33.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.07 1.348 . . . . 0.0 109.007 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.0 t -143.67 136.05 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.45 1.1 . . . . 0.0 110.879 -168.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -150.38 162.04 41.31 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.288 1.835 . . . . 0.0 111.484 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -69.77 142.5 53.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.849 0.86 . . . . 0.0 112.081 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.0 m -66.54 125.93 27.27 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.33 -0.856 . . . . 0.0 112.602 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.8 pt -83.19 -19.87 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.246 1.019 . . . . 0.0 112.477 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.8 p -156.48 155.97 32.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 130.724 3.61 . . . . 0.0 107.323 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.49 158.91 34.97 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -70.65 -40.46 10.82 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -58.59 150.17 71.18 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.332 3.355 . . . . 0.0 113.349 170.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -160.99 146.76 14.51 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.381 1.473 . . . . 0.0 112.098 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.05 1.74 . . . . 0.0 110.859 -174.39 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.257 1 O4'-C1'-N19 112.597 4.397 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 C3'-C2'-C1' 103.46 2.177 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 O4'-C4'-C3' 108.411 2.08 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 O5'-C5'-C4' 114.717 3.226 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.55 0 C4'-C3'-C2' 99.662 -3.038 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.014 0 O4'-C1'-N19 111.76 3.56 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.8 m -138.03 12.45 2.86 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -170.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.5 m -163.53 155.24 17.15 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.402 1.881 . . . . 0.0 110.992 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.09 -71.6 2.6 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.769 1.176 . . . . 0.0 111.993 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.0 p -167.89 147.43 4.85 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.026 1.731 . . . . 0.0 111.675 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 m -171.29 146.92 2.4 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.68 1.992 . . . . 0.0 110.709 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -95.81 144.49 17.28 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.659 1.123 . . . . 0.0 111.82 173.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -158.8 148.95 19.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.295 1.438 . . . . 0.0 112.213 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 ttm105 -75.56 31.77 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.689 1.996 . . . . 0.0 115.384 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.79 172.7 7.21 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.85 1.26 . . . . 0.0 111.627 172.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -51.04 119.16 11.57 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 124.045 0.938 . . . . 0.0 112.448 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -85.32 -175.16 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.902 3.068 . . . . 0.0 111.754 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -149.02 160.54 34.84 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 126.53 1.932 . . . . 0.0 110.615 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.3 138.49 46.01 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.27 3.313 . . . . 0.0 115.319 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -154.94 156.98 37.04 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.686 1.594 . . . . 0.0 110.384 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.83 10.6 0.49 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.599 1.559 . . . . 0.0 114.42 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 14.8 p -152.87 150.64 29.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.092 1.357 . . . . 0.0 111.442 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.19 146.83 50.6 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.964 1.706 . . . . 0.0 110.889 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.47 147.48 18.55 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.838 1.685 . . . . 0.0 109.731 166.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.054 1.742 . . . . 0.0 107.832 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -133.69 154.23 51.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.845 0.858 . . . . 0.0 111.773 -168.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.81 34.55 30.66 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.685 0.659 . . . . 0.0 113.285 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.57 164.93 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.357 1.463 . . . . 0.0 113.203 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.6 t -83.09 153.05 25.06 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.239 0.615 . . . . 0.0 111.13 168.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.56 -15.91 62.82 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.495 -0.753 . . . . 0.0 112.386 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -95.45 -4.27 45.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.617 1.567 . . . . 0.0 114.031 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 85.2 m -67.8 133.54 49.4 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.503 1.121 . . . . 0.0 109.263 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 p -106.79 163.65 12.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -61.14 -27.58 68.49 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.093 0.557 . . . . 0.0 111.181 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -71.59 -37.49 70.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.56 1.144 . . . . 0.0 112.301 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.81 -47.45 75.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.682 0.674 . . . . 0.0 110.399 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.48 -44.59 85.03 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.673 -0.642 . . . . 0.0 110.679 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -63.63 -39.71 95.05 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.013 0.824 . . . . 0.0 112.772 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.86 -28.33 65.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.36 1.436 . . . . 0.0 112.852 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.66 -33.92 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.929 0.891 . . . . 0.0 111.831 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -99.96 -24.67 14.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.2 p -71.38 -18.39 62.36 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.518 1.508 . . . . 0.0 114.112 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -69.38 -7.12 34.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.017 -1.052 . . . . 0.0 113.83 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -100.5 -5.1 27.48 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.107 1.363 . . . . 0.0 113.642 171.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.23 -174.92 23.06 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.602 1.573 . . . . 0.0 115.087 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.87 128.69 14.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.231 3.288 . . . . 0.0 112.642 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.0 mt -116.91 126.11 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.909 1.684 . . . . 0.0 109.281 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.54 -40.45 42.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.684 1.194 . . . . 0.0 111.859 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.51 174.41 6.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.777 1.231 . . . . 0.0 113.094 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.84 142.63 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.115 2.166 . . . . 0.0 108.524 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.6 t -137.52 118.48 14.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.467 0.707 . . . . 0.0 111.673 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 94.2 mt -82.69 142.7 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.1 t -92.82 128.76 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.829 0.852 . . . . 0.0 109.76 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -125.44 153.62 43.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.327 1.451 . . . . 0.0 112.927 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.63 150.83 48.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.408 1.083 . . . . 0.0 111.565 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -81.18 -20.95 40.11 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -127.36 -39.67 1.86 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.972 0.909 . . . . 0.0 112.708 -170.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 67.9 m -82.36 -20.44 37.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.457 0.703 . . . . 0.0 112.132 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 58.56 21.79 9.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.487 1.915 . . . . 0.0 114.044 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -76.88 147.68 36.91 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 128.365 2.666 . . . . 0.0 110.804 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.1 t -69.07 134.76 49.81 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -87.29 -2.08 58.37 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 96.09 6.6 58.96 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 125.102 1.334 . . . . 0.0 114.839 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.05 164.64 31.47 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.585 1.183 . . . . 0.0 113.824 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.83 171.44 20.05 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.785 2.034 . . . . 0.0 110.994 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -142.59 151.25 41.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.814 1.246 . . . . 0.0 110.906 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.3 t -131.47 126.86 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.298 1.839 . . . . 0.0 108.513 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -105.61 112.3 25.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.149 0.98 . . . . 0.0 110.441 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.65 157.96 16.67 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.322 -0.862 . . . . 0.0 111.245 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.34 -9.05 59.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -151.64 146.58 25.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.774 1.63 . . . . 0.0 111.573 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.6 -33.21 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.11 -24.57 58.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -81.42 -29.31 33.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.901 1.281 . . . . 0.0 111.801 174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.47 70.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 110.628 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -58.99 -40.03 83.6 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.16 -0.962 . . . . 0.0 112.23 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.49 -62.34 1.95 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.929 0.892 . . . . 0.0 110.242 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.83 71.68 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -63.06 -33.25 75.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.004 0.922 . . . . 0.0 112.641 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -84.49 -24.07 29.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.638 0.654 . . . . 0.0 112.703 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -82.84 -45.97 13.63 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.398 1.079 . . . . 0.0 113.318 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -100.25 -11.49 20.32 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.4 112.97 4.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.684 -1.26 . . . . 0.0 110.933 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.25 9.12 70.55 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.242 1.401 . . . . 0.0 114.633 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ptm -75.65 172.93 11.75 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.703 1.751 . . . . 0.0 111.502 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.24 134.66 54.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.075 0.95 . . . . 0.0 111.136 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -141.68 116.87 10.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.587 1.555 . . . . 0.0 109.239 -174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.84 25.23 10.12 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.571 1.548 . . . . 0.0 113.199 -173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.85 -3.55 83.01 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.395 1.474 . . . . 0.0 114.613 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.48 130.52 44.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.122 1.369 . . . . 0.0 110.15 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.4 122.25 22.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.033 0.833 . . . . 0.0 110.011 170.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -101.65 151.63 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.677 0.791 . . . . 0.0 111.631 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -106.82 149.87 26.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.317 1.847 . . . . 0.0 109.37 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.0 t -144.37 132.48 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.766 1.226 . . . . 0.0 110.224 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -156.47 154.72 30.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 112.651 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -70.01 136.18 50.13 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.362 -0.836 . . . . 0.0 112.328 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.3 m -68.84 126.94 31.33 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.417 -0.802 . . . . 0.0 112.975 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.5 pt -83.2 -19.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.084 0.954 . . . . 0.0 113.138 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.9 p -155.48 158.13 38.03 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 129.998 3.319 . . . . 0.0 107.508 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.77 159.05 41.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 -176.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 6.4 tpp85 -63.47 -50.54 72.88 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.921 1.689 . . . . 0.0 114.776 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.09 149.84 47.1 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.226 2.617 . . . . 0.0 111.397 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -151.97 2.6 0.37 Allowed 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -174.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.461 1.905 . . . . 0.0 111.812 -173.265 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.128 0 O4'-C1'-N19 111.795 3.595 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.245 1 O4'-C1'-N19 115.624 7.424 . 0.191 2z . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.117 1 O4'-C1'-N19 112.318 4.118 . 0.028 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.351 0 O4'-C1'-N19 111.21 3.01 . 0.133 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.592 0 O4'-C1'-N19 111.633 3.433 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.43 -1.942 0 O4'-C1'-N19 112.151 3.951 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.5 t -163.26 150.78 13.03 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.289 1.436 . . . . 0.0 111.171 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.7 p -81.65 -11.57 59.04 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.406 1.082 . . . . 0.0 113.363 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.52 31.01 2.45 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.703 1.62 . . . . 0.0 114.61 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.3 p -82.62 -20.22 36.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.7 p -169.22 158.62 8.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.97 1.708 . . . . 0.0 111.595 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.53 104.45 1.68 Allowed Glycine 0 N--CA 1.47 0.926 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -152.58 20.36 0.62 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -169.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 58.88 32.56 22.35 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.916 1.686 . . . . 0.0 114.346 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.64 33.61 2.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.611 1.565 . . . . 0.0 112.035 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -174.73 39.34 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 128.297 2.639 . . . . 0.0 114.799 -169.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.43 162.44 40.65 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.472 2.781 . . . . 0.0 112.14 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -157.81 143.44 12.46 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.608 1.563 . . . . 0.0 110.314 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.86 136.07 58.98 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.143 3.228 . . . . 0.0 114.003 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -149.22 28.48 0.82 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.176 0.99 . . . . 0.0 112.883 -168.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.411 ' H ' HG23 ' A' ' 169' ' ' VAL . 58.2 m 68.11 1.36 2.77 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.429 2.292 . . . . 0.0 114.73 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.7 p -156.79 154.44 29.94 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.044 1.338 . . . . 0.0 112.088 -172.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.8 mt -127.98 148.98 50.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.346 1.858 . . . . 0.0 111.389 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.67 146.28 17.49 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 126.297 1.903 . . . . 0.0 109.57 166.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.68 123.91 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.502 1.921 . . . . 0.0 107.372 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -130.64 153.33 49.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.883 1.273 . . . . 0.0 112.735 -167.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.9 12.26 60.68 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.265 1.412 . . . . 0.0 114.502 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.33 160.77 26.54 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.31 1.844 . . . . 0.0 114.275 -169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.4 t -75.06 151.45 38.69 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.478 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -68.68 -16.11 63.73 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.549 -0.72 . . . . 0.0 112.629 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -100.58 -2.52 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.622 1.569 . . . . 0.0 114.313 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.7 m -64.9 139.77 58.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.693 1.197 . . . . 0.0 109.495 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 p -108.76 161.65 14.91 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.177 0.991 . . . . 0.0 111.471 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -59.04 -30.94 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.681 0.792 . . . . 0.0 111.136 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -67.31 -40.0 85.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.817 1.247 . . . . 0.0 112.015 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.48 -49.78 67.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.795 0.438 . . . . 0.0 110.273 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.4 -43.56 79.41 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 110.997 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -62.48 -44.74 95.65 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.352 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.31 -29.29 67.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.645 1.111 . . . . 0.0 112.872 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.88 -28.69 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.363 1.065 . . . . 0.0 112.057 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -100.16 -20.52 15.93 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.0 p -68.73 -16.16 63.73 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.289 1.404 . . . . 0.0 113.979 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.72 -15.34 63.46 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 171.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.54 -12.36 27.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.977 1.311 . . . . 0.0 113.586 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.28 177.84 25.48 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.008 1.289 . . . . 0.0 114.323 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.4 134.18 26.07 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 124.569 3.512 . . . . 0.0 112.332 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.7 127.45 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.93 1.692 . . . . 0.0 109.889 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.08 -25.43 17.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.228 1.411 . . . . 0.0 113.574 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -159.91 156.86 27.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.938 0.895 . . . . 0.0 112.548 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.2 t -153.05 135.85 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.131 2.173 . . . . 0.0 108.282 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -149.07 125.01 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.567 0.747 . . . . 0.0 111.79 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.3 mt -86.16 146.75 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.182 0.993 . . . . 0.0 108.846 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.74 132.55 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.301 1.041 . . . . 0.0 109.38 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -124.69 153.51 42.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.992 1.317 . . . . 0.0 113.112 -170.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.85 141.32 53.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.257 1.423 . . . . 0.0 111.366 172.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -75.54 -20.31 58.75 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -113.45 -38.28 4.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.385 1.074 . . . . 0.0 112.853 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 60.0 p -94.51 -17.85 22.02 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 62.89 12.46 5.8 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.406 1.882 . . . . 0.0 114.081 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.76 154.47 31.94 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.326 1.45 . . . . 0.0 110.308 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.1 t -61.68 141.33 57.9 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.558 -0.714 . . . . 0.0 110.82 172.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -75.92 0.22 19.12 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.879 0.872 . . . . 0.0 112.754 170.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.04 18.86 55.15 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.955 1.264 . . . . 0.0 113.287 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -154.54 164.57 38.5 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.841 1.305 . . . . 0.0 114.246 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.09 170.43 22.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.622 1.969 . . . . 0.0 111.449 -168.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -135.56 151.76 50.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.388 1.475 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.48 130.42 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.833 2.053 . . . . 0.0 109.046 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -119.52 113.85 21.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.031 1.333 . . . . 0.0 112.254 -170.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -93.23 154.79 17.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.985 0.914 . . . . 0.0 111.929 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -81.73 4.64 21.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.215 1.006 . . . . 0.0 112.841 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -155.98 129.22 8.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.081 1.752 . . . . 0.0 110.777 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 118' ' ' CYS . 7.7 p -66.87 -27.14 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.83 -24.33 48.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.101 0.864 . . . . 0.0 113.08 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -78.85 -27.41 44.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.611 0.764 . . . . 0.0 111.734 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.24 73.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.976 0.51 . . . . 0.0 110.507 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.74 -34.66 76.22 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.013 -1.054 . . . . 0.0 112.688 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.18 -63.56 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.022 0.929 . . . . 0.0 110.045 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.83 -36.52 67.59 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.83 -38.12 77.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.059 0.943 . . . . 0.0 112.673 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.06 -21.12 27.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.547 0.739 . . . . 0.0 112.444 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -81.44 -46.51 14.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.602 1.161 . . . . 0.0 112.849 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.93 -14.59 25.82 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -171.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -64.69 111.03 2.57 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.658 -1.276 . . . . 0.0 110.76 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.82 5.82 64.16 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.47 1.509 . . . . 0.0 114.774 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.9 ptm -76.97 173.31 11.92 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.931 1.866 . . . . 0.0 111.36 169.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -118.45 137.91 52.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.28 1.032 . . . . 0.0 111.361 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.9 tp -145.8 120.46 9.82 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.454 1.502 . . . . 0.0 109.976 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.3 t70 57.63 23.36 9.27 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.678 1.591 . . . . 0.0 113.466 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.28 83.09 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.499 1.523 . . . . 0.0 114.625 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.72 130.24 45.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.276 1.43 . . . . 0.0 110.668 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.29 138.91 54.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 168.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 pt -115.92 143.95 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.351 0.661 . . . . 0.0 111.266 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -106.95 144.43 33.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.799 1.639 . . . . 0.0 108.297 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 t -140.3 135.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.98 0.912 . . . . 0.0 110.628 -170.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.32 162.59 39.13 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.543 1.537 . . . . 0.0 111.654 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.47 139.23 40.75 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 112.111 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.8 m -70.06 126.86 30.92 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.206 -0.934 . . . . 0.0 112.911 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 6.4 pt -86.12 -0.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.5 p -155.19 -163.64 1.59 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 129.24 3.016 . . . . 0.0 109.322 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -150.88 169.3 22.05 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.921 1.288 . . . . 0.0 113.861 169.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.9 159.37 55.25 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.119 0.968 . . . . 0.0 112.572 171.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -70.77 149.18 60.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.377 2.718 . . . . 0.0 113.28 -171.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 68.2 -16.82 0.18 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 127.799 2.44 . . . . 0.0 117.0 169.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.58 1.552 . . . . 0.0 113.358 -178.422 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.429 1 O4'-C1'-N19 112.555 4.355 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.197 0 C4'-C3'-C2' 100.009 -2.691 . 0.134 5n . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.266 0 O4'-C1'-N19 110.444 2.244 . 0.612 1z . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.222 0 O4'-C1'-N19 111.094 2.894 . 0.169 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 C5'-C4'-C3' 110.813 -3.125 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 0 C5'-C4'-C3' 110.795 -3.137 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.541 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.6 p -164.13 170.83 15.88 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.205 1.402 . . . . 0.0 111.802 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.1 m -74.35 3.12 7.88 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.0 -11.17 84.96 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.902 1.239 . . . . 0.0 115.206 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.8 t -162.32 133.8 5.24 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.941 1.296 . . . . 0.0 111.361 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.3 p -167.43 144.55 4.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.456 1.502 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -99.84 -11.1 44.54 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 124.647 1.117 . . . . 0.0 114.677 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -66.82 142.61 57.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.848 1.259 . . . . 0.0 111.248 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 78.14 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.415 1.086 . . . . 0.0 111.849 170.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.98 37.92 0.18 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.073 2.149 . . . . 0.0 111.708 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -168.52 34.38 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 126.707 2.003 . . . . 0.0 115.855 -168.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.04 149.69 88.94 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.134 2.556 . . . . 0.0 112.335 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -151.94 153.09 31.05 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 126.204 1.802 . . . . 0.0 110.639 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -38.1 125.17 0.77 Allowed 'Trans proline' 0 C--N 1.355 0.909 1 C-N-CA 125.97 4.447 . . . . 0.0 116.896 -168.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -156.97 137.38 12.98 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.409 1.884 . . . . 0.0 109.43 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.9 m -59.48 -28.26 66.85 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.096 0.958 . . . . 0.0 112.697 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 81.7 m -85.33 117.17 24.1 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.123 0.969 . . . . 0.0 110.058 171.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.7 mt -102.73 145.65 29.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.12 1.368 . . . . 0.0 110.452 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.02 144.95 16.13 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.879 1.704 . . . . 0.0 110.651 168.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.06 124.83 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.864 2.066 . . . . 0.0 107.634 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.03 154.71 47.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.832 1.253 . . . . 0.0 113.141 -166.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.39 18.01 61.3 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.798 1.189 . . . . 0.0 114.263 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.93 163.13 22.75 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.539 1.936 . . . . 0.0 114.237 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -80.28 149.05 30.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.828 168.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.55 -16.36 64.15 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.435 -0.791 . . . . 0.0 112.675 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -96.22 -4.39 42.54 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.449 1.5 . . . . 0.0 114.302 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -68.52 133.43 48.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.529 1.132 . . . . 0.0 109.377 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.8 p -106.3 164.16 12.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.182 0.993 . . . . 0.0 111.598 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -60.51 -29.47 69.12 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.176 0.59 . . . . 0.0 111.123 172.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -69.1 -40.16 78.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.711 1.205 . . . . 0.0 112.232 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.05 -49.47 67.53 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.187 0.449 . . . . 0.0 110.266 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.52 -42.47 78.5 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.907 -0.496 . . . . 0.0 110.978 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.61 -44.82 95.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.26 175.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.26 -32.38 72.52 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.929 1.241 . . . . 0.0 112.4 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.26 -29.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 112.273 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.16 -21.02 15.69 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 74.2 m -66.74 -17.24 64.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 120.105 1.321 . . . . 0.0 113.644 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -67.76 -14.52 63.02 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.999 -1.063 . . . . 0.0 113.829 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -97.5 -13.62 21.59 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.91 1.284 . . . . 0.0 113.857 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.81 -174.12 31.66 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.55 1.071 . . . . 0.0 114.761 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.04 136.27 16.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.437 3.425 . . . . 0.0 111.988 -171.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.5 mt -129.35 125.43 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.683 1.593 . . . . 0.0 109.742 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.16 -33.62 26.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.758 1.223 . . . . 0.0 112.669 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -166.39 170.2 13.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.254 1.021 . . . . 0.0 112.805 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.9 t -143.8 138.18 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.939 2.095 . . . . 0.0 108.5 175.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.0 m -138.33 109.06 6.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.256 1.022 . . . . 0.0 111.306 -171.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.89 149.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 171.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t -103.84 133.08 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.433 1.093 . . . . 0.0 109.61 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -128.24 153.73 46.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.191 1.396 . . . . 0.0 113.456 -169.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.41 138.83 49.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.787 1.235 . . . . 0.0 111.155 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -74.42 -21.31 59.68 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -118.0 -38.16 3.28 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.337 1.055 . . . . 0.0 112.463 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.9 m -83.84 -14.15 51.97 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.785 0.834 . . . . 0.0 113.177 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 54.08 38.71 29.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.273 1.829 . . . . 0.0 113.476 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -131.32 153.52 49.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.606 2.362 . . . . 0.0 109.53 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.3 t -60.09 138.19 57.94 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.05 -0.406 . . . . 0.0 111.474 -177.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -76.89 0.62 20.23 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.807 0.843 . . . . 0.0 112.939 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.47 13.58 53.38 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.28 1.419 . . . . 0.0 113.975 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.51 164.49 38.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.822 1.296 . . . . 0.0 113.98 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.57 172.67 17.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.21 1.804 . . . . 0.0 111.273 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -138.63 154.87 48.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.0 1.32 . . . . 0.0 111.233 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.8 t -134.34 121.13 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.521 1.928 . . . . 0.0 108.116 -171.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -102.51 98.81 8.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.252 1.021 . . . . 0.0 110.552 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -76.57 161.68 28.39 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.189 -0.945 . . . . 0.0 112.174 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.18 7.94 45.12 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.547 1.139 . . . . 0.0 113.026 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -155.42 132.84 11.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.57 1.548 . . . . 0.0 111.13 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.63 -27.07 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 112.783 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.458 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 9.6 t70 -80.16 -29.74 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.189 0.904 . . . . 0.0 113.049 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.28 -30.32 60.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.26 0.624 . . . . 0.0 111.495 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.5 -43.29 77.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.352 0.661 . . . . 0.0 111.679 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 21.1 mtmt -58.03 -36.93 73.42 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.082 -1.011 . . . . 0.0 112.674 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.71 -57.31 4.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.196 0.599 . . . . 0.0 110.878 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.65 67.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.977 -1.077 . . . . 0.0 112.93 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -55.9 -47.23 77.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.819 1.248 . . . . 0.0 112.293 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -27.96 37.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.359 0.663 . . . . 0.0 111.675 -174.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -71.36 -52.41 18.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.937 1.695 . . . . 0.0 113.374 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.74 -14.12 37.96 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -64.22 111.0 2.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.766 -1.209 . . . . 0.0 111.144 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.78 8.13 65.69 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.628 1.585 . . . . 0.0 114.646 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -75.76 173.11 11.54 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.793 1.796 . . . . 0.0 111.457 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.07 136.64 53.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.214 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.4 tp -145.47 118.99 9.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.5 1.52 . . . . 0.0 109.531 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 58.13 22.74 9.39 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.422 1.489 . . . . 0.0 113.428 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.81 -5.77 83.27 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.633 1.587 . . . . 0.0 114.605 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.56 130.36 41.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.336 1.454 . . . . 0.0 110.707 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.52 131.44 43.29 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.3 pt -110.94 152.64 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.946 0.898 . . . . 0.0 110.225 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -122.75 153.13 39.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.485 1.114 . . . . 0.0 109.489 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -142.79 137.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.575 -167.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -150.18 169.84 20.36 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.643 1.977 . . . . 0.0 111.54 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -78.31 142.29 37.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.347 1.059 . . . . 0.0 112.003 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.3 t -64.69 138.78 58.59 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 6.7 pt -96.16 -21.28 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.672 1.189 . . . . 0.0 113.665 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.5 p -161.4 146.01 13.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.472 2.709 . . . . 0.0 108.404 -171.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -152.44 165.78 33.99 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -170.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -69.07 -48.57 27.36 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.26 145.33 24.06 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.142 2.561 . . . . 0.0 111.064 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -72.51 -14.51 61.67 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 129.201 3.0 . . . . 0.0 114.1 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.345 1 O4'-C1'-N19 113.99 5.79 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.209 0 O4'-C1'-N19 111.655 3.455 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 0 O4'-C1'-N19 110.449 2.249 . 0.403 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 O5'-C5'-C4' 114.455 3.039 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.104 0 O4'-C1'-N19 112.05 3.85 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.292 0 C5'-C4'-C3' 112.142 -2.239 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -64.05 -27.15 68.91 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -171.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -72.92 -16.62 61.55 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.011 0.924 . . . . 0.0 113.292 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.4 -42.08 3.28 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.443 1.497 . . . . 0.0 112.299 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.4 m -148.17 115.97 6.37 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.479 1.112 . . . . 0.0 111.782 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.6 p -167.72 172.68 9.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.885 1.674 . . . . 0.0 111.419 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.16 11.5 60.44 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.723 1.154 . . . . 0.0 114.041 172.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -57.76 128.09 35.31 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.675 1.238 . . . . 0.0 110.773 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -97.23 2.39 50.85 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.566 1.546 . . . . 0.0 114.792 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.45 47.87 0.98 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.897 1.679 . . . . 0.0 113.268 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -169.07 32.02 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.546 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -167.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.55 155.95 65.23 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.65 2.234 . . . . 0.0 111.873 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -157.47 157.98 30.41 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.113 1.765 . . . . 0.0 110.521 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -44.63 131.56 9.87 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.98 3.787 . . . . 0.0 115.94 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -152.56 137.8 17.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.921 1.689 . . . . 0.0 109.243 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 73.0 m -58.45 -23.62 58.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.74 0.816 . . . . 0.0 112.958 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 83.8 m -104.36 121.87 44.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.412 1.085 . . . . 0.0 110.755 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.82 145.83 29.53 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.056 1.342 . . . . 0.0 111.225 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.68 144.91 17.57 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.864 1.697 . . . . 0.0 109.563 167.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 t -132.67 121.29 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.364 1.866 . . . . 0.0 107.469 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.54 153.36 46.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.091 1.356 . . . . 0.0 112.013 -167.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.62 28.51 26.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.041 0.829 . . . . 0.0 113.607 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.94 161.65 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.381 1.472 . . . . 0.0 113.595 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.1 t -77.01 153.1 34.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.268 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.55 -16.8 63.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.442 -0.786 . . . . 0.0 112.261 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -96.2 -4.16 43.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.626 1.57 . . . . 0.0 114.528 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.9 m -65.05 138.15 58.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.643 1.177 . . . . 0.0 109.57 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -110.72 162.98 14.22 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.168 0.987 . . . . 0.0 111.464 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -57.67 -31.71 66.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.097 0.959 . . . . 0.0 111.172 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -67.32 -40.35 85.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.91 1.284 . . . . 0.0 112.066 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.49 -48.87 68.46 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.877 0.471 . . . . 0.0 110.284 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.75 -44.75 82.05 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.837 -0.539 . . . . 0.0 110.812 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.67 -44.13 97.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.213 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.05 -29.94 68.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.757 1.162 . . . . 0.0 112.922 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.95 -28.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.366 1.066 . . . . 0.0 111.894 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -100.43 -21.53 15.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.3 p -68.48 -17.7 64.24 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.383 1.447 . . . . 0.0 114.004 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -66.72 -13.49 61.39 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -97.27 -9.1 28.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.122 1.369 . . . . 0.0 113.756 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.2 -175.99 25.37 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.936 1.255 . . . . 0.0 114.837 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.34 134.83 17.72 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.428 3.419 . . . . 0.0 112.241 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 93.8 mt -124.39 125.93 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.695 1.598 . . . . 0.0 109.76 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.68 -34.75 24.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.921 1.288 . . . . 0.0 112.828 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -164.49 166.47 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.302 1.041 . . . . 0.0 112.569 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.7 t -147.55 135.75 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.901 2.08 . . . . 0.0 108.936 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.6 m -138.44 110.26 7.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.648 1.179 . . . . 0.0 111.506 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.61 144.76 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.5 t -106.17 135.87 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -127.37 155.92 42.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.36 1.464 . . . . 0.0 113.117 -170.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.98 150.96 38.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.272 1.029 . . . . 0.0 111.192 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -81.42 -23.66 37.39 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -123.64 -36.29 2.78 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.399 1.08 . . . . 0.0 112.723 -170.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.3 m -82.05 -23.62 35.74 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.685 0.794 . . . . 0.0 111.899 169.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . 0.257 90.0 mtt180 60.0 20.87 9.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.711 2.005 . . . . 0.0 115.321 169.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 46.9 ptt85 -94.29 164.76 12.9 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.059 1.743 . . . . 0.0 110.104 168.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 27.3 t -59.91 141.57 55.24 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 122.106 -0.371 . . . . 0.0 110.084 169.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -76.46 2.59 13.28 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.154 0.982 . . . . 0.0 112.681 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.54 18.95 57.77 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.517 1.056 . . . . 0.0 113.239 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -154.87 165.45 36.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.993 1.377 . . . . 0.0 113.971 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.33 173.03 17.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.786 2.034 . . . . 0.0 110.943 -169.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.64 151.83 49.74 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.245 1.418 . . . . 0.0 110.873 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.26 118.95 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.551 1.941 . . . . 0.0 108.177 -170.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -104.24 100.61 10.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.523 1.129 . . . . 0.0 110.906 -170.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -78.45 158.02 28.78 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.446 -0.783 . . . . 0.0 111.733 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -86.1 6.29 29.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.091 0.956 . . . . 0.0 113.136 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -159.16 139.69 12.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.516 1.527 . . . . 0.0 111.719 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.47 -31.59 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.984 0.914 . . . . 0.0 112.896 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.449 ' HA ' ' HE3' ' A' ' 173' ' ' LYS . 23.1 t70 -78.21 -28.82 48.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.321 0.964 . . . . 0.0 112.921 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -73.43 -28.2 61.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.515 0.726 . . . . 0.0 111.64 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.0 65.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.459 0.703 . . . . 0.0 111.371 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 170' ' ' ASP . 55.7 mtmt -59.58 -36.29 75.95 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 120.797 -1.19 . . . . 0.0 112.492 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -62.87 -64.4 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.122 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.51 68.56 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -60.2 -32.79 71.43 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.292 1.037 . . . . 0.0 112.986 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -91.1 -22.06 20.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.539 0.736 . . . . 0.0 112.441 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -80.23 -47.32 14.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.557 1.143 . . . . 0.0 113.098 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.23 -11.43 30.29 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -171.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -66.03 112.83 4.05 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.704 -1.247 . . . . 0.0 110.925 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.22 3.42 63.42 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.592 1.568 . . . . 0.0 114.794 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -76.97 170.23 16.89 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.855 1.827 . . . . 0.0 112.439 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.6 137.05 44.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.719 1.208 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 24.6 tp -148.0 116.91 6.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.701 1.6 . . . . 0.0 109.602 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 54.85 33.91 20.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.339 1.456 . . . . 0.0 112.45 -170.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.88 -17.95 8.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.157 1.361 . . . . 0.0 114.313 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.0 mmt-85 -76.66 135.99 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.445 1.123 . . . . 0.0 109.748 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.38 129.48 34.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -111.12 157.78 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 111.302 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -125.8 152.6 45.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.883 1.673 . . . . 0.0 109.327 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -142.53 137.96 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.148 0.979 . . . . 0.0 110.838 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -156.2 162.2 40.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.413 1.485 . . . . 0.0 111.882 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.17 143.99 36.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.996 0.918 . . . . 0.0 111.685 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.4 m -67.22 129.26 39.33 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.894 -1.129 . . . . 0.0 112.703 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.9 pt -83.67 -21.65 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.302 -0.874 . . . . 0.0 112.422 171.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 12.0 p -153.81 144.81 22.77 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.905 3.282 . . . . 0.0 107.209 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -162.7 168.77 21.08 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -81.16 -48.86 1.05 Allowed Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.268 1.427 . . . . 0.0 114.774 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.78 179.0 6.37 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.778 2.986 . . . . 0.0 111.425 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -137.71 143.04 41.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.929 1.292 . . . . 0.0 112.014 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.251 1.178 0 C-N-CA 126.266 1.826 . . . . 0.0 112.135 -170.537 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.213 0 O4'-C1'-N19 111.62 3.42 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.222 1 O4'-C1'-N19 112.462 4.262 . 0.099 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.121 0 C3'-C2'-C1' 103.66 2.4 . 0.264 2o . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.253 0 O4'-C1'-N19 111.751 3.551 . 0.085 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.241 0 O4'-C1'-N19 111.111 2.911 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.301 0 O4'-C1'-N19 110.224 2.024 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.5 p 55.46 17.75 2.34 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.088 2.155 . . . . 0.0 116.505 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.3 p -164.54 156.62 16.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.46 1.504 . . . . 0.0 112.183 -173.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.27 162.73 23.8 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.001 1.286 . . . . 0.0 112.981 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.0 m -148.53 151.08 34.5 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.147 1.379 . . . . 0.0 111.655 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.3 m -65.67 135.65 55.28 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.293 -0.88 . . . . 0.0 111.977 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.32 4.65 80.61 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.256 0.931 . . . . 0.0 114.752 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -62.92 129.97 42.74 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.979 1.389 . . . . 0.0 111.296 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.1 mtt85 -88.58 -1.77 58.24 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.919 1.287 . . . . 0.0 114.113 -170.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.63 148.81 34.88 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.594 1.558 . . . . 0.0 112.801 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 p30 31.69 58.25 1.17 Allowed Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 126.819 2.048 . . . . 0.0 116.338 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.72 146.86 49.53 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.538 2.826 . . . . 0.0 111.561 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -86.17 152.95 56.48 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.171 1.389 . . . . 0.0 112.604 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.96 144.32 57.08 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.249 3.299 . . . . 0.0 114.469 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -154.72 139.44 17.06 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.222 1.409 . . . . 0.0 110.359 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 58.6 m -55.67 -30.39 60.97 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.066 1.346 . . . . 0.0 112.597 170.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 t -87.59 130.8 34.63 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.178 0.991 . . . . 0.0 110.912 171.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.6 mt -118.3 145.77 44.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.327 1.851 . . . . 0.0 110.412 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.98 148.65 18.88 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.775 1.655 . . . . 0.0 110.542 167.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.64 130.86 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.342 1.857 . . . . 0.0 108.221 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.74 152.12 48.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.031 0.932 . . . . 0.0 111.41 -168.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.69 32.63 18.13 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 123.765 0.697 . . . . 0.0 113.668 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.5 159.52 21.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.994 1.318 . . . . 0.0 113.252 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.3 t -76.02 156.37 34.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.681 169.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.52 -19.26 63.72 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.505 -0.747 . . . . 0.0 112.127 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -94.05 -4.6 49.17 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.573 1.549 . . . . 0.0 114.282 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -66.97 132.93 48.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.465 1.106 . . . . 0.0 109.256 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.9 p -106.54 162.79 13.42 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.279 1.032 . . . . 0.0 111.153 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -60.7 -27.97 68.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.958 0.503 . . . . 0.0 111.22 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -70.94 -37.67 72.86 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.583 1.153 . . . . 0.0 112.514 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.83 -47.63 71.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.662 0.665 . . . . 0.0 110.438 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.1 -44.38 83.17 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.819 -0.55 . . . . 0.0 110.647 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -61.89 -41.68 98.18 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.419 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.17 -32.84 72.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.313 1.415 . . . . 0.0 112.689 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -77.42 -29.2 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.556 1.143 . . . . 0.0 111.933 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -99.99 -24.58 14.58 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.141 0.882 . . . . 0.0 113.364 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.9 m -69.33 -19.79 63.87 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.235 1.379 . . . . 0.0 113.693 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -70.19 -7.23 40.18 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.964 -1.085 . . . . 0.0 113.909 173.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -102.32 -5.57 24.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.456 1.502 . . . . 0.0 113.753 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.41 -175.65 24.86 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.385 1.469 . . . . 0.0 114.969 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.57 135.75 20.39 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.324 3.349 . . . . 0.0 112.476 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.51 127.71 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.767 1.627 . . . . 0.0 110.121 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.29 -32.03 19.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.933 1.293 . . . . 0.0 112.837 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -163.59 166.16 22.72 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.9 t -146.55 136.14 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 127.062 2.145 . . . . 0.0 108.161 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.8 m -133.0 110.24 10.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.037 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.0 mt -80.03 143.29 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.09 128.5 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.93 149.43 42.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.185 1.394 . . . . 0.0 112.496 -173.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.57 143.08 48.41 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.939 0.895 . . . . 0.0 111.281 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -76.14 -22.93 54.88 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -119.46 -34.73 3.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.456 1.102 . . . . 0.0 112.658 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 72.3 m -83.11 -20.06 35.55 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.476 -0.765 . . . . 0.0 112.497 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 54.18 45.43 27.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.229 1.812 . . . . 0.0 112.659 170.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -138.15 156.89 47.29 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 129.336 3.054 . . . . 0.0 108.865 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.4 t -58.2 137.95 56.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.122 0.487 . . . . 0.0 111.289 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -79.22 -5.44 54.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.95 0.9 . . . . 0.0 112.773 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.17 14.63 62.01 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.777 1.18 . . . . 0.0 113.766 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.05 160.92 41.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.554 1.169 . . . . 0.0 113.148 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.93 15.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.381 1.873 . . . . 0.0 111.517 -168.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.44 152.1 42.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.404 1.482 . . . . 0.0 110.627 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.42 128.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.125 1.77 . . . . 0.0 109.071 -169.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.65 100.41 9.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.865 1.266 . . . . 0.0 111.826 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -76.78 159.06 30.43 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.576 -0.703 . . . . 0.0 111.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.27 3.72 45.58 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.954 0.902 . . . . 0.0 113.134 172.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -160.83 139.97 10.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.555 1.542 . . . . 0.0 111.67 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.79 -31.6 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.52 0.728 . . . . 0.0 112.567 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.62 -23.22 56.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.279 0.945 . . . . 0.0 113.12 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -82.52 -30.32 29.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.858 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.71 76.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.336 0.654 . . . . 0.0 111.458 169.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -61.54 -32.66 72.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.641 1.176 . . . . 0.0 112.489 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.94 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.889 0.876 . . . . 0.0 109.663 171.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.04 69.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.24 -34.27 74.86 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.932 0.893 . . . . 0.0 112.651 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -87.95 -23.62 23.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.557 0.743 . . . . 0.0 112.272 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -77.81 -45.8 23.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.51 1.124 . . . . 0.0 113.037 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.1 -12.34 21.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -65.66 112.83 3.85 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.615 -1.303 . . . . 0.0 110.861 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.17 8.58 71.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.495 1.522 . . . . 0.0 114.595 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.9 ptm -76.35 173.85 10.93 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.811 1.805 . . . . 0.0 111.523 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.61 135.16 54.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.296 1.039 . . . . 0.0 111.27 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -143.12 117.36 9.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.769 1.628 . . . . 0.0 109.224 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 29.0 t70 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.168 1.387 . . . . 0.0 112.45 -169.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.64 -5.18 65.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.648 1.118 . . . . 0.0 114.66 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.6 mmt-85 -92.05 129.62 37.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.891 1.346 . . . . 0.0 109.931 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.91 128.33 35.24 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.135 170.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -107.35 155.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 111.671 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -115.21 148.52 39.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.395 1.878 . . . . 0.0 108.64 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.8 t -144.73 136.44 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.46 1.104 . . . . 0.0 110.499 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.17 158.47 36.33 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.954 1.302 . . . . 0.0 112.438 -170.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -72.8 138.08 46.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.661 0.784 . . . . 0.0 111.822 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.3 m -72.33 130.46 40.82 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.3 pt -91.76 -14.94 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.733 1.213 . . . . 0.0 113.24 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.7 p -158.31 167.45 29.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.817 3.247 . . . . 0.0 108.416 -171.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -152.75 161.11 42.99 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -66.54 -46.39 58.32 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -83.07 158.98 15.5 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.579 2.853 . . . . 0.0 111.384 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -96.04 145.83 25.14 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.437 1.095 . . . . 0.0 113.055 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.263 1.825 . . . . 0.0 110.715 -178.859 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.351 1 O4'-C1'-N19 113.294 5.094 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.093 0 O4'-C1'-N19 111.533 3.333 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.178 0 O4'-C1'-N19 111.926 3.726 . 0.35 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 O4'-C1'-N19 111.347 3.147 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.601 0 O4'-C1'-N19 111.168 2.968 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.162 0 O4'-C1'-N19 111.624 3.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.583 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.9 p -164.55 174.91 10.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.319 1.448 . . . . 0.0 111.704 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 p -78.55 10.02 3.54 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.035 1.334 . . . . 0.0 113.839 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.42 -2.98 29.96 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.05 1.31 . . . . 0.0 115.177 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.4 p -147.83 17.68 1.12 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.827 1.651 . . . . 0.0 113.02 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.5 p -159.16 160.14 35.18 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.567 -1.333 . . . . 0.0 113.675 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.58 176.83 53.54 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.602 1.096 . . . . 0.0 113.18 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -152.88 127.68 9.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.122 0.969 . . . . 0.0 111.653 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -66.36 -20.33 66.05 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.797 1.239 . . . . 0.0 113.47 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.68 23.88 10.62 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.107 1.763 . . . . 0.0 114.386 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -171.94 63.85 0.36 Allowed Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 130.148 3.379 . . . . 0.0 110.294 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -75.4 178.95 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.593 2.862 . . . . 0.0 111.18 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -144.94 139.59 15.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.394 1.478 . . . . 0.0 110.048 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -48.26 136.95 24.69 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.575 3.517 . . . . 0.0 115.529 -171.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -156.84 141.4 16.77 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.719 1.607 . . . . 0.0 109.625 -171.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 96.4 m -58.92 -28.17 65.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.624 0.77 . . . . 0.0 112.224 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 71.8 m -87.52 124.05 33.07 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.707 1.203 . . . . 0.0 110.593 174.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -112.06 142.47 44.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.89 1.676 . . . . 0.0 110.151 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.61 145.05 17.57 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.497 1.522 . . . . 0.0 110.255 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.93 119.61 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.049 1.74 . . . . 0.0 107.814 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -126.47 158.85 35.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.406 1.482 . . . . 0.0 111.998 -167.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.56 25.03 55.11 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.127 0.87 . . . . 0.0 113.6 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.24 154.41 37.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.884 1.273 . . . . 0.0 113.342 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.8 t -72.67 143.24 48.18 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.778 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.02 -12.5 51.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -100.92 3.93 42.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.998 1.719 . . . . 0.0 114.032 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -63.46 143.04 58.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 109.806 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.5 p -110.96 159.71 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.681 0.792 . . . . 0.0 111.618 170.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.52 -30.79 67.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.889 0.876 . . . . 0.0 111.041 172.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -69.08 -38.33 78.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.748 1.219 . . . . 0.0 112.359 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -65.11 -48.05 75.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.486 0.585 . . . . 0.0 110.169 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.3 mt -59.01 -42.23 89.61 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.77 -0.581 . . . . 0.0 111.193 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.25 -45.91 92.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.107 0.867 . . . . 0.0 111.382 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -67.68 -31.32 71.21 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.406 1.457 . . . . 0.0 112.744 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.7 -29.22 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.521 1.128 . . . . 0.0 112.547 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -100.57 -27.8 13.22 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.1 p -73.31 -12.58 60.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 120.456 1.48 . . . . 0.0 114.311 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -67.64 -10.32 51.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.952 -1.092 . . . . 0.0 113.434 168.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -102.79 -7.89 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.479 1.511 . . . . 0.0 114.084 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.05 -175.95 31.35 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.597 1.094 . . . . 0.0 115.377 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.31 137.66 19.12 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.313 3.342 . . . . 0.0 112.036 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 73.4 mt -134.24 124.58 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.679 1.592 . . . . 0.0 109.902 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.2 -24.77 18.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.304 1.042 . . . . 0.0 113.557 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.38 159.73 28.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.725 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.9 t -150.83 136.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.354 2.261 . . . . 0.0 108.273 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.7 t -146.25 122.76 11.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.528 0.731 . . . . 0.0 112.024 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.62 143.96 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.363 1.065 . . . . 0.0 108.596 172.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.2 t -104.25 135.13 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.26 1.024 . . . . 0.0 110.205 -170.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -127.56 151.26 49.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.571 1.548 . . . . 0.0 112.879 -171.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -70.91 141.2 51.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.64 1.176 . . . . 0.0 111.421 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -78.22 -20.53 51.59 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -175.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -114.61 -38.74 3.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.415 1.086 . . . . 0.0 112.187 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.5 m -84.41 -16.24 43.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.802 0.841 . . . . 0.0 113.042 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 53.17 41.94 32.15 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.333 1.853 . . . . 0.0 113.323 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -134.6 153.37 52.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.077 2.551 . . . . 0.0 109.281 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.9 t -60.51 137.26 58.18 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 111.232 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -77.6 1.38 19.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.032 0.933 . . . . 0.0 112.986 173.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.65 17.21 58.77 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.431 1.015 . . . . 0.0 113.755 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -154.53 166.7 32.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.937 1.351 . . . . 0.0 114.204 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.41 171.51 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.945 2.098 . . . . 0.0 111.056 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.47 150.7 48.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.146 1.378 . . . . 0.0 111.065 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.0 t -135.63 120.25 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.482 1.913 . . . . 0.0 108.303 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -107.17 100.69 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.57 1.148 . . . . 0.0 111.053 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.69 161.94 29.18 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.787 0.835 . . . . 0.0 111.983 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -94.13 7.61 44.6 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.289 1.036 . . . . 0.0 112.851 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.13 130.49 7.93 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.515 1.526 . . . . 0.0 111.571 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.26 -28.96 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.897 0.879 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.87 -24.5 48.51 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.407 1.003 . . . . 0.0 113.27 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -81.61 -29.46 33.28 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.802 0.841 . . . . 0.0 111.76 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.92 83.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.191 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -59.85 -34.38 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.283 1.033 . . . . 0.0 112.631 172.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.53 -62.85 1.22 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.773 0.829 . . . . 0.0 109.845 173.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.87 -35.2 70.64 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.27 -33.66 71.31 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.306 1.042 . . . . 0.0 112.852 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -89.05 -24.11 22.4 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.682 0.793 . . . . 0.0 112.307 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -78.79 -45.06 21.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.425 1.09 . . . . 0.0 113.152 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.1 -11.82 27.57 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.56 113.07 3.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.594 -1.316 . . . . 0.0 110.904 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.54 7.29 72.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.26 1.409 . . . . 0.0 114.733 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptm -76.22 173.16 11.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.693 1.746 . . . . 0.0 111.278 170.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -115.55 135.47 54.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.162 0.985 . . . . 0.0 111.028 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.9 tp -141.46 121.25 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 109.797 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.65 25.87 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.761 1.625 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.86 19.41 57.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.562 1.077 . . . . 0.0 114.445 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -131.7 132.12 43.66 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.544 1.538 . . . . 0.0 110.19 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.91 133.02 46.09 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.724 -0.61 . . . . 0.0 110.518 174.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.9 pt -111.0 159.0 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.887 0.875 . . . . 0.0 111.797 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -126.31 145.28 50.49 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.855 2.062 . . . . 0.0 108.857 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.36 134.46 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 118.968 0.803 . . . . 0.0 111.396 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -152.76 162.97 40.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 111.236 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -70.22 142.76 52.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.696 0.799 . . . . 0.0 111.655 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.6 m -63.47 124.07 20.38 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.276 -0.89 . . . . 0.0 112.634 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 13.0 pt -81.8 -22.06 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.86 0.864 . . . . 0.0 112.549 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.9 p -144.92 151.18 38.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.719 2.807 . . . . 0.0 107.12 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.07 155.89 37.69 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.808 0.843 . . . . 0.0 113.178 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.67 -41.6 9.73 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -172.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.6 146.1 23.84 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.093 2.529 . . . . 0.0 110.823 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -149.54 6.55 0.64 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -172.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 55.8 m . . . . . 0 C--O 1.251 1.135 0 C-N-CA 126.542 1.937 . . . . 0.0 110.77 -175.779 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.481 1 O4'-C1'-N19 114.868 6.668 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.228 0 O4'-C1'-N19 111.632 3.432 . 0.071 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 0 C4'-C3'-C2' 101.134 -1.566 . 0.165 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.079 1 O4'-C1'-N19 112.217 4.017 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.291 0 C5'-C4'-C3' 109.949 -3.701 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.1 0 C5'-C4'-C3' 111.652 -2.566 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.482 ' N ' ' HG ' ' A' ' 108' ' ' SER . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 p -140.56 -0.34 1.57 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.8 p -169.01 144.89 3.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.023 1.329 . . . . 0.0 111.888 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.94 -61.74 2.94 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 125.326 1.441 . . . . 0.0 113.738 171.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.4 m -92.83 9.26 36.05 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.728 1.611 . . . . 0.0 112.275 172.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.482 ' HG ' ' N ' ' A' ' 103' ' ' GLY . 69.1 m -156.92 137.97 13.57 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.924 2.09 . . . . 0.0 109.847 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.43 140.07 22.38 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.899 0.761 . . . . 0.0 111.715 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -161.98 133.2 5.22 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.411 1.084 . . . . 0.0 111.126 -173.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -2.21 21.96 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.98 26.88 4.87 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.312 1.445 . . . . 0.0 113.113 167.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 p30 178.99 58.39 0.07 OUTLIER Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 130.886 3.674 . . . . 0.0 112.505 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -78.67 -175.37 2.7 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 123.969 3.113 . . . . 0.0 111.167 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -146.95 136.8 11.95 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.868 1.267 . . . . 0.0 110.732 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.91 130.73 40.71 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.228 3.286 . . . . 0.0 113.623 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -161.04 167.67 25.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.142 1.377 . . . . 0.0 111.635 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 56.1 m -67.95 -14.15 62.73 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -171.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.7 m -98.45 128.15 44.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.447 1.099 . . . . 0.0 110.109 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.3 mt -115.44 146.76 41.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.281 1.433 . . . . 0.0 110.702 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.79 149.45 17.26 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.147 1.832 . . . . 0.0 110.614 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.6 t -136.67 129.23 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.028 2.131 . . . . 0.0 107.853 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -133.83 154.72 50.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.38 1.072 . . . . 0.0 112.684 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.45 30.21 50.26 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.056 0.836 . . . . 0.0 114.074 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.46 160.93 23.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.48 1.512 . . . . 0.0 113.521 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.1 t -72.34 155.09 40.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.013 0.925 . . . . 0.0 111.861 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.59 -17.61 62.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.457 0.703 . . . . 0.0 112.628 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -96.17 -5.55 40.31 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.083 1.353 . . . . 0.0 114.402 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.7 m -69.29 136.29 51.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.6 p -106.88 164.83 11.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.639 1.175 . . . . 0.0 111.484 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -59.26 -30.22 68.13 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.629 0.772 . . . . 0.0 111.147 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -70.61 -38.64 73.99 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.597 1.159 . . . . 0.0 112.166 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -66.36 -48.41 70.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.267 0.485 . . . . 0.0 110.341 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.0 mt -56.69 -44.79 81.83 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.815 -0.553 . . . . 0.0 110.941 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -60.97 -45.67 93.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.131 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -67.14 -29.05 68.66 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.227 1.376 . . . . 0.0 112.878 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -80.33 -27.68 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.44 1.096 . . . . 0.0 112.046 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -100.48 -23.73 14.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.4 p -70.39 -17.73 63.03 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.242 1.383 . . . . 0.0 113.911 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.57 -11.24 52.22 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 170.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -100.72 -7.14 24.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.376 1.47 . . . . 0.0 113.717 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.21 -178.47 24.82 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.221 1.391 . . . . 0.0 115.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.99 135.6 21.38 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.561 3.507 . . . . 0.0 112.668 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.47 124.26 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.062 1.745 . . . . 0.0 109.654 -174.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.12 -23.26 20.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.349 1.06 . . . . 0.0 113.493 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -161.48 162.44 30.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.0 t -151.28 135.49 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.236 2.214 . . . . 0.0 107.956 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.4 m -137.97 116.73 12.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.752 1.221 . . . . 0.0 111.393 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.84 147.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.1 t -96.95 127.68 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.111 0.964 . . . . 0.0 108.827 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.32 152.5 38.87 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.152 1.381 . . . . 0.0 112.137 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -77.28 151.55 34.99 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.343 0.657 . . . . 0.0 112.299 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -79.96 -23.67 41.48 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -122.37 -35.6 3.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.087 0.955 . . . . 0.0 112.756 -171.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 71.1 m -84.84 -23.45 29.03 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.522 -0.736 . . . . 0.0 112.428 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . 0.25 84.6 mtt180 58.42 23.57 10.77 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.47 1.908 . . . . 0.0 114.937 169.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 46.1 ptt85 -100.19 168.2 9.96 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.084 2.154 . . . . 0.0 110.097 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.5 t -58.97 141.18 54.5 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.91 0.385 . . . . 0.0 110.093 168.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -84.08 1.29 44.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.44 1.096 . . . . 0.0 112.858 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.97 8.81 62.98 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.707 1.146 . . . . 0.0 114.241 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -144.96 161.35 39.57 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.747 1.273 . . . . 0.0 113.424 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.1 13.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.051 1.74 . . . . 0.0 111.815 -168.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -145.69 156.27 43.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.999 1.72 . . . . 0.0 110.853 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.95 134.33 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.369 1.867 . . . . 0.0 109.171 -169.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.16 99.18 6.71 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.238 1.415 . . . . 0.0 111.078 -171.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -79.58 158.91 27.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.02 0.928 . . . . 0.0 112.202 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.81 3.52 50.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.741 1.217 . . . . 0.0 113.063 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -157.99 137.35 11.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.563 1.545 . . . . 0.0 111.246 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.22 -32.83 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.318 0.647 . . . . 0.0 112.673 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.4 -24.42 54.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.901 0.773 . . . . 0.0 113.014 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.97 -29.15 35.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.307 1.043 . . . . 0.0 111.914 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.6 73.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.211 0.604 . . . . 0.0 110.97 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -59.78 -35.24 74.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.409 1.084 . . . . 0.0 112.502 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.22 -64.39 0.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.032 0.933 . . . . 0.0 110.015 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.11 -35.56 69.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.61 -34.5 72.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.172 0.989 . . . . 0.0 112.83 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -88.48 -24.71 22.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.611 0.764 . . . . 0.0 112.197 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -78.22 -45.57 22.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.429 1.092 . . . . 0.0 113.164 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.67 -11.43 29.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -66.02 112.98 4.12 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.611 -1.305 . . . . 0.0 111.106 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.68 8.68 73.08 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.35 1.452 . . . . 0.0 114.609 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 ptm -75.91 173.65 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.739 1.77 . . . . 0.0 111.435 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -117.38 134.54 54.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.204 1.002 . . . . 0.0 111.057 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.6 tp -143.7 118.87 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.51 1.524 . . . . 0.0 109.389 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 54.77 31.78 16.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.404 1.481 . . . . 0.0 112.44 -169.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.42 -4.87 66.01 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.694 1.14 . . . . 0.0 114.504 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.7 mmt-85 -92.98 130.06 38.68 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.933 1.367 . . . . 0.0 109.897 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.48 130.17 40.03 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.094 0.861 . . . . 0.0 109.817 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -109.08 160.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.027 0.931 . . . . 0.0 111.08 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.6 mtm-85 -127.81 156.31 42.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.481 1.112 . . . . 0.0 109.775 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.9 t -143.96 140.26 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.781 1.232 . . . . 0.0 110.962 -168.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.8 161.46 40.64 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.374 1.47 . . . . 0.0 112.151 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -72.66 137.79 46.27 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.03 0.932 . . . . 0.0 111.561 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 t -75.54 130.81 39.45 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.25 -0.906 . . . . 0.0 112.56 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.3 pt -93.4 -16.03 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.505 1.122 . . . . 0.0 113.523 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 16.7 p -154.65 161.77 41.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 129.716 3.207 . . . . 0.0 108.278 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -160.18 165.77 30.96 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.23 -52.01 50.06 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.06 151.6 39.47 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.181 2.587 . . . . 0.0 111.447 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -70.12 -18.25 63.23 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.369 1.868 . . . . 0.0 111.843 -175.391 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.235 1 O4'-C1'-N19 113.494 5.294 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.433 0 O4'-C1'-N19 111.888 3.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 0 C4'-C3'-C2' 99.96 -2.74 . 0.38 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 O5'-C5'-C4' 114.81 3.293 . 0.0 OUTLIER '7D dist 2z wannabe' 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.252 0 O4'-C1'-N19 112.066 3.866 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.058 0 C5'-C4'-C3' 110.301 -3.466 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.2 p -95.6 -2.66 47.84 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.833 1.253 . . . . 0.0 114.338 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 91.6 p -160.98 166.13 28.79 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.627 1.571 . . . . 0.0 112.084 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.51 -159.11 42.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.509 1.052 . . . . 0.0 112.962 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -160.78 153.55 21.03 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.074 1.35 . . . . 0.0 112.012 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -145.55 19.98 1.51 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.2 28.14 50.13 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 121.122 -0.986 . . . . 0.0 113.406 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -74.95 -2.86 28.99 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.477 1.511 . . . . 0.0 114.649 -171.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 72.54 9.69 5.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.892 2.477 . . . . 0.0 114.126 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.91 165.56 17.55 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.424 1.49 . . . . 0.0 111.979 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.8 m120 44.92 62.12 10.82 Favored Pre-proline 0 N--CA 1.485 1.313 0 C-N-CA 125.667 1.587 . . . . 0.0 114.655 171.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.16 168.47 24.67 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.829 3.019 . . . . 0.0 111.566 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -144.4 151.35 50.78 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 126.039 1.736 . . . . 0.0 110.49 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -50.22 140.61 33.17 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 124.536 3.491 . . . . 0.0 115.115 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -159.35 138.46 11.16 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.286 1.434 . . . . 0.0 110.245 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.7 m -57.35 -26.71 61.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.35 1.06 . . . . 0.0 112.612 170.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.9 m -90.0 114.58 26.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.555 1.542 . . . . 0.0 110.159 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.3 mt -102.17 146.94 27.25 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.627 1.171 . . . . 0.0 111.295 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.02 148.86 16.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.322 1.915 . . . . 0.0 110.47 168.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.54 124.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.192 1.797 . . . . 0.0 108.011 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -132.12 155.19 48.58 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.892 1.277 . . . . 0.0 111.91 -167.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.14 29.96 43.93 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.886 0.755 . . . . 0.0 113.398 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.79 163.84 25.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.485 1.514 . . . . 0.0 113.168 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.8 t -76.06 154.51 35.59 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.005 168.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.0 -18.57 64.76 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.225 -0.922 . . . . 0.0 112.244 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -96.93 -1.43 45.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.846 1.658 . . . . 0.0 114.589 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 93.4 m -63.1 137.7 58.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.383 1.073 . . . . 0.0 109.611 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 p -110.34 161.64 15.43 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.861 0.864 . . . . 0.0 111.556 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.65 -27.22 68.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.336 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -69.61 -39.84 76.99 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.633 1.173 . . . . 0.0 112.251 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -65.88 -47.96 73.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.227 0.467 . . . . 0.0 110.315 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.0 mt -56.8 -44.36 81.87 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.764 -0.585 . . . . 0.0 110.921 174.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -63.17 -41.1 99.18 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.49 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.45 -31.12 69.24 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.174 1.352 . . . . 0.0 112.62 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.79 -28.91 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.374 1.07 . . . . 0.0 112.393 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -100.58 -27.47 13.39 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.1 p -71.83 -15.42 62.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.307 1.412 . . . . 0.0 114.109 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.9 -11.13 55.12 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.95 -1.094 . . . . 0.0 113.751 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -102.85 -5.18 23.86 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.302 1.441 . . . . 0.0 114.061 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.2 28.4 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.785 1.183 . . . . 0.0 115.307 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.5 135.42 18.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.313 3.342 . . . . 0.0 112.227 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.51 127.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.658 1.583 . . . . 0.0 110.187 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.91 -28.19 19.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.121 1.369 . . . . 0.0 113.325 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -162.61 167.08 23.8 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -149.38 137.16 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.448 2.299 . . . . 0.0 108.338 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.1 m -135.4 113.54 11.3 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.467 1.107 . . . . 0.0 111.635 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.34 144.97 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.294 -0.879 . . . . 0.0 108.835 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.5 t -105.51 133.51 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.338 1.055 . . . . 0.0 109.935 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -127.53 152.72 47.24 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.489 1.516 . . . . 0.0 112.958 -170.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.69 140.34 53.55 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.608 1.163 . . . . 0.0 111.535 172.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -71.87 -21.29 61.68 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.39 1.076 . . . . 0.0 113.807 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -126.72 -35.18 2.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.135 0.974 . . . . 0.0 112.781 -171.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.2 m -81.72 -15.2 55.16 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.424 -0.798 . . . . 0.0 112.844 171.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 53.58 40.23 31.15 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.357 1.863 . . . . 0.0 113.383 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -132.58 153.06 51.39 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.732 2.413 . . . . 0.0 109.476 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.2 t -59.96 137.83 57.98 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 122.013 -0.429 . . . . 0.0 111.286 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -76.89 0.45 20.87 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.654 0.781 . . . . 0.0 112.819 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.28 15.26 57.6 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 124.983 1.278 . . . . 0.0 113.721 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.53 165.15 36.02 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.948 1.356 . . . . 0.0 114.448 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.18 172.2 18.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.416 1.886 . . . . 0.0 111.509 -169.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.87 156.33 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.603 1.561 . . . . 0.0 110.908 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.84 131.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.801 2.04 . . . . 0.0 108.726 -168.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -114.79 97.5 6.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.688 1.195 . . . . 0.0 111.517 -170.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -76.57 156.89 32.45 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.105 0.562 . . . . 0.0 111.592 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -86.78 3.82 43.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.775 0.83 . . . . 0.0 113.189 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -160.64 143.38 13.02 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.537 1.535 . . . . 0.0 111.781 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.13 -31.72 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -74.48 -28.58 61.08 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.583 1.083 . . . . 0.0 112.859 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -75.42 -30.71 60.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.921 0.888 . . . . 0.0 111.673 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.97 -43.62 67.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.695 0.798 . . . . 0.0 111.444 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -59.33 -35.16 73.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.248 1.019 . . . . 0.0 112.419 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.17 -64.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.161 0.984 . . . . 0.0 110.163 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.3 69.54 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.41 -33.82 71.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.503 1.121 . . . . 0.0 112.845 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -89.34 -21.63 23.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.674 0.789 . . . . 0.0 112.391 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -81.17 -44.73 17.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.546 1.138 . . . . 0.0 113.071 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.7 -12.07 26.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -172.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -64.68 114.79 4.66 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.682 -1.261 . . . . 0.0 111.024 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.04 4.85 77.8 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.472 1.51 . . . . 0.0 114.695 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.4 ptm -73.25 169.18 17.63 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.839 1.82 . . . . 0.0 111.373 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -106.24 134.96 48.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.706 0.803 . . . . 0.0 110.975 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 46.7 tp -144.86 123.22 12.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.81 1.644 . . . . 0.0 109.327 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 55.25 33.57 20.93 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.099 1.36 . . . . 0.0 112.649 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.21 4.61 89.84 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.781 1.181 . . . . 0.0 114.601 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.8 mmt-85 -113.28 131.67 55.84 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.243 1.417 . . . . 0.0 110.431 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.43 131.08 44.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.91 0.777 . . . . 0.0 109.196 168.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.4 pt -110.68 160.19 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.733 0.813 . . . . 0.0 112.064 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -119.82 148.14 43.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.13 1.772 . . . . 0.0 108.919 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -141.95 135.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.316 1.047 . . . . 0.0 110.395 -172.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -156.57 165.52 36.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.222 1.409 . . . . 0.0 111.884 -170.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -80.87 141.95 34.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.371 1.068 . . . . 0.0 111.634 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.2 m -68.9 128.86 38.18 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.004 -1.06 . . . . 0.0 112.68 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.1 pt -87.73 -19.54 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.32 1.048 . . . . 0.0 112.474 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.0 p -154.02 154.17 33.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 130.302 3.441 . . . . 0.0 107.544 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -159.29 166.28 31.58 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -172.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -65.25 -53.54 39.13 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -81.53 159.66 19.49 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.416 2.744 . . . . 0.0 111.979 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -158.53 146.82 18.45 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.283 1.433 . . . . 0.0 112.298 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.362 1.865 . . . . 0.0 110.767 -178.53 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.394 0 C4'-C3'-C2' 100.417 -2.283 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 110.842 2.642 . 0.491 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 O5'-C5'-C4' 114.033 2.738 . 0.533 5z . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 0 O5'-C5'-C4' 114.145 2.818 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.283 1 O4'-C1'-N19 112.352 4.152 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.092 0 C5'-C4'-C3' 111.216 -2.856 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 m -86.51 -9.37 56.33 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.6 m -168.57 163.25 12.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.555 2.342 . . . . 0.0 110.212 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.03 -61.83 4.29 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 125.061 1.315 . . . . 0.0 112.532 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.9 m -78.69 -8.63 58.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.658 1.183 . . . . 0.0 112.663 171.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.0 m -149.23 150.3 32.37 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.526 2.331 . . . . 0.0 109.599 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.38 145.69 34.86 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.495 0.569 . . . . 0.0 112.112 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -155.07 127.61 7.93 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.589 1.155 . . . . 0.0 110.733 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -67.73 -15.11 63.48 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.38 37.65 1.0 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.519 1.528 . . . . 0.0 113.432 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -178.15 66.03 0.19 Allowed Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 129.128 2.971 . . . . 0.0 111.682 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.24 168.08 25.64 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.608 2.872 . . . . 0.0 111.304 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -155.49 141.55 12.95 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.51 1.524 . . . . 0.0 109.702 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.53 136.78 33.22 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.252 3.301 . . . . 0.0 114.742 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -155.59 150.91 26.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.413 1.485 . . . . 0.0 110.093 -172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.1 m -67.1 -5.65 14.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.119 1.368 . . . . 0.0 114.006 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 27.3 p -132.51 151.82 51.77 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.703 1.201 . . . . 0.0 112.002 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.0 mt -126.48 151.58 47.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.893 2.077 . . . . 0.0 110.539 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.84 149.71 18.14 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.131 1.824 . . . . 0.0 110.496 167.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.8 129.49 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.396 1.878 . . . . 0.0 107.889 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -136.73 150.6 48.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.815 0.846 . . . . 0.0 111.641 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.19 32.6 19.84 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.923 0.773 . . . . 0.0 113.26 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.9 mt -77.34 162.83 26.98 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.36 1.464 . . . . 0.0 113.642 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -78.91 152.52 31.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.792 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -16.75 63.31 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.427 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.57 -5.06 52.44 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.465 1.506 . . . . 0.0 114.288 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -67.71 135.42 52.71 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.476 1.111 . . . . 0.0 109.615 172.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.5 p -118.02 163.85 15.98 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.747 1.219 . . . . 0.0 110.761 172.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.77 -24.54 65.85 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.444 0.697 . . . . 0.0 111.725 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -58.02 -45.78 86.37 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.965 1.706 . . . . 0.0 111.774 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.92 -48.32 46.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.914 0.885 . . . . 0.0 110.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.57 -38.62 81.63 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.323 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -62.05 -45.97 91.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.239 0.927 . . . . 0.0 112.054 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.92 -31.01 69.6 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.097 1.317 . . . . 0.0 112.771 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.4 t -80.12 -30.58 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.603 1.161 . . . . 0.0 112.484 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -100.6 -25.59 14.11 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.7 p -71.29 -14.21 62.14 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.388 1.449 . . . . 0.0 113.91 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -67.2 -14.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.948 -1.095 . . . . 0.0 113.586 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.71 -8.54 34.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.009 1.324 . . . . 0.0 113.718 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -177.82 25.93 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.102 1.334 . . . . 0.0 114.65 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.98 135.48 25.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.327 3.351 . . . . 0.0 112.272 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.54 132.76 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.891 1.676 . . . . 0.0 110.504 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.81 -28.8 15.07 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.105 1.362 . . . . 0.0 113.111 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -164.3 164.45 22.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.008 0.923 . . . . 0.0 113.007 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.9 t -147.9 132.01 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.074 2.15 . . . . 0.0 107.732 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 56.6 m -132.63 104.83 6.85 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 80.5 mt -81.21 138.82 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 168.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.6 t -94.72 123.11 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -115.49 156.03 26.42 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.061 1.344 . . . . 0.0 112.083 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.81 161.95 28.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.877 0.871 . . . . 0.0 112.85 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -87.9 -28.39 21.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -115.81 -41.97 3.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.977 0.808 . . . . 0.0 112.793 -169.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.5 p -88.19 -23.73 23.51 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.45 0.7 . . . . 0.0 112.586 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 61.51 22.61 13.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.623 1.969 . . . . 0.0 114.088 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.8 mtm180 -79.55 159.57 26.82 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.868 2.067 . . . . 0.0 110.142 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -62.17 136.71 58.06 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.829 -0.544 . . . . 0.0 109.832 168.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -81.19 1.64 31.2 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.958 0.903 . . . . 0.0 113.032 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.38 10.18 62.41 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.626 1.107 . . . . 0.0 114.261 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -150.99 162.86 40.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.793 1.282 . . . . 0.0 113.484 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.82 172.72 17.73 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.237 1.815 . . . . 0.0 111.686 -169.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.78 155.1 46.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.823 1.649 . . . . 0.0 110.396 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.9 132.61 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.758 1.623 . . . . 0.0 109.298 -168.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -116.92 107.62 14.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.779 1.232 . . . . 0.0 111.996 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -85.52 157.55 20.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.411 1.085 . . . . 0.0 111.39 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -83.84 7.73 17.07 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.955 0.902 . . . . 0.0 113.18 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -160.89 143.44 12.67 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.774 1.629 . . . . 0.0 111.281 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.88 -33.8 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.525 0.73 . . . . 0.0 112.492 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.44 -25.53 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -78.91 -28.29 43.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.115 0.966 . . . . 0.0 111.968 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.6 64.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.547 0.739 . . . . 0.0 111.017 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -59.31 -36.97 76.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 0.0 112.285 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.05 -65.19 0.73 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.524 0.729 . . . . 0.0 109.944 170.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.0 65.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -61.57 -25.04 67.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.624 1.17 . . . . 0.0 113.329 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.28 4.59 36.72 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.612 1.565 . . . . 0.0 113.007 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -107.91 -52.23 2.79 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.21 1.404 . . . . 0.0 113.02 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.01 46.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -65.83 112.4 3.73 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.851 -1.156 . . . . 0.0 111.171 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.27 7.73 69.44 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.087 1.803 . . . . 0.0 114.746 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.3 ptm -75.58 162.22 28.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.75 1.775 . . . . 0.0 112.816 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.36 133.02 34.15 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.215 . . . . 0.0 110.733 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.3 tp -145.53 111.4 5.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 109.085 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.4 t70 54.36 36.23 24.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.235 1.414 . . . . 0.0 112.064 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.83 -22.01 6.14 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.287 1.422 . . . . 0.0 114.224 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -73.18 141.34 47.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.29 1.045 . . . . 0.0 110.322 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -85.3 126.05 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.2 pt -106.07 139.32 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.238 0.615 . . . . 0.0 111.294 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.11 146.78 23.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.655 1.182 . . . . 0.0 109.006 170.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -141.67 134.71 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.77 1.228 . . . . 0.0 110.097 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -156.67 159.96 38.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.909 1.284 . . . . 0.0 112.224 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -69.04 142.27 54.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.772 0.829 . . . . 0.0 112.041 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.8 m -65.77 119.09 10.6 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.441 -0.787 . . . . 0.0 112.291 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.2 pt -82.76 -14.92 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.288 1.035 . . . . 0.0 112.522 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 21.2 p -160.37 158.07 28.96 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 131.218 3.807 . . . . 0.0 107.192 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -152.58 150.26 29.35 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -165.25 96.71 0.84 Allowed Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 126.367 1.867 . . . . 0.0 111.448 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -87.29 -4.66 7.64 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 124.19 3.26 . . . . 0.0 113.565 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -155.19 160.9 41.23 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.016 1.326 . . . . 0.0 112.626 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 127.298 2.239 . . . . 0.0 113.772 -176.318 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.226 0 O4'-C1'-N19 111.931 3.731 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.352 0 C5'-C4'-C3' 110.84 -3.106 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.52 0 C4'-C3'-C2' 100.768 -1.932 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 C5'-C4'-C3' 110.94 -3.04 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.944 0 C4'-C3'-C2' 99.71 -2.99 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.081 0 O4'-C1'-N19 111.638 3.438 . 0.026 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.542 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.5 t -162.36 169.31 20.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.241 1.416 . . . . 0.0 111.469 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 t -167.56 -172.74 1.99 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.512 1.925 . . . . 0.0 110.737 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.42 5.09 58.09 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.252 1.406 . . . . 0.0 115.107 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.0 m -140.79 125.08 17.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.478 1.511 . . . . 0.0 109.96 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.7 m -67.69 -9.47 43.81 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -169.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.2 -3.82 88.6 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.06 1.314 . . . . 0.0 114.422 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -71.66 152.6 42.71 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.09 1.445 . . . . 0.0 112.812 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -94.0 1.84 56.18 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.85 25.65 10.78 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -159.14 66.15 2.9 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 127.978 2.511 . . . . 0.0 111.508 -175.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -75.58 167.14 27.12 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.081 2.521 . . . . 0.0 110.766 173.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -145.19 152.93 52.06 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.904 1.682 . . . . 0.0 110.195 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -49.46 134.53 32.39 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.291 3.328 . . . . 0.0 114.139 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -156.12 137.56 13.99 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.614 1.565 . . . . 0.0 109.468 -171.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 27.4 p -63.25 -20.72 65.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.469 0.708 . . . . 0.0 112.82 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.6 m -90.87 127.23 36.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.101 0.96 . . . . 0.0 110.853 169.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.49 144.22 44.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.741 1.616 . . . . 0.0 110.337 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.62 143.14 16.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 167.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.0 124.99 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.877 1.671 . . . . 0.0 107.697 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -129.01 163.99 24.17 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.249 1.42 . . . . 0.0 111.311 -168.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 29.93 59.56 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.471 -0.768 . . . . 0.0 113.574 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.3 mt -76.54 166.82 22.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.659 1.184 . . . . 0.0 112.924 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -85.71 151.92 23.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.039 0.936 . . . . 0.0 110.12 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.54 -18.69 65.5 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.065 -1.022 . . . . 0.0 112.327 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.39 -3.6 55.06 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.678 1.591 . . . . 0.0 114.559 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.0 m -66.8 135.27 53.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.195 0.998 . . . . 0.0 109.427 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 p -109.64 162.82 14.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.098 0.959 . . . . 0.0 111.64 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -61.08 -27.63 68.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.313 0.645 . . . . 0.0 111.297 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -70.01 -40.08 75.45 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.776 1.23 . . . . 0.0 112.085 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -65.97 -48.84 69.95 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.185 0.448 . . . . 0.0 110.219 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.26 -43.13 82.77 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.943 -0.473 . . . . 0.0 111.119 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.57 -49.1 79.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.733 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -66.9 -29.38 69.25 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.815 1.189 . . . . 0.0 112.944 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.53 -29.15 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.549 1.139 . . . . 0.0 112.122 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -100.64 -23.44 14.66 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 97.7 p -69.22 -15.84 63.47 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.287 1.403 . . . . 0.0 113.939 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.55 -15.33 63.6 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -95.07 -15.26 23.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 0.0 113.631 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.8 -175.6 32.82 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.823 1.202 . . . . 0.0 114.738 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.71 138.61 21.58 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.594 3.529 . . . . 0.0 111.955 -173.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 82.3 mt -130.0 123.33 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.162 1.385 . . . . 0.0 109.678 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.81 69.87 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.136 0.974 . . . . 0.0 111.771 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.86 175.07 5.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.417 1.087 . . . . 0.0 113.054 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.77 142.16 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.965 2.106 . . . . 0.0 108.785 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.5 t -139.98 118.87 12.52 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 111.67 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.72 147.4 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.731 0.812 . . . . 0.0 109.31 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.97 134.49 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 109.472 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -127.31 155.53 43.4 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.183 1.393 . . . . 0.0 113.174 -169.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.59 139.04 47.21 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.417 1.087 . . . . 0.0 111.059 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -74.68 -21.33 59.46 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -116.76 -39.31 3.31 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.989 0.915 . . . . 0.0 112.448 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.3 m -87.12 -16.22 36.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.976 0.91 . . . . 0.0 113.034 176.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 63.97 10.3 5.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.475 1.91 . . . . 0.0 114.953 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -86.67 157.49 19.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.916 2.086 . . . . 0.0 111.145 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.3 t -61.11 139.74 58.03 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.897 -0.502 . . . . 0.0 110.666 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -77.77 -0.06 25.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.833 0.853 . . . . 0.0 112.848 172.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.01 11.55 61.34 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.021 1.296 . . . . 0.0 113.833 -178.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -148.11 165.93 29.36 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.753 1.263 . . . . 0.0 114.185 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.86 169.13 25.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.813 2.045 . . . . 0.0 111.169 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -133.32 147.05 51.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.013 1.325 . . . . 0.0 110.838 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.6 t -129.32 124.82 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.708 2.003 . . . . 0.0 107.856 -171.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.1 100.38 9.72 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.576 0.75 . . . . 0.0 110.634 -172.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.03 156.26 31.95 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.873 -1.142 . . . . 0.0 111.489 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.93 8.11 21.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.957 0.903 . . . . 0.0 112.769 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -157.07 135.82 11.6 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.107 1.763 . . . . 0.0 110.861 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.12 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.296 0.639 . . . . 0.0 112.441 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.53 -24.66 49.91 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -172.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.44 -26.94 34.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.05 0.94 . . . . 0.0 112.0 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.64 -41.16 65.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.579 0.752 . . . . 0.0 111.355 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -59.33 -31.91 69.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 0.0 112.584 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.64 -63.58 1.04 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.257 1.023 . . . . 0.0 110.039 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -36.43 65.55 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -59.47 -30.1 68.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.748 1.219 . . . . 0.0 113.313 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -93.48 -22.58 18.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.942 0.897 . . . . 0.0 112.42 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -79.77 -45.54 18.63 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.553 1.141 . . . . 0.0 113.145 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.43 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -66.83 113.49 4.94 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.649 -1.282 . . . . 0.0 111.197 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.18 75.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.537 1.541 . . . . 0.0 114.521 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -73.94 162.71 28.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.744 1.772 . . . . 0.0 111.467 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -104.28 134.31 47.71 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.429 1.091 . . . . 0.0 110.943 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.8 tp -144.46 114.96 7.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.06 1.744 . . . . 0.0 109.079 -175.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 23.71 10.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.338 1.455 . . . . 0.0 113.272 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.39 -10.89 72.98 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.72 1.629 . . . . 0.0 114.536 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -90.05 134.41 34.26 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.415 1.486 . . . . 0.0 109.756 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.77 135.95 38.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.23 0.923 . . . . 0.0 108.888 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.3 pt -106.39 152.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.042 0.937 . . . . 0.0 110.652 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -110.86 155.92 21.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.075 0.95 . . . . 0.0 109.606 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -143.76 136.45 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.424 1.09 . . . . 0.0 110.416 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -155.64 161.06 40.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.171 1.389 . . . . 0.0 111.249 -175.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -69.98 137.15 51.19 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.47 -0.769 . . . . 0.0 110.392 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 97.0 p -80.0 141.97 35.44 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.191 -0.943 . . . . 0.0 112.127 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.9 pt -84.59 3.73 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 121.054 -1.029 . . . . 0.0 112.982 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.0 p -156.58 -176.55 6.03 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 130.547 3.539 . . . . 0.0 108.726 -170.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -162.08 -177.62 5.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.185 1.794 . . . . 0.0 111.89 169.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -50.82 126.56 24.64 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.17 1.388 . . . . 0.0 112.848 -170.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.04 158.19 46.04 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.511 2.807 . . . . 0.0 111.698 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -159.88 147.47 16.74 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.557 1.543 . . . . 0.0 112.258 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.252 1.2 0 C-N-CA 126.194 1.798 . . . . 0.0 110.938 -174.949 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 O4'-C1'-N19 111.551 3.351 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.048 1 O4'-C1'-N19 112.381 4.181 . 0.01 5n . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.443 0 C4'-C3'-C2' 100.072 -2.628 . 0.143 1z . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 O5'-C5'-C4' 115.053 3.466 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 O4'-C1'-N19 110.736 2.536 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.239 0 C5'-C4'-C3' 111.644 -2.571 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -81.45 -11.04 59.36 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.6 p -164.0 -49.83 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.678 1.191 . . . . 0.0 113.062 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.15 -151.4 36.79 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.578 1.085 . . . . 0.0 113.023 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.5 m 67.45 14.41 9.61 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.738 1.615 . . . . 0.0 114.672 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.3 t -160.84 159.6 30.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.464 1.506 . . . . 0.0 111.419 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.41 143.88 31.07 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.512 1.053 . . . . 0.0 112.778 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -145.37 152.7 40.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.475 1.91 . . . . 0.0 110.032 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ptt-85 -138.69 35.79 2.21 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -169.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.38 34.95 2.99 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.761 1.624 . . . . 0.0 111.412 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -177.62 54.21 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 128.362 2.665 . . . . 0.0 113.238 -168.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -74.97 -175.72 2.5 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.607 2.872 . . . . 0.0 112.073 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -144.48 144.28 24.66 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.228 1.811 . . . . 0.0 110.095 -174.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -47.82 136.8 22.16 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 124.533 3.489 . . . . 0.0 115.452 -173.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -157.76 145.64 18.74 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.308 1.443 . . . . 0.0 110.632 -169.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 81.6 m -58.03 -29.58 65.45 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.651 1.18 . . . . 0.0 112.398 169.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 55.6 m -83.12 124.37 30.42 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.408 1.483 . . . . 0.0 110.298 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.1 mt -117.6 144.13 45.45 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.838 1.655 . . . . 0.0 110.615 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.16 147.71 18.66 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.784 1.659 . . . . 0.0 110.06 167.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.13 131.34 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.509 1.924 . . . . 0.0 107.851 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -138.13 139.87 39.63 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.942 0.897 . . . . 0.0 111.342 -168.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.32 26.43 6.93 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.024 0.821 . . . . 0.0 114.18 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.9 mt -74.47 162.72 28.55 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.631 1.173 . . . . 0.0 113.388 -174.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -84.67 155.88 21.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.3 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.93 -17.65 63.34 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.308 -0.87 . . . . 0.0 112.416 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -92.8 -5.05 51.95 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.846 1.658 . . . . 0.0 114.271 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.7 m -68.87 136.02 51.99 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.562 1.145 . . . . 0.0 109.548 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 38.1 p -118.66 162.29 18.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.598 1.159 . . . . 0.0 111.004 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.32 -27.74 66.16 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.7 0.8 . . . . 0.0 111.654 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -56.0 -46.84 78.6 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.349 1.86 . . . . 0.0 111.905 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -69.89 -46.87 64.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.93 0.892 . . . . 0.0 110.046 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.4 -41.39 84.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.182 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.19 -47.77 84.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.317 0.962 . . . . 0.0 111.11 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.5 -30.85 69.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.245 1.384 . . . . 0.0 113.014 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.7 -30.93 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.629 1.171 . . . . 0.0 112.356 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -100.44 -26.45 13.86 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -73.16 -8.99 58.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.534 1.515 . . . . 0.0 114.234 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.07 -15.54 63.79 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.857 -1.152 . . . . 0.0 113.033 168.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -94.73 -11.67 28.65 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.437 . . . . 0.0 113.621 176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.26 -178.29 29.56 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.006 1.289 . . . . 0.0 114.52 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.58 138.1 28.88 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.223 3.282 . . . . 0.0 112.114 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 55.6 mt -130.94 126.66 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.819 1.648 . . . . 0.0 110.179 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.25 -19.26 17.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -158.46 162.07 37.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.074 0.852 . . . . 0.0 113.183 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.9 t -146.5 136.21 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.013 2.125 . . . . 0.0 107.472 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -133.48 109.16 9.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 110.936 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.22 134.99 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t -88.88 103.4 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -95.1 148.91 21.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.549 1.14 . . . . 0.0 111.924 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.95 157.83 36.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.778 0.831 . . . . 0.0 112.509 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -85.99 -23.27 26.93 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -119.0 -39.97 2.88 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.517 1.127 . . . . 0.0 112.596 -169.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 79.6 p -85.61 -21.09 28.62 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.416 1.007 . . . . 0.0 112.607 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 57.04 26.26 11.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.645 1.978 . . . . 0.0 113.557 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -104.5 164.69 11.57 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 128.296 2.638 . . . . 0.0 109.49 172.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.5 t -60.56 135.75 57.85 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.742 -0.599 . . . . 0.0 110.54 172.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -78.11 -2.08 35.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.751 0.82 . . . . 0.0 112.64 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.67 11.94 60.0 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.869 1.223 . . . . 0.0 114.125 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -147.45 163.6 35.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.469 1.135 . . . . 0.0 113.186 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.07 174.23 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.159 1.784 . . . . 0.0 112.054 -168.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.41 150.04 43.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.292 1.837 . . . . 0.0 109.99 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.5 t -136.79 135.11 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.288 1.835 . . . . 0.0 108.716 -169.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -120.43 97.79 5.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.496 1.118 . . . . 0.0 112.245 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -77.73 161.9 27.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.346 0.659 . . . . 0.0 112.012 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.27 10.28 38.42 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.209 1.003 . . . . 0.0 112.799 171.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -156.72 131.35 8.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.59 1.556 . . . . 0.0 111.383 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.09 -29.17 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.939 0.896 . . . . 0.0 112.585 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.77 -28.18 44.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.239 0.927 . . . . 0.0 112.916 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.08 -30.02 55.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.514 0.726 . . . . 0.0 111.635 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.08 80.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.179 0.592 . . . . 0.0 111.419 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -60.07 -40.29 88.98 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.4 -58.08 8.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.707 0.803 . . . . 0.0 110.408 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.31 -38.63 77.48 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.13 -40.16 88.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.949 0.9 . . . . 0.0 112.222 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -81.65 -26.32 34.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.127 0.571 . . . . 0.0 112.506 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -74.83 -48.26 26.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.638 1.175 . . . . 0.0 113.286 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.31 -12.27 30.46 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -169.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -66.65 111.88 3.89 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.614 -1.304 . . . . 0.0 111.141 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.83 7.2 68.84 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.367 1.937 . . . . 0.0 114.572 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 ptm -73.76 168.65 18.96 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.68 1.74 . . . . 0.0 111.721 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.71 135.82 49.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.6 tp -145.07 117.97 8.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.145 1.778 . . . . 0.0 109.353 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 55.39 28.46 11.52 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.751 1.621 . . . . 0.0 113.42 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.38 6.96 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.721 1.153 . . . . 0.0 114.527 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -109.08 140.61 42.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.706 1.602 . . . . 0.0 110.503 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 136.63 39.09 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 168.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.9 pt -117.22 154.66 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -116.8 156.27 27.53 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.512 1.525 . . . . 0.0 109.498 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.82 137.43 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.853 1.261 . . . . 0.0 110.024 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -156.92 166.1 34.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.815 1.246 . . . . 0.0 111.853 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.79 140.29 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.234 -0.916 . . . . 0.0 112.211 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.9 m -81.45 141.13 34.18 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.68 2.33 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.912 1.285 . . . . 0.0 113.525 173.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 40.6 p -150.62 -173.33 4.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 128.791 2.837 . . . . 0.0 110.269 -170.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -154.7 168.52 26.56 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -53.24 134.2 51.23 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.19 2.596 . . . . 0.0 111.51 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.55 145.36 58.12 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.285 2.656 . . . . 0.0 111.302 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -162.27 146.33 12.07 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.532 1.533 . . . . 0.0 112.228 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.17 1.788 . . . . 0.0 110.847 -177.578 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.277 0 C5'-C4'-C3' 111.014 -2.991 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O4'-C1'-N19 111.974 3.774 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 C3'-C2'-C1' 103.677 2.419 . 0.472 5z . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.429 0 O4'-C1'-N19 111.864 3.664 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.253 1 O4'-C1'-N19 113.021 4.821 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.359 0 O5'-C5'-C4' 113.871 2.622 . 0.212 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.5 t -164.05 155.4 16.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.312 1.445 . . . . 0.0 111.151 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.9 p -79.42 -15.32 58.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.535 1.134 . . . . 0.0 113.277 171.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.61 -93.64 0.18 Allowed Glycine 0 C--N 1.343 0.962 0 C-N-CA 125.098 1.332 . . . . 0.0 111.965 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -130.37 13.27 5.54 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.79 1.636 . . . . 0.0 112.771 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.2 t -147.74 108.58 4.2 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.527 -1.358 . . . . 0.0 111.486 -175.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.27 136.95 22.13 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.193 0.901 . . . . 0.0 113.006 -172.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.02 137.95 50.09 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.153 0.981 . . . . 0.0 111.573 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -76.43 90.24 3.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.345 0.658 . . . . 0.0 110.674 -170.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.44 156.82 29.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.031 1.732 . . . . 0.0 111.146 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 39.18 61.89 5.18 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 126.011 1.725 . . . . 0.0 114.306 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.07 134.05 28.42 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.638 2.892 . . . . 0.0 110.759 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -97.04 132.95 24.81 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.175 0.99 . . . . 0.0 111.757 -173.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.52 125.35 17.53 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.521 3.481 . . . . 0.0 113.862 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -160.4 167.54 27.13 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.46 1.504 . . . . 0.0 111.512 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 71.0 m -65.26 -15.04 62.07 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -171.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.0 t -107.17 123.02 47.66 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.426 1.012 . . . . 0.0 111.061 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.04 149.48 24.52 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.836 1.654 . . . . 0.0 110.952 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.51 142.36 15.47 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.078 1.799 . . . . 0.0 110.227 167.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.98 127.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.623 1.969 . . . . 0.0 107.638 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -136.85 157.06 47.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.972 0.909 . . . . 0.0 111.386 -168.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.96 36.22 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.211 0.91 . . . . 0.0 113.675 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.24 160.29 31.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.426 1.491 . . . . 0.0 113.38 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -77.65 152.52 33.79 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 167.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.62 -18.2 65.24 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.307 -0.871 . . . . 0.0 112.726 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -100.74 -1.7 34.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.812 1.645 . . . . 0.0 114.243 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.9 m -65.85 136.41 56.13 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.615 1.166 . . . . 0.0 109.366 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.8 p -115.16 165.56 12.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.151 0.981 . . . . 0.0 111.644 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.94 -25.34 67.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.458 0.703 . . . . 0.0 111.748 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -68.61 -42.18 78.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.261 1.024 . . . . 0.0 111.461 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -66.87 -49.23 66.31 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.167 0.587 . . . . 0.0 110.386 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -58.93 -40.1 83.56 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.709 -0.619 . . . . 0.0 111.402 174.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.3 ttp-105 -59.53 -49.46 77.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.043 0.838 . . . . 0.0 111.625 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.01 -30.24 69.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.7 1.137 . . . . 0.0 113.057 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -79.56 -28.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.53 1.132 . . . . 0.0 112.042 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -100.67 -23.44 14.64 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.4 p -70.65 -18.3 62.85 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.363 1.438 . . . . 0.0 113.942 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -67.46 -10.51 52.18 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -101.79 -5.83 24.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.314 1.446 . . . . 0.0 113.912 174.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.92 -178.16 25.7 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.951 1.262 . . . . 0.0 115.049 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.79 137.82 25.26 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.433 3.422 . . . . 0.0 112.28 -170.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.66 131.05 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.948 1.699 . . . . 0.0 110.032 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.46 -26.59 15.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.996 1.318 . . . . 0.0 113.222 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -163.41 165.23 24.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 113.077 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -146.89 133.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.837 2.055 . . . . 0.0 107.762 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.0 m -131.38 102.96 6.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.555 1.142 . . . . 0.0 110.749 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.6 mt -77.59 140.5 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t -91.31 120.71 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -111.2 143.66 41.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.53 1.132 . . . . 0.0 112.634 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -62.79 145.86 53.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.642 1.577 . . . . 0.0 111.974 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -72.09 -20.27 61.68 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -174.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -125.53 -34.61 2.65 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.113 0.965 . . . . 0.0 113.299 -170.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.6 p -94.78 -18.95 20.77 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.347 0.976 . . . . 0.0 113.38 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 59.81 16.3 5.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.92 1.688 . . . . 0.0 114.11 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.29 159.66 27.14 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.763 1.625 . . . . 0.0 109.933 169.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.0 t -57.19 136.95 56.46 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.465 -0.772 . . . . 0.0 110.49 170.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -75.46 -1.45 24.13 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.413 0.685 . . . . 0.0 112.737 173.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.13 59.54 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.646 1.593 . . . . 0.0 113.742 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -148.46 162.57 39.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.962 1.363 . . . . 0.0 114.256 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.31 172.25 17.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.761 2.024 . . . . 0.0 111.272 -169.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -138.94 155.6 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.363 1.465 . . . . 0.0 110.217 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -138.78 126.27 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.642 1.577 . . . . 0.0 109.151 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -108.51 101.19 10.37 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 111.737 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -76.75 159.76 29.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.294 1.038 . . . . 0.0 111.573 172.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.87 4.79 43.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.881 0.872 . . . . 0.0 113.005 171.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -159.82 136.14 8.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.368 1.467 . . . . 0.0 111.754 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.12 -30.71 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.001 0.921 . . . . 0.0 112.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.11 -23.57 51.81 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.479 1.036 . . . . 0.0 113.224 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -80.98 -29.6 35.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.788 170.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.57 81.97 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.236 0.614 . . . . 0.0 110.99 168.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -61.45 -31.94 71.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.31 1.044 . . . . 0.0 112.862 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.67 -64.25 0.9 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.76 0.824 . . . . 0.0 109.671 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.73 -34.96 70.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.27 -34.72 72.59 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.064 0.946 . . . . 0.0 112.883 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -88.78 -23.44 22.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.59 -45.38 19.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 113.114 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.82 31.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.33 111.32 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.698 -1.252 . . . . 0.0 111.057 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.56 8.64 70.26 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.278 1.418 . . . . 0.0 114.703 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.7 ptm -75.75 172.33 12.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.758 1.779 . . . . 0.0 111.471 170.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -115.28 135.41 54.18 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.974 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 40.0 tp -141.28 118.7 11.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.575 1.55 . . . . 0.0 109.534 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.5 t70 56.78 25.03 9.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.683 1.593 . . . . 0.0 113.417 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.08 8.6 71.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.01 1.291 . . . . 0.0 114.805 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -116.35 133.0 56.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.887 1.675 . . . . 0.0 110.614 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.43 129.69 38.94 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.819 -0.551 . . . . 0.0 110.267 173.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.9 pt -107.24 166.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.094 0.958 . . . . 0.0 111.008 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -142.54 151.15 41.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.096 1.759 . . . . 0.0 109.096 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.7 t -144.18 143.51 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.324 1.05 . . . . 0.0 112.569 -165.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -153.38 166.36 32.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.025 2.13 . . . . 0.0 111.419 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.02 149.0 48.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.522 -0.736 . . . . 0.0 111.543 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 91.6 p -79.89 124.28 28.52 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.081 -1.012 . . . . 0.0 113.374 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.0 pt -79.69 -16.94 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.609 1.164 . . . . 0.0 113.181 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.0 p -155.25 154.38 32.09 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 130.808 3.643 . . . . 0.0 106.842 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.84 148.26 23.75 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -172.14 105.63 0.35 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 127.972 2.509 . . . . 0.0 109.546 -173.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.41 156.15 58.91 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.771 2.314 . . . . 0.0 110.6 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -60.5 120.58 10.23 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.362 1.065 . . . . 0.0 112.589 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 128.778 2.831 . . . . 0.0 109.434 -176.72 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.111 1 O4'-C1'-N19 113.414 5.214 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.246 1 O4'-C1'-N19 114.771 6.571 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.287 0 O4'-C1'-N19 111.652 3.452 . 0.119 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.459 0 O5'-C5'-C4' 114.388 2.992 . 0.094 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 O4'-C1'-N19 111.097 2.897 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.001 0 O4'-C1'-N19 111.887 3.687 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.4 m 63.18 25.92 15.04 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.082 1.353 . . . . 0.0 112.83 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -74.99 -9.36 58.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.36 -171.84 54.96 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.886 1.232 . . . . 0.0 113.152 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 76.7 p -163.58 155.55 17.38 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.8 1.24 . . . . 0.0 112.574 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.8 p -169.11 174.91 5.98 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.465 1.906 . . . . 0.0 110.59 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.4 32.8 0.97 Allowed Glycine 0 N--CA 1.477 1.403 0 C-N-CA 125.455 1.503 . . . . 0.0 114.584 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -78.0 -3.41 41.9 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.615 1.966 . . . . 0.0 114.789 -175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 71.24 -1.96 2.55 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 128.437 2.695 . . . . 0.0 115.941 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.3 41.92 1.06 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.193 1.397 . . . . 0.0 111.678 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -170.11 42.79 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 127.11 2.164 . . . . 0.0 114.866 -167.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -66.45 150.98 84.06 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.487 2.125 . . . . 0.0 110.43 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.81 139.93 13.39 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.138 1.375 . . . . 0.0 110.172 -173.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.63 130.49 37.03 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.098 3.199 . . . . 0.0 113.873 -172.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -153.7 30.8 0.46 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.96 0.904 . . . . 0.0 113.11 -168.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 82.9 m 61.37 18.59 9.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.033 2.133 . . . . 0.0 114.218 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.2 t -157.52 137.4 12.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.349 1.46 . . . . 0.0 110.043 -170.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.3 mt -121.2 141.45 50.84 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.65 1.58 . . . . 0.0 110.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.23 144.73 17.42 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.482 1.515 . . . . 0.0 110.197 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.03 122.45 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.444 1.898 . . . . 0.0 107.472 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -129.23 147.58 51.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.767 1.227 . . . . 0.0 111.786 -167.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.53 31.7 11.18 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 124.071 0.843 . . . . 0.0 113.547 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.13 162.43 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.438 1.495 . . . . 0.0 113.153 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.3 t -81.83 154.62 25.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.27 0.628 . . . . 0.0 110.998 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.3 -17.38 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.093 -1.004 . . . . 0.0 112.601 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.37 -4.22 54.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.535 1.534 . . . . 0.0 114.279 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.5 m -66.81 133.59 50.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.67 1.188 . . . . 0.0 109.649 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.6 p -108.67 163.77 12.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.268 1.027 . . . . 0.0 111.546 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -61.32 -27.32 68.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.279 0.632 . . . . 0.0 111.176 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -73.69 -36.77 65.32 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.824 1.249 . . . . 0.0 112.57 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -66.07 -48.47 70.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.639 0.654 . . . . 0.0 110.28 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.95 -41.22 86.92 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.786 -0.571 . . . . 0.0 111.009 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -58.36 -50.04 75.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.867 0.758 . . . . 0.0 111.667 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.47 -29.39 68.82 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.655 1.116 . . . . 0.0 113.135 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -80.01 -29.42 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.093 0.957 . . . . 0.0 112.011 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -100.6 -22.0 15.1 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -69.19 -20.35 63.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.366 1.439 . . . . 0.0 113.799 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -67.68 -11.3 57.97 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 172.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -100.1 -9.38 22.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.191 1.396 . . . . 0.0 113.7 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.9 -173.09 27.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.914 1.245 . . . . 0.0 115.185 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.25 132.78 12.8 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.288 3.325 . . . . 0.0 112.758 -169.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.07 128.73 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.813 1.645 . . . . 0.0 109.367 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.04 -40.98 29.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.749 1.22 . . . . 0.0 111.872 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -169.6 173.86 6.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.993 1.717 . . . . 0.0 111.614 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.15 140.08 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.492 1.917 . . . . 0.0 108.428 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 t -142.37 116.25 9.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.253 0.621 . . . . 0.0 111.765 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.46 150.69 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.093 0.957 . . . . 0.0 109.974 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.12 132.37 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.173 0.989 . . . . 0.0 109.265 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -125.7 151.17 46.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.111 1.364 . . . . 0.0 112.867 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.32 149.31 42.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.061 0.945 . . . . 0.0 111.423 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -78.98 -24.35 43.86 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -123.4 -35.09 3.0 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.154 0.981 . . . . 0.0 113.019 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.8 m -84.52 -22.71 30.08 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.579 0.751 . . . . 0.0 112.165 170.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . 0.262 86.2 mtt180 58.84 25.02 13.06 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.385 1.874 . . . . 0.0 114.821 169.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -97.57 166.56 11.45 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.066 2.147 . . . . 0.0 110.064 168.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.9 t -58.48 140.73 53.49 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.938 -0.476 . . . . 0.0 110.049 168.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -75.6 -8.52 56.98 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 172.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 98.24 13.68 41.38 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.022 1.296 . . . . 0.0 113.94 -174.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -149.27 161.45 42.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.897 1.332 . . . . 0.0 113.633 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -161.5 174.03 14.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.582 1.953 . . . . 0.0 110.54 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -143.56 152.86 41.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.07 120.67 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.321 1.848 . . . . 0.0 108.091 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -98.81 125.59 44.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.61 1.164 . . . . 0.0 109.573 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -105.86 148.94 27.0 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.101 0.96 . . . . 0.0 112.089 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.52 -1.97 54.92 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -155.88 132.91 10.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.672 1.589 . . . . 0.0 111.062 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.47 -30.52 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.29 -17.87 60.18 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -86.78 -28.34 23.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.642 1.177 . . . . 0.0 112.076 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.01 -39.27 79.4 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.729 -0.607 . . . . 0.0 110.408 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -64.16 -23.58 67.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.706 1.202 . . . . 0.0 113.283 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.98 -64.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.776 0.83 . . . . 0.0 109.183 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -36.62 61.71 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -58.83 -31.97 68.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.188 0.995 . . . . 0.0 113.286 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -92.66 -10.53 36.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.103 0.961 . . . . 0.0 112.74 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -96.5 -49.83 4.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.896 1.278 . . . . 0.0 112.559 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.28 -16.19 40.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -63.99 115.66 5.12 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.989 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.84 6.54 76.0 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.226 1.393 . . . . 0.0 114.397 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -77.17 169.22 18.72 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.732 1.766 . . . . 0.0 111.704 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -117.22 123.96 47.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.888 0.875 . . . . 0.0 111.51 -174.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 11.5 tp -127.75 111.86 14.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.158 1.783 . . . . 0.0 109.351 -169.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 31.5 t70 56.31 27.27 11.62 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.081 1.353 . . . . 0.0 112.991 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.8 -1.18 80.68 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.386 1.469 . . . . 0.0 114.738 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -103.14 127.37 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.381 1.473 . . . . 0.0 110.041 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.01 128.57 36.41 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.34 155.64 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.725 0.81 . . . . 0.0 111.394 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -124.52 151.96 44.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.548 1.539 . . . . 0.0 109.245 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.1 t -141.51 136.2 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.285 1.034 . . . . 0.0 111.287 -168.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -147.25 159.27 43.85 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.357 1.863 . . . . 0.0 111.504 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -69.89 143.63 52.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.416 0.686 . . . . 0.0 111.855 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.9 m -84.28 124.31 31.1 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -172.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.8 pt -80.98 -13.78 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.272 1.029 . . . . 0.0 113.016 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 22.6 p -156.7 162.39 39.8 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 130.143 3.377 . . . . 0.0 108.399 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 160.76 39.32 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -68.42 -40.7 20.78 Favored Pre-proline 0 N--CA 1.48 1.038 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -61.24 157.19 41.33 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.218 3.279 . . . . 0.0 113.002 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -157.73 145.31 18.53 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.897 1.279 . . . . 0.0 112.478 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.29 1.836 . . . . 0.0 110.926 -174.641 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.177 0 O4'-C1'-N19 111.728 3.528 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 0 C5'-C4'-C3' 110.29 -3.474 . 0.028 4n . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.433 0 O4'-C1'-N19 110.764 2.564 . 0.247 3b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 0 O5'-C5'-C4' 115.161 3.543 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 P-O3'-C3' 123.34 3.033 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.153 1 O4'-C1'-N19 112.557 4.357 . 0.06 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.3 m -57.32 132.9 54.45 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.684 1.193 . . . . 0.0 112.652 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.1 m 67.21 9.17 6.75 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.869 1.668 . . . . 0.0 114.635 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.3 163.63 52.02 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.834 1.207 . . . . 0.0 113.396 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.9 m -83.67 128.11 34.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.772 0.829 . . . . 0.0 111.504 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 t -166.55 171.11 12.08 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.482 1.513 . . . . 0.0 110.979 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.66 89.19 1.14 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 173.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.88 111.52 9.11 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.731 0.812 . . . . 0.0 111.602 -173.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -86.24 -6.73 58.91 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.232 1.413 . . . . 0.0 114.197 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.3 140.85 41.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.338 1.455 . . . . 0.0 112.256 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 37.11 59.65 3.87 Favored Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 126.232 1.813 . . . . 0.0 114.555 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.14 136.71 35.38 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.482 2.788 . . . . 0.0 110.855 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.36 153.2 73.92 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.737 1.215 . . . . 0.0 112.637 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.69 140.53 56.02 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.152 3.235 . . . . 0.0 114.253 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -155.55 139.91 16.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.029 1.331 . . . . 0.0 110.231 -171.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.9 m -58.55 -28.51 65.57 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.483 1.113 . . . . 0.0 112.616 170.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 88.3 m -82.13 124.35 29.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.922 0.889 . . . . 0.0 110.224 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.2 mt -114.83 143.91 44.35 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.911 1.685 . . . . 0.0 110.475 172.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.52 148.38 18.3 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.646 1.594 . . . . 0.0 110.552 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.11 131.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.412 1.885 . . . . 0.0 107.823 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -137.36 154.87 49.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.541 1.136 . . . . 0.0 111.608 -168.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.25 30.14 38.49 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.8 0.714 . . . . 0.0 113.603 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.73 162.12 25.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.291 1.436 . . . . 0.0 113.159 -176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -79.85 156.65 27.26 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.999 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.3 mt -70.44 -18.82 63.01 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.714 -0.616 . . . . 0.0 111.996 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.21 -4.71 51.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.727 1.611 . . . . 0.0 114.452 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.7 m -66.84 136.98 56.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.451 1.1 . . . . 0.0 109.397 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 28.3 p -110.22 162.56 14.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.371 1.069 . . . . 0.0 111.434 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -60.19 -29.09 68.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.673 0.789 . . . . 0.0 111.028 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.73 -37.5 79.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.458 1.103 . . . . 0.0 112.197 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.16 -48.9 66.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.358 0.527 . . . . 0.0 110.279 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.34 -43.17 88.18 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.764 -0.585 . . . . 0.0 110.897 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -57.99 -49.47 76.72 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.758 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.24 -29.73 69.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.779 1.172 . . . . 0.0 113.018 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -80.15 -29.25 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.454 1.102 . . . . 0.0 112.208 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -100.61 -24.5 14.43 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.4 p -69.34 -17.6 63.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.312 1.415 . . . . 0.0 113.913 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -67.78 -14.38 62.9 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.86 -13.02 24.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.777 1.231 . . . . 0.0 113.635 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -174.54 30.65 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.734 1.159 . . . . 0.0 114.941 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.78 140.74 23.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.563 3.509 . . . . 0.0 112.174 -171.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.26 131.9 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 0.0 110.197 -173.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.91 -25.55 14.97 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.203 1.401 . . . . 0.0 113.658 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -161.83 157.77 24.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.357 1.063 . . . . 0.0 112.39 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -148.27 130.4 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 127.182 2.193 . . . . 0.0 107.653 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.5 t -143.65 118.03 9.65 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.484 0.714 . . . . 0.0 111.802 -174.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.03 144.55 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 169.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.0 t -96.94 128.96 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -121.02 151.4 39.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.408 1.483 . . . . 0.0 111.931 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -77.21 144.46 38.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.101 0.56 . . . . 0.0 111.874 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -75.26 -23.09 57.41 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -117.24 -38.27 3.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.352 1.061 . . . . 0.0 112.447 -173.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.4 m -82.33 -23.91 34.87 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.577 -0.702 . . . . 0.0 112.661 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 56.9 36.21 27.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.928 1.691 . . . . 0.0 113.694 170.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.83 164.05 19.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 128.318 2.647 . . . . 0.0 109.2 170.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.8 t -58.41 139.24 55.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.16 0.505 . . . . 0.0 111.113 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -81.38 1.93 30.69 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.437 1.095 . . . . 0.0 112.711 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.8 11.48 63.61 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.681 1.134 . . . . 0.0 114.236 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -148.99 163.68 36.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.594 1.187 . . . . 0.0 113.277 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.77 170.4 22.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.57 1.948 . . . . 0.0 111.568 -168.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -141.35 150.13 42.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.359 1.464 . . . . 0.0 111.171 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.71 127.29 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 109.347 -170.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -99.18 109.02 21.75 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.334 1.454 . . . . 0.0 111.007 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -83.29 160.99 21.59 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.342 -0.849 . . . . 0.0 111.03 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -94.88 8.72 41.8 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.064 0.946 . . . . 0.0 113.001 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -156.68 133.18 10.03 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.511 1.525 . . . . 0.0 111.241 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.03 -30.13 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.54 0.736 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -75.8 -28.52 58.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.435 1.016 . . . . 0.0 113.115 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.73 -27.46 50.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.225 0.61 . . . . 0.0 111.78 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.33 -41.24 70.07 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.317 0.647 . . . . 0.0 111.307 169.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -60.73 -35.71 77.03 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.196 0.999 . . . . 0.0 112.21 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.52 -63.68 1.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.021 0.928 . . . . 0.0 110.16 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.82 68.86 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.47 -36.01 79.23 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.959 0.904 . . . . 0.0 112.61 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.87 -24.4 26.7 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.515 0.726 . . . . 0.0 112.234 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -76.67 -47.12 23.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.54 1.136 . . . . 0.0 112.98 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.14 -12.43 26.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -170.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -65.62 113.38 4.19 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.517 -1.364 . . . . 0.0 110.866 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.21 8.53 71.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.235 1.398 . . . . 0.0 114.728 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.0 ptm -76.55 175.67 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.741 1.771 . . . . 0.0 111.485 169.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -119.72 135.37 54.86 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.254 1.021 . . . . 0.0 111.57 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.1 tp -146.07 121.33 10.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.982 1.713 . . . . 0.0 109.321 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.0 t70 56.44 27.56 12.31 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.272 1.429 . . . . 0.0 112.603 -169.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.09 81.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.751 1.167 . . . . 0.0 114.355 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.48 130.29 43.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.874 1.337 . . . . 0.0 109.636 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.07 128.83 37.28 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.6 pt -108.65 159.45 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.941 0.896 . . . . 0.0 111.581 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -121.02 149.5 42.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.506 1.923 . . . . 0.0 108.938 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -145.98 137.24 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.453 1.101 . . . . 0.0 110.371 -171.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -157.15 162.82 39.37 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 112.329 -172.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -73.43 138.36 45.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.454 -0.779 . . . . 0.0 111.286 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 26.7 m -75.86 139.8 41.88 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 37.5 pt -90.29 3.03 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.21 1.004 . . . . 0.0 113.257 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.6 p -155.97 -168.37 2.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 129.818 3.247 . . . . 0.0 109.376 -172.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -152.47 175.13 13.05 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.246 1.419 . . . . 0.0 112.823 169.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -60.6 140.1 92.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.247 1.419 . . . . 0.0 111.222 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.25 145.61 65.15 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.745 2.963 . . . . 0.0 112.716 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -158.95 163.18 36.73 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.076 1.351 . . . . 0.0 113.008 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.528 1.931 . . . . 0.0 112.219 -176.398 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.266 1 O4'-C1'-N19 112.582 4.382 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 O4'-C1'-N19 111.502 3.302 . 0.179 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.206 1 O4'-C1'-N19 112.293 4.093 . 0.21 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.397 0 C5'-C4'-C3' 112.089 -2.274 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 O4'-C1'-N19 112.042 3.842 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.259 0 P-O3'-C3' 122.744 2.537 . 0.165 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.036 -0.425 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.4 p 66.06 -33.41 0.18 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 129.119 2.968 . . . . 0.0 116.487 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 91.2 p -152.41 -13.19 0.18 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.381 1.472 . . . . 0.0 114.248 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -170.32 152.19 18.37 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.906 1.241 . . . . 0.0 113.252 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.0 m -158.19 155.1 28.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.541 1.936 . . . . 0.0 110.14 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.6 m -70.1 -13.71 62.33 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.9 155.16 26.4 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.659 2.075 . . . . 0.0 111.435 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -145.63 112.14 5.84 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.262 1.025 . . . . 0.0 111.571 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -74.25 -12.08 60.46 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.85 27.99 7.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.634 1.573 . . . . 0.0 113.518 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -169.2 66.33 0.61 Allowed Pre-proline 0 CA--C 1.557 1.23 0 C-N-CA 129.686 3.194 . . . . 0.0 110.793 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.34 178.93 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.06 3.174 . . . . 0.0 111.345 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -153.01 152.94 29.06 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.768 1.627 . . . . 0.0 110.929 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.2 138.32 71.73 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 124.066 3.177 . . . . 0.0 114.522 -172.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -157.57 142.84 17.03 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.911 1.284 . . . . 0.0 110.712 -170.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 71.0 m -59.0 -28.71 66.64 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.207 1.003 . . . . 0.0 112.062 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 56.1 m -86.61 127.32 34.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.804 1.242 . . . . 0.0 110.274 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.5 mt -118.0 148.96 41.72 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.899 1.68 . . . . 0.0 111.049 175.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.14 147.15 16.2 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.363 1.935 . . . . 0.0 110.832 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 t -136.46 128.63 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 108.576 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -133.13 153.56 51.41 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.153 1.381 . . . . 0.0 111.141 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 30.94 21.11 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 123.861 0.743 . . . . 0.0 113.696 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -78.33 160.62 27.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.952 1.301 . . . . 0.0 113.4 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -81.36 151.56 27.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.488 0.715 . . . . 0.0 110.354 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.34 -16.67 64.02 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.073 -1.017 . . . . 0.0 112.819 175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -95.39 -3.17 47.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.421 1.488 . . . . 0.0 114.233 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.1 m -65.62 135.14 54.66 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.709 1.204 . . . . 0.0 109.69 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -108.04 162.68 13.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.355 1.062 . . . . 0.0 111.463 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.89 -29.35 69.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.304 0.641 . . . . 0.0 111.165 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -68.72 -38.39 80.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.501 1.12 . . . . 0.0 112.395 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -66.6 -49.8 65.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.639 0.654 . . . . 0.0 110.463 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.32 -41.37 84.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.717 -0.615 . . . . 0.0 111.09 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -62.99 -43.2 99.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.081 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -68.68 -33.45 74.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.185 1.357 . . . . 0.0 112.502 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.51 -28.18 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.45 1.1 . . . . 0.0 112.331 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -100.15 -23.12 14.93 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.6 m -69.15 -14.86 63.23 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.207 1.367 . . . . 0.0 113.691 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -68.17 -14.31 62.89 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.868 -1.145 . . . . 0.0 113.696 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -95.75 -13.8 23.86 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.878 1.271 . . . . 0.0 113.605 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.24 -174.58 31.91 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.099 1.333 . . . . 0.0 114.339 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.91 136.84 21.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.193 3.262 . . . . 0.0 111.934 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.1 mt -131.81 127.1 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.588 1.555 . . . . 0.0 109.789 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.87 -25.08 20.03 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.926 1.29 . . . . 0.0 113.322 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -164.28 167.33 20.02 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.12 135.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.213 2.205 . . . . 0.0 107.76 171.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.0 m -127.05 102.86 7.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.892 1.277 . . . . 0.0 110.511 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.5 mt -78.53 140.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.998 -1.064 . . . . 0.0 108.157 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.9 t -97.33 127.59 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -115.64 143.84 44.78 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.849 1.26 . . . . 0.0 112.096 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.25 139.17 58.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.577 1.151 . . . . 0.0 111.361 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -70.15 -20.56 63.14 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -117.84 -42.72 2.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.049 0.939 . . . . 0.0 112.13 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.3 m -88.28 -17.09 31.46 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.033 0.933 . . . . 0.0 113.396 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 78.5 mtm-85 64.37 8.48 4.26 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.615 1.966 . . . . 0.0 115.377 169.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -82.6 165.39 20.11 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.224 1.809 . . . . 0.0 110.574 169.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.4 t -57.5 140.91 49.42 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.868 -0.52 . . . . 0.0 110.181 168.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -77.8 0.0 25.45 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.86 0.864 . . . . 0.0 112.659 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.55 12.16 63.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.183 1.373 . . . . 0.0 113.478 -174.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -153.27 161.92 41.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 123.028 1.394 . . . . 0.0 113.811 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.69 175.02 13.67 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.575 1.95 . . . . 0.0 111.371 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.8 156.4 46.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.479 1.511 . . . . 0.0 110.101 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.9 t -139.54 136.76 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.306 1.842 . . . . 0.0 109.193 -168.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -120.5 94.21 4.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.687 1.195 . . . . 0.0 111.678 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -74.62 161.45 29.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.685 0.794 . . . . 0.0 111.96 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.28 8.85 43.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.469 1.107 . . . . 0.0 112.871 171.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -157.45 135.51 10.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.503 1.521 . . . . 0.0 111.714 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.78 -33.15 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.572 0.749 . . . . 0.0 112.633 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -73.64 -27.6 61.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.306 0.957 . . . . 0.0 112.725 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.36 -29.03 41.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.648 0.779 . . . . 0.0 111.881 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.26 -41.85 69.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.447 0.699 . . . . 0.0 111.351 169.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -59.86 -35.69 75.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.587 1.155 . . . . 0.0 112.322 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.43 -62.67 1.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.293 1.037 . . . . 0.0 110.031 171.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.37 68.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -175.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.35 -30.02 68.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.808 1.243 . . . . 0.0 113.202 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -93.14 -28.77 16.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.867 0.867 . . . . 0.0 112.178 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -74.19 -47.09 37.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.21 1.004 . . . . 0.0 113.355 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.93 -12.35 39.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.89 115.26 5.17 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.209 -0.932 . . . . 0.0 110.982 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 86.76 4.18 82.8 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.421 1.486 . . . . 0.0 114.647 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -73.84 158.91 33.65 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.73 1.765 . . . . 0.0 111.748 172.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -103.89 116.77 32.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.077 0.951 . . . . 0.0 110.724 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.6 tp -122.7 111.65 16.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.443 1.897 . . . . 0.0 109.151 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.53 23.56 9.33 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.239 1.416 . . . . 0.0 113.467 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.35 8.82 65.82 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.024 1.297 . . . . 0.0 114.699 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -115.37 134.24 55.29 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.994 1.718 . . . . 0.0 110.107 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -78.93 126.62 30.94 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 109.663 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.85 167.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.924 0.889 . . . . 0.0 111.789 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -137.23 142.41 42.06 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.728 2.011 . . . . 0.0 108.048 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 18.6 t -137.96 140.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.651 0.78 . . . . 0.0 111.581 -168.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -152.57 164.8 36.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.17 1.788 . . . . 0.0 111.224 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.31 141.96 41.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.347 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.4 m -75.89 135.82 40.13 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.162 -0.961 . . . . 0.0 112.855 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 8.4 pt -95.44 -6.28 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.621 1.168 . . . . 0.0 113.51 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.6 p -156.59 -170.45 3.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 129.781 3.232 . . . . 0.0 109.428 -173.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -147.49 169.85 18.66 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.342 1.457 . . . . 0.0 114.473 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.97 162.89 11.17 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.472 1.109 . . . . 0.0 112.35 171.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -60.01 146.84 95.04 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.849 3.033 . . . . 0.0 112.691 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -159.12 158.96 33.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.164 1.386 . . . . 0.0 112.824 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 C--O 1.254 1.294 0 C-N-CA 126.443 1.897 . . . . 0.0 112.163 -175.36 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.137 0 O4'-C1'-N19 111.77 3.57 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.217 0 O4'-C1'-N19 111.222 3.022 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.192 0 C5'-C4'-C3' 110.455 -3.363 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.378 0 O4'-C1'-N19 111.13 2.93 . 0.188 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.419 0 O4'-C1'-N19 111.267 3.067 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.343 0 O4'-C1'-N19 110.877 2.677 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.9 t 69.45 177.83 0.26 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.085 1.754 . . . . 0.0 113.52 -177.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 87.7 p -164.89 172.99 12.16 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.346 1.859 . . . . 0.0 111.449 -176.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.37 -101.37 0.89 Allowed Glycine 0 N--CA 1.471 0.968 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.6 m -73.35 -20.01 60.88 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.4 0.68 . . . . 0.0 112.195 168.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.8 m 63.59 20.63 12.34 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.466 1.907 . . . . 0.0 115.146 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.3 136.58 20.55 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.25 0.929 . . . . 0.0 111.669 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -118.15 80.79 1.57 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.226 1.41 . . . . 0.0 109.374 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 56.5 mtt85 55.01 35.44 24.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.399 1.879 . . . . 0.0 112.32 -172.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.59 145.62 24.55 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.303 2.241 . . . . 0.0 109.327 -171.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 46.02 65.72 6.32 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 125.057 1.343 . . . . 0.0 113.236 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.17 179.4 6.56 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.977 3.118 . . . . 0.0 111.739 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -146.96 142.37 16.99 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.908 1.683 . . . . 0.0 109.64 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -51.52 142.44 39.2 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.119 3.213 . . . . 0.0 115.228 -174.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -154.64 139.8 17.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.46 1.504 . . . . 0.0 109.991 -172.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 87.7 m -58.62 -28.17 65.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.252 1.021 . . . . 0.0 112.532 171.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.1 t -88.94 129.69 35.58 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.398 1.079 . . . . 0.0 110.786 171.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.1 mt -118.67 146.54 44.62 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.488 1.915 . . . . 0.0 110.379 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.06 149.25 18.7 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.723 1.63 . . . . 0.0 110.955 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.47 128.46 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.505 1.922 . . . . 0.0 107.838 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -136.88 150.81 48.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.156 0.982 . . . . 0.0 112.175 -167.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.15 30.18 23.4 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 123.972 0.796 . . . . 0.0 113.383 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.09 162.87 23.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 113.349 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 t -81.81 157.8 24.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.694 0.798 . . . . 0.0 112.216 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.83 -19.91 62.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.402 0.681 . . . . 0.0 112.083 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.56 -6.38 54.77 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.447 1.499 . . . . 0.0 114.364 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.7 m -69.02 134.56 49.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.727 1.211 . . . . 0.0 109.482 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 p -108.22 162.66 13.87 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.289 1.036 . . . . 0.0 111.348 173.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -61.12 -28.65 69.25 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.075 0.55 . . . . 0.0 111.132 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -70.43 -36.73 74.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 112.53 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -67.22 -49.49 64.31 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.605 0.639 . . . . 0.0 110.289 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.54 -43.62 80.08 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.806 -0.559 . . . . 0.0 110.901 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -57.22 -50.33 73.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.657 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.11 -29.9 68.94 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.593 1.088 . . . . 0.0 113.074 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.82 -27.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.479 1.112 . . . . 0.0 112.015 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -100.51 -24.15 14.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.055 0.942 . . . . 0.0 113.488 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.3 p -69.82 -17.19 63.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.362 1.437 . . . . 0.0 113.868 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -66.86 -12.81 60.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -98.68 -8.28 26.44 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.287 1.435 . . . . 0.0 113.751 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.52 -175.55 26.81 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.982 1.277 . . . . 0.0 115.004 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.14 137.21 21.12 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 124.413 3.409 . . . . 0.0 112.248 -170.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.5 mt -128.62 131.35 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.977 1.711 . . . . 0.0 110.016 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.03 -25.18 15.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.065 1.346 . . . . 0.0 113.439 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.11 164.19 25.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.5 t -148.49 134.44 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.175 2.19 . . . . 0.0 108.056 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 70.9 m -132.83 110.6 10.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.36 1.064 . . . . 0.0 111.351 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.41 139.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t -90.3 108.33 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -99.51 143.86 29.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.908 1.283 . . . . 0.0 111.933 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.57 141.89 55.34 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.86 0.864 . . . . 0.0 112.641 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -69.0 -21.6 64.13 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.411 1.084 . . . . 0.0 113.768 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -124.91 -39.22 2.28 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.046 0.939 . . . . 0.0 112.33 -172.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 71.1 m -81.69 -16.59 50.79 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 173.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 78.2 mtm-85 56.41 36.67 27.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.984 1.714 . . . . 0.0 113.158 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -134.18 156.71 47.86 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.363 2.665 . . . . 0.0 109.38 -174.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.6 t -59.63 135.05 57.56 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.057 0.455 . . . . 0.0 111.117 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -81.23 2.14 29.16 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.157 0.983 . . . . 0.0 112.869 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.74 17.8 57.59 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.415 1.007 . . . . 0.0 113.95 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.405 ' CD1' " H4'" ' B' ' 4' ' ' ' G' . 53.7 p90 -153.47 162.55 41.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 122.615 1.198 . . . . 0.0 113.318 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.65 173.59 16.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.251 1.82 . . . . 0.0 111.875 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -141.17 152.4 44.63 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.784 1.633 . . . . 0.0 110.485 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 67.1 t -137.74 132.61 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.176 1.79 . . . . 0.0 108.955 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -115.89 101.67 8.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 111.509 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -78.73 160.08 27.62 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.918 0.887 . . . . 0.0 111.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -91.29 6.68 44.29 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.118 0.967 . . . . 0.0 113.017 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -158.23 134.73 9.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.398 1.479 . . . . 0.0 111.57 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.63 -29.39 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.91 0.884 . . . . 0.0 112.672 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.91 -27.37 49.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.468 1.031 . . . . 0.0 112.989 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.45 -29.2 52.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.675 0.79 . . . . 0.0 111.786 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.41 -39.5 74.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.259 0.624 . . . . 0.0 111.65 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.29 -39.1 85.71 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.112 -0.993 . . . . 0.0 111.962 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -62.91 -61.94 2.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.794 0.838 . . . . 0.0 110.079 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.21 -39.27 69.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -61.58 -39.18 90.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.856 0.863 . . . . 0.0 112.466 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -82.66 -25.36 33.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.276 0.63 . . . . 0.0 112.417 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -76.12 -51.84 11.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.534 1.134 . . . . 0.0 112.792 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.13 -14.19 39.36 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.1 112.6 3.45 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.521 -1.362 . . . . 0.0 111.068 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.22 8.4 68.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.47 1.509 . . . . 0.0 114.609 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.8 ptm -75.68 174.72 9.41 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.739 1.769 . . . . 0.0 111.465 169.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -120.12 135.32 55.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.248 1.019 . . . . 0.0 111.494 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.4 tp -145.46 120.58 10.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.966 1.706 . . . . 0.0 109.276 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 56.53 27.47 12.36 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.424 1.489 . . . . 0.0 112.573 -169.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.58 84.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.727 1.156 . . . . 0.0 114.274 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.82 130.36 44.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.855 1.328 . . . . 0.0 109.622 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.26 130.92 42.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 122.09 -0.381 . . . . 0.0 110.171 171.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.0 pt -110.84 143.99 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.566 0.746 . . . . 0.0 111.389 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -102.35 144.41 30.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.694 1.598 . . . . 0.0 108.634 172.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.8 t -141.62 134.92 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.566 1.147 . . . . 0.0 109.911 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -156.31 158.2 37.04 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.925 1.29 . . . . 0.0 111.731 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.43 140.64 54.13 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.578 -0.701 . . . . 0.0 110.98 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.5 m -73.66 126.5 30.46 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.411 -0.806 . . . . 0.0 112.261 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 12.0 pt -86.07 -14.8 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.368 1.067 . . . . 0.0 112.762 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 15.7 p -159.21 165.02 34.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 129.98 3.312 . . . . 0.0 108.701 -172.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -152.05 159.95 43.57 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -75.57 -45.6 4.27 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.63 174.74 10.81 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.79 2.993 . . . . 0.0 111.039 175.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -135.29 141.38 45.67 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.656 1.182 . . . . 0.0 112.231 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 C--O 1.253 1.239 0 C-N-CA 126.291 1.836 . . . . 0.0 112.16 -169.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.279 1 O4'-C1'-N19 112.78 4.58 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 1 O4'-C1'-N19 112.729 4.529 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.187 0 C5'-C4'-C3' 111.407 -2.729 . 0.06 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.405 " H4'" ' CD1' ' A' ' 161' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.765 0 O4'-C4'-C3' 108.791 2.351 . 0.134 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 O4'-C1'-N19 111.058 2.858 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.095 0 O4'-C1'-N19 111.327 3.127 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.2 p -163.37 172.55 14.43 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.693 1.597 . . . . 0.0 111.388 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 89.4 p -160.68 174.06 14.53 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.756 1.222 . . . . 0.0 112.228 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.67 -111.07 3.26 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.119 0.866 . . . . 0.0 111.854 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.6 m -61.75 -11.55 12.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.905 1.682 . . . . 0.0 114.839 -175.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.1 m -68.77 -6.22 25.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.954 1.302 . . . . 0.0 114.024 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.01 49.92 4.57 Favored Glycine 0 N--CA 1.47 0.929 0 C-N-CA 124.753 1.168 . . . . 0.0 111.207 -175.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -73.49 -7.2 50.79 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -169.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 53.26 41.4 32.14 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.149 1.78 . . . . 0.0 112.68 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -136.1 146.32 46.86 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.805 1.642 . . . . 0.0 111.181 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 p30 32.8 57.94 1.42 Allowed Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 126.38 1.872 . . . . 0.0 115.993 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.89 151.41 68.31 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.768 2.979 . . . . 0.0 112.107 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -85.24 154.62 60.16 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.522 1.129 . . . . 0.0 111.773 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.44 145.26 37.49 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.184 3.256 . . . . 0.0 113.877 174.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -155.08 141.6 18.79 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.188 1.395 . . . . 0.0 110.432 -173.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 81.8 m -58.86 -28.93 66.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.616 1.166 . . . . 0.0 112.374 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.4 t -89.89 130.81 36.07 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.381 1.072 . . . . 0.0 110.755 171.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.8 mt -118.39 148.07 42.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.579 1.952 . . . . 0.0 110.593 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.1 149.61 18.0 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.132 1.825 . . . . 0.0 111.461 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.63 128.78 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.786 2.034 . . . . 0.0 108.027 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -136.05 145.42 45.99 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.304 1.042 . . . . 0.0 111.635 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.35 29.06 9.83 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 124.343 0.973 . . . . 0.0 114.014 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.6 mt -83.65 156.51 22.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.008 1.323 . . . . 0.0 112.874 -173.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 t -79.71 152.69 29.75 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 171.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.84 -18.86 65.59 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.481 -0.762 . . . . 0.0 112.232 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.81 -6.88 57.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.374 1.47 . . . . 0.0 114.358 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 m -74.98 130.98 40.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.3 p -104.5 165.51 11.01 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.377 1.071 . . . . 0.0 111.567 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -60.64 -29.12 69.07 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.016 0.526 . . . . 0.0 111.2 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.25 -37.87 71.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.471 1.108 . . . . 0.0 112.422 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -65.87 -48.7 70.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.563 0.619 . . . . 0.0 110.284 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.5 mt -55.64 -43.66 76.4 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.912 -0.493 . . . . 0.0 110.865 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -62.42 -43.24 99.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.871 0.759 . . . . 0.0 112.366 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.3 -29.96 67.94 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.067 1.303 . . . . 0.0 112.633 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.27 -29.92 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.398 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -100.29 -24.86 14.43 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.3 p -70.97 -11.47 60.98 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.228 1.377 . . . . 0.0 114.097 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -66.61 -15.87 63.77 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.987 -1.071 . . . . 0.0 113.608 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -95.59 -14.84 23.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.85 1.26 . . . . 0.0 113.645 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.77 -177.89 33.48 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 124.878 1.227 . . . . 0.0 114.687 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.67 136.83 21.69 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 124.33 3.353 . . . . 0.0 111.931 -172.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.31 125.87 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.72 1.608 . . . . 0.0 109.755 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.65 -27.01 21.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.919 1.288 . . . . 0.0 113.176 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.08 166.19 23.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.82 137.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.972 2.109 . . . . 0.0 107.883 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -138.29 106.42 5.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.131 0.973 . . . . 0.0 111.053 -172.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.7 146.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.344 -0.847 . . . . 0.0 108.969 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.5 t -94.98 123.61 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -114.24 151.02 33.47 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.65 1.18 . . . . 0.0 112.169 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.31 148.76 43.21 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.607 0.763 . . . . 0.0 112.748 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -74.18 -21.02 60.01 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -125.41 -40.89 2.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.118 0.967 . . . . 0.0 112.701 -170.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 90.8 p -86.19 -17.03 35.93 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.394 0.997 . . . . 0.0 113.289 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.4 mtm-85 63.86 9.01 4.19 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.154 1.782 . . . . 0.0 114.686 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -88.87 166.31 14.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.212 1.405 . . . . 0.0 111.295 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.2 t -58.64 140.89 53.87 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.857 0.36 . . . . 0.0 110.088 169.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -85.04 2.76 41.81 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.322 1.049 . . . . 0.0 113.074 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.43 16.8 61.58 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.231 0.92 . . . . 0.0 113.785 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -150.2 159.5 44.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.601 1.191 . . . . 0.0 112.9 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.6 175.42 13.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.148 1.779 . . . . 0.0 111.568 -168.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -142.81 154.99 44.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.48 1.512 . . . . 0.0 110.6 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -138.42 131.65 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.213 1.805 . . . . 0.0 109.194 -168.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -114.4 96.73 5.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 0.0 111.463 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.81 158.41 32.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 111.7 173.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.36 0.67 53.47 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -157.13 157.46 34.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.176 1.39 . . . . 0.0 112.224 173.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.21 -26.16 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.62 -33.15 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.507 1.049 . . . . 0.0 112.874 -170.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -75.76 -23.59 55.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.562 0.745 . . . . 0.0 112.063 169.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.42 62.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.362 0.665 . . . . 0.0 111.233 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -60.03 -37.76 80.72 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.292 1.037 . . . . 0.0 111.975 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.76 -63.34 1.24 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.005 0.922 . . . . 0.0 110.195 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.98 69.75 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -60.49 -38.05 83.05 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.889 0.875 . . . . 0.0 112.464 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -83.54 -26.43 30.12 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.57 0.748 . . . . 0.0 112.128 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -76.09 -46.37 29.34 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.432 1.093 . . . . 0.0 112.973 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -91.9 -15.22 28.4 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -64.46 112.28 3.05 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.745 -1.222 . . . . 0.0 110.717 172.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.23 7.26 70.13 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.34 1.448 . . . . 0.0 114.796 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.3 ptm -74.91 172.13 12.8 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.889 1.845 . . . . 0.0 111.449 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -116.49 134.1 55.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.342 1.057 . . . . 0.0 111.242 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.2 tp -145.79 119.37 9.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.78 1.632 . . . . 0.0 109.286 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.5 t70 56.94 27.69 13.53 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.529 1.532 . . . . 0.0 112.468 -169.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.43 -2.49 82.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.737 1.16 . . . . 0.0 114.175 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.81 128.16 42.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.814 1.307 . . . . 0.0 109.694 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.76 127.93 34.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.853 170.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.9 pt -108.66 154.24 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.03 0.832 . . . . 0.0 112.327 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -110.78 146.78 35.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.885 1.674 . . . . 0.0 108.697 172.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.91 139.16 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.557 1.143 . . . . 0.0 110.674 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -155.52 164.49 38.61 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.223 1.409 . . . . 0.0 112.387 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -79.74 142.81 35.09 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.199 -0.938 . . . . 0.0 111.517 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 49.9 m -75.76 134.31 40.5 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.126 -0.984 . . . . 0.0 113.592 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.6 pt -93.42 -14.2 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.696 1.198 . . . . 0.0 113.432 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 18.4 p -157.73 166.85 31.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 129.635 3.174 . . . . 0.0 108.586 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -152.7 165.8 34.16 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -73.03 -47.41 8.16 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.86 152.91 19.4 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.448 2.765 . . . . 0.0 111.288 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -84.0 145.4 28.54 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.008 0.923 . . . . 0.0 113.364 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 38.0 m . . . . . 0 C--O 1.252 1.234 0 C-N-CA 126.518 1.927 . . . . 0.0 110.639 177.727 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 1 O4'-C1'-N19 112.237 4.037 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.153 0 O4'-C1'-N19 111.332 3.132 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.513 0 O3'-P-O5' 99.778 -2.222 . 0.621 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 C5'-C4'-C3' 111.822 -2.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.652 0 C5'-C4'-C3' 111.399 -2.734 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.257 0 C5'-C4'-C3' 110.038 -3.642 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 m -146.0 147.34 31.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.834 1.254 . . . . 0.0 111.412 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.9 p -86.45 -3.98 59.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.642 1.177 . . . . 0.0 114.17 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.35 -170.72 20.53 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.906 1.717 . . . . 0.0 113.249 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.9 m 70.52 6.12 5.68 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.224 1.809 . . . . 0.0 114.647 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.8 t -163.93 158.93 20.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.118 1.767 . . . . 0.0 110.913 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.86 151.74 32.4 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.43 1.014 . . . . 0.0 113.011 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -159.82 130.22 5.62 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.9 1.28 . . . . 0.0 111.158 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -92.95 -6.64 48.04 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.885 1.274 . . . . 0.0 114.213 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.0 136.55 36.63 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.612 0.765 . . . . 0.0 111.268 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m120 35.76 57.87 2.88 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 126.51 1.924 . . . . 0.0 114.935 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.01 159.57 51.38 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.758 2.305 . . . . 0.0 112.573 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -67.29 145.07 98.48 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.375 0.67 . . . . 0.0 111.68 171.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -53.1 146.61 37.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.144 3.23 . . . . 0.0 114.39 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -155.18 139.03 16.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.383 1.473 . . . . 0.0 110.205 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 66.0 m -55.81 -30.65 61.72 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.944 1.297 . . . . 0.0 112.638 170.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.0 t -86.28 128.23 34.89 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.318 1.047 . . . . 0.0 110.73 171.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.59 145.44 45.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.423 1.889 . . . . 0.0 110.27 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 148.2 18.56 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.804 1.669 . . . . 0.0 110.589 168.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.77 132.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.713 2.005 . . . . 0.0 108.034 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -137.91 152.15 48.72 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.444 1.098 . . . . 0.0 111.958 -167.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.08 29.15 26.36 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.172 0.891 . . . . 0.0 113.759 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.89 159.07 29.14 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.278 1.431 . . . . 0.0 113.596 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.0 t -72.83 155.41 39.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.613 0.721 . . . . 0.0 111.878 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -70.97 -12.46 61.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.793 0.837 . . . . 0.0 112.723 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -103.86 -4.68 23.21 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.478 1.911 . . . . 0.0 114.615 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.4 m -62.61 134.95 57.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.41 1.084 . . . . 0.0 110.058 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 p -108.25 162.18 14.31 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.26 1.024 . . . . 0.0 111.667 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.57 -26.68 68.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.298 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.37 -36.19 66.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.161 0.984 . . . . 0.0 112.203 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.51 -50.61 68.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.748 0.704 . . . . 0.0 110.289 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.8 mt -60.15 -40.05 88.49 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.537 -0.727 . . . . 0.0 111.15 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.89 -47.44 84.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.141 0.882 . . . . 0.0 111.775 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.31 -32.59 72.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.82 1.191 . . . . 0.0 112.478 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.07 -29.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.438 1.095 . . . . 0.0 112.463 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.47 -22.97 14.84 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -68.03 -17.06 64.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.281 1.401 . . . . 0.0 113.631 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -68.08 -13.86 62.53 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.868 -1.145 . . . . 0.0 113.72 172.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -96.22 -10.82 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.93 1.292 . . . . 0.0 113.747 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.14 -173.95 28.0 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.968 1.271 . . . . 0.0 114.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.64 138.03 21.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.427 3.418 . . . . 0.0 112.147 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.5 mt -130.9 130.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.897 1.679 . . . . 0.0 109.891 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.02 -23.7 16.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.896 1.278 . . . . 0.0 113.468 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.67 162.5 29.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.83 0.852 . . . . 0.0 112.97 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.93 134.16 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.047 2.139 . . . . 0.0 107.399 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.3 t -137.08 111.18 8.34 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.529 0.732 . . . . 0.0 110.804 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 75.3 mt -84.82 138.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t -89.24 118.9 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -107.85 142.74 37.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.454 1.102 . . . . 0.0 112.545 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.54 140.52 58.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.835 1.254 . . . . 0.0 111.443 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -71.25 -20.19 62.26 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -173.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -117.57 -44.53 2.75 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.369 1.068 . . . . 0.0 112.043 -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 61.7 m -86.63 -17.98 32.48 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 62.42 14.38 6.87 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.222 1.809 . . . . 0.0 114.585 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -88.67 166.5 14.05 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.794 2.038 . . . . 0.0 110.132 169.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.0 t -58.44 137.26 57.44 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.108 170.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -73.73 -1.71 20.3 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.629 0.771 . . . . 0.0 112.515 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.57 6.3 59.73 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.857 1.694 . . . . 0.0 113.583 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -147.38 159.75 43.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.934 1.35 . . . . 0.0 113.971 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.54 174.77 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.446 1.898 . . . . 0.0 111.368 -169.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -143.09 153.09 42.56 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.567 1.547 . . . . 0.0 110.667 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.7 129.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.96 1.704 . . . . 0.0 108.993 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -114.15 97.94 6.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.709 1.204 . . . . 0.0 111.2 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -75.81 160.66 29.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.822 0.849 . . . . 0.0 111.807 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -92.13 7.01 44.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.154 0.982 . . . . 0.0 112.969 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.06 134.32 9.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.362 1.465 . . . . 0.0 111.483 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.91 -29.48 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 112.711 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.27 -27.26 47.42 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 0.977 . . . . 0.0 113.136 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -77.77 -28.27 50.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.63 0.772 . . . . 0.0 111.726 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.06 -39.5 72.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.209 0.604 . . . . 0.0 111.464 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -60.59 -37.51 81.57 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.055 -1.028 . . . . 0.0 112.156 172.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.85 -62.51 1.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.895 0.878 . . . . 0.0 109.976 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.98 -38.59 70.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -61.7 -35.36 77.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.969 0.907 . . . . 0.0 112.487 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -86.29 -25.43 25.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.453 0.701 . . . . 0.0 112.299 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -76.35 -47.94 21.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.597 1.159 . . . . 0.0 112.972 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.63 -12.09 30.19 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -66.67 110.9 3.4 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.626 -1.296 . . . . 0.0 111.041 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.13 6.84 68.59 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.84 1.686 . . . . 0.0 114.61 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.3 ptm -74.52 168.22 20.17 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.793 1.796 . . . . 0.0 111.453 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -111.8 133.87 53.73 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.054 0.942 . . . . 0.0 111.15 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.3 tp -141.72 116.58 9.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.001 1.72 . . . . 0.0 109.153 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.17 32.27 15.6 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.22 1.408 . . . . 0.0 112.569 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.68 -1.49 82.84 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.953 -1.092 . . . . 0.0 114.756 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -96.27 133.41 40.64 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.875 1.338 . . . . 0.0 110.114 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -73.35 127.29 32.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.181 0.9 . . . . 0.0 109.146 169.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 pt -103.64 155.9 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.737 0.815 . . . . 0.0 110.586 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -122.64 155.16 36.94 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.939 1.295 . . . . 0.0 109.587 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 36.5 t -144.0 139.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.763 1.225 . . . . 0.0 110.585 -169.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -155.05 158.12 38.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.253 1.421 . . . . 0.0 111.94 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -72.68 138.32 46.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.0 m -74.45 131.23 40.87 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.311 -0.868 . . . . 0.0 113.192 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 21.2 pt -90.89 -15.1 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.643 1.177 . . . . 0.0 113.167 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.8 p -156.84 161.2 39.72 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 129.657 3.183 . . . . 0.0 108.366 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.65 155.14 31.27 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 52.5 tpt85 -69.4 -43.93 24.58 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.27 145.52 10.87 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.366 2.711 . . . . 0.0 110.711 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -161.09 151.54 17.9 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.53 1.132 . . . . 0.0 112.886 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--O 1.252 1.187 0 C-N-CA 126.488 1.915 . . . . 0.0 112.086 -176.264 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.467 1 O4'-C1'-N19 112.392 4.192 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.46 " H2'" " H2'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.427 -2.186 0 O4'-C1'-N19 111.495 3.295 . 0.089 5n . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.46 " H2'" " H2'" ' B' ' 2' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.54 2.292 0 O4'-C1'-N19 111.351 3.151 . 0.438 1z . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 O5'-C5'-C4' 114.918 3.37 . 0.01 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.64 0 C4'-C3'-C2' 99.921 -2.779 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.129 0 O4'-C1'-N19 111.576 3.376 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.6 p -162.36 164.22 27.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.154 1.382 . . . . 0.0 111.602 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 t -93.03 2.14 56.93 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.186 -0.946 . . . . 0.0 113.369 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -158.91 47.0 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.824 1.202 . . . . 0.0 113.074 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.1 m 71.24 -43.74 0.57 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 128.102 2.561 . . . . 0.0 114.999 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.1 m -85.89 -21.14 28.14 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.058 -1.026 . . . . 0.0 113.425 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.24 147.42 5.59 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.541 1.543 . . . . 0.0 113.842 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -165.18 148.01 8.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.446 1.898 . . . . 0.0 111.007 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.02 51.13 2.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.936 0.894 . . . . 0.0 113.07 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.27 26.25 2.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.934 1.694 . . . . 0.0 112.616 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -162.59 59.97 0.98 Allowed Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 128.452 2.701 . . . . 0.0 112.298 -170.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.46 168.82 19.44 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.64 2.893 . . . . 0.0 112.06 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -163.19 143.16 6.95 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.854 2.062 . . . . 0.0 109.277 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -44.56 131.03 9.62 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 124.521 3.481 . . . . 0.0 115.336 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -153.12 137.83 16.97 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.76 1.624 . . . . 0.0 109.712 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 59.6 m -55.9 -29.73 60.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.562 1.145 . . . . 0.0 112.513 171.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.1 t -88.86 129.13 35.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.523 1.129 . . . . 0.0 110.886 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -119.85 147.18 44.99 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.731 2.013 . . . . 0.0 110.482 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.4 150.84 17.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.993 1.758 . . . . 0.0 111.086 168.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.43 131.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.558 1.943 . . . . 0.0 108.105 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.46 151.8 47.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.404 1.082 . . . . 0.0 111.959 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.87 30.01 33.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.103 0.858 . . . . 0.0 113.422 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -80.29 159.23 25.91 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.408 1.483 . . . . 0.0 112.68 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 t -77.94 151.35 33.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.011 0.524 . . . . 0.0 111.737 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -16.05 63.68 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -96.98 0.84 49.5 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.974 1.709 . . . . 0.0 114.106 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.1 m -65.14 142.8 58.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.943 1.297 . . . . 0.0 109.829 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.3 p -119.87 161.11 21.39 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.901 0.88 . . . . 0.0 110.865 169.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -59.15 -24.96 63.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.828 0.851 . . . . 0.0 111.621 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -58.61 -44.44 89.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.113 1.765 . . . . 0.0 111.861 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -71.17 -45.96 62.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.021 0.928 . . . . 0.0 110.322 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.4 mt -59.42 -44.33 92.91 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.776 -0.578 . . . . 0.0 110.79 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -58.5 -47.59 83.61 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.864 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.68 -29.38 69.38 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.763 1.165 . . . . 0.0 113.163 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.6 t -79.22 -30.08 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.405 1.082 . . . . 0.0 112.371 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -100.57 -26.63 13.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.4 p -70.09 -20.07 63.22 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.357 1.435 . . . . 0.0 113.885 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.27 -11.97 58.91 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -104.11 -6.44 21.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.089 1.355 . . . . 0.0 114.329 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.13 -175.31 32.41 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.85 138.73 19.01 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.59 3.526 . . . . 0.0 111.986 -171.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.14 133.33 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.85 1.66 . . . . 0.0 110.503 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.06 -22.69 14.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.254 1.421 . . . . 0.0 113.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -160.87 159.26 29.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.006 0.922 . . . . 0.0 112.696 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.1 t -152.86 132.7 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.621 2.368 . . . . 0.0 107.536 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -148.53 123.32 9.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.315 0.646 . . . . 0.0 112.234 -171.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.27 144.0 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.963 0.905 . . . . 0.0 108.681 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 t -92.01 128.4 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -115.61 140.58 49.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.105 1.362 . . . . 0.0 112.047 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.17 140.14 58.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.855 1.262 . . . . 0.0 111.683 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -72.1 -21.01 61.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -118.26 -38.15 3.23 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.407 1.083 . . . . 0.0 112.353 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.2 m -88.97 -12.13 42.38 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.993 0.917 . . . . 0.0 113.377 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 55.65 33.18 20.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.264 1.826 . . . . 0.0 114.237 170.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -133.46 163.47 29.29 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.051 2.54 . . . . 0.0 110.584 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.5 t -54.09 135.3 43.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.198 0.599 . . . . 0.0 112.014 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -77.99 -0.79 29.14 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.927 0.891 . . . . 0.0 112.708 174.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.92 10.86 64.2 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.291 1.424 . . . . 0.0 113.859 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -149.53 161.18 42.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.65 1.214 . . . . 0.0 113.786 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.68 173.79 15.54 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 111.963 -168.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.39 155.21 44.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.686 1.594 . . . . 0.0 111.47 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 88.6 t -140.93 134.15 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.659 1.984 . . . . 0.0 108.838 -169.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.29 101.88 8.3 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.087 1.355 . . . . 0.0 111.39 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.65 162.5 27.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.907 172.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -91.75 6.74 44.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.257 1.023 . . . . 0.0 112.981 171.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -159.24 137.77 10.76 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.638 1.575 . . . . 0.0 111.596 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.07 -35.88 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.637 . . . . 0.0 112.645 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.71 -27.49 62.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.215 0.916 . . . . 0.0 112.596 -174.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -77.4 -36.07 53.71 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.976 0.91 . . . . 0.0 111.885 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.87 90.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.258 0.623 . . . . 0.0 111.298 169.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -65.37 -27.15 68.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.956 1.702 . . . . 0.0 112.793 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.99 -61.48 1.83 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.276 1.031 . . . . 0.0 109.431 168.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.15 67.79 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -58.45 -33.54 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.671 1.188 . . . . 0.0 112.842 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -88.92 -18.74 26.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.927 0.891 . . . . 0.0 112.461 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -84.64 -43.93 13.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.713 1.205 . . . . 0.0 112.948 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.87 -12.4 29.01 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -64.39 116.58 6.22 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.602 -1.311 . . . . 0.0 111.061 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.18 5.52 76.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.599 1.571 . . . . 0.0 114.872 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.2 ptm -76.24 163.1 27.38 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.656 1.728 . . . . 0.0 112.595 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -83.9 128.52 34.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.57 1.148 . . . . 0.0 110.189 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.9 tp -150.45 123.13 8.59 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.927 1.291 . . . . 0.0 110.175 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 55.02 31.51 16.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.541 1.536 . . . . 0.0 113.04 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.88 4.0 85.16 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.389 1.471 . . . . 0.0 114.69 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -116.96 153.36 32.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.619 1.568 . . . . 0.0 111.271 -175.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -87.9 121.62 30.54 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.6 pt -99.58 155.14 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.014 0.526 . . . . 0.0 112.044 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -112.75 144.7 41.82 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.943 1.697 . . . . 0.0 108.662 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.4 t -141.61 134.67 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.552 1.141 . . . . 0.0 109.796 -172.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -156.69 159.75 38.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.661 1.184 . . . . 0.0 112.225 -169.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.05 138.84 50.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.521 0.728 . . . . 0.0 111.281 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 67.2 m -70.62 125.79 27.8 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.494 -0.754 . . . . 0.0 112.105 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.2 pt -84.81 -16.15 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.063 0.945 . . . . 0.0 112.874 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.8 p -157.77 166.17 33.45 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 129.797 3.239 . . . . 0.0 108.397 -171.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -152.18 159.91 43.49 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -68.13 -44.38 38.07 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.78 164.81 29.6 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.205 2.603 . . . . 0.0 111.307 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -78.42 -3.61 44.17 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 128.666 2.786 . . . . 0.0 112.066 -177.43 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.4 0 O4'-C1'-N19 112.037 3.837 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.159 1 O4'-C1'-N19 113.198 4.998 . 0.147 1c . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.497 0 O5'-C5'-C4' 114.383 2.988 . 0.264 1z . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C5'-C4'-C3' 111.562 -2.626 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.346 0 O4'-C1'-N19 111.489 3.289 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.129 0 O4'-C1'-N19 111.547 3.347 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_